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Genital chlamydia is the most commonly diagnosed sexually transmitted infection. In 
August 2008, the Scottish government directed its health boards to involve 
community pharmacies in providing chlamydia testing and treatment for young 
people. Lothian Health Board envisaged a pharmacy-based chlamydia testing and 
treatment (CT&T) service to be able to reach deprived population. This research 
project set out to evaluate the implementation of the CT&T in Lothian, Scotland. 
However, the Lothian CT&T service suffered from setbacks such as; implementation 
delays, minimal advertising of the service, low uptake, withdrawal by central 
government of specific funding to support the service costs, and subsequent 
termination of the service in Lothian by March 2011. As it turned out, the CT&T 
service ran in Lothian for only 10 months. As events unfolded, the aims of the PhD 
research were successively revised so as to undertake an integrated set of studies that 
provide important insights and generalizable knowledge about the rationale for such 
a service, the process of implementation, including barriers and facilitators, and the 
potential to utilise routine data to assess the impact of a new service. An additional 
component was added, in that I undertook an analysis of an anonymous routine data 
on chlamydia testing obtained from the microbiology reference laboratory of Lothian 
to describe the epidemiology of chlamydia in Lothian (2006-2010) and to report an 
impact of recent policy changes (2008-2009) on chlamydia surveillance activity.  
Methods  
The Centre for Disease Control (CDC) framework for programme evaluation was 
used to guide design the evaluation of the CT&T service, and a subset of ‘strategic’ 
stakeholders for the service was involved throughout. Four studies were undertaken 
towards the evaluation, and these employed diverse methods, as follows: (i) A 
training need survey of pharmacists and their support staff was undertaken in 166 
community pharmacies in Lothian, to inform the training session held prior to the 
CT&T service launch. (ii) A survey of 33 strategic stakeholders in Lothian was 
undertaken to provide input to the evaluation objectives and to identify their 
perceptions and concerns in relation to the CT&T initiative and its evaluation. (iii) A 
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survey of potential service users, young people aged 15-24 years, was carried out at 
the Genito-Urinary Medicine (GUM) clinic and two other sexual health drop-in 
clinics in Lothian. The survey ascertain their preferences regarding specific aspects 
of the CT&T service, and their views on issues identified in previous literature as 
facilitators or barriers with regard to utilising of such a service. (iv) In order to 
understand the service provider’s perspective on setting up and delivering of the 
CT&T service, in-depth interviews were undertaken with participating and non-
participating pharmacists. Eleven pharmacists were purposively sampled from 66 
pharmacies invited by NHS Lothian to pilot the service roll-out.   
Finally, after the Lothian CT&T service had been terminated, 3 strategic stakeholders 
for Lothian, and a Scottish Government representative were contacted by email, to 
elicit their views on factors contributing to policy decisions regarding pharmacy-
based CT&T services.  
Results 
The analysis of disaggregated (individual) routine laboratory data showed that age, 
gender, year of testing and deprivation were associated with the chlamydia testing 
outcome measures. The before-and-after analysis, with respect to recent major 
policy/guidance changes (that is, publication of the sexual health service standards 
for Scotland in 2008, and of SIGN guidelines for chlamydia in 2009), showed that 
surveillance activity for chlamydia increased only transiently (i.e. in 2009 only). The 
annual surveillance target for women aged 15-24 years, of 300 tests / 1000 
population, was achieved in 2009 only, but targets for males aged 15-24 years (of 
100 tests / 1000 population) were not achieved.  
With respect to the evaluation studies, the training needs survey (i) had a 53% 
pharmacy response rate from the pharmacies comprised 41% pharmacists, 32% 
technicians and 26% counter assistants. The survey showed differences in self-
assessed training needs between pharmacy staff groups (pharmacists/ technicians/ 
counter staff). With regard to pharmacist-only competencies, the highest rates of 
substantial training needs were for clarity regarding the medico-legal aspects (Fraser 
guidelines), taking a sexual history, criteria for referral and reviewing own and staff 
competencies for the CT&T service (83% to 77%). With respect to all staff 
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competencies, the greatest self-reported training need was for inter-communicative 
aspects of providing the service – for respondents overall, 56% to 83% across 
competencies within this domain.  
For the stakeholder survey (ii), the response rate was 52% (n=17). Sixteen 
stakeholders indicated their strong or moderate concern regarding young peoples’ 
knowledge about the service. The stakeholders also acknowledged the difficulty 
inherent in promoting the service to those who might benefit from using it. A view 
commonly expressed by respondents was that sexual health counselling concomitant 
with testing would be difficult to deliver through the CT&T service, due to: the 
difficulty in achieving privacy; a busy retail environment; and pharmacists tending 
not to have the necessary skills. However, they also acknowledged that chlamydia 
service delivery is problematic everywhere and not just in pharmacies. The key 
benefits of the service suggested for young people included increase accessibility, 
normalization of chlamydia testing and its ability of provision of sexual health 
service to hard-to-reach population. Such a service was perceived to enhance the role 
of pharmacist in public health provision. The survey also sought input of strategic 
stakeholders to ensure that the evaluation questions of most importance to them were 
included. All the proposed evaluation questions were marked as important. Some 
suggested questions such as client’s satisfaction with the service or related to the 
service logistical planning could not be incorporated in the later components of the 
intended evaluation as the service uptake was too low to answer those questions.  
The survey of potential service users (iii) had an overall response rate of 20% (n=78). 
Young people who responded indicated that they felt confident that a pharmacy 
would offer complete confidentiality for testing, provide reliable test results and have 
knowledgeable staff to provide the service (90% to 93%). That said, these 
respondents indicated a preference to be tested in GUM clinic (32%) or drop-in 
clinics (34%), with only 11% indicating a preference for being tested in a pharmacy. 
Those who had not previously been tested for chlamydia placed more importance on 
a toilet facility in a pharmacy they would chose for chlamydia testing, whereas 
younger respondents (≤ 19 years) placed more importance on a less busy pharmacy.  
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Analysis of in-depth interviews with pharmacists (iv) comprising interviews with 11 
lead pharmacists (4 respondents from pilot pharmacies and 7 from non-pilot 
pharmacies) found that pharmacists were enthusiastic about their newly developed 
public health role. The respondents foresee a shift to pharmacies for being a first port 
of call for clients. They were also generally positive about the anticipated attitude of 
general practitioners and pharmacy support staff towards their provision of 
chlamydia service. From a pharmacist’s perspective, barriers to delivering the CT&T 
service were identified as workload and lack of adequate physical infrastructure 
within a pharmacy such as a consultation room and a toilet facility. On the other 
hand, the assurance of financial incentives for providing the service was a facilitator. 
Given the poor uptake of service, the pilot service interviewees did not have enough 
experience of service delivery to reflect on different aspects of the service. The key 
explanation proposed by pharmacists for the low uptake of the service was 
inadequate advertising, and it was felt that the service had been withdrawn too soon 
to judge its effect. This study also revealed that miscommunication between Lothian 
Health Board and pharmacies had been a common reason why many invited 
pharmacies did not take part in the pilot service. 
Conclusion 
The Lothian CT&T service had been designed to improve access to chlamydia 
services for young people living in deprived areas in Lothian, which generally are 
more geographically distant from existing (non-GP) chlamydia services that are 
available in Lothian. The enthusiasm found among pharmacists to deliver the CT&T 
service, and the acceptability to potential service users of the various characteristics 
of the service, suggests that as part of a multi-faceted approach to chlamydia service, 
a pharmacy-based testing and treatment would be a useful additional choice for 
young people to such a service.  
Despite this, the uptake of the service was very low. It is possible that this is due to 
the virtual absence of advertising for the service. Furthermore, the service was short 
lived, being cancelled after 10 months. Both these circumstances might reflect the 
fact that the initial impetus for the service was at Government level, not within 
Lothian Health Board, and the service being supported by special central government 
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funding that ceased after 10 months. This highlights the importance of robust 
commitment to any new service initiative that is being considered, in particular 
among key policy-makers / budget-holders. 
Nevertheless the research findings of this thesis are useful to inform planning of 
future initiatives in provision of chlamydia testing to young people in community 
pharmacies, and as such will enhance the chances of successful outcomes. 
Furthermore, many of the findings will be of considerable utility in developing 
chlamydia services in other health care settings, and even for other public health 
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CHAPTER 1: INTRODUCTION TO THE THESIS 
1.1 Introduction 
Community pharmacy is now being recognized as a mainstream contributor to the 
provision of public health services in the
 
United Kingdom (UK) (Silcock et al., 2004, 
Richardson and Pollock, 2010). The new NHS pharmacy contract and current 
legislative changes
 
provide a basis for community pharmacy to become fully 
integrated
 
into NHS public health and long-term care programmes. Sexual health 
service delivery (including chlamydia testing and treatment, and emergency 
contraception (EC)) is a component of public health services to be provided through 
community pharmacies in Scotland (NHS Circular PCA(P)(2008)17).  
In 2008, a Scottish government directive stated that all health boards should 
implement a pharmacy based chlamydia testing and treatment service for young 
people (aged 15-24 years) so that they can access chlamydia testing kits directly from 
the community pharmacies, and so that anyone with a positive test result can access 
treatment from a pharmacist, without requiring consultation with a medical doctor. 
Partner notifications could also be provided through the same route.  
This thesis reports a set of studies around the implementation of a pharmacy-based 
chlamydia service in Lothian, Scotland. This introductory chapter provides an 
overview of the research undertaken for this PhD and a brief overview of the thesis, 
chapter by chapter.  
1.2 Overview of the research 
For my PhD research studies, I set out to undertake an evaluation of the pharmacy-
based Chlamydia Testing and Treatment service (CT&T) service
1
 that was shortly to 
be implemented in Lothian. However, as is explained more fully in chapter 5, 
unforeseen circumstances affected the CT&T service launch and delivery - 
implementation delays, minimal advertising of the service, low uptake, withdrawal 
by central government of specific funding to support the service costs, and shortly 
                                               
1 In this thesis, CT&T refers only to the chlamydia testing and treatment service in Lothian Health 
Board. Similar services in other parts of the Scotland, and elsewhere, are referred to as “pharmacy-
based chlamydia service”. 
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thereafter withdrawal of the service by Lothian Health Board. As the initial delays 
made it more and more apparent that formal evaluation of the CT&T service would 
not be possible as originally intended, within the timescale of my PhD studies, the 
evaluation studies that had been planned were reconsidered and revised so that they 
could still offer some formative evaluation of the service. In particular, it became 
apparent that it would not be possible to undertake the outcome analysis that I would 
have wished to, if service uptake and time were not issues. Therefore, in place of an 
outcome analysis, an analysis of routine laboratory data was undertaken to describes 
the recent epidemiology of chlamydia infection in Lothian (2006-2010) and also 
analyse an impact of recent policy changes (2008-2009) on chlamydia surveillance 
changes.  
When, ultimately, it became clear that the service was to be withdrawn, it was 
realised that there was thus no utility even in formative evaluation, in terms of 
feeding back to the CT&T service stakeholders in Lothian. The challenge then arose 
as to how to present the research undertaken as a PhD research thesis. Reflection on 
the research undertaken shows that it comprises a set of related studies that, both tell 
the story of the interrupted evaluation and, describe efforts to nevertheless undertake 
useful and informative research. Considered as a whole, the evaluation research and 
laboratory data analysis provides important insights and generalisable knowledge 
about the rationale for such a service, the process of implementation, including 
barriers and facilitators, and the potential to utilise routine data to assess the impact 
of a new service.  
This thesis therefore presents an integrated set of studies that describe the initial 
work undertaken to plan the evaluation and the studies ultimately completed. The 
studies included provide an epidemiology of chlamydia in Lothian from 2006 to 
2010 and investigates the impact of policy changes in 2008-2009 on chlamydia 
surveillance activity, and investigate different aspects of the implementation of the 
service from the perspective of strategic stakeholders, service providers (pharmacists 
and their support staff) and potential clients.  
The objectives of the PhD research reported in this thesis are detailed in section 6.5. 
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1.3 Thesis outline 
The chapters that comprise the remainder of the thesis are outlined below: 
Chapter 2 reports a literature review of the epidemiology of chlamydia, chlamydia 
screening services and policies related to chlamydia testing, more specifically in UK.   
Chapter 3 reports analyses of routinely collected chlamydia data in Lothian from 
2006 to 2010, addressing chlamydia testing activity and diagnosis trends. This 
provides a description of the epidemiology of chlamydia in Lothian, Scotland and 
hence provides a background to the development of a pharmacy-based chlamydia 
service in Lothian. However the study also aimed to ‘pilot’ how an outcome analysis 
of the CT&T service evaluation might have looked albeit, clearly, execution of such 
was going to be impossible time-wise. The analysis undertaken is with respect to an 
(earlier) ‘natural experiment’ that occurred, the introduction of sexual health service 
standards in 2008 and revised SIGN guidelines for chlamydia in 2009. The analysis 
undertaken was a comparison of changes in chlamydia testing activity in Lothian, 
from before to after these policy changes. This also allowed me to examine the 
feasibility of using routine data to evaluating the impact of a similar natural 
experiment, a change in sexual health service delivery such as introduction of 
pharmacy-based chlamydia testing and treatment. 
Chapter 4 provides a structured review of the literature on community pharmacy 
provision of a chlamydia service. It concludes by providing a conceptual framework 
for pharmacy-based chlamydia service and, suggests issues that should be addressed 
in future evaluations of such a service.  
Chapter 5 describes in detail the specifications of the Lothian CT&T service, and its 
timeline. 
Chapter 6 provides an overview of research methods used in this thesis. I detail the 
methods used for programme evaluation and the rationale for the questions chosen 
for the evaluation. This chapter also describes how the delays in service 
implementations, and later limited uptake of the service, required modifications to 
the methods initially proposed. The final objectives of my PhD research are outlined 
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here, together with a brief overview of the methods chosen to address these 
objectives.  
Chapters 7 to 10 in turn report each of the studies that contribute towards an 
evaluation of the short-lived CT&T service in Lothian. Each chapter gives further 
detail of study-specific methods (not covered in the more general methods of chapter 
6), reports results and provide some discussion specific to that study. The rationale 
for including discussion within the relevant study chapters are to ensure some 
immediate interpretation and discussion of results reported, and to prevent the final 
discussion chapter from becoming too cumbersome, allowing it to focus on 
integrative discussion.  
Chapter 7 describes a training needs assessment (TNA) survey undertaken with the 
community pharmacy staff in Lothian with respect to pharmacy delivery of CT&T 
service. This survey informed the development of a training programme for 
community pharmacy staff in Lothian prior to launch of CT&T. 
Chapters 8 describes a strategic stakeholder survey which aimed to ascertain 
whether the proposed evaluation questions were what the strategic stakeholders 
judged important to answer, and to invite suggestions as to any other questions  that 
should be addressed. In addition it also aimed to elicit their views on various 
challenges that such a service would face and their views on likely success of the 
service.  
Chapter 9 describes a survey of potential service users, to explore acceptability to 
them of various aspects of the planned pharmacy chlamydia service. 
Chapter 10 presents results for an in-depth interview study with both pharmacists 
who piloted the CT&T service in their respective pharmacies, and also with 
pharmacists who were invited by NHS Lothian to provide the CT&T service but 
declined to do so. The purpose of this study was to elicit facilitators of and barriers to 
the provision of CT&T service as perceived by pharmacists, and to draw on their 
views to suggest a chlamydia service model that is feasible from the perspective of 
pharmacists.  
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A brief chapter 11 presents the responses from a small subset of key stakeholders 
when contacted after the CT&T service had terminated in Lothian, about the reasons 
for its termination after running for only a short period of 10 months. It also reports 
viewpoints of the stakeholders with respect to the obstacles in the implementation of 
the CT&T service. 
The concluding chapter (chapter 12), draws together the main findings of the thesis 
with an integrated discussion. I also discuss the unforeseen circumstances that 
impacted on the implementation and sustainability of the CT&T service in Lothian, 
in specific, but also in Scotland overall. The implications for specific issues in 
programme planning and implementation are highlighted and recommendations for 
further research are discussed.  
1.4 Audience for this thesis 
This thesis makes a meaningful contribution to the literature on chlamydia screening 
and pharmacy services, and increases our knowledge about the feasibility of a 
pharmacy-based chlamydia testing and treatment service. However, the thesis has 
additional relevance and would be useful to a number of different audiences. A key 
audience would be the policymakers, both at a pharmacy level, in the NHS and 
within government. Findings of some of the studies that contributed towards the 
formative evaluation of the CT&T service - such as the stakeholder survey, TNA and 
some components of the in-depth interviews with pharmacists – would be useful to 
programme stakeholders (including practitioners) wishing in future to develop or 
implement a similar service. In addition, the methods employed in evaluating this 
service, and the difficulties encountered during the evaluation, would add 
considerable knowledge to the literature on evaluation of public health programmes. 
In this regard, these studies would be useful to the methodologists and researchers 
working in the field of programme evaluation. 
1.5 Looking ahead 
When setting out on my evaluation of the proposed CT&T service, I was aware that 
it would require me to develop a much broader set of research skills than my training 
so far. However, I was excited at the prospect, and pleased that I would be doing this 
in the context of sexual health services, my particular public health interest. When 
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the various unforeseen circumstances began to become apparent it was disconcerting 
and disappointing. However my supervisors reassured me that all research suffers 
setbacks, and that I should think creatively about how to revise the studies planned, 
so as to nevertheless complete useful research and produce new knowledge. In the 
event I have experienced even broader research training than I had anticipated, and 
the chapters ahead give an account of this, and of my findings and reflections.    
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CHAPTER 2: BACKGROUND TO CHLAMYDIA – 
EPIDEMIOLOGY AND HEALTH POLICIES IN 
THE UNITED KINGDOM 
2.1 Introduction  
This chapter reviews the literature on the epidemiology and burden of chlamydia, 
with a focus on the prevalence of chlamydia in the United Kingdom (UK) in general 
and Scotland in particular. It then explores the government’s health services 
strategies, policies and targets for chlamydia in Scotland. The policy developments 
detailed within this chapter provide an indication of the opportunities available for 
community pharmacies in Scotland, and although similar developments are occurring 
within England, Wales and Northern Ireland, they are not addressed within this 
thesis.  
For reporting chlamydia diagnosis, the terms ‘prevalence’ and ‘positivity’ have been 
used interchangeably in the literature. However in this chapter, the term prevalence 
is used, if a study reported results from population screening and positivity if the 
study reported results from testing in health care settings. The diagnostic rate 
describes the number of the population that tested positive for chlamydia / 100, 000 
population.  
Sexually transmitted Infections (STIs) have been recognized as a major public health 
problem. Among all STIs, genital chlamydia is the most commonly diagnosed 
infection (Health Protection Agency, 2010). It is caused by the bacterium Chlamydia 
trachomatis. It is readily treatable by antibiotics and its transmission can be 
controlled by also treating partners of infected persons. However approximately 70% 
of women and 50% of men infected with chlamydia remain asymptomatic, resulting 
in a large pool of cases that remain undiagnosed and untreated. The recommended 
test for chlamydia diagnosis is nucleic acid amplification technique (NAAT). Taking 
compliance with therapy into account, the recommended treatment for 
uncomplicated chlamydia infection is with the antibiotic Azithromycin 1 g, given as 
a single oral dose. Alternative antibiotic regimes are recommended where patients 
are unable to take Azithromycin. Abstinence during and one week after the treatment 
and partner notification are also recommended (Scottish Intercollegiate Network 
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(SIGN), 2009). Partner notification involves informing the sexual partners of the 
index patient infected with chlamydia that one of their sexual partners has been 
found to be infected so they might be too, and so should have a test or at least a 
treatment.  
2.2 Epidemiology of chlamydia 
2.2.1 Global Evidence 
Accurate epidemiological information about the occurrence of chlamydia is 
imperative for prevention and control programmes, in particular for targeted 
screening. Estimates of chlamydia prevalence vary according to the methods used in 
the study, such as the study settings, type of population targeted, age and gender 
(Adams et al., 2004).  
The European Centre for Disease Prevention and Control (ECDC) published its first 
comprehensive report of STI surveillance data in June 2011 (European Centre for 
Disease Prevention and Control, 2011). This report is based on case report and/or 
aggregate data from 23 countries in the European Union, with 88% of all the cases 
being reported by four countries (United Kingdom, Sweden, Denmark and Norway). 
The overall diagnostic rate increased from 143 per 100, 000 population in 2000 to 
332 per 100, 000 in 2009. In 2009, the highest rates were observed in Iceland (711 
per 100 000 population), Denmark (541), Norway (474), Sweden (408), UK (348) 
and Finland (250). The lowest rates were observed in eight countries (Cyprus, 
Greece, Lithuania, Luxembourg, Poland, Romania, Slovakia and Slovenia) with rates 
less than 10 per 100, 000 population. It was however cautioned that the interpretation 
of the overall trend is difficult as it is highly influenced by changes in testing and 
screening practices and the development of surveillance systems over time and 
across countries. Three quarters (75%) of all chlamydia cases were diagnosed in 
young people aged between 15 and 24 years; male to female ratio was 0.68 in 2009 
meaning that almost 50% more cases were reported in women than in men. 
2.2.2 Evidence from the United Kingdom 
For the UK specifically, data have been collected routinely from GUM clinics 
throughout the UK. The Health Protection Agency (HPA) collates a UK dataset 
annually from England, Wales, Northern Ireland and Scotland. The number of 
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chlamydia diagnoses in the past decade in UK has increased from 67,173 (males 
29,390; females 37,783) in the year 2000 to 114,686 (58,042; 56,530) (Figure 2-1). 
Thus there is an overall 100% increase in chlamydia diagnoses among males and 
50% increase among females, in the year 2009 as compared to the year 2000.  
Figure 2-1: United Kingdom - number of new diagnoses of chlamydia made in GUM 












The number of chlamydia diagnoses rose more rapidly in the first six years of the 
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diagnoses narrowed from 2004 onwards, becoming negligible from 2007 onwards.  
The most commonly cited population based studies on chlamydia include ‘National 
Survey of Attitude and Lifestyle’ (NATSAL) and the ‘Chlamydia Screening Study’ 
(ClaSS). The NATSAL was a probability sample survey of men and women aged 
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trachomatis infection. Of these, 71% agreed and provided the urine sample. This 
study found the prevalence of chlamydia infection to be 3% (95% C.I. 1.7% to 5.0%) 
among women aged 18-24 years. In men the prevalence in the same age group was 
2.7% (95% C.I. 1.2% to 5.8%). Among men the prevalence was highest in the 25-34 
year age group (3%; 95% C.I. 1.7% to 5.1%). Non-married status, age, and reporting 
partner concurrency of two or more sexual partners in the past year were 
independently associated with chlamydia infection.  
In ClaSS study, 19, 773 eligible men and women aged 16-39 years from GP registers 
in Bristol and Birmingham were invited for chlamydia screening (Low, 2007). The 
screening uptake rate was 32%. Prevalence of chlamydia infection in 16-24 years old 
was 6.2% (95% C.I 4.9% to 7.8%) among women and 5.3% (95% C.I. 4.4% to 6.3%) 
among men.  
A systematic review of studies from UK found a strong association of age group and 
study setting with the prevalence of chlamydia among females (Adams et al., 2004). 
Table 2-1 is adopted from the Adam (et at. 2004) study indicates that the positivity is 
highest among individuals younger than 20 years of age and higher in studies 
conducted in health care settings compared to population-based studies. For example, 
among those under 20 years of age, estimates for chlamydia positivity were 17%  in 
genitourinary medicine clinics, 14% in antenatal clinics, 14% in termination of 
pregnancy (TOP) clinics, 12% in youth clinics, 10% in family planning clinics, and 
9% in general practice, compared to 4% in population based studies (Adams et al., 
2004). 
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Table 2-1: Among females, percentage chlamydia positivity (with 95% CI), overall, and separately by age group and setting. 
Setting 
 
Age group (in years) Overall positivity by 
setting 
N** 
<20 20–24 25–29 ≥ 30 
Population-based 3.8     (1.0 - 8.3) 2.7     (1.1 - 5.0) 2.2   (0.9 to 4.1) 0.9 (0.4 to 1.5) 1.6     (1.0 to 2.3)  1725 
GP Surgery 8.6     (6.6 - 0.9) 5.9     (4.7 - 7.2) 2.9   (1.2 to 5.2)  1.1 (0.2 to 2.7) 7.1     (6.7 to 7.6) 13,207 
Family planning clinic 10.0     (9.1 - 0.9) 7.4     (5.7 - 9.4) 3.8   (2.2 to 6.0)  1.5 (0.5 to 2.8) 8.1     (7.6 to 8.7) 9,512 
Youth clinic 12.3   (10.0 - 4.9) 10.1  (7.0 - 13.6) - - 12.2 (10.8 to 13.7) 1,996 
Antenatal clinic 13.5   (9.5 to 9.1) 6.5   (3.5 - 10.4) 7.2 (2.4 to 14.2)  0.0 (1.2 to 1.2) 8.5   (6.6 to 10.6) 803 
*TOP clinic 13.6   (10.6 - 6.8) 9.7   (6.5 - 13.3) 2.0   (0.3 to 5.1)  1.2 (0.2 to 2.9) 8.5     (7.4 to 9.8) 2,114 
GUM clinic 17.3 (13.6 - 21.3) 12.4 (10.3 - 14.7) 4.9   (2.6 to 8.0)  5.1 (2.7 to 8.3) 12.7 (11.5 to 14.0) 2,831 
* TOP=Termination of Pregnancy **N Number of individuals in the model 
Adopted from (Adams et al., 2004) systematic review and meta-analysis
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2.2.2.1 National Chlamydia Screening Programme in England 
In England, the phased implementation of the National Chlamydia Screening 
Programme (NCSP) began in September 2002 (National Chlamydia Screening 
Programme, 2008). It offers opportunistic screening for chlamydia to sexually active 
individuals aged 15-24 years. In the first year, the majority of young men were being 
screened in Community Contraceptive Services (CCS) (43 per cent) and educational 
settings (26 per cent). Young women were screened predominantly in CCS (63 per 
cent) and youth settings (15 per cent). Progressively, the screening venue was 
diversified into a wider range of settings for both young men and women including 
outreach, prisons, pharmacies and by postal testing kits (PTK). Five years on, 
educational settings (22 per cent), youth settings (15 per cent), and CCS (13 per cent) 
remain the most commonly used screening venues for young men. For young 
women, CCS (31 per cent), youth settings (19 per cent) and also general practice (14 
per cent) were the most commonly used screening settings. The community 
pharmacies undertook nearly 3% of all screening tests among men and women.  
Differences in positivity across screening venues in NCSP are in line with the 
previous findings of a meta-analysis by Adam et al. The highest positivity was 
reported among young people tested in contraceptive services (10.4 per cent), using 
PTK (10.3 per cent) and in youth settings (10.3 per cent), while people tested in 
educational settings had a much lower positivity (4.3 per cent). The higher positivity 
reported in the NCSP compared to the prevalence from population based studies 
(such as NATSAL) is a result of the high risk population targeted in the screening 
programme, such as those displaying high risk sexual behaviours or those from the 
black ethnic minority (Riha et al., 2011). 
The national screening targets set out by the Department of Health in England are 
called chlamydia ‘Vital Signs Indicator’ (VSI) and it measures the proportion of the 
15-24 year old total population tested for chlamydia outside of GUM clinics. The 
target set by the Department of Health in England was 17% of the eligible population 
to be tested during the year 2008-9, 25% during 2009-10 and 35% during 2010-11. It 
is however debatable how the success of the chlamydia screening programme should 
be measured - by number of people tested (as would be reflected by the VSI), 
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number of infection treated or by the reduction in the prevalence or incidence of the 
infection. Modelling by the Health Protection Agency (HPA) estimated that 
reduction in the prevalence of chlamydia could be achieved by screening of 26-43% 
of the 16-24 year old population per year, in addition to robust arrangement for 
contact tracing and treatment of sexual partners of index patients. The national audit 
report on chlamydia screening has shown that 22% of the 15-24 year old population 
have been tested for chlamydia in 2008/09 (National Audit Office, 2009). Of those 
who tested positive for chlamydia, 12% were not traced to be treated. Moreover 72% 
of the primary care trusts in England failed to meet the standards of tracing and 
treating partners of infected patients. This mean that the effect of screening would be 
diminished by the high levels of repeated infection due to lack of treatment of 
existing sex partners, exposure to infected new sex partners or treatment failure 
(Heijne et al., 2011). The report concluded that the programme was unlikely to 
produce a significant reduction in prevalence and provided poor value for money.  
2.2.2.2 Prevalence of chlamydia infection in Scotland 
In Scotland, the trends in chlamydia diagnoses have been similar to the rest of the 
UK and Europe. Scotland does not currently have a national screening programme 
for chlamydia. Chlamydia screening in the general population has not yet been made 
widely available and currently patients have to visit their GP or sexual health clinics, 
such as GUM or FP clinics, to be tested. Many patients accessing these services for 
emergency contraceptive (EC) consultation, abortion or other sexual health problems 
are opportunistically offered chlamydia testing. A survey conducted in family 
planning clinics in Scotland reported that women aged under 20 or over 30 years 
were significantly more likely to decline to be tested than women aged 20 to 30 
(Kettle et al., 2002).  
Figure 2-2 shows the rising trends of diagnoses of chlamydia among men and women 
in the GUM clinic setting in Scotland from 1996-2009. The largest (year on year) 
absolute increase among males was observed in 2003 (565 more diagnoses than the 
preceding year) and then in 2004 (490 more diagnoses). Among females the largest 
increase was observed in 2001 (679 more diagnoses) and then in 2005 (598 more 
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diagnoses). The absolute number of diagnoses decreased in 2008 and 2009 in 
females and in 2009 in males.  
Figure 2-2: Scotland - number of new diagnoses of chlamydia made in GUM clinics, by 











Source: ISD Scotland – STISS 
Similar to the trends in the rest of the UK and Europe, chlamydia infection is found 
predominately in young people - in 2009, 63% and 79% of all male and female 
diagnoses respectively, were made in persons aged less than 24 years (Figure 2-3). 
Figure 2-3: Scotland - number of new diagnoses of chlamydia made in GUM clinics, by 

































































































Source: ISD Scotland – STISS (2009) 
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The graphs in figure 2-2 and 2-3 comprise diagnoses made in GUM clinics only. 
However, nearly half of all chlamydia diagnoses are made in settings other than 
sexual health clinics i.e. mostly in general practices. Thus Health Protection Agency 
of Scotland (HPS) collects aggregated laboratory data for chlamydia and reports a 
more comprehensive picture of chlamydia diagnoses made in different health boards 
in Scotland.  
Figure 2-4 and 2-5 are the stacked area graphs indicating time trends of contribution 
of GUM and non-GUM settings in chlamydia diagnoses, separately for females and 
males. Over half to two thirds of women were diagnosed in clinical settings other 
than the GUM and this trend has been consistent throughout the last decade (Figure 
2-4). In contrast to women, men were more commonly diagnosed at GUM clinics 
(Figure 2-5). However this trend is gradually declining with more men being 
diagnosed in non-GUM settings. For example, in the year 2000, 89% of the men 
were diagnosed in a GUM setting. This trend gradually declined over the last decade, 
so that in the year 2009, 65% of the men were diagnosed in the GUM clinics.  
Figure 2-4: Females - diagnoses of chlamydia made in GUM clinic & non-GUM settings 





































































Data source: Health protection Scotland (2008) 
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Figure 2-5: Males - diagnoses of chlamydia made in GUM clinic & non-GUM settings in 











Figure 2-6 shows the comparison of chlamydia testing and positivity for men and 
women across two age bands – 15-24 years and 25-49 years. Within each age band, 
the majority of chlamydia testing (~76%) is performed on women, but a higher 
positivity was observed in men than women. Across the two age bands, three times 
as many positive diagnoses were made in women younger than 25 years of age than 
in the older age group. Similarly twice as many diagnoses were made in men 
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Data Source: Scotland’s sexual health information 2007. (Health protection Scotland & ISD) 
Figures 2-7 and 2-8 shows the rates of diagnoses of chlamydia made in GUM clinic 
setting in 2009, by NHS board of residence in Scotland, separately for males and 
females. Among men, the highest diagnostic rate was observed in Tayside, followed 
by Lothian and Fife. Among women, the highest diagnostic rate was in Tayside, 
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Figure 2-7: Males in Scotland - rates of diagnoses of chlamydia made in GUM clinic 











Source: ISD Scotland – STISS (2009) 
Figure 2-8: Females in Scotland - rates of diagnoses of chlamydia made in GUM clinic 
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2.2.3 Cost effectiveness of chlamydia screening 
The cost effectiveness of chlamydia screening is demonstrated using empirical 
estimates of screening uptake and incidence of complications of chlamydia infection. 
A number of mathematical models have been generated to consider the cost 
effectiveness of different screening/testing strategies for chlamydia at various levels 
of prevalence. One study which used a dynamic model of chlamydia screening taking 
into account the transmission of chlamydia and the complication rate, suggested that 
chlamydia screening would be cost saving after 4-5 years of screening programmes 
(Welte et al., 2000). One model considered three different probabilities of chlamydia 
progression to pelvic inflammatory disease (PID) at 1%, 10% and 30%. This study 
found that annual screening is only cost effective in those with the highest prevalence 
of infection i.e. men and women aged under 20; or if the PID progression is 10% or 
higher (Adams et al., 2007).  
It has been argued that in the evaluation of cost effectiveness of chlamydia screening 
programmes, the rates of complications have been over estimated (van Valkengoed 
et al., 2004). The rationale for recommending a screening programme for chlamydia 
infection was based on two earlier randomised control trials (RCTs) of screening 
versus normal care conducted in 1990s, which demonstrated a greater than 50% 
decrease in the incidence of PID (Ostergaard et al., 2000, Scholes et al., 1996). 
However these studies were criticized for methodological limitations – for example 
for measuring outcome in only a small proportion of women randomised, 
ascertainment of outcome based on case notes (rather than utilising laparoscopic 
diagnosis), and a large loss to follow up in both the screening and control groups. 
Moreover neither of the trials evaluated opportunistic chlamydia screening as it is 
currently practised. The most recent evidence from Uppsala women’s population-
based cohort study from Sweden (Low et al., 2006) estimated the population 
cumulative incidence of PID, ectopic pregnancy and infertility by the age of 35 
years, stratified by their prior chlamydia test status. The cumulative incidence of PID 
was estimated at 3.9% (95% CI 3.7% to 4.0%) overall: 5.6% (4.7% to 6.7%) in 
women who ever tested positive for chlamydia, 4.0% (3.7% to 4.4%) in those with 
negative tests, and 2.9% (2.7% to 3.2%) in those who were never screened. 
Similarly, the study identified considerably lower estimates for ectopic pregnancy 
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and infertility than previously estimated. A subsequent systematic review of the 
economic evaluations of chlamydia screening undertaken by the same group of 
authors (Low et al., 2007) failed to offer any firm recommendations about the cost 
effectiveness of chlamydia screening, because of the lack of a reliable natural history 
data. Similarly a more recent systematic review of the evidence of infertility 
following chlamydia infection demonstrates the absence of such evidence and an 
overall lack of research on the natural history of chlamydia infection in women 
(Wallace et al., 2008). 
A recent evaluation of cost, cost effectiveness and sex equity with the national 
chlamydia screening programme showed that increasing male screening coverage 
from 8% (baseline value for 2008-9) to 24% (to match female coverage) would cost 
over six times as much as increasing partner notification efficacy from 0.4 partners 
per index case (baseline value for 2008-9) to 0.8 (Turner et al., 2010). The study 
concluded that increasing the effectiveness of partner notification would not only be 
more cost effective than increasing male coverage, but at the same time would 
equalise the ratio of women to men diagnosed.  
2.2.4 Rising trends of chlamydia diagnoses - an epidemic or 
an artifact of surveillance 
The sharp rising trend in chlamydia diagnoses, observed particularly in first 5 years 
of the last decade, has been hypothesised to be due to improved testing coverage, 
diagnostic techniques, widespread change in the riskiness of sexual practices, 
antimicrobial resistance and arrested immunity (Vickers and Osgood, 2010). 
Improved case finding due to increased testing volume or coverage are identified as 
the most important factors responsible for an observed increase in the annual 
incidence rate of chlamydia infection (Miller, 2008, Vickers and Osgood, 2010, 
Hughes et al., 2007). Coverage reflects the proportion of the population that is 
reached by testing / screening activities. Due to the relatively constant population 
denominator, increases in coverage which will generally lead to more cases being 
identified will in turn lead to a higher calculated incidence of chlamydia against that 
constant population. These observed increases may occur in the face of an 
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unchanging, increasing or even declining true incidence rate (Miller, 2008, 
Burckhardt et al., 2006).  
The rate of chlamydia diagnoses made had also been shown to be affected by the 
diagnostic test accuracy. The diagnostic tests examined for detection of Chlamydia 
trachomatis were nucleic acid amplification techniques (NAAT), culture techniques 
such as gene probes (GP), enzyme immuno-assay (EIA) and direct immuno-
fluorescence (DFA). A systematic review examined 30 studies on the diagnostic 
probability of the different testing techniques for chlamydia and demonstrated that 
NAAT used on non-invasive samples such as urine were more effective at detecting 
asymptomatic chlamydia infection than other tests (Watson et al., 2002). In Scottish 
laboratories, from January 1992 there was a gradual shift of laboratories to more 
sensitive NAAT diagnostics, which were comprehensively provided by all 
laboratories by September 1998. A Scottish study reporting trends in chlamydia 
diagnoses on routine GUM clinic surveillance data demonstrated an overall 55% 
increase in diagnoses following a gradual shift of laboratories to more sensitive 
NAAT diagnostics (Burckhardt et al., 2006). However in Sweden, the incidence of 
chlamydia infection began to rise before the introduction of NAAT testing. 
There is also some evidence that a screening programme based on early case 
detection and treatment results in an early reduction in prevalence, but is then 
followed by a rebound in prevalence (Brunham et al., 2005). A control strategy 
based on shortening the average duration of infection interferes with the effects of 
immunity on population susceptibility to infection and that, in the absence of 
strategies to alter sexual behaviour, results in a later increase in prevalence. 
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2.3 Sexual health policy & guidelines for Scotland 
The policy developments in Scotland, in relation to sexual health in general and 
chlamydia in particular, are described in this section. 
2.3.1 Respect and Responsibility – a strategy and action plan 
In January 2005, the Scottish Government launched a national strategy for improving 
sexual health in Scotland, 'Respect and Responsibility: A Strategy and Action Plan 
for Improving Sexual Health'  against a background of rising teenage pregnancies 
and STIs (The Scottish Government, 2005). The strategy was based on the principles 
of self respect, respect for others, on strong relationships and on recognising the 
diversity of needs and lifestyles of people in Scotland.  
The strategy seeks to improve access to information and services related to sexual 
health whilst allowing flexibility for local services to respond to local needs. To 
support the implementation of Respect and Responsibility, a National Sexual Health 
Advisory Committee (NSHAC) was formed. This committee set up a number of 
groups to look at particular issues such as national data collection, rural issues and 
staff training as well as engaging with stakeholders within, as well as out of, the NHS 
to address wider societal issues related to sexual health.  
2.3.2 National databases on sexual health 
‘Respect and Responsibility’ advocated the development of a national sexual health 
information system to support service planning. Hence the Information Service 
Division Scotland (ISD) and Health Protection Scotland (HPS) collaborated to create 
DASH (Data Augmentation for Sexual Health). Its purpose was to focus on sexual 
health data development to support service planning and redesign. A new clinical 
management system was also developed, called National Sexual Health System 
(NaSH), to support sexual health services throughout Scotland. The NaSH system is 
initially intended for use in the GUM and sexual and reproductive health clinics. 
However, the intention is that it can be used wherever these specialised services are 
provided, for example in acute HIV care, community pharmacy or general practice 
settings. The system is currently being rolled out throughout Scotland in GUM 
clinics and family planning clinics. In addition to providing an electronic patient 
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record for sexual health, the system will also provide secondary data for national 
reporting. 
2.3.3 Quality Improvement Scotland sexual health services 
standards  
One of the key recommendations within ‘Respect and Responsibility’ was the 
development of clinical standards to evaluate and improve the quality of provision of 
sexual health services in Scotland. The sexual health services standards were 
published in April 2008 by Quality Improvement Scotland (QIS) (NHS Quality 
Improvement Scotland, 2008). Three standards are pertinent to the provision of STI 
services, and are described below: 
i. Standard statement 1: A comprehensive range of specialist sexual health 
services is provided locally and individuals with the greatest need are 
treated as a priority.  
Under this standard, 80% of individuals with priority sexual health conditions 
should be seen by the specialist sexual health service. Moreover, there should be 
a minimum of 2 full working days per week of specialist sexual health service 
available within 30 minutes travel time from each settlement of over 10,000 
people.  
ii. Standard Statement 3: NHS boards ensure the development and delivery of 
integrated approaches to sexual health improvement, particularly in 
relation to young people. 
This standard focused on the provision of chlamydia testing. Its following three 
components are particularly relevant: 
 Standard 3.1: 60% of chlamydia tests per year are taken from males and 
females aged under 25 years. 
 Standard 3.2: For males aged 15-24 years, the annual rate of chlamydia tests 
performed in the NHS board area is greater than 100 per 1000 population. 
 Standard 3.3: For females aged 15-24 years, the annual rate of chlamydia 
tests performed in the NHS board area is greater than 300 per 1000 
population 
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iii. Standard statement 4: Individuals who are diagnosed with a sexually 
transmitted infection see an appropriately trained member of staff to 
organise partner notification. 
According to this standard, partner notification should be offered in all settings 
delivering sexual health care, including primary care, youth services and 
community pharmacies. To meet this standard, an essential criterion is that for 
every 100 individuals diagnosed with chlamydia in a specialist sexual health 
setting, 64 contacts are verified as having attended within 90 days of first partner 
notification interview.  
Quality Improvement Scotland has also developed a self assessment framework to 
support NHS boards in providing information to monitor their performance against 
the standards. The performance of each health board will be monitored against these 
standards and recommendations on improvements will be made.   
2.3.4 SIGN guideline for chlamydia  
The Scottish Intercollegiate Guidelines Network (SIGN) was formed in 1993 to 
improve the quality of health care for patients in Scotland by reducing variation in 
practice and outcome, through the development of evidence based clinical guidelines 
containing recommendations for effective practice. The revised SIGN guidelines 
(Number 109) on the management of genital chlamydia infection were issued in 
March 2009 with the intention of advising on policy for the most cost effective 
testing strategy at a population level and to consolidate best practice in the 
management of individual cases of diagnosed infection (Scottish Intercollegiate 
Network (SIGN), 2009). The guideline updated SIGN 42, published in 2000, to 
reflect the most recent evidence. The following recommendations are worth noting: 
i. Resources for chlamydia testing in women should be targeted where prevalence 
is known to be highest, i.e. first those aged 15-19 and then those aged 20-24 
ii. Resources for chlamydia testing in men should be targeted where prevalence is 
known to be highest, i.e. those aged under 25 
iii. Postal testing kits should be used to increase chlamydia testing among young 
men 
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iv. All patients attending GUM clinics should be tested for chlamydia 
v. In health care settings other than GUM, testing should be most strongly advised 
for those who have had two or more partners in the past 12 months  
vi. Patient diagnosed with chlamydia must receive partner notification either by 
trained practice nurses within general practice or health advisers in GUM 
vii. Those who have been diagnosed with chlamydia in the previous 12 months 
should be tested  
viii. Test for re-infection is recommended at 3-12 months or sooner if there is a 
change of partner 
ix. Uncomplicated chlamydia should be treated with Azithromycin 1g as a single 
dose, including for pregnant women 
2.3.5 Healthy Respect programme  
Healthy Respect is a Scottish government funded national health demonstration 
project established in Lothian following the recommendation in the Government’s 
White paper ‘Towards a Healthier Scotland’ published in year 1999 (Healthy 
Respect, 2010). It was implemented in two phases from 2001 to 2008. It aimed to 
help young people in Lothian to develop a positive attitude to their own sexuality and 
that of others and a healthy respect for their partners, with the aim of reducing 
unintended teenage pregnancies and STIs. It provides free and confidential 
information and advice about sexual health and relationships through youth friendly, 
Healthy Respect accredited drop-in clinics, website, advertising campaigns, schools 
and youth clubs. It also connects with hard to reach groups through community 
education, social work, voluntary organisations and the NHS. Healthy Respect staff 
and partners come from a variety of areas including education, the voluntary sector, 
youth work, community learning and development, medical and nursing, social 
marketing and health promotion. 
The evaluation of phase 2 of Healthy Respect indicated that it is able to improve the 
knowledge of sexual health more among boys than girls. It had a significant effect in 
the improvement of use of condoms by boys but no change was seen in the intention 
of girls to use condoms. Moreover, all these changes were more evident among those 
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from more affluent areas. During the Healthy Respect demonstration period, the 
trends for chlamydia positivity and teenage pregnancy in Lothian did not differ from 
the rest of the Scotland. However it was acknowledged in the evaluation report that it 
is difficult to determine what impact Healthy Respect had had on teenage pregnancy 
or chlamydia infection rates in Lothian. Healthy Respect is now integrated into NHS 
Lothian and will continue to work in partnership with other agencies.  
2.3.6 The Sexual Health and Blood Borne Virus Framework 
2011-2015 
Most recently, the Scottish Government published ‘the Sexual Health and Blood 
Borne Virus framework’ in August 2011. This framework for the first time brings 
together four policies in relation to sexual health, HIV, hepatitis B and hepatitis C, 
into a single integrated strategy. It was based on the premise that these health 
problems do not occur in isolation, hence needing an integrated approach. It adopted 
an outcome based approach where the progress against the outcomes will be 
monitored nationally through a small set of indicators. It also advocated a multi 
agency approach where the NHS, Local Authority, Scottish Prison Service and Third 
Sector should all work in an integrated way to achieve the outcomes. The target 
outcomes set out in this framework are as follows: 
i. Fewer STIs and unintended pregnancies 
ii. A reduction in the health inequalities gap in sexual health 
iii. People affected by blood borne viruses leading longer, healthier lives 
iv. Sexual relationships are free from coercion and harm 
v. A society and culture whereby the attitudes of individuals, the public, 
professionals and the media in Scotland towards sexual health are positive, non-
stigmatising and supportive 
It was emphasised that any sexual health improvement interventions developed to 
achieve these outcomes, should have a sound or promising evidence base and should 
be monitored and evaluated. The progress towards these outcomes will be monitored 
nationally as well as across health boards. In terms of provision of the service for 
young people it was particularly emphasised to provide accessible sexual health 
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services to young people, for example, through drop-in services for young people in, 
or close to, schools, particularly in areas of greatest need (for example, areas of high 
prevalence, remote/rural areas where there are fewer specialised sexual health 
services).  
2.3.7 Changes in pharmacy regulations to enable the 
provision of pharmacy-based sexual health service 
In February 2002, the health minister launched the strategy for pharmaceutical care 
in Scotland ‘The Right Medicine’ (Scottish Executive, 2002). It outlined the way in 
which community pharmacies could play their role in promoting public health and 
providing better access to quality service to patients. Following on this, a new NHS 
community pharmacy contract in Scotland was developed after consultation of the 
Scottish government with the professional bodies and its phased implementation was 
started in April 2006 (Scottish Executive, 2003). As part of this new contract, the 
health boards were instructed to plan and secure the provision of pharmaceutical care 
services (PCS) in their respective areas through community pharmacies. A range of 
public health services were negotiated locally between NHS Boards and local 
pharmacy contractors, but from an agreed framework. 
The sexual health services commissioned through community pharmacies included 
pharmacy-based chlamydia service and EC service. However chlamydia testing by 
pharmacies required legislative changes, particularly in terms of over the counter 
provision of Azithromycin through pharmacies for the full implementation of a 
pharmacy-based chlamydia service. EC already had over-the-counter status in 
Scottish pharmacies (legislated in 2001). In August 2008, in Scotland, Azithromycin 
for the treatment of chlamydia infection was made available through community 
pharmacies using a Patient Group Direction. 
The chronology of a pharmacy-based chlamydia service in Scotland, in general, and 
the CT&T service in Lothian Health Board, in particular, have been described in 
more detail in chapter 5.  
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2.4 Summary of findings and discussion  
The diagnoses of chlamydia infection have been on the rise in the past decade. It is 
speculated that most of the rise in diagnoses is a result of increased testing and better 
detection techniques. However reaching those individuals at greatest risk remains 
problematic. The various policies and guidelines developed in the last decade were 
intended to improve the sexual health outcomes and inequalities in outcomes.  
The NCSP was rolled out in England in 2002, supported by funding of £150m by the 
health department. In Scotland, there is no national screening programme, but the 
SIGN guidelines recommends to opportunistically target young people for chlamydia 
testing. The substantial investment for the chlamydia screening in NCSP and the 
recommendations in the SIGN guidelines are based on the premise that untreated 
asymptomatic chlamydia infection is associated with long term complications such 
as ectopic pregnancy and infertility. However as discussed in section 2.2.3, much of 
this assumption is either based on observational studies or on RCTs published in the 
1990s that have been criticized for considerable selection and measurement bias. If 
the success of the current screening programme is to be measured by the reduction in 
the prevalence of infection, then this has yet not been demonstrated in the NCSP, 
which has been implemented since 2002. Hence it is uncertain whether opportunistic 
screening of young people can control the chlamydia epidemic. For a screening 
programme to be effective in the long term, a sufficiently high proportion of the 
target population needs to be screened at the defined screening interval. By 
definition, opportunistic screening does not achieve a high coverage. Taken together 
with the lack of evidence of the effectiveness of an opportunistic chlamydia 
screening programme, the appropriateness of chlamydia screening programmes has 
now being questioned widely in literature (Low, 2007, Mayor, 2009).  
Regardless of the debate of the cost effectiveness of chlamydia screening, it might 
also be important to analyse whether such services are able to achieve its desired 
objectives of improving accessibility for young people. It would therefore be useful 
to see whether the sexual health policies and guidelines for chlamydia testing in 
Scotland have produced any change in testing practice in GUM and non-GUM 
settings. New chlamydia testing venues such as community pharmacies were added 
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to provide wider choice and access of testing to young people, particularly those 
living in deprived areas. Hence the comparison of the provision of testing in different 
health service locations and whether the testing is able to detect cases in deprived 
areas needs to be further investigated. 
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CHAPTER 3: ANALYSES OF ROUTINE DATA 
FOR CHLAMYDIA IN LOTHIAN, SCOTLAND -
2006 TO 2010 
3.1 Introduction 
In Chapter 2, I have provided a detailed literature review of the epidemiology of 
chlamydia in UK as well in other parts of Europe. As described in section 2.2.2, the 
number of chlamydia diagnoses has increased tremendously in the last decade. For 
example the number of chlamydia diagnoses in the past decade in UK has increased 
from year 2000 to year 2009 by 71%, from 67,173 to 114,686 overall. This 
comprises a 100% increase in chlamydia diagnoses among males (29,390 to 58,042) 
and a 50% increase among females (37,783 to 56,530) (Figure 2-1). As further 
discussed in chapter 2 (section 2.2.4), the sharp rising trend in chlamydia diagnoses 
has been hypothesised to be due to improved testing coverage, diagnostic techniques, 
widespread change in the risky behaviour related to sexual practices, antimicrobial 
resistance and arrested immunity (Vickers and Osgood, 2010). 
Accurate epidemiological information about the occurrence and distribution of 
chlamydia is necessary for the prevention and control programmes, in particular for 
targeted screening. This chapter focuses in detail on chlamydia testing and diagnostic 
activities in Lothian across a five year period from 2006 to 2010. This time period 
was chosen to allow the comparison of trends pre and post implementation of the 
CT&T service. The analysis of routinely collected laboratory data for chlamydia 
provides a descriptive epidemiology for Lothian of three chlamydia outcomes; 
namely surveillance rate, diagnostic rate and positivity rate.  
The CDC framework of programme evaluation emphasized the importance and 
utility of the surveillance systems for performance measurement and program 
evaluation (Centre for Disease Control and Prevention and U.S. Department of 
Health and Human Services, 2005). These routine dataset are suggested by the CDC 
as a useful resource in programme planning and formative evaluation by serving two 
purposes; firstly, it identifies the key burden and risk factors - the descriptive and 
analytic epidemiology of the public health problem. Secondly, these are useful in 
measuring long term and population based outcomes. Although it was not possible to 
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examine the impact of CT&T service in terms of standard chlamydia outcomes, an 
‘equivalent’ analysis has been undertaken of the changes in chlamydia testing 
activity after the publication of the Quality Improvement Scotland (QIS) sexual 
health service standards (in 2008) and the SIGN guidelines for chlamydia (in 2009). 
These two documents have been described in detail in chapter 2 (section 2.3).  
Apart from examining the impact of these publications, the analysis also enables a 
consideration of the feasibility of using routine laboratory data (as currently 
collected) for investigating changing trends in chlamydia testing and outcomes, such 
as might be expected to occur after a change in service provision, such as an 
introduction of CT&T. Recent studies in England had demonstrated the feasibility of 
collecting data directly from laboratories to monitor testing trends against the 
recently developed vital sign indicators for chlamydia (Jennison et al., 2010, Slater et 
al., 2007).  
3.2 Aims and Objectives 
The primary aim of this chapter is to describe the epidemiology of chlamydia testing 
and diagnostic outcomes, and to explore the association of these outcomes with key 
socio-demographic variables. 
The specific objectives are: 
 to analyse anonymous disaggregate data for chlamydia testing and diagnoses 
trends in Lothian across the 5 year period from January 2006 to December 2010. 
 to investigate the changes in chlamydia testing trends before and after the 
introduction of policy guidelines relevant to chlamydia testing; i.e. QIS sexual 
health services standards in 2008 and SIGN guidelines for chlamydia in 2009  
A secondary aim of this study is to examine the feasibility of using routine data to 
assess the impact of introducing some new service or policy, on the outcomes of 
chlamydia surveillance activities. This issue is addressed in the discussion section of 
this chapter. 
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3.3 Methods 
3.3.1 Possible sources of routinely collected chlamydia data  
Routine data are defined as data that have regular and continuing collection, use 
standard definitions, include some degree of obligation to collect the data completely 
and regularly, and are collected at the national or regional level (Stevens et al., 
2005). Data on STIs diagnosed in Scottish GUM clinics have been continuously 
collected since 1922 (Information Service Division Scotland). The information 
service division (ISD) Scotland, reports national and local statistics for chlamydia 
based on aggregate data from GUM clinic. Following on from the recommendations 
of a national sexual strategy for Scotland, ‘Respect and Responsibility’(The Scottish 
Government, 2005) to develop high quality data for sexual health, a phased transition 
from recording data on STIs in STISS (Sexually Transmitted Infections Surveillance 
System) to NaSH (National Sexual Health System) took place in 2009. NaSH is 
implemented as one national database to record all clinic details, events and episodes 
of care for each patient coming to the specialist sexual health service in Scotland. 
The biggest limitation of the NaSH system, as well as the previous STISS is that it 
does not include diagnoses made in settings other than GUM or FP clinic. Hence a 
comprehensive picture of chlamydia testing activity cannot be obtained from NaSH 
databases alone.  
Nearly half of all chlamydia diagnoses are made in settings other than sexual health 
clinics i.e. mostly in general practices. Health Protection Agency (HPA) Scotland 
collects aggregated laboratory data for chlamydia and reports a more comprehensive 
picture of chlamydia diagnoses made in different health boards in Scotland. However 
existing surveillance undertaken by HPA, Scotland, collects only positive results in 
aggregate form (and not the overall level of testing) (Mackenzia et al.). Thus it is 
neither possible to use these data to assess population coverage of chlamydia testing; 
nor whether testing is being targeted at those at highest risk of infection, as per 
Scottish sexual health policy. Moreover, the aggregate data reported from 
laboratories across Scotland as well for GUM clinic did not accounted for duplicate 
records, equivocal or inhibitory results.   
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As described earlier, an annual sexual health report has been produced by ISD and 
HPS since 2005. The reporting of chlamydia data by both ISD and HPS is 
undertaken based on ‘NHS boards of testing’ rather than by ‘NHS board of 
residence’. There are two issues that could affect the estimates of aggregate data 
based on NHS board of testing: 
1. People may /do cross NHS board boundaries to access services 
2. Sometimes chlamydia testing for one health board is performed in the 
laboratories within another health board (for example, some tests for Scottish 
Borders, Falkirk and Motherwell are performed in Lothian Health Board). 
The ASSIST study in England demonstrated the feasibility and importance of 
collecting chlamydia testing disaggregate data from laboratories (Slater et al., 2007). 
It was proposed that if a disaggregate data on chlamydia testing were collected from 
laboratories; the reporting of chlamydia testing activity would be enhanced in the 
following ways:  
i. A more comprehensive means to monitoring chlamydia testing activity would be 
possible. 
ii. A unified dataset would eliminate the need to combine data from disparate 
sources to report testing activity for chlamydia. In general it would be more 
representative for the source population. 
iii. Data linkage with other relevant datasets would be possible, for example, with 
SIMD based on a common variable such as residential postcode.  
Given the comprehensiveness of laboratory data, I decided to use routine laboratory 
data for exploring chlamydia testing trends in Lothian over the span of last 5 years. 
Choosing this 5 year period allowed me to undertake analysis of chlamydia testing 
activity over a reasonable time span in Lothian. It also allowed description of any 
changes in the testing activity resulting from the emergence of relevant chlamydia 
policy / guidance in 2008 and 2009.    
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3.3.2 Variables available for analysis 
The following variables were available and requested from the Chlamydia 
trachomatis laboratory dataset; 
1. Test identifier 
2. Specimen date 
3. Specimen type 
4. Age in years 
5. Gender 
6. Test result 
7. Test location 
3.3.3 Deprivation variable used for analyses 
As has been pointed out in section 5.2, one rationale for the CT&T service in Lothian 
was to improve access, and implicit in this rationale was a wish to improve testing 
rates in young people from lower socio-economic areas. This was built into the 
design of Lothian CT&T service, by selecting pilot pharmacies in areas of higher 
deprivation (Section 5.4.1.2). Therefore any analysis of changes in testing activity 
and outcome would benefit from having a measure of socio-economic status as a 
potential stratification variable.  
Socio-economic status is a multi-dimensional concept reflecting a person’s income, 
employment status, levels of education, home ownership, wealth and number/type of 
assets. The individual level information on socio-economic status needed was not 
available in the laboratory dataset. Such data is very time-consuming to collect at the 
individual level, but there are area based indicators of average socio-economic status 
for small geographical areas – labelled deprivation variable. Initial work in United 
Kingdom on obtaining an area based measures of deprivation was undertaken by 
Carstair and Morris (Carstairs and Morris, 1991). The Carstair’s index is now out of 
date, but the SIMD now provides a most updated measure of multiple deprivations at 
a data-zone level (The Scottish Government, 2009).  Previous studies have employed 
data linkage techniques, of linking postcode information of patient’s data with SIMD 
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dataset, to obtain corresponding area measure of deprivation of the patients 
(Hutchinson et al., 2004, MacLeod et al., 1999, Hanlon et al., 2005, Challier et al., 
2000, Yu et al., 2011). For the current study, I had retrieved SIMD dataset at data-
zones level for Lothian and provided this dataset to the statistician at the 
microbiology laboratory for linkage with records with those tested for chlamydia. 
The record linkage is described in detail in the next section. 
The average size of a data-zone in SIMD 2009 is approximately 1500 people. Data-
zones have a specified minimum population to avoid the risk of data disclosure, and 
are not subject to frequent boundary change hence more suitable for comparison over 
time. The SIMD 2009 is a composite area-based measure of 38 indicators within the 
following seven domains (the percentages show the weights attributed to each 
domain): 
 Current income (28%) 
 Employment (28%) 
 Health (14%) 
 Education (14%) 
 Geographic access (9%) 
 Crime (5%)  
 Housing (2%) 
The weights reflect both the robustness of the domain and the relative importance 
afforded to the domain in terms of its contribution to the concept of multiple 
deprivation. Each LSOA in Scotland has been assigned an overall SIMD 2009 score 
and also a rank (1=most deprived LSOA to 6, 505=least deprived LSOA in 
Scotland). The SIMD ranks are also categorised to provide SIMD quintiles, with 
quintile 1 specifying most deprived and quintile 5 least deprived. SIMD 2009 data 
and guidance on the methodology used as well as the variables used to construct the 
domains to derive the index is available from the Scottish Government website 
http://www.scotland.gov.uk/Topics/Statistics/SIMD.   
An SIMD linked data set therefore provided two further variables for analysis: 
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1. Deprivation quintile 
2. Urban-Rural (U-R) classification  
3.3.4 Data processing 
The processing of chlamydia data took place at two stages, firstly by the laboratory 
based statistical analyst prior to the extraction of data as per my request, and next, by 
me, once I had the anonymised data in my possession.   
3.3.4.1 Data processing at the laboratory 
The lab undertook a special processing of the raw dataset before it was handed over 
to me, to accommodate my intended research. Lab data retrieval and linkage with the 
SIMD dataset was undertaken by the scientific officer at the Bacteriology Reference 
Laboratory of Royal Infirmary, Edinburgh. Hence I received the processed data after 
removal of all personal identifications. The processing of the row dataset undertaken 
in the laboratory was as follows: 
i. A new variable called ‘Unique cluster code’ was created based on name, 
soundex code, gender, DOB and the Community Health Index (CHI) number 
(CHI is a population register, which is used in Scotland for health care 
purposes. The CHI number uniquely identifies a person on the index). I later 
used this variable, in the absence of CHI number, for de-duplication purpose 
(see section 3.3.4.2.1).  
ii. Age in years was calculated by subtracting the date of birth from the date of 
specimen submission. This enabled exclusion of exact DOB from the dataset to 
further ensure anonymity. 
iii. Record linkage: The Scottish government website provides information on 
SIMD deprivation score and its quintiles and other relevant variables (such as 
urban-rural classification) for each full postcode in Scotland. Hence for the 
Lothian postcodes (a total of 21, 796 full postcodes in Lothian), I retrieved 
variables on deprivation quintile and urban-rural classification from SIMD 
and, provided this dataset to the laboratory for data linkage. The laboratory 
dataset for which the postcode information was available (52.5% of the 
original lab database), it was linked with the SIMD dataset. The linked dataset 
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therefore provided these two additional geographical variables, only for cases 
with full postcode information. The full postcode information was later 
removed, for the confidentiality purpose, before the laboratory processed 
dataset was handed over to me.  
3.3.4.2 Further data processing once the data was received 
Data was received by me in a protected hard disk in CVS format. Upon receipt of the 
lab data, it was imported to SPSS version 17. It undertook the following processing 
to make the data ready for analysis. Figure 3-1 is a flow diagram showing the steps 
of data processing undertaken by me and the final datasets used for the analysis. 















Note: One record may fulfil several exclusion criteria. 
3.3.4.2.1 De-duplication 
It was estimated that approximately 5-20% of chlamydia tests in a calendar year are 
repeat ones on the same individual due to repeat sample taken at a single consultation 
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or sample taken at a different consultations for the same clinical episode 
(Information Service Division Scotland and National Service Scotland, 2008). Hence 
multiple samples should be identified and de-duplicated systematically within the 
dataset.  
For preparation of the dataset a de-duplication algorithm (Figure 3-2) was adapted to 
prevent multiple samples from the same episode being counted as proposed in the 
CTAS study (Health Protection Agency, 2008). A duplicate is defined as the latter of 
two samples which had been taken from an individual within a seven day continuous 
period. Duplicates were removed and single test records were retained.  





Where test results from duplicates detected chlamydia (i.e. one is positive and a 
second record is negative) and the date of specimen are within seven days, the 
positive result was retained. If the test result does not detect chlamydia (i.e. negative 
or equivocal), then negative is retained in preference to equivocal result. If the test 
results of the duplicates are same but are from different sample sites, then the order 
of preference of retaining the sample record were: genital, urine sample, rectal, 
pharyngeal or other sample. A total of 19, 713 records (8%) were removed by this 
process.   
3.3.4.2.2 Data inconsistencies and completeness 
Analysis of the dataset for completeness of individual data fields and inconsistencies 
was conducted to assess data quality. As described earlier, a full extract of all 
chlamydia testing data was requested. As well as minimising the workload on data 
provider, this also allowed me to identify data error and completeness of lab dataset. 
The following inconsistencies in the data were identified: 
i. For 169 records, specimen site did not match with gender. For example, for 130 
records, cervical specimen was recorded for male. 
Matched Unique cluster code –Yes Matched specimen dates –Yes Remove 
duplicates     OR 
Matched Unique cluster code –Yes Specimen dates within 7 days –Yes 
Remove duplicates  
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ii. For 4865 records, gender was coded as ‘unidentified’. A higher proportion of 
reporting of unidentified gender (64% of all unidentified gender reported in 5 
years) occurred in year 2007 (n=1640) and 2008 (n=1812). Moreover 61% 
(n=2985) of these were reported in PTK tests with highest numbers reported in 
2007 (n=1110) & 2008 (n=1635). These two years also represent the highest 
testing activity for PTK. 
iii. For 143 records, no age was recorded. It is possible to cross check patients DOB 
and gender with patients CHI number. CHI number is the unique patient identifier 
for health care services within Scotland and consists of a 10-character code. The 
first 6-digits of the CHI correspond to the date of birth (DDMMYY), two digits, a 
9
th
 digit which is always even for females and odd for males and an arithmetical 
check digit. However as I did not have access to CHI number and full DOB for 
confidentiality reasons, this cross checking was not possible. Therefore 4865 
records for unidentified gender and 143 records for age need to be removed in 
dataset 1 (used for gender and age analyses). 
3.3.4.2.3 Recoding 
Variables such as specimen type, location and test result have multiple codes. These 
variables were re-categorised as follows: 
i. Specimen Type: This variable had 42 codes. It was re-coded into 5 categories: 
1=‘genital swab’, 2= ‘urine sample’, 3= ‘rectal swab’, 4= ‘pharyngeal swab’ and 
5= ‘other’ (This category primarily includes conjuctival samples). SIGN 
guidelines covers chlamydia infection of genital tract, rectum or pharynx. 
Records with chlamydia tests from other sites, for example, ocular chlamydia 
infections were excluded from the analysis since they were unlikely to be 
transmitted sexually. Hence specimen indicated for genital chlamydia testing 
were specimen obtained by swabbing the cervix, vagina, urethra, rectum or 
pharynx, as well as urine samples.  
ii. Test Result: This variable had 18 codes. It was re-coded into 3 categories: 1= 
Positive, 2= Negative, 3= Inhibitory/ Equivocal. 
iii. Test Location: This variable had 572 codes. It was recoded into 5 categories: 1= 
GP surgery and community midwives, 2= GUM clinic, 3= Family planning 
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clinic, 4= Healthy Respect and outreach, 5= Others. The ‘other’ category 
primarily included test requests from hospital wards. Whereas Health Respect 
and outreach primarily represent tests undertaken through PTK. 
iv. Age: The age was categorised as: ≤14yrs, 15-19yrs, 20-24yrs, 25-29yrs, 30-
34yrs & ≥ 35. The categories ≤14yrs & ≥ 35yrs were only used for initial 
description of the sample. The calculation of diagnostic, surveillance and 
positivity rates and for the logistic regression analyses, the ≤14yrs and ≥ 35 were 
excluded.  
v. Years of testing was retained as a discrete variable for 5 years from 2006 to 
2010 separately. For the logistic regression analyses, the first two years (i.e. 
2006 and 2007) were merged to create a category ≤2007, to examine the impact 
of sexual health policies on chlamydia testing activity which were published in 
2008 and onwards.  
At this stage, two datasets were created as shown in figure 3-1. Dataset 1 includes all 
tested genital samples with definitive results. Dataset 1 was used for an overall 
description of chlamydia testing in Lothian and for part one of the policy analysis. 
Dataset 2 is a subset of dataset 1, where the individuals tested were 15-34 years of 
age and was used for the later part of the policy analysis and for the description and 
analysis of the three outcome measures.   
3.3.5 Outcome Measures 
Three outcome measures have been selected for the analysis of chlamydia testing 
activity trends in Lothian. These outcome measures are: 
3.3.5.1 Population surveillance rate (Coverage) 
Population surveillance rate reflects the coverage of chlamydia testing activity 





Population surveillance rate is a process measure and is used as a ‘standard’ measure 
for chlamydia testing activity in health care settings in Scotland (Standards 3.2 & 
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3.3), as proposed in 2008. Up until 2010 / 11, it has also been used by NCSP to 
monitor its programme performance. 
3.3.5.2 Population diagnostic rate (Prevalence) 
This measure reflects both coverage and positivity of testing at all health care 




RateDiagnosisPopulation   
 
3.3.5.3 Positivity rate 






Positivity is an important element of surveillance since it gives an indication as to 
whether testing is being targeted at those most in need, those who are chlamydia 
positive. NCSP have proposed to replacing population surveillance rate, with 
population diagnostic rate and positivity rate, from 2011 / 12. It is judged that these 
measures will better reflect chlamydia control activity, among those aged 15-24 
years old, in both NCSP and non-NCSP settings, including GUM clinics. 
3.3.5.4 Comparison of the three outcome measures / definitions 
Figure 3-3 overleaf is a diagrammatic representation of the three outcome measures. 
In each diagram the entire ‘area’ population is hypothetically split into (the same) 
three subsets – not tested, tested but negative, and tested positive. In each diagram, 
the mauve slice (or in the bottom diagram, slices) indicate(s) the numerator for the 
outcome measure, whereas the grey slices (or in the bottom diagram, slice) 
represent(s) the remainder of the denominator (because the entire denominator of 
course includes the numerator as well). The diagram therefore aids understanding of 
how the three outcome measures differ in what they encapsulate.  
It can be seen that positivity rate is a testing activity outcome measure, and requires 
only the laboratory dataset provided to undertake analysis. However surveillance rate 
and diagnostic rate are population-based measures and, in order to calculate these 
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outcomes, it is required to obtain the relevant Lothian population estimates over the 
relevant years.  
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Figure 3-3: Diagrammatic representation of outcome measures for chlamydia testing   
Test negative Test positive Not tested
Diagnostic 
rate
Test negative Test positive Not tested
Positivity
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3.3.5.5 Other outcomes relevant to the analysis of sexual health policy & 
guidelines for Scotland 
Age focused testing outcomes are used in the analysis of QIS sexual health service 
standards and SIGN guideline for chlamydia. These standards and guideline have 
been discussed in detail in section 2.3. The key points relevant to the analyses of 
routine data for chlamydia are described below: 
The sexual health services standards were published in April 2008 by Quality 
Improvement Scotland (NHS Quality Improvement Scotland, 2008). Standard 
statement 3 is about the provision of chlamydia testing. Its following three 
components are particularly relevant: 
i. Standard 3.1: 60% of chlamydia tests per year are taken from males and 
females aged under 25 years. 
ii. Standard 3.2: For males aged 15-24 years, the annual rate of chlamydia tests 
performed in the NHS board area is greater than 100 per 1000 population. 
iii. Standard 3.3: For females aged 15-24 years, the annual rate of chlamydia tests 
performed in the NHS board area is greater than 300 per 1000 population. 
While standards 3.2 and 3.3 use population surveillance rate as an outcome measure, 
as already described (section 3.3.5.1), the appropriate outcome measure for standard 
3.1 is an age targeted proportion of all testing (i.e. number of tests among those <25 
years old / total number of tests).  
The revised SIGN guidelines (Number 109) on the management of genital chlamydia 
infection then followed the next year in March 2009 (Dhar et al., 2010). Its key 
recommendations relevant to my current analyses of data are as follows: 
i. Resources for chlamydia testing in women should be targeted where prevalence 
is known to be highest, i.e. first those aged 15-19 and then those aged 20-24. 
ii. Resources for chlamydia testing in men should be targeted where prevalence is 
known to be highest, i.e. those aged under 25. 
iii. Postal testing kits should be used to increase chlamydia testing among young 
men 
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Although the above SIGN guideline recommendations does not provide measurable 
targeted outcomes, these recommendations are also evaluated while presenting the 
analysis of QIS sexual health service standards in terms of any increase in testing 
activity in the defined age group as well as the use of PTK among men.  
3.3.6 Obtaining population denominators needed for 
analyses of surveillance rate and diagnostic rates 
The denominator for population surveillance rate and for population diagnostic rate 
is a midyear population, so these outcomes required accessing GROS population 
figures for Lothian for the relevant years. The laboratory dataset would provide 
numerator counts of tests undertaken (for surveillance rate) or of positive test results 
(for diagnostic rate). However, it was also wished to be able to include gender and 
age group in the analysis. Therefore the population counts were obtained for 32 cells 
(corresponding to the 32 unique combinations of the three explanatory variables: age 
category (4 categories i.e. 15-19 years, 20-24 years, 25-29 years & 30-34 years); 
gender (2 categories i.e. male & female); and year of testing (4 categories i.e. 2006-
07, 2008, 2009 and 2010) (Table 3-1). For the analysis by SPSS, however, what 
needs to be input is not numerator and denominator, but numerator and remainder of 
denominator (for example, for population surveillance rate, tested (t) and not tested 
(N-t), where ‘not tested’ = denominator - numerator). An outcome variable was 
therefore created, where ‘1’ refers to the unique combination count of ‘tested’ and 
‘0’ refers to the unique combination counts of ‘not tested’. The final step prior to 
analysis was to declare the variable containing t and N-t as a weight variable in SPSS 
to simulate the current frequencies of the unique combination of the explanatory 
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Table 3-1: Development of aggregated data set for analysis of population surveillance 
rate – two rows created for each of the 32 population x year combinations 
Explanatory variables - Combination codes Outcome Counts 
Age category 
















No = 0 
Aggregate 
number 












A similar exercise was undertaken for the analysis of population diagnostic rate 
(Table 3-2). However, the numerator counts for each 32 unique aggregates is 
obtained from the laboratory dataset for the number of positive tests (p), and N-p is 
obtained by subtracting p from the midyear Lothian population estimate for each 
unique combination of age, sex and year population (N). A variable containing p and 
N-p is then declared as a weight variable in SPSS for the analysis of population 
diagnostic rate. 
Table 3-2: Development of aggregated data set for analysis of population diagnostic 
rate – two rows created for each of the 32 population x year combinations 
Explanatory variables - Combination codes Outcome Counts 
Age category 
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3.3.7 Statistical analysis 
3.3.7.1 Descriptive statistics 
Descriptive statistics were produced. Proportions of chlamydia testing activity across 
different health care settings, age categories, gender and years were plotted in graphs. 
3.3.7.2 Logistic regression analyses  
Logistic regression analyses are performed separately for surveillance rate, positivity 
rate and diagnostic rate (see section 3.3.5, for the definition of the three outcome 
measures). The multivariate modelling was used to describe the associations of these 
outcome measures with available epidemiological variables, not to construct a 







), significance level for the Wald test and its degrees of freedom, 
OR and C.I. for each explanatory variable are presented in the final model.    
3.3.7.3 Multiple imputations of missing values 
For the analysis of positivity rate was performed on the SIMD-linked dataset which 
provided two additional SIMD variables (deprivation quintile and urban-rural 
classification) were available as potential explanatory variables. As discussed in 
section 3.3.4.1, data linkage for the two SIMD-linked variables could only be 
achieved for 53% of the full laboratory dataset. Performing multivariate logistic 
regression would result in list-wise deletion of cases with any missing value on any 
covariate. Thus the high proportion of missing values for deprivation and urban-rural 
would lead to the exclusion of a substantial proportion of the tested population, 
which in turn leads to substantial loss of precision and power and would introduce 
bias (Sterne et al., 2009a).  
In SPSS, missing value analysis can be performed to assesses whether the data is 
missing completely at random (MCAR) - when subjects with missing data form a 
random subset of study sample; or missing not at random (MNAR) - when the 
probability that an observation is missing depends upon unobserved subject 
information. Moreover, when the (missing) value of the variable depends on 
characteristics that are observed, missing values are called MAR (missing at random) 
and need complicated statistical modelling. Complete case analysis on MCAR data 
would give an unbiased, though less precise estimates. However, when the data is 
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MAR, multiple imputations (MI) have been recommended as a means of dealing 
with the missing data. In MI, each missing value is replaced by a set of ‘m’ > 1 
plausible values drawn from their predictive distribution, based on all other 
information available in the data set. This results in ‘m’ complete datasets, each of 
which can be analyzed by complete-data methods (Schafer and Olsen, 1998, Sterne 
et al., 2009a). 
Missing value analysis performed on the SIMD-linked dataset confirmed that the 
dataset is MAR. The missing values for deprivation quintile and urban-rural 
classification differ across gender and age categories, because the variable is mainly 
missing in GUM clinic testing data, and it is GUM where most of the tests for males 
are performed and where there is more testing of the younger age category. Missing 
data were therefore imputed in SPSS, using multiple imputation command to 
generate 5 ‘complete’ sets of data. It has been recommended that any  imputation 
procedure should include explanatory variables involved in the planned analysis, the 
outcome variable (Moons et al., 2006, Sterne et al., 2009a), and any variables not 
used in the analysis which nevertheless have strong correlations with incomplete 
variables (He, 2010). The variables identified for the current MI procedure include 
age category, gender, year of testing, SIMD quintile, urban-rural classification, result 
category and test location. The test location is not used in modelling, but missing 
SIMD values were far less common for non-GUM cases, so test location was 
included in the MI procedure.  
Analytical procedures in SPSS, which work with MI datasets, first produce output 
for each complete imputed dataset, and then provide pooled estimates from those 
outputs. The logistic regression models for positivity rate are reported and compared 
both for pooled estimates obtained after running analysis of MI datasets, as well as 
estimates obtained after list-wise deletion of cases with missing values in the original 
dataset.  
For the analysis of population diagnostic and surveillance rate, multiple imputations 
would have been required at aggregate level, but this was beyond the scope of this 
research.   
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3.3.8 Ethical approval 
Studies involving access to routine data from the NHS laboratory require Caldicott 
Guardian approval, which was later sought from the NHS Lothian board (Reference 
number: JMS/JI/10175) (Appendix 1). 
 
Chapter 3: Analysis of routine data…………………………….  
51 
3.3.9 Presentation of results  
The results are presented in six sections as follows: 
 Overall description of dataset (for both complete dataset and SIMD linked 
dataset), for various demographic and descriptive variables (section 3.4.1).  
 Description of population surveillance rate stratified for age, gender and year of 
testing; and the association of these explanatory variables with the population 
surveillance rate (section 3.4.2).  
 Description of population diagnostic rate stratified for age, gender and year of 
testing; and the association of these explanatory variables with the population 
diagnostic rate (section 3.4.3).  
 Description of positivity rate stratified for age, gender and year of testing; and the 
association of these explanatory variables with the positivity rate (section 3.4.4.1).  
 Description of positivity rate with additional SIMD linked variables i.e. 
deprivation quintile and urban-rural classification (section 3.4.4.2). This section 
present results that estimate the association of positivity rate with age, gender, 
year of testing as well as deprivation quintile and urban-rural classification. 
Logistic regression analysis was performed on the original dataset to allow list-
wise deletion of cases with missing values (i.e. missing values for deprivation 
quintile and urban-rural classification); and on multiple imputed (MI) datasets. 
Pooled estimates from multiple imputed datasets are reported.  
 Analyses of chlamydia testing activities before and after the introduction of the 
QIS sexual health service standards (2008) and the SIGN guideline (2009) are 
presented in section 3.4.5 
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3.4 Results 
3.4.1 Description of Lothian laboratory dataset 
Table 3-3 gives the basic description of chlamydia testing activity in Lothian. The 
tests were evenly distributed across the five years. Genital samples accounted for 
nearly half of all the chlamydia samples taken. Further analysis of specimen type by 
gender (data not shown) suggests that genital samples were predominantly (97.8%) 
taken from female, whereas, urine samples were more evenly distributed among 
males (45.6%) and females (51%).  
Of all the tests performed, 49% were on ≤ 24 year olds. The largest proportion of 
tests were performed in GP surgeries (37.3%), followed by GUM clinic (34.4%). The 
overall positivity rate for the five years was 7.8%.  
Since SIMD linkage was achieved for nearly half of the dataset (53.4%), missing 
value analysis was undertaken to identify any variations in missing values for SIMD 
linked variables across the available laboratory database variables (Table 3-4). The 
SIMD-linked variables were primarily missing in tests undertaken in GUM clinics 
(99.9%), Healthy Respects drop-ins (99.9%) and FP & WW clinics (60.3%). 
Furthermore, these variables are more commonly missing among tests undertaken for 
males (77%). This disparity in missing SIMD variables for males was primarily 
because males were more commonly tested in sexual health clinics and these clinics 
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Table 3-3: Descriptive statistics for genital chlamydia laboratory data 
Variable* n  (%) 
Year of testing   
2006 42614 19.4 
2007 40710 18.6 
2008 44759 20.4 
2009 46823 21.4 
2010 44369 20.2 
Specimen Type   
Genital Swab 102014 46.5 
Urine 115702 52.8 
Rectal 1524 0.7 
Pharyngeal 35 0.0 
Gender   
Female 161070 73.5 
Male 58205 26.5 
Age (in years)   
≤ 14 1684 0.8 
15-19  36635 16.7 
20-24 67643 30.9 
25-29 45171 20.6 
30-34 26570 12.1 
≥ 35 41530 18.9 
Test Result   
Positive 17042 7.8 
Negative 202233 92.2 
Test Location   
GP Surgery 81821 37.3 
GUM 75350 34.4 
FP & WW 18993 8.7 
HR & Outreach 8425 3.8 
Others 34686 15.8 
Dataset 1 (N=219275), see Figure 3-1 
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Table 3-4: Number (%) missing values for SIMD deprivation and urban-rural 
explanatory variables, by categories of key routine data variables  
Variable Missing values in each category* 
 n % 
Total missing values 104365 47.6 
Age in years   
≤ 14 218691 65.3 
15-19  202260 53.6 
20-24 185109 49.5 
25-29 195459 47.3 
30-34 203899 42.1 
≥ 35 195325 42.3 
Gender   
Female 117640 36.9 
Male 206000 77.2 
Test Location   
GP Surgery 142250 5.9 
GUM 219217 99.9 
FP & WW 211740 60.3 
HR & Outreach 219267 99.9 
Others 188991 12.7 
Year of testing   
2006 195204 43.5 
2007 196698 44.5 
2008 196037 48.1 
2009 196125 50.6 
2010 197401 50.7 
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Table 3-5 shows the distribution of SIMD linked variables in the laboratory dataset 
and for the Lothian population. The first three deprivation quintiles are more 
frequently represented in the SIMD-linked laboratory data subset as compared to the 
Lothian data-zone population. For example, the most deprived quintiles represent 
15.9% of the laboratory data subset compared to 12.6% of the Lothian data-zone 
population categorised as most deprived. Similarly, testing from the urban areas is 
slightly more represented (95%) in the laboratory data subset than that for Lothian 
data-zone population (92%). 
Table 3-5: Distributions for deprivation and urban-rural variables separately for the 
SIMD linked laboratory dataset and for the Lothian population 
 




SIMD linked variables n % % 
Deprivation Quintile    
1 (Most Deprived) 18261 15.9 12.6 
2 24225 21.1 19.5 
3 21028 18.3 16.8 
4 19550 17.0 17.7 
5 (Least Deprived) 31846 27.7 33.4 
Urban-Rural Classification    
Urban 108976 94.8 92.1 
Rural 5943 5.2 7.9 
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3.4.2 Population surveillance rate  
The population surveillance rate (see 3.3.5.1 for definition) in men by year for 
different age categories is shown in Figure 3-4. In order to make it easier for visual 
comparisons of rates in the male and female graph, the y-axis of the graph for males 
is on the same scale as that for females. Across different age categories, the rates 
were highest among 20-24 year old males and then among those 25-29 years old. 
Across five years, the surveillance activity was only slightly increased in 2009.  
Figure 3-4: Males – population surveillance rate / 1000 males (mid-year population) in 














































2006 2007 2008 2009 2010
2006 53 105 81 50
2007 49 103 75 48
2008 55 115 74 53
2009 64 116 76 51
2010 60 110 71 50
15-19 20-24 25-29 30-34
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In a similar way, the population surveillance rates among women by year and age 
categories are shown in Figure 3-5. Overall population surveillance rate for females 
was approximately three times as high as for males. The rates were highest among 
20-24 year old females and then 15-19 years old. Across the five years, rates have 
tended to increase among 15-19 years old and 20-24 years old but remained more 
stable among the later age categories.  
Figure 3-5: Females – population surveillance rate / 1000 females (mid-year 


















































2006 2007 2008 2009 2010
2006 239 297 201 131
2007 207 276 193 128
2008 244 317 200 136
2009 269 325 205 140
2010 254 302 181 128
15-19 20-24 25-29 30-34
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A multivariate logistic regression analysis of population surveillance rate with three 
independent explanatory variables (age category, year of testing and gender) shows a 
statistically significant association with each variable (p-value of <0.001). Table 3-6 
shows the adjusted OR and 95% C.I, regression coefficients (log odds) and its S.E. 
and Wald statistics p-value for each of the three variables. Appendix 2 shows crude 
OR and 95% C.I. for the association of population surveillance rate. Refer to figure 
3-3 for understanding odds ratio for surveillance rate. 
Table 3-6: Population surveillance rate – multivariate logistic regression analysis of its 
association with age, gender and year of testing 
Variables in the 
main effect model Log Odds S.E. Sig. 
Adjusted 
OR 
95% C.I. for OR 
Lower Upper 
Age Category  
(in Yrs)     
<0.001* 
      
15-19 0.569 0.009  1.77 1.74 1.80 
20-24 0.992 0.008  2.70 2.65 2.74 
25-29 0.458 0.008  1.58 1.56 1.61 
30-34 0   1.00   
Gender     <0.001**        
Female 1.258 0.006  3.52 3.48 3.56 
Male 0   1.00   
Year of Test     <0.001***       
2008 0.081 0.007  1.08 1.07 1.10 
2009 0.125 0.007  1.13 1.12 1.15 
2010 0.031 0.007  1.03 1.02 1.05 
2006-07 0   1.00   
Constant -3.139 0.009 <0.001 0.043     
Wald statistics (df): * 16969.73(3), **45676.09(1), ***338.01(3) 
According to the Wald criteria, all the three variables are significantly associated 
with having a chlamydia test. In the model, after adjusting for all the three 
explanatory variables, odds of being tested in a population among those aged 20-24 
years old were 2.7 times (95% CI: 2.65 to 2.74) more as compared to 30-34 years 
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old.  For females, the odds of being tested in a population were 3.52 times (95% CI: 
3.48 to 3.56) as compared to males. Compared to 2006-07, the odds of being tested 
in a population were 8% more likely in 2008 and 13% more likely in 2009, but falls 
to 3% in 2010.  
Next, an interaction term ‘age category by gender’ was entered in the main effect 
model. Appendix 3 presents the results of this analysis with three explanatory 
variables and the interaction term ‘age category by gender’ added in the main effect 
model. Figure 3-6 is a simple graphical representation of the odds ratio of population 
surveillance rate for age categories and gender, calculated by multiplying the odds 
ratio of each combination of age and gender categories in Appendix 3. The reference 
category is 30-34 years old males. As can be seen in figure 3-6, across all age 
categories, the odds of being tested in a population was higher among females 
compared to males. As compared to the reference group, the OR in the 15-19 year 
olds was more than 5 times as higher among females (OR =5.97) than males in the 
same age category (OR=1.13). Further examination of the interaction term in 
Appendix 3 suggests that the highest log odds for interaction category (which 
represent the largest interaction effect) is 0.612 for ‘15-19 year olds by female’. The 
Wald statistics for the interaction term was statistically significant (Wald statistics 
(df) = 1289.2 (3); p-value <0.001). 
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Figure 3-6: Association of population surveillance rate with gender and age, including 










Next, an interaction term ‘age category by year of testing’ was entered in the main 
effect model. Appendix 4 presents the results of this analysis with three explanatory 
variables and the interaction term ‘age category by year of testing’ added in the main 
effect model. Figure 3-7 is the graphical presentation of OR for population 
surveillance rate with different combinations of age categories and year of testing, 
when an interaction term (age category by year of testing) is included in the model. 
The reference category is 30-34 year old for the year 2006-07. Within each age 
category, the odds of being tested in a population were progressively higher in 2008 
and 2009 as compared to 2006-07. In 2010, the odds of being tested though higher 
among 15-19 and 20-24 year old compared to same categories in 2006-07, but 
decreased for older age categories as compared to 2006-07. Within each year, the 
odds of being tested in a population were highest for the 20-24 year old age category. 
The Wald statistics for the interaction term was statistically significant (Wald 
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Figure 3-7: Association of population surveillance rate with year of testing and age, 










If the sample size is large, almost any difference between models is likely to be 
reliable (statistically significant) (Tabachnick and Fidell, 2007). In the current 
scenario, the addition of interaction terms only adds little extra meaning to the main 
effect model at the cost of a more complex model. Hence it was decided to keep a 
more parsimonious model by not including an interaction term in the model. 
Therefore the main effect model was retained for final discussion and comparison 
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3.4.3 Population diagnostic rate  
Figures 3-8 and 3-9 compares the population diagnostic rates for males and females 
in different age categories across five years. Among the different age categories in 
males, the highest rates were observed among 20-24 years old at 1834/100,000 in 
2006 and declining to 1456/100,000 in 2010. Within each age category, the rates 
from 2006 to 2010 remained relatively stable among 15-19 year olds, but tended to 
decrease in the older age categories.  
Figure 3-8: Males - population diagnostic rate / 100, 000 males (mid-year population) in 


















































2006 2007 2008 2009 2010
2006 948 1834 1027 485
2007 743 1455 876 504
2008 896 1742 793 478
2009 878 1654 768 315
2010 976 1456 705 297
15-19 20-24 25-29 30-34
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Figure 3-9: Females - population diagnostic rate / 100, 000 females (mid-year 











The diagnostic rates among females (Figure 3-9) have a decreasing trend across the 
four age categories with the highest rates observed among 15-19 years old 
(3276/100,000 in 2009). Across five years, the rates remained similar in 15-19 year 
old age category, but tended to decrease in the later age categories.  
Table 3-7 shows the main effect model of a multivariate logistic regression analysis 
performed on diagnostic rate as an outcome and three explanatory variables: age 
category, year of testing and gender. Univariate analysis indicated that all the three 
variables were statistically significant with a p-value of <0.001, see Appendix 2). 
Refer to figure 3-1 for understanding odds ratio for diagnostic rate.  
In the model, after adjusting for all the three explanatory variables, the odds of 
diagnoses among 15-19 year olds and 20-24 year olds were five times more likely 
(95% CI 4.86 to 5.54 among 15-19 year olds; and 5.19 to 5.90 among 20-24 year 
olds) than 30-34 year olds in the population. The odds of diagnosis were 74% more 









































2006 2007 2008 2009 2010
2006 3127 2779 1098 397
2007 2468 2541 888 360
2008 3051 2563 1011 340
2009 3276 2489 839 347
2010 3119 2181 776 306
15-19 20-24 25-29 30-34
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year of testing, except for the year 2010, where the odds of diagnosis in a population 
was 11% less likely than early years i.e. 2006-07.  
Table 3-7: Population diagnostic rate – multivariate logistic regression analysis of its 
association with age, gender and year of testing 
Variables in the 
main effect model 
Log Odds S.E. Sig. 
Adjusted 
OR 
95% C.I. for OR 
Lower Upper 




   
15-19 1.65 0.033  5.19 4.86 5.54 
20-24 1.71 0.032  5.53 5.19 5.90 
25-29 0.83 0.035  2.30 2.15 2.47 
30-34 0   1.00   
Gender          
Female 0.55 0.017 <0.001** 1.74 1.69 1.80 
Male 0   1.00   
Year of Test   <0.001***    
2008 0.006 0.022  1.01 0.96 1.05 
2009 -0.03 0.022  0.97 0.93 1.01 
2010 -0.11 0.023  0.89 0.86 0.93 
2006-07 0   1.00   
Constant -5.86 0.033 <0.001 0.003   
Wald Statistics(df): *4016.65(3), **1093.25(1), ***29.24(3) 
 
Two interaction terms, age category by gender and age category by year of test, were 
separately entered in the main effect model (analysis not shown here). The Wald 
statistics for each interaction term were statistically significant (p-value <0.001). 
However, as noted in section 3.4.2, given the large sample size, statistical 
significance would be expected even for a fairly modest absolute effect. Here the 
value of Wald statistics was even lower than the corresponding Wald statistics values 
for interaction terms in the logistic regression model for the population surveillance 
rate (Wald statistics (df) for: age category by year of testing =71.21(9); age category 
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by gender = 709.67 (3). Hence it was decided that there was no need to retain the 
interaction term in the model.  
3.4.4 Positivity rate  
3.4.4.1 Association with age, gender and year of testing  
Figure 3-10 and 3-11 indicate the positivity rate among males and females for the 
different age categories across the five years. Overall, the positivity tended to 
decrease with increasing age-band, both among males and females. The highest 
positivity was observed in 2006 among 15-19 year old males (18%) and females 
(13%). Positivity rate remained relatively stable between 2007-2010 among 15-19 
year old males and females. For the later age categories, among males and females, 
the positivity decreased in successive years. 
Figure 3-10: Males - positivity rate across years 2006 to 2010, among 15 to 34 year 






































2006 2007 2008 2009 2010
2006 18.0 17.4 12.8 9.8
2007 15.1 14.1 11.6 10.5
2008 16.4 15.2 10.8 9.1
2009 13.9 14.2 10.1 6.2
2010 16.2 13.3 10.0 6.0
15-19 20-24 25-29 30-34
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Figure 3-11: Females - positivity rate across years 2006 to 2010, among 15 to 34 year 












As can be seen in Appendix 5, the population diagnostic rate was consistently higher 
for females as compared to males at each age year, however the reverse was true for 
the positivity rate i.e. the positivity rate was higher among males as compared to 
females.   
Univariate analysis indicated that all the three variables were statistically significant 
with a p-value of <0.001 (Appendix 2). Table 3-8 shows the main effect model of a 
multivariate logistic regression analysis performed on positivity rate as an outcome 
and three explanatory variables: age category, year of testing and gender. The odds 
of being tested positive was highest among 15-19 years olds (OR 3.75; 95% CI; 3.50 
to 4.01) then among 31-34 year olds. The odds of a positive test were 0.52 times 
lower among females (95% C.I. 0.50 to 0.54) as compared to males. Compared to the 




























2006 2007 2008 2009 2010
2006 13.3 9.4 5.5 3.0
2007 12.0 9.3 4.6 2.8
2008 12.6 8.2 5.1 2.5
2009 12.4 7.8 4.1 2.5
2010 12.5 7.3 4.3 2.4
15-19 20-24 25-29 30-34
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Table 3-8: Positivity rate – multivariate logistic regression analysis of its association 
of with age, gender and year of testing 
Variables in the 
main effect model Log 
Odds S.E. Sig. 
Adjusted 
OR 
95% C.I. for OR 
Lower Upper 




   
15-19 1.32 0.03  3.75 3.50 4.01 
20-24 0.95 0.03  2.60 2.43 2.77 
25-29 0.46 0.04  1.58 1.47 1.70 
30-34 0.00   1.00   
Gender   <0.001**    
Female -0.66 0.02  0.52 0.50 0.54 
Male 0.00   1.00   
Year of Test     <0.001***       
2008 -0.08 0.02  0.93 0.89 0.97 
2009 -0.17 0.02  0.85 0.81 0.89 
2010 -0.18 0.02  0.84 0.80 0.88 
2006-07 0.00   1.00   
Constant -2.61 0.03 <0.001 .073   
Wald Statistics (df): * 2122.78(3), **1346.28(1), ***82.07(3) 
Two interaction terms, age category by gender and age category by year of testing, 
were separately entered in the main effect model. The Wald statistics for the 
interaction terms were statistically significant (p-value <0.01). The Wald statistics 
and corresponding p-values for the interaction terms were even lower than for those 
in the hierarchical model for population surveillance rate and population diagnostic 
rates, indicating an even less strong relationship between these categories. Hence it 
was decided to retain the main effect model for the discussion purpose.  
3.4.4.2 Further analysis of positivity rate by deprivation  
Figures 3-12 and 3-13 show the positivity rate for the age categories across the 
deprivation quintiles for females and males respectively. Within each deprivation 
quintile among females, the chlamydia positivity was highest among 15-19 year age 
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category and decreased with the increasing age category. Across the deprivation 
quintiles, positivity was highest in the most deprived quintile and then decreased 
successively in the lesser deprived quintiles. The only exception is the 15-19 year old 
age category among females where the positivity was similar in the two most 
deprived quintiles (13% and 14% respectively). Among males, the pattern was 
similar but less regular in that in deprivation quintiles 2 and 4, 15-19 years old have 
positivity rate lower than 20-24 year old. The highest positivity was seen among 15-
19 year old males in the most deprived quintile (23%).  
Figure 3-12: Females - positivity rate across deprivation quintiles, among 15 to 34 year 



























15-19 20-24 25-29 30-34
15-19 12.9 13.8 12.1 11.1 9.3
20-24 10.2 9.2 7.3 7.6 6.1
25-29 5.3 4.7 4.4 4.1 3.8




5  (Least 
deprived)
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Figure 3-13: Males - positivity rates across deprivation quintiles, among 15 to 34 year 











Figure 3-14 shows the distribution of positivity across the deprivation quintiles, 
separately for each year. Across the deprivation quintiles, positivity tended to be 
highest in the most deprived quintile for each year and decreased successively in the 
lesser deprived quintiles. Within each quintile, other than middle quintile, the 
positivity showed an overall trend of decreasing across the five years. 
Figure 3-14: For each year - positivity rate across deprivation quintiles, among 15 to 

























15-19 20-24 25-29 30-34
15-19 22.6 17.3 20.3 15.7 14.2
20-24 19.5 19.4 16.5 16.9 14.4
25-29 13.3 11.5 12.2 11.6 9.5
























2006 2007 2008 2009 2010
2006 10.1 9.9 7.2 8.0 7.0
2007 10.0 9.0 7.8 6.9 6.4
2008 10.3 8.9 7.1 7.2 6.0
2009 8.7 7.7 6.6 6.4 5.0
2010 7.8 7.8 7.7 6.4 5.4
1 (Most deprived) 2 3 4
5  (Least 
deprived)
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Chlamydia positivity among those tested in the urban population was 7.5%, whereas 
for those tested in the rural population, it was 9.1% (data not shown).  
Table 3-9 shows three models of logistic regression analyses with explanatory 
variables. In order to make comparison with the second and third models where 
SIMD-linked variables were added, model 1 shows the adjusted OR and 95% CI, 
from Table 3-8, for three independent variables age category, year of testing and 
gender. In model 2, deprivation quintile and 2-fold urban-rural classification were 
added along with age category, gender and year of testing in a full dataset to allow 
for list-wise deletion of cases with missing values. Finally in model 3, pooled results 
of logistic regression analyses on five (imputed) complete datasets are presented 
(also see Appendix 6 for  co-efficient and S.E of model 3).  
In model 2, based on list-wise deletions of cases with missing values, the odds ratios 
for age category and gender had similar but stronger trends as compared to model 1. 
To check whether the alteration in the strength of association with age category and 
gender are due to the reduced dataset (bias) or due to the effect of the addition of 
SIMD-linked variables (confounding), the analysis (with age, gender and year as 
predictor variables) was rerun on the reduced dataset, which include only cases with 
values for SIMD-linked variables. This showed that the stronger association of age 
and gender persisted and hence were not a consequence of the addition of the SIMD-
linked variables (analysis not shown here). This suggests that the addition of 
deprivation quintile and urban-rural classification variables do not explain the change 
in estimates for association with age category and gender. In model 2, the odds of 
being tested positive, relative to the least deprived testees, was highest among the 
most deprived quintile (OR 1.59; 95% CI; 1.47 to 1.72) and decreased with 
decreasing deprivation quintile. Relative to those tested in the urban areas, the odds 
of being tested positive was 16% higher (95% CI; 1.04 to 1.30) in those from rural 
areas.  
In model 3, after multiple imputations, the pooled OR for age category and gender 
are closer to those in model 1 but with a narrower 95% C.I, due to smaller standard 
errors. The ORs for deprivation quintile had a decreasing trend, but the strength of 
association was similar to what was seen in model 2. However, the ORs for urban-
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rural classification became non significant. The ORs for year categories remained 
similar in all the three models.  
Table 3-9: Positivity rate and deprivation - multivariate logistic regression analysis by 
age, gender, deprivation and year of testing 
 Model 1 Model 2 Model 3* 
Variables in the 
main effect model 
Adjusted 
OR 
95% C.I Adjusted 
OR 




Lower Upper Lower Upper Lower Upper 
Age Category          
15-19  3.75 3.50 4.01 4.62 4.16 5.12 3.62 3.55 3.69 
20-24 2.60 2.43 2.77 3.23 2.92 3.57 2.59 2.53 2.66 
25-29 1.58 1.47 1.70 1.78 1.59 1.98 1.57 1.50 1.64 
30-34  1.00   1.00   1.00   
Gender          
Female 0.52 0.50 0.54 0.43 0.40 0.46 0.52 0.48 0.57 
Male    1.00   1.00   
Year of testing          
2008 0.93 0.89 0.97 0.92 0.86 0.98 0.92 0.87 0.96 
2009 0.85 0.81 0.89 0.79 0.74 0.85 0.84 0.80 0.89 
2010 0.84 0.80 0.88 0.81 0.75 0.86 0.83 0.78 0.88 
2006-07    1.00   1.00   
Deprivation 
Quintiles 
         
1 (Most deprived)    1.59 1.47 1.72 1.58 1.49 1.67 
2    1.47 1.36 1.58 1.45 1.38 1.52 
3    1.27 1.17 1.37 1.29 1.17 1.42 
4    1.19 1.10 1.30 1.20 1.09 1.31 
5 (Least Deprived)    1.00   1.00   
2 fold Urban Rural 
classification 
         
Rural    1.16 1.04 1.30 1.15 0.97 1.34 
Urban    1.00   1.00   
Constant 0.073   0.054   0.057   
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Based on model 3, the odds of positivity among 15-19 year olds were 3.6 times (95% 
CI 3.55 to 3.69) more likely compared to 30-34 year olds. The odds ratio had a 
decreasing but positive trend with increasing age category. The odds of positivity 
among females were 0.52 times (95% C.I 0.48 to 0.57) less likely than males. As 
compared to the year 2006-07, the odds of being tested positive decreased in 
successive years. The odds of being tested positive was highest among the most 
deprived quintile (OR 1.58; 95% C.I 1.49 to 1.67) compared to the least deprived 
quintile. There was a decreasing but positive trend in the successive deprivation 
quintiles compared to the least deprived quintile. 
Three interaction terms; ‘deprivation quintile by year of testing’, ‘deprivation 
quintile by age category’ and ‘deprivation quintile by gender’ were separately 
entered in the main effect model in the MI datasets. Pooled estimates of OR for all 
the three interaction terms were non significant, hence the main effect model was 
retained. 
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3.4.5 Chlamydia testing activity before and after the 
introduction of Scottish national policy and guidelines 
This section presents the analyses to address the QIS sexual health service standards. 
Some references are also made to the SIGN guideline recommendations which are 
considered relevant or implicit in the discussed standards. 
 
 
The distribution of chlamydia tests across age-bands among males and females are 
shown in figures 3-15 and 3-16 respectively. For males the two shades of blue slices 
within each bar show the proportion of tests performed in the two youngest age 
categories (under 25 years old). For females this age group is represented by the two 
shades of mauve slices. The largest proportion of tests were performed among those 
aged 20-24 years old (~30% among males and ~31% among females), followed by 
among 25-29 year olds (~24% among males, ~24% females respectively). 
With respect to examining whether activity reflected policy and guidelines, red and 
green arrows indicate the timing of (i) introduction of SH service standards (2008) 
and (ii) publishing of the SIGN guidelines (2009) respectively and red dotted line 
across the bars for 2008 onwards indicates the 60% SH service standards target.  
It can be seen that the proportion of tests performed among <25 years old males 
increased from 41% in 2007 to 44% in 2009. The increase in chlamydia testing 
activity observed during same period among women aged <25 years was from 49% 
to 51%. However in neither gender was the threshold target achieved. 
For both males and females, 60% of all tests per year are taken from <25 
year old (including <15 years) (Standard 3.1) 
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Figure 3-15: Males - distribution by age-band of genital chlamydia tests performed, 













Figure 3-16: Females - distribution by age-band of genital chlamydia tests performed, 
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Distribution of all tests across age bands
<=14 15-19 20-24 25-29 30-34 >=35
>=35 18.1 17.9 16.6 16.8 16.7
30-34 9.4 9.3 9.0 8.7 8.6
25-29 22.3 24.1 23.5 23.6 23.3
20-24 31.1 30.9 31.9 30.9 31.0
15-19 18.3 17.0 18.2 19.0 19.3
<=14 0.9 0.8 0.8 0.9 1.0
2006 2007 2008 2009 2010

















Distribution of all tests across age bands
<=14 15-19 20-24 25-29 30-34 >=35
>=35 23.5 24.9 23.9 23.0 23.6
30-34 9.8 9.2 9.2 9.1 9.3
25-29 24.8 24.8 24.1 24.0 23.9
20-24 29.4 29.1 30.7 30.4 29.8
15-19 12.0 11.4 11.8 13.1 13.0
<=14 0.6 0.5 0.3 0.4 0.5
2006 2007 2008 2009 2010
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Figures 3-17 and 3-18 shows that between 2008 to 2010, the 60% testing target for 
<25 years old had only been achieved in HR & outreach among males; and in GUM 
clinics and HR & outreach among females. However note that Healthy Respect 
venues were primarily meant to serve young people under 25 years.  
Figure 3-17: Males - distribution by age-band of genital chlamydia tests performed, 

































Distribution of all tests across age bands
<=14 15-19 20-24 25-29 30-34 >=35
>=35 27.0 8.1 13.4 23.0 27.1
30-34 8.3 5.7 5.8 9.0 10.6
25-29 17.7 18.0 25.4 24.9 23.1
20-24 26.8 36.0 26.4 31.8 25.8
15-19 18.4 30.6 28.6 11.0 12.9
<=14 1.8 1.6 0.4 0.2 0.4
Other HR & Outreach FP & WW GUM GP Surgery
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Figure 3-18: Females - distribution by age-band of genital chlamydia tests performed, 

































Distribution of all tests across age bands
<=14 15-19 20-24 25-29 30-34 >=35
>=35 20.8 4.1 21.4 10.5 17.8
30-34 11.5 3.1 10.7 6.3 8.8
25-29 23.4 11.7 29.6 21.9 23.6
20-24 25.4 28.5 23.4 35.7 34.0
15-19 18.0 48.2 14.0 24.4 15.3
<=14 0.9 4.5 0.9 1.1 0.6
Other HR & Outreach FP & WW GUM GP Surgery
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Figure 3-19 shows the relative proportion of tests undertaken among males and 
females in different health care settings. Among males, tests were predominantly 
(70%) performed in GUM & FP clinics. However among females nearly 42% of the 
tests were performed in a GP surgery and another 35% were performed in the GUM 
& FP clinics. The Healthy Respect and outreach accounted for only 4% and 5% of all 
the tests among females and males respectively.  
Figure 3-19: Distribution by service provider of chlamydia tests undertaken among 











As described earlier, the Healthy Respect and outreach mainly represents testing 
undertaken through PTK. Testing activity through PTK decreased by half in 2009 
despite the SIGN guideline recommendation to increase PTK testing activity for 
males (Figure 3-20). While it would be good to be able to explain proportion of 
males and females using PTK, this would be unreliable since a quarter of the PTK 
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Figure 3-20: Testing through Healthy Respect programme and outreach (PTK) -
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Figure 3-21 compares the surveillance rate among males and females, across the five 
year period from 2006-2010. Overall, the peak of surveillance activity, both among 
males and females, was noticed in 2009 and than declined in 2010. The surveillance 
rates among 15-24 year old males reached 93/1000 males in 2009 but declined to 
88/1000 males in 2010. The overall rates among 15-24 years old females indicate 
that criterion for this standard was just met in 2009 but declined again in 2010 to 
282/1000 females. This indicates a short-lived higher surveillance activity targeted 
for 15-24 year olds in 2009 following SH standards and SIGN guideline 
recommendations to focus the resources for chlamydia testing among those aged 
under 25 years. 
Figure 3-21: Population surveillance rate among 15 to 24 year old males and females 










Population Surveillance rate in males aged 15-24 years: 100/1000 population 
(SH standard 3.2) 
Population Surveillance rate in females aged 15-24 years: 300/1000 population 






































Females 272 247 286 301 282
Males 82 79 88 93 88
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3.5 Discussion 
The analysis of laboratory data for chlamydia testing activity in Lothian shows that 
nearly three years after the launch of QIS sexual health service standards, the Lothian 
Health Board has not yet been able to achieve a testing target of 60%, both in males 
and females. The surveillance activity particularly increased in 2009 but declined 
again in 2010. The annual surveillance target of 300 tests / 1000 population was 
barely achieved for women in 2009, whereas among males the highest rates achieved 
were 93 tests/ 1000 population in the same year (in contrast to the target rates of 
100/1000 males). A large proportion of males were being tested in GUM and FP 
clinics (70%), in contrast to females which were primarily being tested in GP clinics 
(42%) followed by GUM and FP clinics (35%). Surveillance rate (testing coverage) 
was highest among 20-24 year age category both among males and females, followed 
by 15-19 year old females, but 25-29 year old males. The diagnostic rate was highest 
among 15-19 years old females with a decreasing trend. In males the diagnostic rate 
is highest among 20-24 year olds for all five years, followed by 15-19 year olds in 
2008 onwards. The positivity rate was highest in 15-19 years old, both among males 
and females and had a decreasing trend in the later age categories. The positivity was 
three times higher among males compared to females in contrast to the diagnostic 
rate which was 1.7 times higher among females compared to males. The positivity 
rate was highest in the most deprived quintile (with a decreasing trend) and higher in 
a rural than in an urban population.  
This chapter described chlamydia testing activity in the context of existing Scottish 
policies. This is the first study in Scotland describing the association of positivity 
rate in relation to deprivation and urban-rural classification, and informs the planning 
of chlamydia surveillance and/or screening activity in contrasting demographic 
settings. The availability of disaggregate data allowed record linkage with 
geographic database (i.e. with SIMD database) and provided additional, but crucial 
variables for analysis purpose. The value of using disaggregated data to describe 
geographical inequalities in sexual health has been widely demonstrated before 
(Shahmanesh et al., 2000, Lacey et al., 1997, Johnson et al., 2010, Kufeji et al., 
2003). The importance of collating data from different testing laboratories to provide 
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disaggregate data for the surveillance activity on chlamydia as well as for other STI 
have recently been identified and considered feasible (Jennison et al., 2010, Slater et 
al., 2007). The two outcome measures, namely the positivity rate and diagnostic rate 
have only recently been proposed by NCSP in 2010/11. This is the first Scottish 
study that reports analysis of these newly proposed outcome measures against the 
known risk factors.  
The analysis comparing ‘before and after’ shows that the introduction of revised 
sexual health standards and guidelines on chlamydia testing led to only a short-lived 
increase in chlamydia testing activity in Lothian. It was suggested in another study 
that when the chlamydia testing rates reach an optimal level, further efforts to 
increase the testing might not be successful due to a ceiling effect (Morgan et al., 
2012). However, this is unlikely to be the case among females in Lothian, since the 
rates in Lothian were lower than many other health boards in Scotland, and these 
health boards have been able to achieve increased testing since 2008 (Information 
Service Division Scotland and National Service Scotland, 2011). 
The current study suggests that the sexual health service standard for chlamydia 
testing per 1000 female population (300 tests) was achieved only transiently in 2009 
in Lothian (301 tests), but dropped to 282 tests in 2010. The service standards for 
male testing were not achieved in Lothian. It is intriguing to note that the 
corresponding ISD figures for chlamydia testing among females in Lothian were 310 
tests / 1000 female in 2009 and 298 tests / 1000 females in 2010. For males, the 
corresponding ISD figures were 102 tests / 1000 males in 2009 and 101 tests / 1000 
males in 2010 (Information Service Division Scotland and National Service 
Scotland, 2011). From the ISD figures, it appears that the testing targets were also 
achieved for males in 2009 and were sustained in 2010. However, the database on 
which the ISD report was based includes equivocal, unconfirmed, indeterminate as 
well as duplicate results. The ISD report has also acknowledged that 5 to 20% of 
tests in a calendar year were duplicate tests and another 1.1% of tests were equivocal 
or inhibitory. In my work on the Lothian laboratory database, I found I had to 
remove 8% of records because they were duplicates and a further 0.7% of records 
because they were for tests noted as having equivocal or inhibitory results. 
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Methodologically, duplicate records should be removed since their retention would 
lead to erroneous inflation of the surveillance rate. However, it is arguable that tests 
with equivocal/inhibitory results should have been retained for the calculation of 
surveillance rate, albeit they could not have contributed anything to analyses of 
positivity or chlamydia prevalence. However, even if these ‘equivocal/inhibitory’ 
records had been retained in the dataset, the surveillance rate per year would have 
been increased among females by only 0.3 percent, and would not have altered at all 
among males. 
It is also notable that the SIGN guideline recommendation for at least 60% testing for 
under 25 years old was not achieved in Lothian. The proportion of tests performed 
among males aged under 25 years was reached to only 44% in 2009, a small increase 
from 2008 (41%). Similarly, among females aged under 25 years, the testing rate 
reached to 51% in 2009 compared to 49% in 2008. However, among the different 
health care settings, GUM clinics were able to achieve testing rates of 60% among 
females. It might be possible that these guideline recommendations were not 
effectively communicated in the various health care settings, more importantly the 
GP practices, whereas the guidelines might have been highly salient in the GUM 
clinics.  
The present study identified that age, gender and year of testing are independently 
associated with chlamydia surveillance, diagnostic and positivity rates. Moreover 
chlamydia positivity has been demonstrated to be significantly associated with 
deprivation category; being highest in the most deprived and then decreasing in 
better off. These results confirm the role of age and gender in the chlamydia testing 
activity (Hughes et al., 2007, Shahmanesh et al., 2000, Johnson et al., 2010, Kufeji et 
al., 2003) and additionally of the role of deprivation status in the detection of 
chlamydia positivity (Shahmanesh et al., 2000, Johnson et al., 2010, Kufeji et al., 
2003). Due to the inappropriateness of the linkage of a variable with a large 
proportion of missing information on postcode, the surveillance rate (coverage) could 
not be calculated for deprivation quintile or urban-rural classification. For the 
available SIMD-linked dataset in our study, 28% of all the tests are performed in the 
least deprived quintile compared to 16% of all the tests in the most deprived quintile. 
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However the testing in the second most deprived quintile is similar to the least 
deprived quintile. A similar trend is noticed both among males and females. If we 
assume that this relationship holds true for all the cases in the dataset (i.e. also for 
cases for which linkage was not achieved), then it contradicts findings of another 
study which demonstrated that testing is highest for more deprived areas for females 
(with a decreasing trend) but not for males (U shaped relationship with the middle 
categories of deprivation having the lowest coverage) (Johnson et al., 2010). The 
same study has also demonstrated that the testing coverage is lower in rural areas 
than in urban centres for males and females.  
It is reassuring that in the last 5 years, the positivity and diagnostic rates have 
decreasing trends for all age categories, both among males and females. However, 
not all of this decrease can be attributed to the increase in population surveillance 
rate which was only noted in the immediate post-policy-change years (i.e. in 2008 
and 2009 when SH strategy and SIGN guidelines were introduced) and fell back to 
the pre-policy rates in 2010. This finding would be compatible with two scenarios. 
Either the population which is being targeted for testing in the more recent years 
have a lower risk of chlamydia (perhaps being the ‘worried well’), or the prevalence 
of chlamydia is decreasing in the population due to low risk sexual behaviour or due 
to natural immunity. NCSP has recommended that the English screening programme 
needs not only to improve coverage but also to identify the high risk people to invite/ 
encourage to be screened.  
In the current study, fewer tests were undertaken in GP practices as compared to 
GUM clinics; the ratio of chlamydia tests in GP practices compared to GUM clinics 
was 0.85 (82793 and 96355 tests respectively). The discrepancy in testing between 
the two health care settings was more noted among males (GP:GUM = 0.34), but the 
reverse was true for females (GP:GUM =1.27). There could be different explanations 
for this contrasting scenario of testing among males and females in the two health 
care settings. Firstly, a higher ratio of female GP principals to female practice 
population was found associated with higher testing rates in females (Kufeji et al., 
2003). However, further linkage with the GP workforce data may be needed for such 
an analysis in our case. Secondly, a historical emphasis in the UK on GUM clinics in 
 
Chapter 3: Analysis of routine data…………………………….  
84 
providing STI testing and partner notification particularly for males might also 
explain why most chlamydia tests for men are performed in the GUM clinic. Thirdly, 
gender difference in health seeking behaviour might have resulted in fewer testing 
opportunities for young men in GP clinics (Galdas et al., 2005), but the annual 
consultation rates in GP practices in 2007 among males aged 15-19 year olds and 20-
24 year olds were 2.11 and 2.16 person-years respectively, suggesting that the 
opportunistic testing for men in primary care is achievable (The Information Centre 
for Health and Social Care, 2008).  
3.5.1 Feasibility of utilising laboratory data for monitoring 
surveillance activity 
The routinely collected data is often questioned for its completeness and scope (Kane 
et al., 2000, Stevens et al., 2005). Limited use of routine data by health service 
managers appeared to relate to problem of accessibility, lack of knowledge about the 
availability of data, complexity of data provision process, lack of resources to 
examine and interpret data and perceived poor data quality and relevance (Wilkinson 
et al., 2007). As the prime purpose of these data is not the provision of indicators for 
evaluation purposes, not all the relevant variables are always available for analysis 
purpose. Clinical information and relevant indicators can be added to a dataset by 
linkage to other databases. However, linkage might not always be possible for all 
individuals and incomplete linkage has been demonstrated to affect estimates both in 
terms of bias and precision (Baldi et al., 2010). A secondary aim of this analysis was 
therefore to examine the feasibility of using routine data to assess the impact of 
introducing some new service or policy, on the outcomes of chlamydia surveillance 
activities (Section 3.2). 
Routine database from Lothian laboratory has a potential to provide a comprehensive 
picture of testing activity and diagnosis of chlamydia in Lothian, Scotland. The 
analysis of routine data helped in detecting changes and time trends, with regard to 
the diagnostic and surveillance activity. However, this study also point to 
improvements that need to be made in the collection of data, in order to assess the 
testing activity in Lothian in future. While the completeness of laboratory data was 
very good for age, year of testing as well as for test location and specimen type, and 
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to a lesser extent to gender, there were many missing values for postcode 
information. This lack of information was predominately in the case of tests 
requested at GUM clinics and Healthy Respect and outreach (only 0.1% of test 
requests have postcode information).To a lesser extent, this applied also to the family 
planning clinic (40%). This is in contrast to 94% and 87% of chlamydia test requests 
from GP surgeries and ‘other’ locations (primarily hospitals) which provided 
postcode information for the patient. In case of GP surgeries, only registered patients 
can attend a particular GP, hence the availability of patient postcode information in 
lab request forms is automated unless it is explicitly requested by the patient that 
such information should not be included in their test request form. In contrast, a 
patient attending a GUM clinic does not need to be a registered patient and hence in 
such a case additional information (such as patient’s postcode) would needed to be 
recorded while requesting a lab test. As evident from the current study, this 
information was not available from the GUM clinic in the Lothian laboratory 
database. Slater et al. obtained this information from patient-based records of the 
GUM clinics (Slater et al., 2007). However automated linkage with GUM database 
was not attempted in this study due to the limitation of time and resources. 
Information regarding patients seeking care from GUM clinic is also not accessible 
by their GPs in Scotland. A proposal of such an access by the GP was identified as 
undesirable by the 64% of the GUM clinic patients (Fernando and Clutterbuck, 
2008). 
The unavailability of postcode information on nearly half of the dataset limits the 
value for the analysis to be done in terms of identifying deprivation and urban-rural 
differences in the outcome measures for chlamydia. I remedy this by undertaking 
multiple imputations of deprivation quintile and urban-rural classification variables, 
in order to perform logistic regression analysis of positivity rate on imputed datasets. 
For the imputation of these variables, outcome variable (i.e. positive or negative 
result) was also used in the imputation process for predicting the missing values of 
variables. In such a scenario, each row of dataset provides a single case scenario for 
the imputation of other variables. Failure to include outcome information has been 
identified to falsely weaken the association (Sterne et al., 2009b). However applying 
the same imputation technique to produce data for the regression analysis of 
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surveillance and diagnostic rates was not possible since, in such a circumstance, the 
dataset were used at aggregate level and the outcome variable was also available at 
aggregate level. Other techniques are available to deal with multiple imputations of 
the aggregate data, but these were not used in the current thesis due to time 
limitation. The unavailability of postcode information from the GUM clinic deters 
the possible analysis to identify the equity of distribution of surveillance and 
diagnostic rate at the population level.  
Information on reason-for-test was not available in the laboratory dataset. It is 
therefore possible that many of these tests are used for diagnosis, such as for the 
investigation of symptoms of vaginal discharge or for the investigation of infertility, 
and this may partly explain the large number of tests in the higher age categories. 
Statistically significant differences in positivity for chlamydia, between screening 
versus diagnostic tests, have been demonstrated in some clinical settings only 
(Stephens et al., 2011). The results from this dataset are not comparable to results of 
other studies reporting on chlamydia screening, since the surveillance laboratory data 
is based on testing requests from diverse health care settings, which provide 
opportunistic as well as diagnostic testing to sexually active individuals seeking care 
for related health problems, and to notified partners.  
The collection of minimum risk factor information (such as multiple partners, 
unprotected sex) is also desired, as the present data conceals variations in respect of 
these risk factors. Similarly information on ethnicity was not available. 
To further examine the feasibility of using routine data for assessing the impact of 
introducing some new service on outcomes of chlamydia surveillance activities, a 
scenario analysis is presented in Appendix 7 to find the additional number of tests 
that would have been required, after the introduction of CT&T, to produce a 
statistically significant change in the proportion of 15-24 year olds tested. It shows 
that a total of 675 additional tests / year would have been required to see a 
statistically significant change in the proportion of young people tested. However, 
defining a performance measure for the CT&T service is complicated, since the 
Scottish government aim was to widen access to sexual health services available 
(The Scottish Government, 2008). Therefore an unchanged number of tests, but a 
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shift in the proportion of tests undertaken in different health care settings such that a 
reasonable proportion of tests are obtained through community pharmacies, could be 
indicative of ‘success’, to a degree, assuming that this was more convenient for the 
population. On the other hand, Lothian Health Board selected pharmacies in outlying 
hard-to-reach (high deprivation) communities, so their implicit aim was to improve 
access (and hence increase testing) among these groups. It could therefore be argued 
that even if there was an increase of 675 or more test per year in Lothian, if these 
were not individuals from the more deprived subsets of the Lothian population, then 
the new service was not really achieving this ‘health equity’ objective. This 
highlights the importance of specification of outputs for evaluation at the same time 
as specification of a new service. However, as has been discussed earlier, the routine 
laboratory data would not allow outcome evaluation of CT&T relating to health 
equity objectives, because information on socio-economic status or geographical 
areas of residence of those who would be tested through CT&T within Lothian 
would not be available.  
3.6 Chapter overview 
This chapter has described the chlamydia testing and diagnostic trends in Lothian 
across five years from 2006-2010. This time period was chosen to provide a context 
for chlamydia policies developed in Scotland and to examine their impact on testing 
activities in Lothian. Logistic regression models were developed to establish how 
age, gender, year of testing, deprivation and urban-rural location are associated with 
chlamydia outcome measures. 
This analysis has also highlighted the deficiencies in existing surveillance data and 
demonstrated that, if postcode information is available in the routinely collected 
dataset, how data linkage could be beneficial in providing additional variables for 
analyses. Similarly the unavailability of the information on reason-for-test had made 
it impossible to separate the noise effect of testing for other reasons (such as 
abortion, infertility or symptoms), from testing encouraged for young people as part 
of an increased surveillance activity.  
Ongoing data analysis to describe the distribution of surveillance, diagnostic and 
positivity rate by key epidemiological variables (such as age, gender and deprivation) 
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and across time will be required to provide continuous evaluation and highlight areas 
where current targeting could be improved. Such analysis should be provided at all 
local health board levels in Scotland so as to assist health boards in improving their 
strategy for targeting of testing and improve equity of coverage and detect a greater 
proportion of chlamydia infection. Information on sexual behaviour, ethnicity, and 
reasons-for-test would provide more elaborate understanding of the variations in the 
chlamydia outcome.  
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CHAPTER 4: COMMUNITY PHARMACY 
PROVISION OF CHLAMYDIA SERVICES – A 
STRUCTURED LITERATURE REVIEW OF 
INTERNATIONAL EVIDENCE 
4.1 Introduction 
Before planning my evaluation the first requirement was to learn as much as possible 
about what is known about the chlamydia testing service delivery through 
community pharmacies. The questions of main interest to me for the review of the 
literature were: 
 What is the feasibility and effectiveness of community pharmacy provision of 
chlamydia testing and treatment services?  
 Among potential clients aged 15 to 24, what are their preferences regarding 
chlamydia testing services? How do different types of chlamydia testing 
strategies employed in pharmacies (such as opportunistic testing during EC 
consultations, specimen collection, result notification and marketing 
strategies) compare in terms of likelihood of use by such clients?  
 Among youth aged 15-24, what are the facilitators of and barriers to 
accessing the chlamydia testing and treatment service in community 
pharmacies?  
 Among the pharmacy staff, what are the facilitators of and barriers to 
implementing the chlamydia testing and treatment service in community 
pharmacies? 
I first looked for previous reviews addressing the above issues, but could not find any 
published review of evidence relating to pharmacy-based chlamydia testing and 
treatment service. I therefore commenced a critical review of the source literature, 
and the following sections describe the methods and report the findings. The chapter 
concludes with identification of gaps in the available literature and suggestions of 
future research questions for chlamydia testing in community pharmacies. 
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4.2 Methods 
4.2.1 Search strategies 
I searched electronic databases (MEDLINE, EMBASE, Web of Knowledge, 
PsycINFO and POPLINE). The search combines terms describing pharmacy service 
(pharmacies, community pharmacies and pharmacist) with chlamydia infection or 
contact tracing. The search strategy used in OvidSP database is provided in 
Appendix 8. Additional papers were identified by reviewing the literature quoted by 
authors discovered within the initial review. Papers not reported in English were 
excluded from review. Grey literature reports were identified by contacts with 
relevant organisations and authors. In addition contacts were made with NHS service 
providers or other relevant persons known to be commissioning / implementing 
chlamydia service through community pharmacies. Searches were undertaken in 
June 2009 and updated in June 2010 and 2011.  
The results were downloaded into Endnote for sifting at title and abstract level. 
Following this sifting, studies for potential inclusion were obtained for full paper 
examination and data extraction. The process is illustrated in the flow chart in Figure 
4-1. 
4.2.2 Inclusion and exclusion criteria 
I selected for inclusion in the review only those studies where chlamydia testing, 
treatment or partner notification was formally introduced as a programme or 
intervention in a pharmacy. There are many studies especially those reported from 
developing countries which evaluated the quality of management of STIs in 
pharmacies or reported the practice or knowledge of pharmacy workers for STI 
management, particularly in relation to syndromic management (Ralph et al., 2001, 
Sihavon et al., 2007, Viberg et al., 2009, Kwena et al., 2008, Jacobs et al., 2004, 
Adams et al., 2007). Other studies reported antibiotic dispensing practice for STIs in 
pharmacies (Wachter et al., 1999) or treatment seeking behaviour of patients with 
symptoms of a STI (Kleinschmidt et al., 2006, Guan et al., 2009, Ngo et al., 2007, 
Sihavong et al., 2006). Most of these studies are from countries, where there is no 
formal regulation in terms of drug prescription and those studies only evaluated the 
competencies of pharmacy staff in adequate management of STIs where there is no 
 
Chapter 4: Literature review of  pharmacy-based chlamydia services…………………………….  
91 
formal programme of STI management. These studies are therefore excluded from 
the current review of literature. Position and policy papers describing the role of 
pharmacists in managing STIs were also excluded (Mayhew et al., 2001, McCree et 
al., 2005, Stergachis et al., 1993).  
Therefore, the studies were included if they:  
 measure one or more outcomes of pharmacy provision of  chlamydia services 
 include empirical data on perceptions or attitudes of health care providers or 
of users of pharmacy chlamydia services  
Studies were excluded if they: 
 focus on chlamydia services in primary care settings other than pharmacies 
 describe service developments without supporting data 
 reported the practice or knowledge of pharmacy worker with respect to STI 
management, particularly in relation to syndromic management but without a 
formal programme in place 
To answer the research questions, I considered both quantitative studies (for 
example, randomized controlled trials (RCTs) and cross-sectional studies), and 
qualitative studies that explore user or provider experiences with testing and 
treatment. 22 articles / reports were included in the full review. 
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4.2.3 Consideration of study quality 
Quality assessment frameworks for research are generally based on a hierarchy of 
evidence with RCTs as the ‘gold standard’. However RCTs and other quantitative 
methodologies are not necessarily best suited to research questions involving varied 
populations with complex needs, nor with regard to assessment of success of service 
in terms of its uptake and feasibility rather than cure. Longitudinal studies and well 
conducted qualitative research are therefore equally likely to provide informative 
evaluation of such interventions. Since most of the studies included here are reports 
of programme evaluation, descriptive in nature and eliciting views of clients and 
service providers regarding the service, assessment of the quality of these studies was 
not straight forward. A traditional systematic review of controlled trials would 
contain a quality assessment stage with the objective of excluding those studies that 
do not provide a reliable answer to the question under review. There is much debate 
and little consensus in the literature regarding how and whether quality should be 
assessed of the qualitative literature (Hannes, 2011, Dixon-Woods and Fitzpatrick, 
2001). I agree with Thomas and Harden (2008) that the quality of the studies should 
be assessed to avoid drawing unfounded conclusions. However, since there is little 
agreement on which to base decisions for excluding studies based on quality criteria, 
I have followed their recommendation that studies should be excluded only if they 
have substantial flaws. I applied seven quality criteria (of basic methodological 
standards) as proposed by Harden for studies on views and perceptions (Harden et 
al., 2004). These criteria are as follows: 
1. An explicit theoretical framework underpinning the study and/or literature review 
2. Aims and objectives clearly stated 
3. A clear description of context of the study 
4. A clear description of the sampling and recruitment procedures 
5. A clear description of methods used to collect and analyse data 
6. Attempts made to establish the reliability or validity of data analysis 
7. Inclusion of sufficient original data to arbitrate between evidence and 
interpretation 
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Appendix 9 gives the illustration of criteria applied to these studies. The Harden 
criteria focused on the generic issues of reporting quality (Harden et al., 2004) and 
all the twenty two included studies were assessed as being of satisfactory quality and 
hence were not excluded from the review. After my thematic synthesis was 
complete, I also undertook a degree of sensitivity analysis, as recommended by 
Thomas and Harden (2008) by examining the relative contributions of studies to the 
final analytic themes. It was found that the more developed studies contributed 
comparatively more to the synthesis and contained many unique themes. 
4.2.4 Abstraction of data and analysis 
Most of the studies included in the review were evaluation studies. The data reported 
included the service audit as well as qualitative understanding of the barriers and 
facilitators identified by the service users and providers. Similarly a few studies also 
explored providers’ willingness to provide the service. 
I used QSR NVIVO-8 software to manage the data and its categorization according 
to the themes (QSR International Pty Ltd, 2008). The final selected papers were 
imported to NVIVO-8. Data for the analysis in this review consisted of either 
verbatim quotations from the study participants of the reviewed studies or findings 
reported by authors that were clearly supported by the study data. These data were 
extracted from the results sections of the publications reviewed.  
Structured summaries of each study were developed by extracting details of the study 
type, objectives and population -age group targeted and geographical location - and 
also the key study findings.  
4.2.4.1 Synthesising qualitative findings 
Previous reviews have employed various methods to qualitatively synthesise the 
systematic review findings (Barnett-Page and Thomas, 2009). Two recently emerged 
methods in reviewing literature on health policy and practice are framework 
synthesis and thematic synthesis (Baxter et al., 2011, Carroll et al., 2011, Pavlin et 
al., 2006, Thomas and Harden, 2008, Oliver et al., 2008). Framework synthesis 
involves a preliminary identification of  a priori framework against which to map 
data from the studies included in the review (Barnett-Page and Thomas, 2009). The a 
priori framework used to extract and synthesise findings is either informed by 
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background material and team discussions with the policy people commissioning the 
review, or is available through a previously developed conceptual models and 
frameworks. As such, it is largely a deductive approach that is considered useful in 
addressing urgent policy questions (Carroll et al., 2011, Dixon-Woods, 2011). 
However, the reliance of the framework synthesis on a pre existing framework or 
themes raises a question whether the chosen framework would offer a ‘conceptual 
fit’ with the review questions. It is also possible that an apparently appropriate a 
priori framework may be found to accommodate only a small proportion of the 
review’s included studies. In such a case, the framework synthesis has a danger to 
‘reduce some of the vividness of insight seen in the best qualitative research’ (Dixon-
Woods, 2011).    
In order to integrate the findings of the reviewed studies, I drew on the principles of 
thematic synthesis (Thomas and Harden, 2007). Thematic synthesis is an inductive 
approach of data synthesis. The first two stages of a thematic synthesis of reviewed 
studies are coding text line-by-line according to its meaning and content, and 
developing descriptive themes. The process of synthesis begins in the descriptive 
stage when the findings are organised into descriptive themes. The review process 
then extends further to the analytical stage by comparing and contrasting the 
descriptive themes and interpreting the relationship between the themes. I used direct 
and referenced quotes, where required, to avoid the potential for inaccurate 
paraphrasing or de-contextualisation. The synthesis of the reviewed studies is 
presented in the results section in two parts. Part one provides a descriptive synthesis 
of various aspects of pharmacy-based chlamydia screening, including testing, 
treatment and partner notification as well as the cost effectiveness reported in these 
studies (sections 3.3.6). Part two of the review presents an analytical synthesis of the 
facilitators and barriers to access and to implement a pharmacy-based chlamydia 
service (section 3.3.7). A hierarchy of themes was then developed by inferring the 
level at which these themes act (i.e. service providers, users and strategic 
stakeholders), and presented as a conceptual model in section 4.4.2. Any links 
between the themes that has been identified or discussed in the studies, or that I have 
inferred during the analytical stage, is shown in the model by means of arrows and 
connection lines. Finally, noticeable gaps in the evidence base are reported.  
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4.2.4.2 Synthesising quantitative findings 
Proportions are reported, where available, for different socio-demographic 
characteristics of the client as well as for chlamydia testing uptake and return rates. 
p-values are reported in the text only if they were available in the reviewed literature. 
In order to calculate an overall estimate of the positivity (percentage of positive test 
results) among people tested through this service, a meta-analysis was undertaken. 
The purpose of this meta-analysis was to report the pooled estimate of chlamydia 
positivity detected through pharmacy screening services. Estimates were pooled and 
are reported as a proportion and 95% confidence interval (95% CI). The results of 
meta-analysis are displayed by Forest plot. The Forest plot shows unadjusted 
prevalence estimates (boxes) with 95% confidence limits (bars). The size of the 
square is proportional to the precision of the study (or sample size). The aggregated 
estimate obtained by combining estimates from all the studies is displayed as a 
diamond.  
The inconsistency of results across studies was summarised using I
2
 test for 
heterogeneity. The test describes the percentage of total variation across studies that 
are due to heterogeneity rather than chance alone (homogeneity) (Higgins et al., 
2003). The I
2
 values lies between 0% and 100%. A value of 0% indicates no 
observed heterogeneity, and larger values show increasing heterogeneity. I
2
 value 
also helps to decide between the two types of statistical models that can be used to 
provide combined estimates. In the fixed effect model, it is assumed that the 
underlying true exposure effect in each study is the same (homogeneity). The overall 
variation reflects the random variation within each study but not any potential 
heterogeneity between studies. The random effect models incorporate variation 
(heterogeneity) between the studies. It is assumed that each study has its own true 
estimate and there is a random distribution of these true estimates around a central 
effect. If large heterogeneity between the studies is found, a random effect model is 
used and vice versa. Random effect methods generally yield large variance and 
confidence interval because a between-study variance component is added to the 
overall variance (Blettner et al., 1999). A sensitivity analysis was undertaken by 
excluding a study reporting chlamydia testing activity for pay-to-use service.  
 
Chapter 4: Literature review of  pharmacy-based chlamydia services…………………………….  
96 
The meta-analysis was conducted using Stats-Direct statistical software, version 
2.7.8 (http://www.statsdirect.com). The meta-analysis is presented in part one of the 
result section, where different models of pharmacy-based chlamydia screening and 
its effectiveness are presented. 
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4.3 Results 
4.3.1 Description of studies included 
After full review of 80 papers, 16 met the inclusion criteria (Golden et al., 2001, 
Bloomfield et al., 2002, van Bergen et al., 2004, Golden et al., 2005, Baraitser et al., 
2007, Cameron et al., 2007, Taylor et al., 2007, Brabin et al., 2009b, McNutt et al., 
2009, Cameron et al., 2010, Thomas et al., 2010, Anderson and Thornley, 2011, 
Cameron et al., 2011, Dabrera et al., 2011, Emmerton et al., 2011, Gale and Watson, 
2011). An additional 6 reports were included, identified through grey literature or by 
consulting an expert group (Anthony and Watson, 2008, Gudka et al., 2010, Muir, 
2008, Taylor Nelson Sofres Healthcare, 2007, Tinelli et al., 2009, Watson, 2008).  
Fourteen of the studies were from the UK, four from the USA, three were from 
Australia and one was from the Netherlands. However the studies from the USA and 
the Netherlands are among the pioneer studies, which tested the feasibility of 
providing chlamydia testing and partner treatment through community pharmacies. 
The studies included are described briefly below and are presented in tables 4-1 to 4-
3 for service feasibility, economic analysis and partner notification strategies 
respectively. The tables present these studies in order of their publication years. 
4.3.2 Evaluation of feasibility and acceptability of a 
pharmacy-based chlamydia service 
Pharmacy Chlamydia Screening Pathfinder was the largest pilot service of its kind 
which offered chlamydia service, free to users (16-24 year olds) via 200 pharmacies 
of a large chain across 31 primary care trusts (PCTs) in areas of London (Table 3-1). 
Taylor Nelson Sofres (TNS) undertook an independent evaluation on behalf of the 
Department of Health of the first two years of a pilot scheme (Taylor Nelson Sofres 
Healthcare, 2007). The evaluation looked at service uptake and patients’ perceptions 
of the service. Over the 2 year pilot, 37,461 tests were supplied via community 
pharmacies. Other small pilots were conducted in London (Baraitser et al., 2007) and 
Manchester (Brabin et al., 2009a, Thomas et al., 2010) in England, Fife (Muir, 2008) 
and Grampian (Anthony and Watson, 2008, Thomas et al., 2010, Tinelli et al., 2009) 
in Scotland, Perth (Gudka et al., 2010) and Queensland (Emmerton et al., 2011) in 
Australia and San Francisco in the USA (Bloomfield et al., 2002). The number of 
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pharmacies involved in these pilots ranged from only 1 pharmacy to 44 pharmacies. 
These pilots mostly targeted women requesting EC. However in some studies, tests 
were also handed out to men and women on self referral. During these pilot, some of 
the chain pharmacies also started providing chlamydia testing through the 
pharmacies as a pay-to-use service. A total of 338 pharmacies from a large chain 
provided the service and its uptake was evaluated (Anderson and Thornley, 2011). 
The feasibility and acceptability of the service was tested by means of service audit 
data, questionnaire survey of client experience, in-depth structured interviews with 
clients and pharmacists and evaluation reports from professional patients paid to visit 
the pharmacies.  
In addition to the service evaluations, surveys were undertaken among pharmacists 
(Cameron et al., 2007, Taylor et al., 2007, Gale and Watson, 2011) and potential 
service users (Taylor et al., 2007) to determine their willingness and acceptability to 
provide chlamydia testing and treatment service in community pharmacies.  
4.3.3 Cost effectiveness of a pharmacy-based chlamydia 
service 
Cost effectiveness analysis of pharmacy provision of chlamydia testing was 
undertaken in Amsterdam, the Netherlands (van Bergen et al., 2004) and Grampian, 
Scotland (Tinelli et al., 2009) as well (Table 4-2).  
4.3.4 Evaluation of partner notification through pharmacies 
Table 4-3 summarises the studies that reported partner notification through 
pharmacies. Expedited partner therapy through community pharmacies has been 
among the first strategies of STI care provision tested through community 
pharmacies in USA. In a randomized controlled trial, women and heterosexual men 
with gonorrhoea or chlamydia infection were assigned to have their partners receive 
expedited treatment through pharmacies or standard referral (Golden et al., 2001, 
Golden et al., 2005). Patients in the expedited-treatment group were offered 
medication through pharmacies for their partners. Patients assigned to standard 
partner referral were advised to refer their partners for treatment and were offered 
assistance in notifying partners. In another study in Lothian, Scotland (Cameron et 
al., 2010, Cameron et al., 2011), index cases with uncomplicated chlamydia were 
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given a pharmacy voucher to pass onto sexual partners. Partners could redeem 
vouchers for free treatment (Azithromycin) at one of 90 pharmacies in the area. To 
determine pharmacists' perceptions about patient delivered partner therapy (PDPT) 
and potential barriers that need to be addressed in pharmacies for successful 
implementation of PDPT, surveys of pharmacists were conducted in Lothian, 
Scotland (Cameron et al., 2007) and New York state in the USA (McNutt et al., 
2009). 
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Objectives of the study Number of 
pharmacies 
participate
d in the 
evaluation 













to  establish  the  efficacy  
and  acceptability  of  
screening  by  PTK  made 
available in pharmacies 
(and other public places)  
1  All sexually active 
individuals, but 
particularly targeted 
white gay men. 
Not 
specified 
193 test kits were picked up 
from the pharmacy in 2 weeks 
and 38% were returned. 




London, UK A questionnaire 







Evaluation of the 
feasibility and 
acceptability to users and 
pharmacists of 






Sexually active men 
and women 
receiving EC or self 
requested chlamydia 




83 tests were taken in 3 months 
with 8 (9.5%) positive for 
chlamydia. Of these, 94% were 
women and 71% from ethnic 
minorities.  
iii) 
(Taylor et al., 
2007) 





To determine the 
acceptability to 
pharmacists and women 




N/A Pharmacists from 
selected community 
pharmacies (n=25) 
Women from the 
community (n=50) 
18-29  84% of the pharmacist 
supported the proposed service. 
76% of the women would accept 
and return the sample. Privacy 
and confidentiality were 















The evaluation of the 
service uptake and  
perceptions of patients 








kits when women 
attended for EC; 
otherwise the kits 
were given when 
requested 
16-24 Over the 2 year pilot, 37, 461 
tests were supplied via 
community pharmacies. The 
number of kits given out per 
store varied from between 2 per 
month to 9 per week. Chlamydia 
positivity:7.9%  
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To measure and compare 
the uptake of chlamydia 
testing in different setting 
including community 
pharmacies 




(and GP, youth 
centres and SH 
drop-ins) 
16-24 1 year pilot. 68% of the 144 kits 
supplied from pharmacies were 










To explore service 
providers’ and service 
users’ experiences of the 
chlamydia study 
10 24 service 
providers and 16 
service users 
16-24 1 year pilot. Both providers and 
users had extremely positive 
experience and were supportive of 
future pharmacy provision of 
screening. Autonomy and 
anonymity were identified as 
facilitators of the service. 
vii) 
(Muir, 2008) 
Fife, Scotland Service audit 
data 
To explore the feasibility of 
offering chlamydia testing in 
pharmacies offering EC 
44 Pharmacists 
proactively offered 
kits when women 
attended for EC; or  
the kits were 
handed out on self 
referral 
13-25 1.5 year pilot. 10% of the client 
receiving EC from pharmacies 
accepted the offer for chlamydia 
test. Chlamydia positivity: 10.5% 
viii) 






To assess the uptake of 
free PTK by women 
requesting EC at 
pharmacies 
33 Women requesting 
emergency 
contraception 
≤ 25  25% of the women accessing EC 
were offered screening. 46% and 
18% of the women respectively 
accepted and returned the kit. 
Chlamydia positivity: 9.1% 
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(Gudka et al., 
2010) 







To develop a feasible 
pharmacy based chlamydia 
screening model 










is 24 ± 5 
years 
6 month pilot. 78% (n=596) of the 
EC clients were offered screening. 
41% agreed to participate. 
Pharmacists successfully identified 
15% of EC consumers to have 
symptoms of STIs and were 
referred to specialist clinic. All the 
46 clients who returned the kit 









To understand why 
pharmacist selectively 
offered screening to EC 
clients 




N/A Pharmacists were keen to expand 
the service but reluctant to offer it 
to married women and those in 
long term relationship. To avoid 
offence, they selected women 











To assess the feasibility of 
pay-to-use chlamydia 
screening in community 
pharmacies 
338 Men and women 






≥16 A total of 14, 378 private tests were 
performed in 2 years. 64% tested 
were females. Chlamydia positivity: 
9.8% in males and 6.8% in 
females. The positivity is highest 




Chapter 4: Literature review of  pharmacy-based chlamydia services…………………………….  
103 





















London, UK In-depth 
interviews 
To understand the issues 
facing pharmacists in 
offering chlamydia 
screening 




N/A The majority were supportive of 
the service, though some were 
concerned about approaching 
young people. Offering screening 
in a non-sexual health context 
was identified as difficult and 
pharmacists selectively 
approached clients accessing 
EC.   
xiii) 
(Emmerton 











To explore, the feasibility of 
community pharmacies for 
distribution of screening kit, 
and association between 
risk based screening and 
test results 
4 English speaking 
women presenting 
for a sexual health 
related product or 
consultation with 
the pharmacists  
≥16 4 month pilot. 12% of the 156 kits 
distributed were returned. 
Chlamydia positivity: 22%. The 
association between risk 
assessment for STI and test 
result was inconclusive. 
Pharmacist described barrier 
related to workload, lack of staff 
and restriction of advertising to 










To explore community 
pharmacists activities and 
attitudes towards the 
provision of sexual health 
services 
N/A Lead community 
pharmacists 




N/A The response rate was 74% 
(n=94). 10% were currently 
providing chlamydia testing, 
however 86% were willing to 
provide chlamydia testing in 
future. 65% were also willing to 
provide PDPT to the chlamydia 
positive clients to give to their 
sexual partners. 
 
Chapter 4: Literature review of  pharmacy-based chlamydia services…………………………….  
104 

































to establish  the  
effectiveness and cost 
effectiveness of a 
pharmacy based chlamydia 
screening offered to women 
accessing EC 
1 pharmacy 
in a health 
centre 
Women who 
collected their EC 
from a pharmacy in 
a health centre 
were offered PTK 
15-29  2 year pilot indicated that the 
uptake of the service was low 
(27%). Chlamydia positivity: 9%. 
Net cost per pelvic inflammatory 
disease prevented ranged from 
cost saving upto £ equivalent of 
£3364.  
ii) 






To assess the incremental 
costs and cases of 
chlamydia identified  






centres and SH 
drop-ins) 
16-24 Testing would cost an additional 
£76,225 / year in Grampian, and 
would identify an additional 145 
index cases of chlamydia. GP 
practices and FP clinics have the 
most favourable cost effectiveness 
ratio than pharmacies  
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d in the 
evaluation 




(Golden et al., 
2001) 









Feasibility of providing 
partner treatment from 
pharmacies  
12 Heterosexual English 
speaking men and 
women and 
diagnosed with  
chlamydia or  
gonorrhoea 
≥14  266/458 randomly selected 
infected patients chose to obtain 
medication for partner from the 
pharmacy. 223/266 (84%) 
successfully did so. 
ii) 
(Golden et al., 
2005) 
Seattle & King 
county, USA 
RCT RCT of expedited 
partner treatment from 
pharmacies, STD clinic 
or direct mailing Vs. 
Standard referral. 
Primary outcome was 
persistent or recurrent 
infection 
12 Heterosexual English 
speaking men and 
women and 
diagnosed with  
chlamydia or  
gonorrhoea 
≥14  Expedited treatment was effective 
than standard referral of partners 
in reducing persistent or recurrent 
infection among patients with 
gonorrhoea (3 percent vs. 11 
percent, p=0.01) but not in those 
with chlamydia infection (11 






 A questionnaire 
survey 
Willingness of 
pharmacists (and other 
health professionals) to 
provide partner testing / 
treatment through 
pharmacies and (other 




N/A 49/50 pharmacists were willing to 
provide free PTK and all 50 
pharmacists were willing to 
provide treatment to patient 
tested positive for chlamydia. 9/50 
(18%) were not willing to provide 
treatment to index patient for their 
partner.   
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Objectives of the study Number of 
pharmacies 
participate
d in the 
evaluation 




(McNutt et al., 
2009) 
8 counties of 






about PDPT and 
potential barriers that 
need to  be addressed in 
pharmacies for 
successful 
implementation of PDPT 
N/A Pharmacists recruited 
from the pharmacies 
N/A 67% of the pharmacists (n=193) 
responded to the survey. 63% 
supported PDPT for chlamydia. 
The potential barrier cited most 
















pharmacies by issuing 
treatment vouchers to 
index cases  
90  Index patient 
diagnosed with 
uncomplicated 
chlamydia were given 
a pharmacy treatment 
voucher to pass on to 
their partner 
15-47  40% of the vouchers were 
redeemed by the partners of 
index patients from the pharmacy. 
87% of the partners were satisfied 
with this method of treatment. 
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4.3.5 Synthesis of findings for a pharmacy-based chlamydia 
service 
This section is divided into two parts. Part I reviews the different aspects of the 
models of chlamydia services implemented in pharmacies, the economic evaluation 
undertaken in reviewed studies and also presents the pooled estimates of chlamydia 
positivity reported in these studies, produced by undertaking the meta-analysis. Part 
II provides a review of facilitators and barriers to access and to implement a 
pharmacy-based chlamydia service. The discussion section then follows, which 
summarises the key findings of these two parts, limitations of the studies reviewed 
and key recommendations for any future evaluation of a similar service.   
4.3.6 Part I: Review of pharmacy-based chlamydia service 
models  
This section addresses the question of how different strategies of pharmacy provision 
of chlamydia testing compare in terms of their acceptability to young people as well 
as to the pharmacists.  
4.3.6.1 Different methods of engaging young people in testing 
The studies reviewed suggest that different strategies were employed to engage 
young people in a pharmacy-based chlamydia service. The most common strategy 
used in these studies was offering chlamydia testing during an EC consultation. 
Although pharmacists were willing to provide EC, they did not consistently offer 
chlamydia screening to such clients and waited to be asked for a kit by clients 
(Baraitser et al., 2007). The kit offering rate to EC clients varied from 25% to 78% 
(Brabin et al., 2009a, Gudka et al., 2010, van Bergen et al., 2004). Pharmacists 
acknowledged offering selective screening to EC clients who they thought would be 
more likely to have chlamydia (Brabin et al., 2009a). They were reluctant to offer it 
to married women and those in long term relationship. To avoid offence, they also 
selected women based on age, education and ethnicity (Thomas et al., 2010). The 
other reason given for not offering the kit was either ‘forgotten’ or ‘too busy’ (van 
Bergen et al., 2004).  
The pharmacists agreed that offering chlamydia screening with EC is an ideal 
opportunity to screen women because, ‘it was not personal, but because they had 
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unprotected sex, it was a responsible approach and entirely the right timing’ (Gudka 
et al., 2010). They judged the combination of discussing STIs and chlamydia with 
EC to be highly realistic, but felt that it may also impose a risk of deterring women 
from accessing EC, since the offer of screening could be construed as a criticism of a 
client’s sexual partner or sexual morality. Hence some pharmacists recommended 
that it should be available to everyone, and not just EC consumers. 
Moreover by this offering strategy, those women who are sexually active and not 
using EC would not be reached. Considering all eligible sexually active women aged 
15–29 years, Van Bergen (et al. 2004) estimated that community coverage of 
chlamydia screening by this strategy was only 13%.  
The other approaches used were displaying self-test kits in pharmacies in buckets 
that were labelled as containing male and female testing kits to be picked up by 
young people (Watson, 2008), offered to clients when presenting for any sexual 
related product or consultation (Emmerton et al., 2011) or given on self request. 
Pharmacists were typically less comfortable with the idea of offering the kit to 
individual customers outside of the sexual health consultation context (Baraitser et 
al., 2007). Therefore it was suggested that the training of pharmacist for the 
provision of chlamydia service should emphasise the importance of the benefit of the 
staff’s proactive approach (Taylor Nelson Sofres Healthcare, 2007). 
4.3.6.2 Preference for specimen type  
With the newer amplification techniques such as nucleic acid amplification tests 
(NAATs), self-collected specimens such as urine and vaginal swabs have been used 
with the same diagnostic accuracy as swab samples obtained by health care 
professionals. In the pharmacy screening studies, self collected samples were 
provided, either urine (Brabin et al., 2009a, Muir, 2008) and / or self-obtained low 
vaginal swabs (LVS) kits (Anthony and Watson, 2008, Gudka et al., 2010, Watson, 
2008).  
A survey of preferences of potential clients for various protocols of chlamydia 
testing in pharmacies in Australia reported urine testing method as being most 
preferred by clients (77%), followed by self-obtained low vaginal swab (15%). Swab 
samples obtained by doctors was preferred by only 8% of the respondents (Taylor et 
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al., 2007). There was a general consensus among consumers that the self-collection 
of vaginal swab was easy to use, and was not a barrier to them (Gudka et al., 2010). 
4.3.6.3 Method of sample submission 
In some pilots, participants were asked to post the home collected urine sample to the 
laboratory in the pre-paid envelope (Brabin et al., 2009a, Thomas et al., 2010, van 
Bergen et al., 2004, Muir, 2008, Taylor Nelson Sofres Healthcare, 2007). Other 
options included collecting the sample on-site in a pharmacy toilet and submitting 
there and then (Muir, 2008), mix of both approaches (Dabrera et al., 2011), or 
collecting the sample at home but submitting directly to the pharmacy or to the 
pathology drop-in site (Gudka et al., 2010). 
In-store toilets were not rated as an important attribute of service provision, by the 
clients (Taylor Nelson Sofres Healthcare, 2007), but some pharmacists provided 
access to an in-store toilet in order to enhance the return rate (Dabrera et al., 2011). 
However, both the pharmacists and the clients equally preferred returning the sample 
to the pharmacy (Gudka et al., 2010), even if that meant an extra workload to them 
(Thomas et al., 2010).  
Submitting the sample to the designated pathology drop-ins was described by the 
clients as a biggest deterrent for completing the test (Gudka et al., 2010). It was 
demonstrated in the same study, that having to submit the sample to the pathology 
drop-ins resulted in wastage of kits.  
In terms of posting the sample, while 30% of the clients indicated their preference to 
send the sample back by post (Gudka et al., 2010), in another study, 54% of the 
participant were concerned about safety of the sample if sent through post 
(Bloomfield et al., 2002). However it is not clear in this study whether by safety they 
meant the danger of being lost or spilled in the post. In another study, clients 
described their lack of confidence that the sample will reach its destination and 
therefore, returning the sample to a pharmacy and physically handing the kit to a 
pharmacy employee, gave a sense of ‘security’ (Taylor Nelson Sofres Healthcare, 
2007).  
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4.3.6.4 Uptake of chlamydia screening  
In the studies reviewed, reported acceptance of and participation in chlamydia testing 
varied widely. Between 10%-47% of those approached by the pharmacists agreed to 
be tested. Once successfully recruited by a pharmacy, the proportion who returned 
home test kits varied widely between 12% and 51% (Baraitser et al., 2007, 
Bloomfield et al., 2002, Brabin et al., 2009b, Emmerton et al., 2011, Gudka et al., 
2010, Muir, 2008, Taylor Nelson Sofres Healthcare, 2007, van Bergen et al., 2004, 
Watson, 2008).  
The Grampian study demonstrated a statistically significant variation in return rates 
across the different sites that participated in their study, with highest return rates 
occurring within the pharmacy-sourced kits (67.6%) and lowest rates occurring with 
kits obtained by self pick from community sites (7.5%). The author discussed the fact 
that the highest return rate from community pharmacies might have been partly due 
to clients having an opportunity of consultation with a pharmacist prior to the issue 
of the kit. This consultation may have provided motivation for the client to return 
their kit (Watson, 2008).  
Different suggestions offered by the clients to improve the uptake of the kits were its 
availability from all pharmacies, making the submission process easier (by providing 
the mail option) and packaging EC and chlamydia kit together with charging a fee 
(Gudka et al., 2010). Pharmacists particularly emphasised the need to increase the 
advertising of the service if wishing to improve uptake. Some pharmacists noted that 
a parallel programme of mailing kits to young people had resulted in the reduced 
number of people asking for screening kit or accepting the offer of screening in the 
pharmacy (Dabrera et al., 2011). 
Though free chlamydia service was considered a strength of the service by the clients 
(Taylor Nelson Sofres Healthcare, 2007), Bloomfield et al. suggested that charging a 
nominal fee would increase the return rate (Bloomfield et al., 2002). In another 
study, 31% of the service user indicated their willingness to pay an average of 
A$26±9 for the kit (Gudka et al., 2010). 
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4.3.6.5 Notification of test results 
Result notification strategies reported in the reviewed studies included having staff 
attempt notification by telephone, text, email, postal letter or return visit to the 
pharmacy as preferred by the client (Anthony and Watson, 2008, Emmerton et al., 
2011, Muir, 2008). However, the most common method of notification of result was 
by telephone by the clinic staff, but only in the case of positive result (Bloomfield et 
al., 2002, Brabin et al., 2009a, Gudka et al., 2010). Those who tested negative were 
not generally directly notified, however in some pilots, a telephone number was  
provided to all participants to enable them to receive their results over the telephone 
(Bloomfield et al., 2002). While it was appreciated by clients how rapidly positive 
test results were made known to them on the telephone (Anthony and Watson, 2008), 
in another pilot, it was suggested by the clients that they should be informed 
regardless of the test result (Bloomfield et al., 2002). A telephone conversation, for 
some service users, was preferred to a face-to-face approach to minimise 
embarrassment (Taylor Nelson Sofres Healthcare, 2007). 
In the Australian pilot, 33% of the clients indicated that obtaining the result through 
the telephone was ‘very difficult’, primarily because it could be obtained only during 
working hours. Hence alternative methods of obtaining their results were suggested, 
such as by post and email (Gudka et al., 2010).  
4.3.6.6 Treatment options 
Across the various studies, treatment options offered to infected persons were 
variable, including attending a sexual health clinic (such as GUM), family planning 
clinic or general practice, having therapy delivered, or picking up medication at their 
local pharmacy. The key benefits stated for the pharmacy option was the 
convenience of accessing pharmacies and their preference to collect the test and 
treatment from the same location (Taylor Nelson Sofres Healthcare, 2007).  
The majority of pharmacists and women felt comfortable with the pharmacist’s role 
with respect to counselling on results and provision of antibiotics (Taylor et al., 
2007). 
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4.3.6.7 Approaches used to notify and treat sexual partners 
Few studies have described strategies for contacting sexual partners of those who test 
positive for chlamydia or the effectiveness of contact efforts undertaken through 
pharmacies. One randomised controlled trial in the USA was amongst the pioneer 
studies that introduced a novel approach of involving pharmacies in STI testing 
(Golden et al., 2001, Golden et al., 2005). In this trial, women and heterosexual men 
with chlamydia or gonorrhoea infection were randomly assigned to receive either 
expedited partner treatment through pharmacies or standard referral. In the treatment 
arm, 76% agreed to give treatment to their partner(s) and most of them obtained 
medication for a partner at a pharmacy (84%). The trial further demonstrated that 
among patients with gonorrhoea, expedited treatment was more effective than 
standard referral of partners in reducing persistent or recurrent infection (3 percent 
vs. 11 percent, p=0.01). However among those with chlamydia infection, the 
expedited partner treatment was not effective (11 percent vs. 13 percent, p=0.17). 
However patients assigned to expedited treatment of sexual partners were 
statistically significantly more likely than those assigned to standard referral of 
partners to report that all of their partners were treated and statistically significantly 
less likely to report having sex with an untreated partner.  
In another study in Lothian, for uncomplicated chlamydia expedited partner 
treatment at a pharmacy was reported as a popular choice of chlamydia treatment 
among partners as demonstrated by the fact that 40% of partner treatment vouchers 
were redeemed from the pharmacy with a median of 2 days of issuance (Cameron et 
al., 2010). The Dutch study also reported successful partner notification achieved in 
73% of the cases (van Bergen et al., 2004). 
In the Grampian study, centralised partner notification was provided by the SHAs for 
all clients who tested positive for chlamydia infection during this study (Anthony and 
Watson, 2008). In addition, if clients had not undergone partner notification with the 
SHAs from the GUM clinic, community pharmacists could issue them partner 
notification forms for self-completion. Partner notification was successfully 
achieved, obtaining a rate per index case of 1.58 contacts identified, 0.99 contacts 
traced and 0.46 contacts identified and treated. This 0.99 partners traced per case 
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exceeded the standard of 0.64, as set by Quality Improvement Scotland (Quality 
Improvement Scotland, 2008). It was observed that partner notification was related to 
the current status of the partner, in that index patients do not usually notify ex 
partners (Taylor Nelson Sofres Healthcare, 2007). 
Surveys in Lothian (Cameron et al., 2007) and New York (McNutt et al., 2009) 
reported 82% and 63% respectively of the pharmacists were willing to supply patient 
delivered partner therapy (PDPT) to the index woman to give to her sexual 
partner(s). Support for the concept of PDPT for chlamydia was highest for 
pharmacist owners/co-owners, followed by supervisory pharmacists and staff 
pharmacists (73.7%, 68.4%, 57.0%, respectively, p= 0.046). Some pharmacists felt 
that PDPT would benefit the health care system in terms of time and money, and that 
it was a good option for improving sexual health (McNutt et al., 2009). Pharmacists 
who were negative towards supplying the index woman with treatment for her 
partner(s), gave reasons such as concern that the partner would receive inadequate 
information about the medication, that the partner would have contraindications to 
Azithromycin therapy, that the partner should have a positive test result before being 
treated, and that the partner should take responsibility for their own health and 
consult a doctor for testing and treatment (Cameron et al., 2007). The pharmacists 
also raised the possibility of offering PDPT to ‘mature’ women only.  
4.3.6.8 Provision of support to pharmacies and referral procedures 
A referral procedure was in place in TNS London and Grampian pilots only 
(Anthony and Watson, 2008, Taylor Nelson Sofres Healthcare, 2007). Pharmacists 
had direct telephone access to sexual health advisers (SHAs) at the GUM clinic and 
were also able to access a 48-hour fast-track referral to GUM clinic for clients who 
were deemed to require a specialist consultation. Participants in the TNS study 
suggested that if the client has to be referred, it would be better if a referral letter 
could be provided to the patients to be handed over to their GP rather than the patient 
having to go and explain the reason for their consultation as ‘some people feel 
uncomfortable starting this conversation with their GP’. 
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4.3.6.9 Strategies for advertising testing service 
In-store promotion of free chlamydia testing in pharmacies for young people was 
generated most commonly by pharmacies (either by pharmacists during EC 
consultation or in-store promotion such as posters) and by local sexual health clinics. 
Social networks are other common explanation of how service users first hear about 
the service (Anthony and Watson, 2008, Brabin et al., 2009b, Taylor Nelson Sofres 
Healthcare, 2007, Watson, 2008). Amongst the 16-24 year old local population, 
awareness of the in-pharmacy screening service has shown a greater than 25% 
increase within one year compared before the service launch (Taylor Nelson Sofres 
Healthcare, 2007). This might suggest that general marketing/communication 
activity, coupled with a visible presence in pharmacy, had improved the knowledge 
of local people about the service.  
While the Manchester and Queensland pilots did not include any measures to raise 
awareness of the screening and its availability, other than the pharmacist offering it 
during EC consultation (Brabin et al., 2009a, Emmerton et al., 2011), the USA and 
Grampian studies used extensive advertising campaigns such as advertisement in a 
local newspaper, posting flyers in the neighbourhood where the kits were available 
and sharing information with several community outreach services and youth centres 
(Anthony and Watson, 2008, Bloomfield et al., 2002). The pharmacists in the 
Queensland pilot described the restriction of in-store advertising by posters and 
leaflets as a major limitation of the service uptake (Emmerton et al., 2011). In the 
Grampian study, the response from service users with regard to the in-store 
pharmacy posters was very positive. ‘I think it was good, it was eye catching, I don’t 
think it would have put anybody off, it wasn’t sort of a turn off, I like the colours of 
the bins etc, no I think it was, it was very well advertised’ (Anthony and Watson, 
2008). 
The two most common suggestions made to promote the service, by the clients as 
well as pharmacists were through television and schools. A number of other 
suggestions were made: advertising in magazines, radio, billboards, the tube, 
buses, nightclubs, public toilets, GP surgeries and local community centres, 
further education and colleges and outside the pharmacy store as well. One 
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suggestion was to provide leaflets about the service when customers make a 
related purchase, for example, condoms (Anthony and Watson, 2008, Taylor 
Nelson Sofres Healthcare, 2007). Respondents wanted it to be simple to pick up 
information. There was also a belief that word of mouth would play an important 
part (Taylor Nelson Sofres Healthcare, 2007).  
4.3.6.10 Meta analysis of test results from pharmacy-based chlamydia 
services 
This meta-analysis combined prevalence figures from 10 studies with 32, 665 
subjects tested for chlamydia in pharmacy chlamydia screening services. The 
difference between the studies was very large (I
2 
= 67% inconsistency; 95% CI 22% 
to 82%). The high value means that most of the variability across studies is due to 
heterogeneity rather than chance. Hence a random effect model was followed. Figure 
3-2 shows the Forrest plot of meta-analysis of the positivity of chlamydia among 
those tested in a pharmacy setting. It showed a positivity of 0.08 for chlamydia (95% 
CI = 0.069 to 0.091).  
Figure 4-2: Forest plot and meta-analysis of published proportions (95% C.I) of 
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across the box). The data were not reported in sufficient detail to enable summary 
age-specific or gender specific prevalence to be calculated. A sensitivity analysis was 
undertaken by excluding the only study reporting prevalence of chlamydia among 
those who used pay-to-use service. The re-calculated proportion of chlamydia was 
0.08 (95% CI = 0.06 to 0.11), meaning that it does not markedly change the 
estimates obtained by including all the studies. 
4.3.6.11 Cost-effectiveness of pharmacy-based chlamydia services 
The costs for the pharmacy-based chlamydia testing were considered similar to that  
of other population-based screening programmes (Bloomfield et al., 2002) (Muir, 
2008). The total cost of a pharmacy service includes the professional fee, cost of 
postal kits, lab tests, training and administration. The cost of testing and treatment 
exists regardless of location of testing and treatment. In effect only the professional 
fee for the pharmacist and developing an infrastructure for service provision can be 
considered as an additional cost. 
Cost-effectiveness was estimated using a pharmaco-economic model which is based 
on using risks for complications as estimated in the international literature. The 
scenarios in which cost savings potentials was found were: using 40% risk of PID; 
or using 20% risk of PID among 15–24 year old women, with a lower cost for the 
laboratory tests (van Bergen et al., 2004). 
The sensitivity analysis of the cost effectiveness model in the three study sites (i.e. 
pharmacies, GP clinic and FP clinic) in a Grampian study suggested that for 
pharmacy sites to be cost-effective, the charges incurred for tests at pharmacy sites 
would have to be abolished, and that test uptake in 16-24 year olds would have to 
increase from current ~100 test undertaken in a year to ~800 per year (Tinelli et al., 
2009). The study concluded that if testing is to be introduced, distribution of testing 
kits through GP practices and family planning clinics would likely to provide the 
most cost effective service, since these sites have the highest return rates. 
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4.3.7 Part II: Review of performance of pharmacy-based 
chlamydia service  
This section provides the review of literature on the facilitators and barriers of the 
chlamydia service from the perspective of service users and pharmacists. 
4.3.7.1 Facilitators of and barriers to access a pharmacy-based 
chlamydia service - perspective of service users 
The following main themes emerged from the thematic analysis of the reviewed 
studies: 
 Perception of risk status and interpretation of STI symptoms  
 Embarrassment and stigma  
 Socio-demographic factors 
 Privacy and confidentiality concerns 
 Anonymity  
 Convenience and access 
 Location of testing service 
 Communication 
 Trustworthiness 
These themes are discussed below.  
4.3.7.1.1 Perception of risk status and interpretation of STI symptoms 
The decision to seek care was found to be influenced by the individual’s perception 
of their risk status and interpretation of symptoms. Those refusing chlamydia testing 
cited low perceived risk as one of their reasons for refusing testing. Among those 
who declined the offer of testing, being married or in a stable relationship or having 
first time sex were perceived as low risks for chlamydia (Gudka et al., 2010, Muir, 
2008). However intercourse without condom with a new or casual partner, or with a 
partner who tested positive for chlamydia, were acknowledged/realised to confer a 
higher risk of chlamydia infection (Anthony and Watson, 2008). Similarly, those 
who were recently tested for chlamydia or were diagnosed with an STI were more 
likely to accept a screening offer (van Bergen et al., 2004, Emmerton et al., 2011) - 
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among participating women, 51% had been tested for STIs in the past 12 months and 
38% had a history of STIs, compared with 20% and 22% respectively among non-
participants. 
Individuals accepting screening were also likely to look for symptoms as a sign of 
disease / infection (Anthony and Watson, 2008). In the TNS study, 16% of the 
participants undertook screening because they had signs or symptoms that concerned 
them (Taylor Nelson Sofres Healthcare, 2007). This is a high percentage, given the 
service was intended to offer an opportunistic health screen to those without 
symptoms. This suggests that the pharmacy staff health check does not reveal the 
symptoms, or that some service users chose not to disclose symptoms at that point. 
However in the Perth pilot, 13% of the clients who were identified as showing 
symptoms of STI were referred for a full sexual health check (Gudka et al., 2010).  
4.3.7.1.2 Embarrassment and stigma 
Service users felt that the pharmacy service would help to avoid embarrassment, 
since it avoided the negative associations or stigma attached to clinic attendance, and 
saved them having to go to the GP (Anthony and Watson, 2008, Taylor et al., 2007, 
Taylor Nelson Sofres Healthcare, 2007).  
However, service users highlighted many facets of embarrassment that are 
potentially associated with the pharmacy service as well, including knowing 
someone in the store, knowing the pharmacist, having to ask for the kit and perhaps 
being overheard doing so by the next person in the queue. Moreover, pharmacists 
perceived that pharmacist’s age and gender also acted as barriers for young people- 
adolescents were perceived to be reluctant to discuss their chlamydia risk if the 
pharmacist was a young male (Taylor et al., 2007, Thomas et al., 2010). Pharmacy is 
also perceived as a public place with a greater chance of being seen by someone the 
user knows. It was however noted that although embarrassment is a huge barrier, it 
was not unique to pharmacies. Instead it relates to the general stigma of seeking care 
for a STI. (Taylor Nelson Sofres Healthcare, 2007) 
Reducing spoken communications between the client and pharmacists was proposed 
as a way to reduce embarrassment, for example, avoiding the need to request the test 
kit by use of tickets/vouchers, which could be handed over at the counter whilst 
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making other purchases (Taylor Nelson Sofres Healthcare, 2007). Respondents also 
suggested that these could be given out during health education classes at school or 
in youth clubs. They suggested ways of making the process of getting the kit in the 
pharmacy more discreet; such as a more subtle label for the screening kit, a less 
distinctive colour for the pack, and always handing over the kit at the counter in a 
bag. However, users were divided on whether kits should be more or less visible 
within stores (Taylor Nelson Sofres Healthcare, 2007).  
4.3.7.1.3 Socio-demographic profile of clients 
The chlamydia service in most pilots was particularly targeted at young people under 
24 years of age. While some pilots focused on women receiving EC (Brabin et al., 
2009b, Emmerton et al., 2011, Gudka et al., 2010, van Bergen et al., 2004), some 
particularly targeted high risk males, for example, a USA San-Francisco study was 
targeted towards gay men (Bloomfield et al., 2002). Still others were targeted to all 
young people (Baraitser et al., 2007, Taylor Nelson Sofres Healthcare, 2007). The 
London TNS pilot while effectively reached young women (79%); did not reach 
young men, a group that was considered hard to reach. It might reflect the greater 
awareness of STIs among females, as demonstrated in the TNS study, however the 
low numbers of men tested in the other pilot suggest this may also be because most 
clients heard about the service from a pharmacist during a consultation for EC 
(Baraitser et al., 2007). Within the targeted age group, women older than 24 years 
were offered the lowest number of kits, but were significantly more likely to accept 
the offer of a screening  kit (Brabin et al., 2009a).  
In terms of education, the majority of participants had received the minimum year 12 
or equivalent qualification, were working fulltime (Gudka et al., 2010, Taylor Nelson 
Sofres Healthcare, 2007) and were from a less deprived area (Watson, 2008). 
Thomas (et al. 2009) reported that pharmacists perceived that educated women were 
more likely to accept the offer of the test since less educated women generally do not 
see the danger of chlamydia.  
In the Dutch study, ethnicity of chlamydia service users reflects the practice 
population (van Bergen et al., 2004), whereas the London pilot predominantly 
reached the ethnic population (56% of the service users were from black, vs. 26% of 
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the black population in London) (Baraitser et al., 2007). In contrast, the London TNS 
pilot was underused by this ethnic minority - of the male users, 9% were black. The 
reason for differential uptake of the service by ethnic minority in the two pilots 
undertaken in London might reflect the type and location of pharmacies offering the 
service. The TNS pilot was undertaken through a high street pharmacy chain, 
whereas the other London pilot was undertaken through independent pharmacies. 
This might suggest that ethnic minority clients are more likely to use the service 
offered through independent pharmacies.  
In contrast to the service uptake, the highest proportion of positive screens, 15%, was 
among the ethnic minority of Surinamese/Antillean in the Dutch study (van Bergen 
et al., 2004) and, 15%, among  black service users in the TNS pilot. However, Asian 
service users had the lowest positivity rate of 4% only (Taylor Nelson Sofres 
Healthcare, 2007). This suggests that the service should be offered particularly in the 
pharmacies that serve high risk ethnic populations. 
4.3.7.1.4 Privacy and confidentiality 
In many pilots, the majority of service users (87% to 95%) were not concerned about 
the privacy achieved in a pharmacy consultation (Baraitser et al., 2007, Gudka et al., 
2010), but in another study, 56% were ‘very concerned’ and 29% were ‘somewhat 
concerned’ about the privacy while receiving the service in the pharmacy 
(Bloomfield et al., 2002). A surveys of young people conducted in the TNS 
evaluation also confirmed that young people perceived that pharmacy chlamydia 
screening would be as confidential as other screening locations (Taylor Nelson 
Sofres Healthcare, 2007). 
While exploring the difference in responses of the service users about their 
perception of privacy in a pharmacy, Gutka (et al., 2010) indicated that the response 
of service users depends upon whether they were asked a closed ended or an open 
ended question. He supported his argument by indicating that when the service users 
were asked a polar (yes/no) question to indicate whether they were concerned about 
privacy, 87% answered that they were not concerned. However, when the same 
service users were asked an open-ended question, almost 50% indicated that they 
experienced a lack of privacy. Many service users noted that the need for privacy 
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during sexual health consultations varies for each individual, but they were clear that 
a dedicated private consultation area was preferable and that they would not feel 
comfortable discussing sexual health ‘over the counter’. In other studies, service 
users expressed their reluctance to access any facility that might draw attention to 
their use of a chlamydia service. They believed that they would feel stigmatised if 
other clients saw them going into the consultation room to speak to the pharmacist in 
private, especially in small pharmacies (Anthony and Watson, 2008, Taylor Nelson 
Sofres Healthcare, 2007).  The difficulties in achieving privacy for sexual health 
consultations were also equally felt by the pharmacists (Dabrera et al., 2011). 
Whether or not a pharmacy has a private consultation area does not appear to 
influence a person’s choice of pharmacy, with only 1% stating this to be a reason for 
choosing one pharmacy over another (Taylor Nelson Sofres Healthcare, 2007). 
However, in some pilots it was a mandatory requirement in order to provide a 
chlamydia service in pharmacy (Gudka et al., 2010, Muir, 2008) 
McNutt studied the level of confidentiality achieved in pharmacy interactions and 
observed that, combining customer and staff measures, 53% of all pharmacy staff-
client encounters met the criteria for confidential interactions. However, it was 
noted that in 81% of pharmacies, a conversation in the pharmacy area could be 
overheard at a distance beyond 6 feet, and in 61% of pharmacies at least 15 feet 
away (McNutt et al., 2009).  The terms privacy, anonymity and confidentiality 
have been used interchangeably and imprecisely in recent research, so there is a 
need for more nuanced evaluation studies in the future. 
4.3.7.1.5 Anonymity  
Another concern of service users was a desire for anonymity. They described 
different aspects of anonymity. They preferred to use a service distant from home, 
to avoid running into anyone they knew (Taylor et al., 2007). The TNS pilot 
demonstrated that more screening was undertaken in stores in large shopping 
centres and at train and tube stations which may reflects anonymity. Some 
preferred a pharmacy service over the GP one, due to the fact that the GP often 
knew them from their childhood and knew their parents as well. Hence it is 
embarrassing to the service users (Taylor Nelson Sofres Healthcare, 2007).  
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Service users were also concerned about providing personal details (such as their 
postcode and date of birth) to the pharmacy staff (Anthony and Watson, 2008, 
Taylor et al., 2007). The perception that information would be shared between 
health care professionals was reported by service users as a barrier to accessing 
treatment. There was uncertainty about the legal guidelines that pharmacists 
operate under, and whether they would keep records of those who have requested 
screening kits (Taylor Nelson Sofres Healthcare, 2007).   
4.3.7.1.6 Convenience and access 
Convenience was the advantage of a service most frequently described by the clients. 
The aspects of convenience highlighted by the clients were no need for appointment 
to access the service (Anthony and Watson, 2008, Baraitser et al., 2007, Gudka et al., 
2010, Taylor et al., 2007, Taylor Nelson Sofres Healthcare, 2007), extended opening 
hours of the pharmacy and easy access from work or home (Baraitser et al., 2007, 
Taylor et al., 2007, Taylor Nelson Sofres Healthcare, 2007). The pharmacy service 
was considered to reduce waiting times for testing and for treatment, which were 
seen as a frustration when trying to arrange appointments with GP surgeries and SH 
clinics (Anthony and Watson, 2008, Baraitser et al., 2007, Bloomfield et al., 2002, 
Taylor Nelson Sofres Healthcare, 2007). In a London pilot, where the service was 
evaluated by simulated clients, they found that they waited less than 2 minutes at the 
pharmacy counter to get a consultation and test kits were obtained on average within 
22 minutes (range  8–35 minutes) (Baraitser et al., 2007).   
4.3.7.1.7 Location of the pharmacy 
Locality influences a service user’s choice of pharmacy; whether it be a considerable 
distance from home to preserve anonymity or attending the local trusted community 
pharmacy close to home or work (Taylor et al., 2007, Taylor Nelson Sofres 
Healthcare, 2007). In the TNS pilot, 36% of respondents chose a pharmacy close to 
home, and 35% chose one close to work. There were mixed feeling about accessing a 
‘local pharmacy’. It was indicated that people would not go where they recognised 
store staff or where they themselves might be recognised, and thus tended to prefer a 
large pharmacy in a shopping area rather than a small local pharmacy. An alternative 
opinion expressed by pharmacists was that local community pharmacists knew their 
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clients well, had forged a relationship with them, and were ideally placed to help 
them (Thomas et al., 2010). The accessibility of the service was seen as a particular 
advantage by many, given the high street availability of the service, and the option of 
going to a different location if preferred.  
In rural areas, transport and the cost of transport was considered as a barrier (Muir, 
2008). However this pilot, which was undertaken predominantly in a rural area in 
Fife, reported that the median travelling distance from a client’s home postcode area 
to the pharmacy was 2.1 miles (range 0.2-30.5miles). However 40% of the clients 
travelled less than 1 mile for treatment.  
4.3.7.1.8 Communication 
The excellent communication skills of the pharmacists and counter staff were 
important to respondents. With regard to the service, all clients felt ‘very 
comfortable’ or ‘comfortable’ discussing sexual health with the pharmacist (Baraitser 
et al., 2007). Clients felt it was appropriate to discuss sexual health issues with their 
pharmacist if s/he appeared approachable and was professional in approach 
(Baraitser et al., 2007, Gudka et al., 2010). They also valued clear and concise 
information being given to them about the service, thereby making them feel 
comfortable (Gudka et al., 2010). The majority of service users commented 
positively on how they had been dealt with by the pharmacy staff and described the 
staff attitude as friendly, helpful and non-judgemental (Anthony and Watson, 2008, 
Baraitser et al., 2007, Gudka et al., 2010, Taylor et al., 2007, Taylor Nelson Sofres 
Healthcare, 2007). However in some cases a service user complained that the 
pharmacy staff member who dealt with his/her request had not been sure of the 
process and/or was very self-conscious, embarrassed and nervous. It was also felt 
that if assistants try to be too caring they can appear patronising (Taylor Nelson 
Sofres Healthcare, 2007).   
4.3.7.1.9 Confidence in a pharmacy service 
A reason for not judging a pharmacy-based chlamydia screening programme as first 
choice was that doctor’s involvement was preferred (Taylor et al., 2007). Clients also 
expressed concerns that the advice received from a pharmacist would not be of the 
same quality as that received from a doctor, and raised questions over test reliability, 
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and whether the pharmacy test would be of the same standard as those used in other 
locations (Taylor Nelson Sofres Healthcare, 2007).  
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4.3.7.2 Facilitators of and barriers to the provision of a pharmacy-based 
chlamydia service - perspective of pharmacists 
The themes that emerged from the analysis of the paper reviewed can be grouped 
into the following facilitators of and barriers to the provision of the pharmacy 
chlamydia service: 
 Pharmacists’ attitude towards the provision of chlamydia service 
 Views regarding the attitude of other stakeholders 
 Perception of risk status of the client 
 Financial incentives 
 Training of pharmacy staff 
 Time and workload 
 In-pharmacy facilities 
 Paperwork 
These themes are discussed in detail below. 
4.3.7.2.1 Pharmacist’s attitude towards the provision of a chlamydia service 
Pharmacists believed that screening fulfilled an important educational goal for the 
pharmacy of bringing sexual health awareness to people (Taylor et al., 2007). Many 
considered chlamydia screening as a service enhancement which demonstrates a 
‘progressive’ and ‘proactive role’ of pharmacy (Thomas et al., 2010) which leads to 
greater customer satisfaction (Baraitser et al., 2007, Cameron et al., 2007). 
Pharmacists described their overall experience in providing the service as very 
positive (Gudka et al., 2010, Taylor Nelson Sofres Healthcare, 2007).  
Pharmacists believed that participation in chlamydia service gave them a chance to 
exercise their professional reputation as a primary health care provider in the field of 
sexual health services (Gudka et al., 2010, Taylor Nelson Sofres Healthcare, 2007, 
Cameron et al., 2007, Baraitser et al., 2007). They also felt that their participation in 
such a service would help in reducing workload on the GPs (Baraitser et al., 2007), 
by providing a first line of care to patients (Taylor et al., 2007). Often their 
participation was  motivated by their awareness of the prevalence of chlamydia in the 
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population served by their site and their desire to address this problem (Anthony and 
Watson, 2008, Taylor et al., 2007). Others described it as an easy add-on to their 
ongoing provision of EC (Dabrera et al., 2011). The perceived benefits for 
pharmacists of providing this service also included greater skills training and job 
satisfaction (Baraitser et al., 2007), and positive impact on the pharmacy business 
because of ‘greater footfall’ (Anthony and Watson, 2008). However, the pharmacists 
also noticed hesitation towards proving the sexual health service to young girls. One 
pharmacist who withdrew from the pilot noted that “It is a good study, and we can 
see the benefits of it, but we feel uncomfortable and out of our depth discussing 
sexual health with young girls. We do not have any female pharmacists. It is just very 
difficult” (Gudka et al., 2010). Training was perceived to develop confidence in 
pharmacist to provide counseling to young people on sexual health matters and is 
discussed in more detail in the relevant theme entitled ‘training of pharmacy staff’  
4.3.7.2.2 Pharmacists views regarding attitudes of other stakeholders 
Pharmacists reported that their support staff have a positive attitude towards 
pharmacy involvement in this service. They described that the pharmacy support 
staff involvement was only limited to promoting the service, whereas for the actual 
handing out of the test and counseling, they were keen to refer them to the 
pharmacists. Pharmacist perceived that the GPs were also supportive in their 
provision of the service (Anthony and Watson, 2008). 
Frequent contacts with administrative staff responsible for the chlamydia service was 
considered positive to ensure that arrangements are satisfactory (Anthony and 
Watson, 2008). However in the TNS study, the project staff indicated their concern 
that, in the case of pharmacy chains, their head offices did not involve project staff in 
the planning/provision of pharmacy staff training (Taylor Nelson Sofres Healthcare, 
2007). It was also felt that to enhance the support to pharmacists, the government and 
pharmacy governing bodies should also be involved in the service (Taylor et al., 
2007).  
Pharmacists had mixed views about client attitudes to screening (Thomas et al., 
2010). The majority of pharmacists indicated that their clients responded positively 
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to the offer of a kit, however a few pharmacists believed that offering screening 
could be construed as criticism of a client’s sexual morality. 
None of the studies explored the attitude of strategic stakeholders responsible for 
policy making regarding the chlamydia screening. 
4.3.7.2.3 Selective offer of service by pharmacists 
Pharmacists believed that they offer the service more often to those women who they 
think were at greater risk (Brabin et al., 2009a, Thomas et al., 2010). Some 
pharmacists clearly stated that they would assess clients risk for STI and their need 
for a kit before deciding whether it was appropriate to offer them. Protective factors 
for chlamydia stated by pharmacists in these studies were aged over twenty, being 
married, having children, from ethnic minority groups and in a steady and long term 
relationship. However, despite knowing the risk factors, some pharmacists indicated 
that they would offer the kits to those who they think are likely to be receptive of the 
offer, such as educated women or older women, because they felt that the ‘less 
educated generally don’t see the danger of chlamydia’, and older women had a more 
responsible attitude (Thomas et al., 2010). 
4.3.7.2.4 Financial incentives 
Reimbursement arrangements varied across pilots, with the Manchester study 
providing no additional financial incentives beyond the payment for EC (Thomas et 
al., 2010), whereas an Australian pilot provided each participating pharmacy with a 
$1000 readiness payment to enable  their involvement with the chlamydia screening 
programme, and a further incentive of $15 per chlamydia screening test returned 
(Gudka et al., 2010). Grampian pilot provided pharmacists a fee of £10 for every 
consultation that resulted in the issue of a test kit (Anthony and Watson, 2008). 
Although most pharmacists indicated the benefits of participating in this scheme in 
terms of enhancing their professional status, given the retail environment of the 
pharmacy, they accepted that it is a mix between professionalism and 
entrepreneurism (Gudka et al., 2010, Thomas et al., 2010). Van-Bergen (et al. 2004) 
indicated that in order to sustain a programme, appropriate financial incentives were 
needed, and suggested that a marked decline in the distribution of test kits in the 
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pharmacy in the second year of the programme might had been a result of the 
absence of financial incentive offered to the pharmacy.  
4.3.7.2.5 Paperwork 
Some pharmacists criticised the leaflets they were given to hand out as ‘overloaded 
with information’ and felt that because of this clients lost interest in testing (Brabin et 
al., 2009a). In addition, some pharmacists (and other providers) considered the 
laboratory form as complicated for some clients to complete and suggested that such 
forms be simplified for the clients (Anthony and Watson, 2008). Extensive record 
keeping required for the service was also described as deterrent to some pharmacists 
(Taylor Nelson Sofres Healthcare, 2007). 
4.3.7.2.6 Time and workload 
The barriers to patient counselling in chlamydia screening that were most often cited 
were workload and time restrictions (Baraitser et al., 2007, Dabrera et al., 2011, 
Gudka et al., 2010, McNutt et al., 2009, Taylor et al., 2007, Taylor Nelson Sofres 
Healthcare, 2007, Thomas et al., 2010). Pharmacists felt that their increasing 
involvement in the provision of other services, meant that adding chlamydia 
screening adds extra well placed pressure on the pharmacy (Taylor et al., 2007). 
They were concerned that the increase in workload would  result in greater chance of 
prescription errors (McNutt et al., 2009).  
Clients also noticed pressure on pharmacists and indicated that it appeared that 
understaffing meant their consultation was interrupted  frequently, since pharmacists 
had to keep an eye on dispensing activities within the pharmacy (Baraitser et al., 
2007). Hence, possible strategies were suggested to free up  pharmacists so they 
could have more time to do public health, such as training other pharmacy staff such 
as dispensers to take up some of the responsibilities of a pharmacist (such as 
checking prescriptions)  (Thomas et al., 2010). Simplification of paperwork was also 
advised as one way of dealing with the workload of the pharmacist (Gudka et al., 
2010). 
4.3.7.2.7 Training of pharmacy staff 
Overall, service providers were satisfied with the training provided which was 
considered comprehensive and detailed. They felt that sexual health training built 
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their confidence and skills (Anthony and Watson, 2008, Baraitser et al., 2007, Taylor 
Nelson Sofres Healthcare, 2007). Most pharmacists said they felt confident and 
comfortable talking about EC and chlamydia screening (Baraitser et al., 2007, Gudka 
et al., 2010, Taylor et al., 2007, Taylor Nelson Sofres Healthcare, 2007). 
However in terms of availability of trained staff, the professional patients reported 
difficulty accessing the service because of unavailability of  an ‘accredited’ 
pharmacist at the time of visiting the pharmacy (Baraitser et al., 2007). Some 
pharmacies in the Manchester and London pilots ceased recruitment over the study 
period, mainly because their trained pharmacist left and could not be replaced.   
Pharmacists also raised concerns about the process for cascading training that 
resulted in no training for new joiners, part time staff and locum pharmacists (Taylor 
Nelson Sofres Healthcare, 2007, Thomas et al., 2010). They also indicated that 
training was not put into frequent practice due to the low uptake of the service. 
Hence they advocated frequent refresher training. There were some suggestions that 
the training should be tailored according to the type of pharmacy staff. Regarding the 
focus of training, it was suggested to highlight the importance of the benefit of staff’s 
proactive approach, since findings indicate some service users would not have used 
the service otherwise (Taylor Nelson Sofres Healthcare, 2007) or did not feel 
comfortable asking for a kit (Taylor et al., 2007).  
4.3.7.2.8 In-pharmacy facilities 
The lack of a toilet facility was perceived by pharmacists as a barrier to providing a 
chlamydia testing service in community pharmacies (Cameron et al., 2007, Gudka et 
al., 2010). Service providers working in stores with toilets were reported to 
encourage customers to avail themselves of the store toilet to use the kit 
straightaway. Mixed views were put forward by pharmacists about the advantage 
offered by in-store toilets. Some felt these would be an advantage, particularly for 
teenagers who might not want to take the test home. Others viewed in-store toilets 
less positively, since they thought it would make test use too obvious. However, as 
reported earlier, potential service users  did not consider an in-store toilet to be 
particularly important (Taylor Nelson Sofres Healthcare, 2007).  
 
Chapter 4: Literature review of  pharmacy-based chlamydia services…………………………….  
130 
The availability of the consultation room was considered part and parcel of achieving 
confidentiality and privacy, so this is discussed in more detail in the relevant theme 
(section 4.3.7.1.4). However it was evident that pharmacists working in a pharmacy 
without a consultation room were less motivated to provide sexual health counseling 
to their clients (McNutt et al., 2009). 
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4.4 Discussion and recommendations 
This chapter provides a comprehensive review of 22 studies found in the published 
and grey literature. It has examined the models of chlamydia screening in 
pharmacies. The economic analysis of the implementation of chlamydia screening in 
community pharmacies is described and the meta-analysis of chlamydia positivity for 
those tested in pharmacy setting is presented. Facilitators of and barriers to the 
pharmacy chlamydia service are then discussed in the light of the conceptual model 
which is developed through the analytical stage of the thematic synthesis. 
4.4.1 Major findings 
Recent evidence from the UK, the USA, Australian and European studies included in 
this review indicated that it is feasible to test young people for chlamydia in a 
community pharmacy setting.  
These studies identified that the chlamydia screening service is generally acceptable 
to the majority of community pharmacists. The uptake of the service was low and 
pharmacists suggested more promotion strategies to increase awareness of the 
service among the target group such as campaigns that target young people in high 
schools, youth clubs, pubs and social networking sites. Most often the participants 
were offered screening during EC consultation. However, women requesting EC, 
represent only a subset of the population needing chlamydia screening. The 
pharmacists were also selective in offering the service to only those EC clients who 
were perceived to be receptive of the service, for example, those who seemed 
educated, or in the higher age group.  
Urine samples were the preferred method of specimen collection. Completed kits 
were returned by the clients by either post to the microbiology laboratory, handed in 
at the pharmacy or at the designated pathology sites. Result notification strategies 
reported in studies varied from asking participants to call, staff-initiated notification 
(by telephone, mobile or text), post, or in person (requiring the person to return to the 
pharmacy). However, clients generally preferred to be notified of the result by phone, 
irrespective of whether they were tested positive or not. Some studies provided more 
than one result notification options to their clients. Persons notified of a positive test 
were counseled and further advised to go to a GUM clinic, GP or pharmacy for 
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treatment. Partner notification was well received from the pharmacies. 
The meta-analysis indicated a pooled proportion of chlamydia infection was 0.08 
(95% C.I 0.069 to 0.091). This proportion corresponds to a percentage of 8%, which 
is very similar to that reported for the meta-analysis of chlamydia positivity from GP 
surgeries (Table 2-1) (Adams et al., 2004). This might suggest that the population 
getting tested in general surgeries are similar, in terms of risk of getting chlamydia 
infection, to those being tested in community pharmacies as well. 
Potential for cost saving through  pharmacy chlamydia screening/testing was  found 
only in a limited set of scenarios, such as assuming relatively high PID-risks (40%) 
or if the uptake of service from the pharmacy is very high, at up to 800 kits / year, 
instead of a current uptake rate of 100 kits / year. 
4.4.2 Development of a conceptual model of the facilitators of 
and barriers to the service provision and access 
In summary, the studies reviewed point to a number of facilitators of and barriers to 
chlamydia testing (access or implementation), among service users and providers. 
The themes and sub-themes identified in this review are summarised in a conceptual 
model in figure 3-3. This model shows that these factors can be classified based on 
the level at which they operate; i) Service user i.e. young people aged 16-24 years; ii) 
Service providers i.e. pharmacists and their support staff; and iii) Stakeholders acting 
at policy level and in decision making regarding a service.  
This review indicates that young people are worried about the maintenance of 
privacy and confidentiality when accessing these services. There seems to be a need 
for young people to be given greater reassurances about this aspect, through publicity 
campaigns. This review also highlighted a diversity of preference among young 
people regarding accessing the pharmacy chlamydia service. Convenience of access 
and location appeared as key factors for some young people deciding upon the use of 
pharmacy service close to their home, study or work place.  Other service users 
indicated their preference for a service which is away from home to ensure 
anonymity of access. Young people also valued those staff members who have a 
non-judgmental but a professional approach towards them so that they feel 
comfortable discussing sexual health issues with them. They also valued clear and 
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concise information about the service provided to them. This also highlights the 
importance of well trained staff - a factor also emphasized in reviews of 
contraceptive service and other public health service delivery to young people and 
was found to have a positive effect on pharmacists’ attitudes (Baxter et al., 2011, 
Anderson and Blenkinsopp, 2006, Eades et al., 2011).  
The current review highlighted the concerns of pharmacists regarding the availability 
of trained staff and the need for recurrent training to incorporate new joiners, part 
time and locum staff so that the continuity of service provision could be ensured. 
However none of the studies in the current review assessed specific areas for future 
training in the provision of chlamydia service.  
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The majority of the pharmacists in this review were positive about providing 
chlamydia service and felt that this was not only an important role of bringing sexual 
health awareness and its provision to young people but also lead to their professional 
development. A recurring theme from studies was a concern of increased workload 
due to the increasing involvement of pharmacists in the provision of public health 
services and hence time management issues. Under staffing was identified as another 
reason adding up to the increased work load on pharmacists.  
Pharmacists regarded the attitude of other stakeholders as important and highlighted 
the need for improved connections between different agencies involved in delivering 
the service. The joint working between different agencies such as; the government, 
pharmacy governing bodies, administrative staff involved in delivering training and 
setting up the service were highlighted as areas needing improvement. The role of 
policy makers was also considered important for sustainable delivery of the service 
and included aspects such as ensuring provision of training, developing easy paper 
work and provision of adequate remuneration. However only one study sought the 
involvement of policy stakeholders and elicited their perception of the pharmacy-
based chlamydia service (Taylor Nelson Sofres Healthcare, 2007) and none of the 
studies ensured an active involvement of stakeholders in the evaluation of the 
pharmacy-based chlamydia service.   
4.4.3 Limitations of studies reviewed and of the literature 
review 
This review is limited in that only studies published in English were included. The 
scope of some of the quantitative evaluation studies was limited by the survey 
question is, for example, is chlamydia testing from pharmacies is acceptable to the 
client? Some of the qualitative studies had very small numbers of participants. While 
the review was able to identify a large body of UK evidence, limited evidence were 
also available from the USA, Australia and the Netherlands, and none of the studies 
from other developed countries was available. This is probably due to the fact that 
the policy changes in UK increasingly required pharmacies to participate in the 
chlamydia service and hence its evaluation was encouraged. Evaluation studies that 
utilised mixed methods often failed to compare and contrast findings, tending to 
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focus on quantitative data and providing scant detail of qualitative analysis and very 
little qualitative data (quotations). However despite the variability of the studies 
included in the review, they had similar / coherent findings. It is also striking that the 
findings support each other strongly, irrespective of whether the studies were 
conducted using predominantly qualitative or quantitative approaches. The 
heterogeneity between the studies did not permit me to synthesize or generalize key 
findings as to how all these factors interact with one another and which factors are 
the most significant. 
The quantitative meta-analysis undertaken in this review is only preliminary. Its 
purpose was to provide only pooled estimates of chlamydia positivity among those 
tested in a pharmacy setting. This would allow making comparisons with chlamydia 
testing undertaken in other health care settings. However the findings of this meta-
analysis should be interpreted in the light of many methodological constraints. This 
meta-analysis only provides crude prevalence estimates of chlamydia. Due to the 
limited data available, it was neither possible to produce estimates stratified for age, 
gender and other risk factors, nor to employ any meta-regression techniques. Unlike 
the meta-analysis techniques used for randomised controlled trials in which stringent 
inclusion criteria can be defined based on study methodology, it is difficult to do this 
with observational studies such as the ones presented in the analysis in this review. 
This is because the observational studies themselves are prone to more biases and 
confounding, and may produce spurious findings. The publication biases are less 
important in the meta-analysis of observational studies in the background of 
numerous other biases and confounding factors that may introduce heterogeneity 
(Egger et al., 1998). 
4.4.4 Strengths of the review 
This is a first review to date that offers a model that conceptualises the facilitators 
and barriers for the provision of, and access to, pharmacy-based chlamydia testing 
and treatment services. The model developed in this review highlights key areas to 
consider in the design and implementation of a pharmacy-based chlamydia services 
for young people. Many of the factors described in this model would also apply to 
other sexual health service provision through pharmacies or even to chlamydia 
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screening services in other health care settings. Hence this model could also be used 
for framework synthesis of qualitative studies of the above mentioned services 
(Carroll et al., 2011). The final product would then be a revised model that may 
include both modified factors and new factors that were not anticipated in this 
original model.  
The provision of structured summaries of the studies in this review (in tables 4-1 to 
4-3) allows readers to judge the extent to which the themes and concepts might 
translate from one situation to other.  
4.4.5 Recommendations for future evaluation 
The review of findings permits some suggestions to be made for future evaluation of 
a pharmacy-based chlamydia service as follows: 
 The views of strategic stakeholders (i.e. those involved in policy of a 
pharmacy-based chlamydia service) were not explicitly elicited in the studies 
reviewed, except in the TNS evaluation. Future evaluations should consider 
involving strategic stakeholders in suggesting what they want an evaluation 
to address  
 There is a need to ensure that all pharmacy staff who have potential dealings 
with clients are trained to enable successful delivery of the screening 
programme. However, since the level of involvement of pharmacy staff 
would be less than those of the pharmacists, the assessment of the training 
needs of across the different staff types is essential 
 There is a need to explore further the concepts of privacy, confidentiality, and 
anonymity, as well as embarrassment and stigma, and the ways in which they 
are interlinked, often being used interchangeably by service providers  
 The reviewed studies did not report why invited pharmacies decided to take 
part, or not, in a particular pilot. A comparison of the perspectives of both the 
pilot pharmacies and those who were invited and decided not to take part, 
would be helpful in designing future service strategies to increase the 
participation of pharmacies 
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These recommendations have been incorporated into the studies that I conducted for 
this PhD that contributed towards an evaluation of the CT&T service.
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CHAPTER 5: DESCRIPTION OF THE CT&T 
SERVICE 
5.1 Introduction 
This chapter first provides the aim of the pharmacy-based chlamydia service and 
provides a brief history of the service in Scotland and more specifically of the CT&T 
service in Lothian. It then describes the proposed specifications of the CT&T service. 
Description of a programme is a key step in an evaluation process. Not only that the 
programme description sets a frame of reference for all subsequent decisions 
regarding the evaluation of a programme, it also enables comparison with similar 
programmes. Proper interpretation of the evidence from the programme evaluation 
depends upon the availability of adequate descriptive information on the intervention 
and its context, so that the transferability of the evidence can be determined 
(Rychetnik et al., 2002). The chapter ends with an overview of the Lothian Health 
Board area, the setting for the current research.   
5.2 Aim and specifications for the pharmacy-based 
chlamydia service in Scotland   
As per Scottish government directive, NHS Circular PCA(P)(2008)17
2
 (Annex C 
Pharmaceutical Services Specification, Public Health Service, Sexual Health 
Service), the pharmacy-based chlamydia service was aimed to ‘provide extended 
access through the NHS to advice and specific sexual health services as part of the 
Public Health Service (PHS) element of the community pharmacy contract’ 
2
 
Appendix B (Part 1) of the circular specified that the service was to provide 
chlamydia testing to sexually active individuals aged 15-24 years, whereas Part 2 
specified  provision of a chlamydia treatment service, where clinically indicated,  as 
specified within a Patient Group Direction (PGD),  to those over 13 years old. 
                                               
2 This is a Scottish government circular, and is available from 
www.sehd.scot.nhs.uk/pca/PCA2008(P)17.pdf 
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5.3 Brief history of the pharmacy-based chlamydia 
service in Scotland 
Table 5-1 sketches the timelines for pharmacy-based chlamydia service in Scotland. 
In August 2008, the Scottish government gave directions to the local health authority 
to implement the pharmacy-based chlamydia service as part of the Public Health 
Service element of the community pharmacy contract. A dedicated funding for the 
provision of the pharmacy-based chlamydia services service was provided by the 
Scottish government to local health boards. It should be noted here that while 
provision of some sort of pharmacy-based chlamydia service was obligatory, the 
Scottish government provided some freedom to health boards to tailor the service 
according to their local circumstances. The target date for commencement of a 
pharmacy-based service was set at 29 August 2008
3
. 
Table 5-1: Timeline of the Scottish government directed pharmacy-based chlamydia 
service in Scotland 
Timeline Scottish government actions/directives 
29 August 2008 Target date set by the Scottish government to start a 
pharmacy-based chlamydia service in pharmacies in all 
health boards 
February  2010 Scottish Government reminder to start the service in those 
health boards where the service has not yet been 
implemented 
October 2010 The Scottish government decision to change the status of 
the service from a ‘national’ to a ‘local’ service.  
31 March 2011 Special funding from the Scottish government for a 
‘national’ service ceases  
Nearly 18 months following the initial  directive, in February 2010, Scottish 
government reminded those health boards where the pharmacy-based chlamydia 
services roll-out was slow to develop, about their ‘strong preference’ to have ‘a 
national chlamydia service available through community pharmacies in all board 
areas’ (see Appendix 10, for the Scottish government reminder). Health boards were 
instructed to share with the Scottish Government, their respective health board’s 
                                               
3 This is a Scottish government circular, and is available from 
www.sehd.scot.nhs.uk/pca/PCA2008(P)17.pdf 
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arrangements for; a) partner notification, b) incentives to pharmacies, c) data 
gathering and d) reducing the cost of the service by indicating best value in 
purchasing kits. This would allow the government to share with other health boards, 
the cost effective arrangements for the above stated issues. Moreover, the same letter 
stated that consideration was being given to some of the issues raised by health 
boards, including; a) the possibility of a national advertising material for the service, 
b) availability of learning resource through NES to be used alongside local training, 
and 3) reviewing current service specifications to ensure that they fit with the new 
SIGN guidelines for chlamydia published in March 2009. It was also indicated that 
the service would be reviewed in the summer of 2010.  
In October 2010 a circular was issued to the health boards in (NHS Circular: 
PCA(P)(2010)26)
4
 indicating a government decision to revise the status of the 
chlamydia service from a ‘national’ sexual health service to a ‘local’ service (see also 
Appendix 11, for the Scottish government decision letter sent to health boards). This 
meant that there would no longer be direct payments from central government to 
support the service costs, but instead the continuation of pharmacy-based chlamydia 
services would be locally negotiated by health boards and funded by local health 
board budgets. The Scottish Government circular
4
 pointed out that this meant that in 
any health board areas where access to a chlamydia testing and treatment service 
through community pharmacy was judged to represent an appropriate and cost-
effective option, it would be possible for the health board to continue such a service 
via their routine budgeting.   
By the time of termination of the service, after 10 months, there had been only 4 tests 
requested via community pharmacy, of which 3 were eligible for the testing kits. All 
the three tested negative and hence no treatment was provided. 
                                               
4This is a Scottish government circular, and is available from 
[www.sehd.scot.nhs.uk/pca/PCA2010(P)26.pdf] 
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5.4 Specifications and the implementation of the 
CT&T service in Lothian  
This section details the service specifications for the CT&T service and outlines the 
timelines of implementation of the service in Lothian.  
5.4.1 Service specifications for the Lothian CT&T service 
The specifications described below are for the CT&T service (i.e. are Lothian Health 
Board specifications), and are broadly similar to the pharmacy-based chlamydia 
service specification provided by the Scottish government, unless specified 
otherwise. A quick reference guide to pharmacists pertaining to Lothian Health 
Board service specifications are provided in Appendix 13. The detailed Scottish 
government service specifications for a pharmacy-based chlamydia testing and 
treatment are described in Annex C of the NHS circular (PCA)(P)(2008)17
5
.  
5.4.1.1 Target population 
The testing part of the CT&T service in Lothian was specified as for 16-20 years old 
males and females. However it was stated that the service could also be provided to 
those within the age range of 15-24 years old, if they were anxious to be treated. This 
meant that the Lothian specification allowed for the possibility of testing 15 year olds 
and those aged 21 to 24 years, as per the Scottish Government’s specification for the 
testing service.  
The treatment service was available for anyone over 13 years old, who stated they 
had tested positive for chlamydia, or were a partner of a chlamydia positive person. 
5.4.1.2 Selection of pharmacies for the provision of CT&T service 
Lothian Health Board decided to pilot the testing service in a limited number of 
pharmacies, before deciding to roll out the service more widely. It was decided to 
select those pharmacies for pilot which were located in geographically disadvantaged 
areas and where ‘there is an identified unmet need for chlamydia testing in that 
population’ (Appendix 12). The treatment service was available from all pharmacies 
in Lothian. NHS Lothian therefore invited 66 community pharmacies to pilot the 
                                               
5 This is a Scottish government circular, and is available from 
[www.sehd.scot.nhs.uk/pca/PCA2010(P)26.pdf] 
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CT&T service. The 66 pharmacies being selected from all 166 pharmacies in Lothian 
were those whose geographic location had the potential to improve access to this 
sexual health service among socio-economically disadvantaged communities. Of 
these 66 invited pharmacies, 12 pharmacies ultimately agreed and started providing 
the CT&T service. 
5.4.1.3 Engaging young people in the service 
The CT&T service was only made available for clients requesting for it. This is in 
contrast to the Scottish government specifications that made the service available for 
clients requesting a chlamydia test as well as for those identified as suitable by a 
pharmacist or other member of their support staff. 
5.4.1.4 Testing process in a community pharmacy 
Counter staff may be the first point of contact for the client who wished to be tested 
for chlamydia in the community pharmacy (Figure 4-1). Hence it was advised that 
pharmacy support staff should know the details about the service and should be non 
judgemental in their interaction with the client. They could ascertain the age of the 
client for eligibility and refer to the pharmacist for counselling and provision of a kit. 
The client would be moved to the private area or consultation room for the remainder 
of the consultation. The pharmacists were instructed to confirm the client’s age and 
to take the sexual history to identify any symptoms of STI. If the client is 
symptomatic, then they would be referred to GUM. If the client was deemed eligible, 
then s/he would be supplied with postal testing kit (PTK). The PTK (Figure 4-2) 
consisted of: i) urine sample bottle, ii) an absorbent sleeve in which the container 
fits, iii) a laboratory form to complete with details of how service user wishes to be 
contacted with the result (phone call, text or email), iv) information leaflet for the 
client and, v) information sheet about other GUM and sexual health clinics in 
Lothian that client or their partner could attend for testing and treatment. The 
samples of Lothian Health Board’s forms and leaflets (iii to v) can be seen in 
appendices 14 to 16. In order to minimise the wastage of kits, it was decided by the 
Lothian Health Board that the absorbent sleeve and lab form would not be given to 
the client in the first instance, but only the sample bottle along with information 
leaflets. 
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5.4.1.5 Return and postage of the sample 
The client would hand over the sample to the pharmacist. Pharmacists would fill in 
their details in the lab form, package the sample and form in a postage-paid, pre-
addressed envelope and post the completed kit to the Laboratory. In the case that the 
client doesn’t return with the sample, then the pharmacist could replace bottle and 
leaflets to be able to use the same PTK for the next client.  










5.4.1.6 Test results 
The test results were to be passed to the health advisor in GUM clinic for follow up. 
The client could also call on automated phone lines giving their PTK number and 
personal identification to get the result. If the result was positive, the client would be 
given three options for receiving treatment; i.e. GUM, GP or community pharmacy.  
5.4.1.7 Treatment at community pharmacy 
If the client opted for treatment from a community pharmacy, they would not need to 
return to the same pharmacy at which they were tested (Figure 5-3). The pharmacist 
would assess the client with a positive result for eligibility for treatment from 
pharmacy under the Patient Group Direction. The treatment is usually a single one 
off dose of Azithromycin antibiotic (1g). If Azithromycin is contraindicated for the 
patient, then s/he would be referred to a GUM clinic for further follow-up. If they 
pay for their prescriptions then the usual prescription charges would apply.   
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5.4.1.8 Partner notification 
Upon receiving treatment from the pharmacy, the index patient would be encouraged 
to complete a confidential partner notification form for partner tracing (Appendix 
17). This form would be returned by the index patient in the prepaid sealed envelope 
to the pharmacist, who will then post it to the GUM clinic. If the patient wishes to 
contact their sexual partners by themselves, then they would be provided with 
enough tri-fold information leaflet for partners (Appendix 18). Sexual partners of 
positive individuals would be offered chlamydia treatment and/or testing regardless 
of age.  










5.4.1.9 Remuneration arrangements  
The remuneration arrangements by the Scottish government were similar for all 
health boards. All community pharmacy contractors with whom the health boards 
have made an arrangement for the provision of the pharmacy-based chlamydia 
service element of the PHS were remunerated in terms of three stage payment as 
follows [NHS Circular: PCA (P) (2008) 17]:   
i. The one-off readiness and administration payment of £270 is intended to 
remunerate staff for set up and ongoing administrative activity during the first 12 
months of this programme. It covers set up costs including training, active co-
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operation with local NHS Board sexual health co-ordinators, GPs and other 
patient referrers, and other administrative activity. 
ii. A flat monthly rate of £40 for the availability of chlamydia services (equivalent 
to an annual rate of £480). 
iii. £25 for each intervention where the patient is provided with treatment for 
chlamydia. 
The start-up payments which were intended to incentivise rapid take up of the new 
services were no longer to be paid from 1 April 2009. Since the chlamydia testing 
service was launched late in Lothian mainly due to the delays of the NHS 
arrangements, the pharmacy contractors did receive the initial set up cost. 
5.4.2 Timelines of the CT&T service in Lothian 
Table 5-2 shows the timelines of the CT&T service in Lothian. Following the 
Scottish government set deadline for the service launch by 29 August 2008, it was 
decided by the key stakeholders in Lothian Health Board in December 2008 that 
while they are undertaking implementation arrangements of the CT&T service, an 
assessment of the training needs of the pharmacy staff would be helpful. In order to 
assess the training needs of pharmacy staff, I undertook a training needs assessment 
survey (TNA) in April-May 2009 (TNA is briefly discussed in 0, also see chapter 7 
for full description of the methods and results of the study). In July 2009, more than 
10 months after the Scottish government directive to start the pharmacy-based 
chlamydia service in their respective health boards, the NHS Lothian sent an 
invitation letter to 66 identified pharmacies, requesting their expression of interest in 
the provision of the service through their pharmacies (see invitation letter in 
Appendix 12). The pharmacies were identified to make sure that the pilot service is 
accessible to young people in areas of higher deprivation and where the specialist 
sexual health services are distant.  
Since the treatment service was to be made available in all pharmacies, the Lothian 
Health Board invited all Lothian community pharmacies in October 2009, to a 
training evening regarding pharmacy-based chlamydia service. This training evening 
was informed by the TNA survey that I had undertaken. After the Scottish 
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government reminder sent in February 2010, to those health boards where the service 
had not yet been implemented (section 5.3), it was felt by the Lothian Health Board 
that there had been an excessive lapse of time since the training provided to 
pharmacists. They therefore organised another training session in Lothian, in March 
2010, which was offered to pharmacists only. 
Table 5-2: Timeline for implementation of the Lothian CT&T service  
Timeline The CT&T service implementation process 
29 August 2008 Scottish Government target start date  
April-May 2009 Training need survey was conducted in community 
pharmacies in Lothian as a component of my PhD 
research 
July 2009 NHS Lothian sought expression of interest from 66 
community pharmacies in Lothian to provide the CT&T 
service. The intention was to initially roll-out the service in 
25 community pharmacies 
October 2009 A training evening was conducted by NHS Lothian, all 
community pharmacies (pharmacists and their support 
staff) in Lothian were invited 
March 2010 A second training evening was conducted by NHS Lothian 
for community pharmacists 
June 2010 The testing service was started in 12 community 
pharmacies in Lothian 
October 2010 Scottish government advised that specific funding for 
pharmacy-based chlamydia service would cease on 31 
March 2011 
31 March 2011 Lothian Health Board discontinued their CT&T service  
The CT&T service in Lothian was eventually rolled out in 12 community pharmacies 
in June 2010 - more than 21 months after the initial directive by the Scottish 
government.  
Following the Scottish government decision in October 2010 to reclassify the service 
(section 5.3), from a national to a local service (with the ‘national’ service contract, 
and hence dedicated Scottish government funding, ceasing on 31 March 2011), 
Lothian Health Board decided to discontinue the service from that same date -31 
March 2011. Therefore the CT&T service in Lothian ran for a short period of 10 
months only. 
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5.5 An overview of the study area – the Lothian 
Health Board 
Current provision of health care in Scotland is shared between 14 geographically-
based local NHS Boards (Figure 5-4a). Lothian Health Board is responsible for the 
south east of Scotland and is the health board with the second largest residential 
population ~ 800,000 people (General Resister Office for Scotland, 2011). The 
Lothian Health Board also shows the second greatest increase in projected population 
between 2004 and 2024 (11 per cent), only after the Border Health Board (15%) 
(General Resister Office for Scotland, 2011). The Scotland is further divided into 32 
local authority areas for administrative control (Directgov). There are four local 
authority areas in Lothian, namely, Edinburgh City, West Lothian, Mid Lothian and 
East Lothian (Figure 5-4b). The principal settlement in Lothian is in the Scottish 
capital, Edinburgh (Table 5-4). The population aged 15-24 constitutes 14% of the 
total population of Lothian (General Resister Office for Scotland, 2011). 
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Figure 5-4: Maps showing a)* the health board areas in Scotland and b)** local 
authority areas in Lothian  














*Source: GROS (General Resister Office for Scotland, 2011) 
** The Edinburgh University Data Library (EDINA) 
 
Table 5-3: Population statistics for local authority areas in Lothian, overall and for 15-







Source: GROS (General Resister Office for Scotland, 2011) 
Local Authority Areas Total Population 15-24 years old 
East Lothian 97, 500 11, 956 
Edinburgh City 486, 120 72, 468 
Mid Lothian 81, 140 10, 300 
West Lothian 172, 080 21, 999 
Total 836, 840 116, 723 
b) Local authority areas in Lothian 
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5.6 Chapter overview 
Current provision of health care in Scotland is shared between 14 geographically-
based local NHS Boards (Figure 5-4a). Lothian Health Board is responsible for the 
south east of Scotland and is the health board with the second largest residential 
population ~ 800,000 people (General Resister Office for Scotland, 2011). The 
Lothian Health Board also shows the second greatest increase in projected population 
between 2004 and 2024 (11 per cent), only after the Border Health Board (15%) 
(General Resister Office for Scotland, 2011). The Scotland is further divided into 32 
local authority areas for administrative control (Directgov). There are four local 
authority areas in Lothian, namely, Edinburgh City, West Lothian, Mid Lothian and 
East Lothian (Figure 5-4b). The principal settlement in Lothian is in the Scottish 
capital, Edinburgh (Table 5-4). The population aged 15-24 constitutes 14% of the 
total population of Lothian (General Resister Office for Scotland, 2011).
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CHAPTER 6: OVERVIEW OF DESIGN AND 
METHODS 
6.1 Introduction  
In chapter 1, I have explained how the initial evaluation plans were affected by 
unforeseen circumstances that beset the CT&T service. Inevitably, the delayed 
timeline for the CT&T service, and the ultimate cancellation of the service, impacted 
the scope of the evaluation and hence the research that could be undertaken for this 
PhD. The studies that were in the event undertaken were planned initially with an 
evaluation in mind, and hence despite revisions made to them, their research designs 
reflect the perspective of programme evaluation. Therefore this chapter first provides 
an overview of programme evaluation methods. It then outlines the evaluation 
studies initially proposed and the revised plans following the implementation delays 
and low uptake that impacted the service in Lothian. Finally, there is a brief account 
of the rationale and the methodological decisions for each particular study. In the 
following chapters these studies will be reported in turn, with each chapter including 
full detail of methods used for that study.  
6.2 An overview of programme evaluation 
Programme evaluation is an essential organisational practice in public health. Patton 
defines evaluation as the systematic collection of information about the 
characteristics, activities and outcomes of programmes to improve programme 
effectiveness, make judgments about the programme, or inform decisions about 
future programme (Patton, 1987). Others focus on the use of evaluation to identify 
and measure outcomes of programmes, that is, conceptualising evaluation as a 
systematic assessment of the extent to which a programme caused the observed 
results (Green and South, 2006, Nutbeam, 1998, Pawson and Tilley, 2008). 
Despite many different definitions and explanations of what evaluation is, there is 
one striking similarity - the systematic nature of an evaluative inquiry. Although 
evaluators employ the same methodological tools for data collection and analyses 
that are used by researchers in empirical studies, research and evaluation differ in 
two important aspects:  
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i. The origins of the research question(s): Evaluation questions are typically elicited 
from programme stakeholders, whereas in empirical research, questions arise 
from prior research or clinical understanding. 
ii. The purpose of research: A key purpose of programme evaluation is to improve 
practice, whereas empirical research primarily focuses on testing hypotheses.  
The results obtained from an evaluation enable managers and staff of that 
programme to create the best possible programmes by making modifications as 
needed, learning from mistakes, and monitoring progress toward achieving 
programme goals and short-term, intermediate, and long-term outcomes (Centre for 
Disease Control and Prevention and U.S. Department of Health and Human Services, 
2005). However, the results of an evaluation can also inform design of other similar 
programmes, and can contribute to the policy making.  
6.2.1 Types of evaluations 
The major distinction between different kinds of evaluation is the stage of the 
programme at which it is carried out. A formative evaluation is carried out at the 
same time as an initiative is being developed and implemented and is frequently 
concerned with the process (Patton, 1987). It is therefore of greater relevance for 
those responsible for the delivery of the intervention to provide important 
information and feedback to guide ongoing decision making and actions to improve 
the outcomes of the intervention (Green and South, 2006). As a change-oriented 
evaluation approach, a formative evaluation is especially focused on identifying 
discrepancies between the expected directions and outputs of the programme and 
what is happening in reality, on analysing strengths and weaknesses, and on 
uncovering obstacles, barriers or even unexpected opportunities. This is turn 
generates understanding about how that programme could be implemented better. 
While formative evaluation is intended mainly to allow improvements to the delivery 
of the intervention currently being evaluated, it is also the case that some issues 
uncovered will be general enough to inform planning and delivery of other similar 
interventions in the future. 
A summative evaluation is carried out towards the end of the programme or, in case 
of a continuing programme, after the programme has stabilised. Summative 
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evaluation is mostly outcome oriented and provides an overall assessment of the 
effectiveness and achievements of the programme (Green and South, 2006, Patton, 
1987). This type of evaluation usually does not directly affect the current 
programme, but it helps stakeholders in deciding the future of this programme or 
similar projects.  
Although formative evaluation is commonly contrasted with summative evaluation, 
but the distinction between them is not clear. Indeed, it is often the case that both are 
undertaken, since formative evaluation is seen as an integral component in 
summative evaluation. For example, formative evaluation can report early outcome 
measures which serve as interim markers to programme effects. Also, tracking 
linkages between inputs, outputs and outcomes can help in identifying causal 
mechanisms that would also inform summative assessment. It is important to note 
that in the evaluation literature, overlapping terms are often used in defining 
formative and summative evaluation. Furthermore, some published literature makes 
further distinctions, describing subtypes within these two forms of evaluation. For 
example, Thompson and McClintock (1998) have defined four stages of evaluation 
namely, formative, process, impact, and outcome. Formative evaluation is defined by 
Thompson and McClintock (1998) as a way of making sure that programme plans, 
procedures, activities, materials, and modifications will work as planned and hence 
this is carried out during the development of a new programme or modification of the 
existing programme. In their schema, process evaluation will look at how well the 
programme is working and whether it is engaging and reaching the target audience, 
and impact and outcome evaluations are defined as ways to evaluate the extent to 
which a program is meeting its intermediate outcomes and long term goals 
respectively (Thompson and McClintock (1998). In contrast, Ferris et al. (1992) have 
defined process and outcome evaluation simply as a precursor names for the 
formative and summative evaluation respectively.  
Irrespective of the contesting claims as to what the different stages of evaluation 
should be termed, it is widely accepted that these stages are interlinked, and that 
formative evaluation is concerned with the process of implementing a programme, 
whereas summative evaluation is more concerned with decision-making about the 
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performance of a programme. This is generally achieved by comparing the observed 
outcomes with what had been expected. The results of both the summative and 
formative evaluation inform decision-making about future resource allocations (and 
ultimately about continuation of the programme).   
As I discuss later in this chapter, while I would have wished to carry out both 
formative and summative evaluation of the CT&T service, the limited time-span of 
PhD study meant it was always unlikely that it would be possible to achieve proper 
summative evaluation on a well-established CT&T service. 
6.2.2 Models and frameworks for programme evaluation 
A typical aim of a programme such as the CT&T service is to produce positive 
change in health behaviour, such as a young person taking a chlamydia test with 
appropriate frequency (in relation to the individual’s risk factors). Positive behaviour 
change of this sort is influenced by a diverse range of factors, both at the individual 
level (for example cognitive and affective) as well as at the environmental level (for 
example socio-cultural and logistical factors). Another issue in population health is 
that interventions need to be able to achieve positive outcomes in ever-changing 
social, organisational, economic and political contexts (Nutbeam, 1998, Rychetnik et 
al., 2002). Thus interventions of this type are generally complex and dynamic, and 
hence are often beyond the close control of implementers. Therefore these types of 
interventions are not suited to being evaluated by experimental study designs. 
Pawson and Tilley (2008) have advocated the use of evaluation study designs that are 
capable of dealing with the issues outlined above.  
In respect to public health programmes, the vast majority of evaluation approaches 
(referred to as models, frameworks, or theories) offer principles, rationales, and 
organisational structures for the procedural choices made by evaluators, so as to 
identify issues and problems with which they must deal (Green and South, 2006, 
Nutbeam, 1998, Patton, 1987, Rootman et al., 2001). Two evaluation approaches 
commonly employed in health service research are the CDC framework and the 
realistic evaluation, and are briefly described below.  
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6.2.2.1 CDC framework for programme evaluation 
The framework for programme evaluation developed by the U.S. Centre for Disease 
Control and Prevention (CDC) involved input from hundreds of public health 
professionals, practitioners working in evaluation and research in the academic field, 
and those involved in community projects (Centre for Disease Control and 
Prevention and U.S. Department of Health and Human Services, 2005).  
This CDC framework recommends that evaluators of an intervention apply 
evaluation ‘standards’ throughout the work (Centre for Disease Control and 
Prevention and U.S. Department of Health and Human Services, 2005). These 
standards (thirty in all) can be viewed as clustering into four domains, comprising 
standards to ensure: 
 Utility: serving the information needs of intended users 
 Feasibility: being realistic, prudent, diplomatic, and economical 
 Propriety: behaving legally, ethically, and with regard for the welfare of those 
involved and those affected 
 Accuracy: revealing and conveying technically accurate information 
These evaluation standards serve as a guide, so as to make a rationale choice from 
amongst the many options available for undertaking each step in the framework. 
Applying these standards will also ensure that an evaluation of a programme would 
produce valid conclusions.  
This CDC framework envisages the design and conduct of an evaluation of a public 
health programme as proceeding generally in steps (Centre for Disease Control and 
Prevention and U.S. Department of Health and Human Services, 2005). The 
framework details six steps (Figure 6-1), for which a general order pertains, in that 
generally earlier steps have to be completed to provide the foundation for subsequent 
progress. The figure shows the centrality of evaluation standards mentioned above.  
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I used the CDC framework to guide me as to the steps needed for my evaluation 
process. The steps are: 
i. Engage with the programme stakeholders 
ii. Describe the programme 
iii. Focus on the evaluation design 
iv. Gather credible evidence about the programme 
v. Justify conclusions of the evaluation 
vi. Ensure use of findings for the programme and share lessons learned 
However, these steps are only guidelines and starting points for tailoring an 
evaluation to a particular public health effort at a particular time. This schema is a 
way of framing an evaluation rather than a specific blueprint. The ordering of the 
first two steps is not crucial, and likely to be dependent on the precise 
programme/context. Also, in an ideal world the steps would not be linear as implied 
by the list, but iterative, as shown in the diagram (Fig 5-1). So the step vi (ensure 
lessons learned) leads on to re-engaging with the stakeholders (i) and revising the 
This figure is adopted from (Centre for Disease Control and Prevention 
and U.S. Department of Health and Human Services, 2005)  
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programme, which then needs re-describing (ii), followed by devising some check-
back evaluation of that revision (iii), and so on.   
6.2.2.2 Realistic evaluation 
Whilst framing the questions for my intended evaluation of the CT&T service, and 
during the process of execution and analysis of the set of studies designed towards its 
evaluation, I adopted the realistic approach to evaluation, as recommended by 
Pawson and Tilley, so as to understand the outcome in terms of any interaction that 
exists between mechanism and context (Pawson and Tilley, 2008). The key feature of 
realistic evaluation is to capture the linkages between the context, mechanism and 
outcome of the intervention. The inter-related questions are: 
i. Mechanism: what is it about a measure which may lead it to have a particular 
outcome pattern in a given context? 
ii. Context: what conditions are needed for a measure to trigger mechanisms to 
produce particular outcome patterns? 
iii. Outcome pattern: what are the practical effects produced by causal mechanisms 
being triggered in a given context?  
These are linked questions that need to be asked about a programme in order that it 
can be understood in realistic terms. So for example, in order to understand why 
certain pharmacies did not take part in the service, it was necessary to understand the 
context in which such a decision could have occurred. Similarly the perceptions of 
the pharmacists were analysed in the context of their organisational position, such as 
being part of a chain pharmacy or owner of an independent pharmacy business.  
6.2.2.3 Logic model for a programme evaluation 
A logic model is a common tool employed by the evaluators to depict graphically 
how the programme is operating, its resources, to whom it targets, and what it 
intends to accomplish (Centre for Disease Control and Prevention and U.S. 
Department of Health and Human Services, 2005). The logic model not only 
provides a causal connection between activities and expected outcomes of a 
programme, but it also helps in formulating the evaluation questions at each stage of 
a programme. Logic models are used extensively in programme planning, 
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implementation and evaluations (Tucker et al., 2006, Kaplan and Garrett, 2005). The 
basic components of a logic model include inputs (resources that potentially enable 
or limit programme effectiveness); activities (techniques, tools, events, and actions of 
the planned programme); outputs (the direct/tangible results of programme activities, 
for example, skills, products); and outcomes (changes in attitudes, behaviours, 
knowledge, skills, status, or level of functioning outside the programme or its staff). 
In section 5.3.2, a logic model is presented for the CT&T service. 
6.2.3 The role of stakeholders in programme evaluation 
Representing the needs and interests of the programme stakeholders throughout the 
evaluation process is fundamental to good programme evaluation. The first step in 
the CDC evaluation framework is identifying and involving stakeholders in the 
process of evaluation of a health system/service (with the intention of retaining them 
through the evaluation). This is particularly the case in community health projects 
(Centre for Disease Control and Prevention and U.S. Department of Health and 
Human Services, 2005, Green and South, 2006). CDC defines stakeholders for a 
public health programme as follows: 
“Stakeholders are people or organisations that are invested in the programme, are 
interested in the results of the evaluation, and/or have a stake in what will be done 
with the results of the evaluation”.  
Engaging a range of stakeholders with different perspectives on the programme helps 
in building both an internal and external buy-in and support for the evaluation 
process (Patton, 1987). Stakeholder involvement would also make the evaluation 
process more objective, enhance communication among key partners, and ensure that 
the data collection is thorough and complete. The range of stakeholders consulted 
should, as far as is feasible, reflect the type of partnership in the project (Green and 
South, 2006). Stakeholders might include practitioners, programme managers, 
politicians, community workers and lay representatives.  
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6.3 Towards an evaluation of the Lothian CT&T 
service 
This section describes my initial steps towards an evaluation plans. The stakeholders 
identified for the CT&T service are described. CDC framework suggests the use of 
logic model for aiding in the evaluation plans. The logic model developed for the 
CT&T service is also described in this section.   
6.3.1 Identifying stakeholders in the CT&T service 
The potential stakeholders for the CT&T service in Lothian were considered and 
identified in an early meeting with the programme implementers. Some additional 
stakeholders were added later from the list of sexual health strategy project board 
members involved in developing the Edinburgh & Lothian Sexual Health Strategy 
for 2005-2010 (NHS Lothian, 2005). These stakeholders were identified under the 
broad categories suggested in the CDC framework (Centers for Disease Control and 
Prevention, 2007), and are shown in Table 5-1. These are not exclusive classes of 
stakeholders, but four ways of thinking about stakeholders, and therefore some 
stakeholders appear in more than one category.  
CDC also identifies participants or service users as a potential category of 
stakeholders. For the CT&T service, participants would be young people aged 15-24 
years for whom the service is designed. The reasons for omitting participants from 
the list of stakeholders who might be involved in the evaluation of the CT&T service 
was that the CT&T service is a top-down programme that the Scottish government 
has directed to health boards to implement. At the time of planning the evaluation, 
the service in Lothian was not yet operational, so there were as yet no service users. 
However, while not involving possible future service users in the specifications of 
the evaluation, it was intended to seek views of the CT&T service in various ways 
from all stakeholders, including service users.  
 
 
Chapter 6: Design and Methods……………………………………………………………………….. 
162 
Table 6-1: Strategic stakeholders identified for the CT&T service in Lothian  
Types of 
Stakeholders 
Questions used to 
identify stakeholders 
Stakeholders 
Implementers Who is directly 
involved in the 
operations of the 
chlamydia testing and 
treatment initiative? 
 CT&T programme director  
 Public health pharmacist lead for 
Lothian 
 Laboratory lead for STI 
 Nurse counsellors in GUM clinic 
Decision 
Makers 
Who is in a position to 
do or decide 
something about this 
initiative? 
 CT&T programme director 
 Lead clinician(s) for sexual health 
 Public health pharmacist lead for 
Lothian 
 Health promotion lead(s)  
Partners Who actively support 
and/or have invested 
in this initiative or in 
the population that the 
programme serves? 
 NHS Lothian sexual health service, 
for example, GUM, Family Planning 
& Well Women service 
 General practitioners 
 Community outreach sexual service 
representatives for youth, for 
example, Caledonian Youth, ROAM 
clinic, LGBT 
 Sexual health specialists and 
practitioners 
 Public health pharmacist(s)  
 Health promotion group 
 
6.3.1.1 Stakeholder terminology used in this thesis 
Two different stakeholder ‘labels’ that are commonly utilised in this thesis are 
discussed below: 
i. Strategic stakeholders: Stakeholders listed in Table 6-1 are those considered to 
be strategic in the vision, specification, launch and delivery of the service. One 
or more of each stakeholder type listed were later invited to participate in the 
stakeholder survey.  
ii. Key stakeholders: Three of the strategic stakeholders (two sexual health 
specialists and a public health pharmacist lead) had a key role in the decision 
making of the CT&T service, particularly in respect of deciding the service 
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specifications. These were also the stakeholders with whom I had regular 
interaction with respect to the design of the intended evaluation studies as well as 
in facilitation of the studies ultimately undertaken. 
6.3.2 Logic model for the CT&T service  
The CT&T service has already been described in chapter 5. Figure 6-2 shows the 
logic model that I had developed for the CT&T service. The rationale for the logic 
model has been given in section 6.2.2.3. The figure reads from left to right and the 
first three columns indicate inputs, activities and outputs of the activities. The 
expectation is that the ‘outputs’ will lead to the hoped-for outcomes. The next three 
columns of the model show the outcomes, subdivided by timing - early, intermediate 
and longer term.  
Activities specified were those that would be expected as part of programme 
planning and execution, such as specification of a protocol for the CT&T service, 
and training of the pharmacy staff. Outputs detailed are those which were expected 
from the proposed activities. Although the ultimate goal was to reduce the prevalence 
of chlamydia among 15-24 years old population in Lothian, there were more 
immediate and targeted outcomes such as availability of trained community 
pharmacy staff for the provision of chlamydia testing; increased access of young 
people to chlamydia testing; and behavioural changes among young people as a 
result of counselling that they receive during CT&T service provision. 
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Publicity of the 
service 
- Specify protocol for 
CT&T service in 
pharmacies, including 
paper work for tests 
and treatments 
- Devise data 
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6.3.3 Devising the evaluation plan 
For the evaluation of the CT&T service, I proposed studies that would investigate 
aspects relevant to both the implementation as well as the expected outcomes of the 
service. This section describes briefly the initial plans for an evaluation of the CT&T 
service.  
6.3.3.1 Focusing the evaluations questions 
Since the CDC framework recommends engaging programme stakeholders in the 
evaluation, the first step was to provide them with an opportunity to reflect on the 
evaluation questions that I had drafted, and to identify any other questions, in respect 
to the CT&T service, which they considered important to evaluate. This was 
undertaken as a formal study (a survey) and is reported in chapter 8. The first column 
of Table 6-2 lists the evaluation questions initially proposed with respect to the 
CT&T service. The evaluation questions drafted were intended to provide a 
formative evaluation of the service as well as to provide a preliminary analysis of the 
outcome of the service – in terms of its impact on chlamydia testing activity in 
Lothian and detecting chlamydia positivity among young people.  
Of these, only questions 1.3 to 1.8 were included in the stakeholders’ survey, for 
their comment. Question 1.1 was excluded from the stakeholder survey because the 
training need survey had already been completed, fast-tracked in order to provide 
timely results to key stakeholders for the development of training evenings for 
pharmacy staff. Question 1.2 was also excluded from the stakeholder’s survey since 
by this time it was already agreed with the key stakeholders that a post TNA survey 
would be useful to monitor the pharmacy staff competencies after delivering training 
and their practical experience with service provision.  
All of questions 1.3 to 1.8 were affirmed as important in the strategic stakeholder 
survey. The second column of Table 6-2 lists the evaluation questions added 
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Table 6-2: Evaluation questions initially proposed and added following stakeholder survey 
Initial questions proposed for the evaluation of the CT&T service Additional questions identified in the stakeholders survey 
Implementation / Formative evaluation questions 
1.1 What training do pharmacy staff need in order to implement the service 
in community pharmacies?  
2.1 What is the level of satisfaction of the clients accessing the CT&T 
service?  
1.2 Is the training provided to pharmacy staff able to develop competencies 
necessary for the provision of the service? 
2.2 How likely it is that the clients would have tested or treated elsewhere if 
the service did not exist? 
1.3 What are the challenges faced by community pharmacies in 
implementing the CT&T service?  
2.3 Would clients find it acceptable to provide information on sex partners in 
community pharmacies?  
1.4 What do community pharmacists/staff perceive as factors contributing to 
the success or failure of the CT&T initiative? (facilitators & barriers)  
2.4 What proportion of youngsters (high risk) knows about the service?  
1.5 What factors do clients perceive as affecting their access to the CT&T 
service? (facilitators & barriers)  
2.5 Do young people want to get tested in pharmacies?   
 2.6 How to promote the service? 
 
2.7 How would pharmacies cope with the time and resources if the demand 
of the service increases? 
 
2.8 Do pharmacists discourage some people in low risk group from being 
tested? 
Effectiveness / Outcome evaluation questions 
1.6  What is the proportion of potential clients tested and/or treated in 
pharmacies? (compared to GP, clinic and GUM)  
2.9 How many clients with positive results do not attend for treatment and 
contact tracing? 
1.7 What is the proportion of partners of infected clients treated in 
pharmacies? (compared to GP, clinic and GUM)  
2.10  What is the prevalence of infection compared to other testers? 
1.8 What are the socio-demographic characteristics of the client assessing the 
CT&T service?   
 
 
Chapter 6: Design and Methods 
167 
6.3.3.2 Initial plans for studies to address evaluation questions 
Table 6-3 lists the outline plans for evaluation studies to answer the final list of 
evaluation questions. 
The assessment of training needs of the pharmacy staff (Q 1.1) was planned and 
executed very early on, to provide timely results to aid the development of training of 
pharmacy staff in Lothian. However it was initially envisaged that this would be the 
first part of a pre-post survey, in that we would execute a follow up TNA survey 
once the service had become fully established in Lothian, to monitor self-report of 
training needs at that point (Q 1.2).  
Pharmacy case studies were planned to understand pharmacy staff perspectives and 
any difference in perspectives across the staff groups, on perceived and actual 
facilitators of and barriers to the implementation of the service (Q 1.3 and Q 1.4). It 
had been intended to group the participating pharmacies based on service uptake 
(low, medium and high provision pharmacies) and then select two pharmacies from 
each group as case studies. It was hoped this would enhance understanding of the 
differences in uptake. Outline plans were for in-depth interview with the pharmacy 
manager, a pharmacist, and a member of support staff in each ‘case’ pharmacy. The 
further questions identified in the stakeholder survey (Q 2.6 to 2.8) were to be 
addressed through the same case study approach.  
Clients’ satisfaction with the service (Q 2.1) was to be assessed by a survey of 
service users. It was hoped to include a survey questionnaire and a reply paid 
envelope with the testing kits, allowing a voluntary completion of the questionnaire 
by the service users. Perceptions of clients regarding facilitators of and barriers to 
accessing the service (Q 1.5) were to be assessed in the same survey. At this stage 
plans to address Q 2.4 to 2.6 were fluid, but the possibility of a sub-study with 
potential service users was under consideration.  
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Table 6-3: Initial ideas for evaluation studies to answer the evaluation questions 
identified  
Initial ideas for evaluation studies Evaluation questions to be answered 
(question numbers correspond to those 
listed in table 6-2) 
Pre & post TNA survey 1.1, 1.2  
Pharmacy case studies 1.3, 1.4  
2.6 to 2.8  
Client satisfaction survey 1.5  
2.1 to 2.6  
CT&T outcome analysis using routine 
data 
1.6 to 1.8   
2.9 to 2.10  
An outcome analysis was intended, using routine laboratory data. This would enable 
comparison of chlamydia testing and positivity rates across three settings, namely 
community pharmacies, GP practices and sexual health clinics (Q 1.6, 1.7, 2.10). A 
postal testing kit (PTK) number assigned to the forms to be filled in pharmacies, for 
laboratory documentation, would allow the identification of pharmacy testing in the 
laboratory dataset. The laboratory data would also allow analysis in terms of any 
variations in testing and positivity by age, gender and year of testing (Q 1.8). 
Analysis by deprivation categories of the clients was not possible, since the 
residential postcode of the clients was not documented on the PTK form. 
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6.4 Revisions to the evaluation studies originally 
envisaged 
However, as has been described in Chapter 5, the CT&T service implementation was 
considerably delayed. As early as July 2009, it became clear that time was running 
out for completion of all the studies planned within the timescale of a PhD. It was 
therefore necessary to begin to re-think the evaluation plans. Then, once the service 
was launched, it became apparent that there was (to be) very limited uptake of the 
service. This means that further revisions were needed to study plans. The final straw 
was the termination of the service just under nine months after its initiation.  
Therefore there had to be successive revisions of study plans, as events unfolded. 
However, at each point great care and thought was taken to try to ensure that the 
adapted evaluation plans would nevertheless elicit useful research findings – either 
for any future pharmacy-based chlamydia service, here or elsewhere, and/or for 
monitoring of chlamydia prevalence in Scotland. Figure 6-3 shows, in the left hand 
half, the evaluation studies initially planned, mapped against a timeline, with the 
dashed line showing the point at which the service launch was intended, initially 
(July 2009). The right-hand half presents the research studies ultimately undertaken, 
with the dashed line here indicating the actual launch of CT&T service (June 2010), 
with the red arrow indicating the delay to launch of service (11 months). The figure 
also shows the constraints of the PhD timeline - the thick black line indicating the 
end of the PhD funding period. 
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Figure 6-3: Chart mapping the initially-planned and finally-executed research studies 
shown against a timeline for the  PhD, and the expected and actual launch dates of 
the CT&T service  
 
    Initial plans for evaluation Research ultimately undertaken 
Year Month        
2008 Sep Initial literature review     
  Oct & initial planning of as intended 
  Nov evaluation    
  Dec    
2009 Jan Initial TNA    as intended   
  Feb Survey  
  Mar      
  Apr  Structured     
  May literature  as intended  
  Jun review  
  *Jul     
  Aug Strategic Stakeholder   
  Sep  Survey Redesign  
  Oct  of  
  Nov     further Strategic 
  Dec   Pharmacy Case Studies   plans Stakeholder 
2010 Jan including planning, data collection  Survey  
  Feb & analysis  delayed but as intended 
  Mar    Non-pilot  
  Apr  Client Pharmacy  
  May  Satisfaction Interview  
  **Jun   Surveys Study  
  Jul     including planning  & analysis 
  Aug        
  Sep Follow-up   Survey  
  Oct TNA   of  
  Nov  Survey   Pilot Potential  
  Dec    Pharmacy Clients 
2011 Jan   Interview  
  Feb CT&T Outcome Analysis  Study ***Routine data analysis of 
  Mar using routine data 2009/10  including testing activity/outcome 
  Apr  planning & 2005 to 2010 
  May  analysis i) Background Descriptive 
  Jun     Epidemiology 
  Jul     ii) Comparison before/ 
  Aug     after changes in  
  Sep     policy/guidance  
 2012 Apr    Post CT&T contact with  
  May        stakeholders 
* Intended start of the CT&T service 
**Actual start of the CT&T service 
*** This analysis is reported as a background work and needs assessment in chapter 3. 
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The stakeholders’ survey and the first part of the TNA survey were undertaken as 
originally intended. However, the very low uptake of the service meant that the 
pharmacy staff did not have any degree of real practical experience of service 
delivery, which might have allowed a later more ‘informed’ self-judgement of their 
competence to deliver the service, and/or need for further training. Nor, given the 
termination of the service, was there any great (formative evaluation) point in a 
reassessment. For these reasons it was felt that there was little value in the follow-up 
part of the original plan for the TNA survey, and so it was not undertaken. The 
design and methods for these two studies are outlined in 0 and 0 respectively. 
However, all remaining studies had to be revised as circumstances overtook the 
CT&T service. The revisions to studies were as follows:  
 The pharmacy case study design was not likely to be productive, because of the 
very low service activity within the pilot pharmacies, so it was redesigned as an 
in-depth interview study with community pharmacists, to ascertain their 
views on the CT&T service. The rationale and design for the study undertaken is 
outlined in 6.6.1.4. 
 A client satisfaction survey was not feasible because of the paucity of service 
users. Only 4 clients requested the service from the pilot pharmacies. It was 
therefore decided that a substitute study of potential interest would be a survey 
with potential clients, to ascertain their views on the proposed CT&T service. 
The rationale and design for the study undertaken is outlined in 6.6.1.3. 
 Similarly, the much delayed launch and low level of the CT&T service activity 
meant that there was no point in attempting to answer outcome evaluation 
questions (as listed in table 6-3) by analysis of routine testing data. However, it 
was judged that analysis of routinely-collected chlamydia testing data for the 
previous 5 years (2006-2010) was nevertheless of potential value, for two 
reasons. One was to provide an epidemiology of chlamydia with respect to 
Lothian Health Board. The other was to demonstrate a ‘pilot’ analysis of what 
would have been undertaken, had the CT&T service started sooner, and the 
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service been better taken up, to evaluate the impact of the introduction of the 
service on testing activity and positivity. A further purpose of this analysis was 
to assess the feasibility of using routine data for surveillance and monitoring 
trends. The analyses of routine data are therefore reported earlier in the thesis in 
chapter 3 as a background work for the CT&T service.  
In addition to the above studies, after the CT&T service was terminated, it was felt 
that there is a need to investigate from key policy stakeholders about the reasons for 
delays in implementation of the CT&T service and also about the reasons for 
termination of the service in Scotland. Albeit a very small data, this part of data 
collection is reported in chapter 11.  
6.5 Objectives of the research reported in this thesis 
In Chapter 5, I have described the unforeseen circumstances that beset the CT&T 
service, and in section 6.4, I have outlined the revisions needed to initial plans for 
research studies. In so far as was possible, given the time and resource constraints on 
PhD research, the revisions were thought through to try to ensure that the research 
ultimately undertaken for this PhD would comprise an integrated set of studies 
contributing to the knowledge of implementing a pharmacy-based chlamydia service. 
If the CT&T service had continued, the study findings would have contributed to an 
overall evaluation of the CT&T service. However, these research studies also add to 
empirical knowledge that could be valuable to future planning of similar pharmacy-
based chlamydia service elsewhere, and even for other public health service 
provision in pharmacies, as well as informing for the development of chlamydia 
screening services in other health care settings. The revised objectives of the PhD 
research reported in this thesis are as follows: 
i. To provide an opportunity for strategic stakeholders to suggest the questions that 
the set of proposed evaluation studies should address and to give their feedback 
on different facilitators of and barriers to the CT&T service that might affect 
both its potential effectiveness and sustainability 
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ii. To assess the training needs of the pharmacists and the support staff for the 
provision of the proposed CT&T service 
iii. To elicit the views of the potential clients about chlamydia services and to 
explore the factors that they perceive as facilitators of and barriers to their access 
to the CT&T service 
iv. To investigate the factors perceived by community pharmacists as facilitators of 
and barriers to success of the CT&T service initiative, and reasons of 
pharmacists’ participation or not in the service  
v. to investigate the reasons for delays in the implementation of the CT&T service 
and its ultimate termination in Lothian and the rest of the health boards in 
Scotland 
6.6 Outline of design and methods for the research 
studies reported in this thesis 
This section outlines the studies undertaken for this PhD. The decision to use a 
particular method was based on the four evaluation standards as advocated by CDC - 
utility, feasibility, propriety, and accuracy. The studies undertaken are outlined 
below. More details of the objectives, methods, results and discussion of each study 
are given in the respective chapters. 
6.6.1 Research studies undertaken towards an evaluation of 
the CT&T service 
This section briefly describes the studies which at the time they were undertaken 
were expected to contribute to an evaluation of the CT&T service in Lothian. Figure 
6-4 maps out the set of studies undertaken, involving four different groups of 
stakeholders as identified in the CDC framework of programme evaluation (Centers 
for Disease Control and Prevention, 2007). As stated in section 6.4, the first two 
studies were undertaken as initially envisaged, while the latter two had to be revised 
as events unfolded. 
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6.6.1.1 Training needs assessment (TNA) survey 
Ascertainment of competencies and training needs was required from pharmacists 
and their support staff to support the implementation of the CT&T service. The 
decision to assess their training needs through a postal survey was fairly 
straightforward. Firstly the information on the training needs of pharmacy staff was 
requested by the key stakeholders to be provided quickly, so that a customised 
training programme could be developed for pharmacists and their staff. Secondly, a 
competency framework for the provision of a pharmacy-based chlamydia service 
was already available (National Health Services and Harmonisation of accreditation 
group, 2008) and therefore it was decided to use it as a basis of eliciting their training 
needs against the identified items. Thirdly, the pharmacy staff often work on pro-rota 
basis. Hence it was felt that if they were invited for a postal survey, the likelihood of 
recruiting staff working on different days would be enhanced. Also, pharmacy 
environment is considered very busy and tight for work force, it was decided that it 
would be more suitable to use postal survey to gather this information at staff’s own 
convenient time. Health technology assessment undertook an extensive review of the 
design and use of questionnaire for health service staff and patients (McColl et al., 
2001) and found that postal surveys are most suitable where the population is very 
geographically diverse and avoid the problem of respondents being unavailable when 
the interviewer calls. 
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Methodologically, a key advantage identified in the self assessment postal 
questionnaire is that no interviewer is involved during the process of self completion, 
so they avoid the potential for social desirability or interviewer bias and hence 
participants respond more truthfully to sensitive questions and are more comfortable 
in providing a critical or less socially acceptable response than when face-to-face 
with the interviewer (Bowling, 1997, McColl et al., 2001). Hence a postal survey of 
the pharmacy staff was considered most suitable. 
A training need assessment questionnaire was developed. This survey is reported in 
chapter 7. The results of this survey were communicated to the key stakeholders who 
then designed training evening for pharmacists and their support staff. The results 
were also communicated, on request, to pharmacist leads in other health boards in 
Scotland.  
6.6.1.2 Strategic stakeholder study  
The aims of the strategic stakeholder study were to confirm that the proposed 
evaluation questions were pertinent to them and to enable strategic stakeholders to 
suggest any other questions which they considered important. In addition, the survey 
was also designed to elicit the strategic stakeholders’ views on various challenges 
that this service would face, and on the perceived outcomes of the new service.  
For eliciting the views of strategic stakeholders, the choice of method was rather 
difficult. This was because of the type of respondents I was interested in eliciting 
their views - those stakeholders who hold some key position in their respective roles 
in the policy making of the CT&T service in Lothian. These stakeholders would 
comprise those with senior posts within the health promotion group, community 
pharmacy public health representatives, laboratory services for chlamydia testing, 
directors/managers of sexual health clinics and community outreach groups, and 
general practitioners with an interest in sexual health of young people.  
In-depth interviews would have been the most obvious choice to ascertain such 
views. However I was as yet inexperienced in interviewing, and I was also fairly 
recently arrived from a different country, and so not yet very familiar with the 
organisation of such services in Lothian. Strategic stakeholders generally hold 
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senior-level positions in their respective organisations and it was thus felt it would be 
unlikely that they would be able to allocate the time needed for face-to-face 
interview with an inexperienced trainee researcher. Since the views/suggestions 
requested from them were potentially contentious, and ideally required some lone 
reflection by them on the issues, after priming. Furthermore, a part of this research 
would inform the decision on the evaluation questions for the rest of the studies and, 
at the time when the survey was decided, it was expected that there was limited time 
interval between this study and the initiation of the CT&T service. It was therefore 
decided that a survey would be a most appropriate way of eliciting information in the 
above mentioned circumstances. This survey is reported in Chapter 8, including 
details of the methods used. The results of the survey were used to modify and/or add 
additional questions investigated in the remaining studies. 
6.6.1.3 Views of potential service users about the CT&T service  
A study with potential service users is designed due to a number of reasons. Firstly, 
previous evaluations of community pharmacy chlamydia service for young people 
have identified, from service users, a number of facilitators of and barriers to access 
a pharmacy chlamydia service However these facilitators and barriers were mostly 
elicited in qualitative interviews undertaken as part of evaluations, and hence all 
interviewees were by definition utilising the pharmacy-based testing service. It is 
therefore unknown what actual or perceived barriers were preventing other young 
people (potential users) from accessing these services. Secondly, given published 
research is predominantly interview-based, the prevalence with which the various 
barriers or facilitators are perceived by potential young service-users is not known. 
Thirdly, it would be of interest to quantify young people’s preferences regarding 
specific aspects of service delivery (such as alternative ways to obtain a testing kit, 
submit a urine sample, receive a test result notification, receive treatment and 
undertake partner notification) to inform future service developments according to 
the needs and preferences of young people. Lastly, it is not yet known if a young 
person’s preference for a pharmacy-based chlamydia service is related to their 
previous experience of accessing other SH care from a pharmacy (such as EC), and / 
or to their previous chlamydia testing experience in other venues.  
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For eliciting the views of ’potential’ service users, there were two inter-related 
decisions as to the selection of venues for recruiting young people in the study, and 
to the choice of research method. The very low uptake of the service meant that it 
was not possible to recruit informants from pharmacies. It was therefore decided to 
recruit participants from sexual health (SH) clinics. The rationale for recruiting 
young people from SH clinics is discussed in detail in chapter 9 (section 9.3.2). 
Briefly, it was anticipated that young people seeking sexual health care from these 
services are sexually active. Hence, this prevents a potential ethical issue of eliciting 
the sexual activity information from young people which was one of the eligibility 
criteria for this survey.  
The second and the most important issue was the selection of the study design. One 
consideration was that, because target participants were not actual users but only 
potential users, the service itself needed to be explained before views could be asked. 
This might be difficult to achieve in the context of an interview or focus group. A 
further consideration was a risk to recruitment if the design decided required young 
people to participate in focus groups or in-depth interviews. This is discussed in 
detail in section 9.3.1.    
The study design decided was therefore a self-complete questionnaire survey with 
potential service users. This study is reported in chapter 9. Study participants were 
recruited from three SH clinics in Lothian i.e. GUM clinic Edinburgh, Caledonian 
Youth (CY) and Midlothian Young People Advise Service (MYPAS).  
6.6.1.4 Views of community pharmacists about the service  
It had become evident during the CT&T service implementation that 54 out of 76 
invited pharmacies did not agree to provide the CT&T service, and I was interested 
to ascertain why many invited pharmacies did not take part in the pilot CT&T 
service. It was therefore decided to recruit both pilot pharmacists (those who 
provided the CT&T service) as well non-pilot pharmacists (those who were invited 
to take part in the CT&T service but decided not to do so). The purpose was to 
understand the decision making process of taking part in the service, hence 
understanding why some pharmacies took part in the service and other did not. The 
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experience of those who took part in the service was explored and their views on the 
discontinuation of the service were evaluated.  
An initial consideration was given to undertaking focus groups separately for the two 
categories of pharmacists. Eventually this was considered not feasible for the current 
research because in addition to the logistic issue of assembling these busy 
professionals at the same time, there were methodological difficulties with this 
research technique as well. Patton (1987) indicated that focus group are typically 
conducted with people who do not know each other. Since, it was likely that the 
potential participants in this professional focus group would know each other; it was 
not possible to guarantee confidentiality and anonymity in their responses. Moreover, 
the ‘problematic silences (lack of disclosure) and problematic speech (strategic 
shaping of comments)’ in group discussions might also become more pronounced 
when the participants know each other  (Hollander, 2004). These processes limit the 
usefulness of focus groups as a tool for understanding individual thoughts, feelings, 
or experiences especially in the context where health professionals are allowed to 
interact together. While the issue of ‘social desirability bias’ could be completely 
ruled out in in-depth interviews or even in surveys, an in-depth interview is more 
suitable for eliciting detailed descriptions of people’s knowledge, views, 
understanding, interpretations, experiences and interactions to meaningfully 
understand social reality (Mason, 2002).  
For the pharmacists’ qualitative interviews, the preference was to conduct the 
interviews face-to-face. However where this was difficult, telephone interviews were 
conducted. Interviews conducted face-to-face also offer the advantage of the 
interviewer being able to probe the participant for responses and clarify any 
ambiguities (Creswell, 2007, Mason, 2002, Patton, 1987). Many detailed and 
complicated questions can be asked. Face-to-face interviewing also offers advantage 
of understanding the body language of the respondent, hence further enriching the 
qualitative data. A theoretically informed approach, by using the theory of planned 
behaviour (TPB), allowed the development of interview guide (Ajzen, 1991). This 
study is reported in detail in chapter 10. A rationale for using TPB for this research 
component is also discussed in detail in section 10.3.4. 
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6.6.1.5 Additional data collection following the cancellation of CT&T 
service  
In April 2012, about 12 months after the cancellation of the CT&T service, three key 
stakeholders of the CT&T service and a Scottish government representative of the 
Pharmacy and Medicines Division of the Scottish Government (PMDSG) were 
contacted through email, to elicit their recollection/views on the events leading up to 
that cancellation. The method and findings of this part of the data collection after the 
CT&T service terminated is reported as a short study in chapter 11.   
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6.7 Data analysis  
The current thesis includes both the qualitative and quantitative studies. An overview 
of analyses undertaken for different studies is given below: 
6.7.1 Quantitative data analysis 
6.7.1.1 Overview of statistical methods 
The statistical tools used to analyze the data collected from the quantitative research, 
employed a range of statistical methods, encompassing descriptive statistics, 
hypothesis testing and statistical modelling. Specialised statistical methods used will 
be detailed in the relevant chapters. The descriptive statistics reported frequencies 
and percentages for categorical variables. Association in r x c tables was tested by 
chi-square (
2
). For the likert scale responses, the association has been tested and 
summarised by means of the non-parametric Kruskal-Wallis test. Spearman’s rank 
order correlation (rho) is used in some places where it was felt important to report the 
strength of association between ordinal likert response variable and other categorical 
variable of interest. In terms of p-value, the Spearman’s correlation coefficient test is 
equivalent to the Kruskal-Wallis test but has the benefit of giving a correlation 
coefficient that shows the strength and direction of association that exists between 
two variables. Confidence intervals (95%) are presented wherever informative. 
6.7.1.2 Statistical software  
Data entry for potential service user’s survey and training needs survey were 
undertaken in Microsoft ACCESS software. This allowed controlled data entry with 
checks to avoid errors during data entry. However further data cleaning was done by 
exporting data into Statistical Package for Social Sciences (SPSS version 17) and 
running frequencies and ranges to identify any obvious errors, and undertaking cross 
tabulation of variables which were related. For the quantitative analysis, SPSS was 
used for further coding of data and analyses. Graphical methods have been used 
extensively, and due to the greater graph functionalities, have been produced using 
Microsoft Office Excel software. In some places, where exact values were felt to be 
more informative, the data table was also presented with graph. For the routine data 
analysis, the de-duplication and multiple imputations of missing values were also 
undertaken in SPSS.  
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6.7.2 Qualitative data analysis 
For the analysis of in-depth interviews with the pharmacists, a framework approach 
was used (Ritchie and Spencer, 1994)  This was carried out by drawing on a-priori 
issues and questions derived from the aims and objectives of the study (deductive) as 
well as those identified from multiple readings and interpretations of the raw data 
(inductive). A number of a-priori themes were also identified from a structured 
literature review; more themes were identified based on the theory of planned 
behaviour. A full account of the framework analysis is given in section 10.3.7. The 
following principles also guided my qualitative data analyses (Ulin et al., 2002), 
which were consistent with Realistic Evaluation as described by Pawson & Tilley: 
i. People differ in their experiences and understandings of reality; how respondents 
interpret and present a situation might not reflect assumptions made by a 
researcher. 
ii. A social phenomenon can only be understood within its own context. 
iii. Exceptional cases may yield insight into a problem or new leads for further 
inquiry. 
iv. Understanding of human behaviour emerges slowly and nonlinearly.  
v. A theory not only guides qualitative research, but is also a result of it. 
Data collection and analysis ran in parallel so that findings that emerged from the 
current case were tested in subsequent cases. 
6.7.2.1 Data management for qualitative analysis 
All the interviews were tape recorded and transcribed verbatim with respondents’ 
permission. Field notes were made immediately after each interview. Data 
management was aided by loading all the transcripts and the field notes to QSR 
NVIVO-8. Field notes were treated as memos attached to each transcript.   
6.8 Ethical considerations 
In the UK, ‘Research Governance Framework for Health and Social Care’ 
(Department of Health, 2005) set standards for research, including mechanisms for 
delivery, requirements for monitoring and assessment of research undertaken and 
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guidelines on research data storage. It also provides clarity on the roles of the 
sponsors, researchers, participants, host organisations and others involved in a 
research study. Under the framework, projects classified as research and those 
involve NHS would require ethical review by a NHS Research Ethics Committees 
(REC) and/or approval from NHS Research and Development (R&D) offices. The 
remit of NHS REC in England is outlined in ‘Governance Arrangements for NHS 
Research Ethics Committee’ (GAfREC) (Hocking et al., 2008). A separate but 
similar document has also been produced for Scotland. Requirements for ethical 
review of NHS research are set out in paragraph 3.1 of GAfREC. It suggests that 
review and approval from the REC is required for any research proposal that would 
involve patients, service users, care professionals and other staff or volunteers, or 
their organs, tissue or data. This also includes all potential research participants 
recruited by virtue of their past or present use of NHS, including NHS patients 
treated under contracts with private sector. Similarly research that requires access to 
past or present NHS patient records, use of, or potential access to NHS premises or 
facilities (including NHS staff) also requires independent review by a local research 
ethics committee. Appendix 20 provides the NHS REC guidelines on the distinction 
between research and evaluation.  
The training needs survey was identified from the outset as a service evaluation. 
Furthermore, it involved respondents who are actually outside of NHS. In any event, 
the stakeholders were clear that as a service evaluation it did not require ethical 
approval from the relevant ethics committee. However for the other studies designed 
to be part of the CT&T service evaluation, given they would collect data from NHS 
employees or service users, or would analyse routine NHS data, advice was sought 
from the scientific officer of the South East Scotland research ethics committee. 
After perusal of protocol, all these evaluation study components were judged as 
service evaluation, in accordance with the governance arrangements for research in 
the UK NHS (Ref number NR/0911AB9 and NR/1005AB8) (Appendices 21 and 22), 
and as such were judged not to require formal review by an NHS ethics committee. 
At that time, when the potential service users’ survey was conducted in 2010, our 
research Centre had not formalised its rules for ethical approval, and in general if 
NHS studies were deemed not to need ethical approval by NHS REC rules, then they 
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were not ethically reviewed. However, it is now the case that all research analysing 
or collecting data from any human participant, requires ethical approval. For analyses 
of anonymised data (no new data collection) this is very light touch, but for all 
studies involving new data collection, ethical approval is required. Therefore, if any 
of these 4 studies were undertaken now, then I would now have to seek ethical 
review by the Centre of Population Health Sciences Ethical Review Group. 
Regardless of the fact that formal ethical approval was not obtained, the conduct of 
all the studies sought to ensure good ethical practice. The information sheets to study 
participant emphasized the strictly voluntary nature of the research. The act of 
mailing back the questionnaire implied respondent consent. In the case of in-depth 
interviews, where I had direct contact with the respondents (either face-to-face or in 
telephonic interviews), the voluntary nature of the research was further emphasised 
both verbally as well in the information sheet for the participants. Information that 
could be identified to individuals was kept in a password-locked computer or locked 
filing cabinet. Further details on ethical considerations are discussed in the relevant 
study chapters. 
6.9 Chapter overview 
This chapter provides an overview of research undertaken for this PhD and explains 
some of the revisions to the research designs needed due to the delayed 
implementation and then negligible uptake of the CT&T service. (One substantial 
change to plans has been reported in chapter 3 - the decision to undertake the routine 
laboratory data analysis, and the before-and-after policy change impact analysis.) 
Chapter 6 has also explained briefly the rationale for choosing specific study designs 
for each research component, and gives an overview of analytical methods employed 
in the studies, and a discussion of ethical issues that have been considered for the 
various study components. The next chapters (7-10), provide in turn details of each 
study undertaken for this thesis.
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CHAPTER 7: TRAINING NEEDS ASSESSMENT 
OF PHARMACISTS AND SUPPORT STAFF FOR 
THE CT&T SERVICE  
7.1 Introduction 
Previous evaluations of pharmacy chlamydia service have recommended that for a 
successful implementation of the chlamydia service in community pharmacies, both 
the pharmacists as well as the front-line community pharmacy workforce should be 
trained (Dabrera et al., 2011, Taylor et al., 2007). Moreover, evaluations in the UK 
have uncovered significant issues such as the unavailability of trained pharmacists to 
hand over the chlamydia testing kits to the potential clients (Baraitser et al., 2007, 
Brabin et al., 2009b), thus limiting the service uptake. It has also been found, in 
evaluation of opportunistic screening for chlamydia among general practitioners, that 
the success of screening depends on health providers having an adequate level of 
awareness and knowledge about chlamydia infection, and possessing effective 
communication skills (Ginige et al., 2007). Therefore, in discussion with the key 
stakeholders of the CT&T service (see definition of key stakeholders in section 
6.3.1.1), it was agreed that the first research to be undertaken would be an 
assessment of training needs, so that these findings could be utilised to inform 
planning of training programmes that could be offered prior to launch of the CT& T 
service. It was therefore decided to design a research study to ascertain respondents’ 
self-reported competencies for delivering CT&T service, and corresponding training 
needs.  
A case study evaluation undertaken to understand the skill mix in community 
pharmacies has shown that the role of pharmacy support staff has expanded 
vertically into areas such as management of service provision (Mullen, 2004). 
However, while pharmacy support staff generally have taken on additional tasks, 
they are only informally trained, often by shadowing or receiving explanations from 
another support staff member or from the pharmacists. It is noteworthy that other 
studies have found that support staff were willing to undertake further training during 
work time (Dabrera et al., 2011, Taylor et al., 2007). It was therefore decided that 
our training needs assessment would involve not just pharmacists but also pharmacy 
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support staff. Therefore this research aimed to identify the training needs among 
different categories of pharmacy staff. It is intended to forward the results of this 
survey to the key stakeholders so that a customized training programme for different 
categories of pharmacy staff could be developed. 
7.2 Objectives 
The objectives of this study were: 
i. to identify, with respect to delivery of the forthcoming CT&T service: 
a. the self-reported competencies of community pharmacists and their 
support staff; 
b. the self-reported training needs of the pharmacists and their support 
staff; 
ii. to carry out further analysis to: 
a.  identifying within respondent (paired) discordance of the 
categorisation of insufficient competency and substantial training 
needs, for pharmacists and their support staff 
b. exploring the association of prior sexual health training of the 
pharmacist with self-reported training needs for the CT&T service   
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7.3 Methods 
7.3.1 Study design 
A self administered postal survey was undertaken with pharmacy staff in all the 166 
community pharmacies in Lothian. The rationale for choosing self administered 
postal survey for this study has been described in section 6.6.1.1.  
7.3.2 Development of the questionnaire 
Methods commonly employed to assess training needs and competence of 
pharmacists includes self assessment of training needs and/or respondent’s rating of a 
list of competence/ skills provided by the researchers (Cameron et al., 2006, Pfleger 
et al., 2008). A number of issues were considered while deciding to undertake a self 
assessment survey of the pharmacy staff. Firstly, for diseases for which there is not 
reasonably frequent consultation with clinical staff, knowledge tests are considered 
inappropriate (Taylor, 1998 , Crilly, 1998). Since this survey was undertaken prior to 
the start of the CT&T service, with pharmacy staff having not yet had any practical 
experience in provision of the chlamydia-related service, it was decided that a 
knowledge test would be inappropriate at this stage. It was felt more appropriate to 
undertake self assessment by the pharmacy staff of competency and training needs, 
as a first step prior to launch of the new service. A further consideration was that a 
number of key competencies, such as counseling skills would require assessment by 
observing performance which was not feasible within the resources of PhD research. 
Colhart et al. (2008), in their systematic review on the effectiveness of self-
assessment by health professionals of their learning needs, did not find sufficient 
evidence regarding the valid assessment of learners need against which to compare 
self-assessed needs. The reliability and validity of any external measure of 
performance as a ‘gold standard’ had also been questioned (Colthart et al., 2008). 
Finally, the key stakeholders had intimated a fairly urgent requirement for some 
insight to the training needs of pharmacy staff for CT&T delivery, so it was decided 
that self assessment of competency of pharmacy staff would be most appropriate to 
collect the information needed to inform advance training for CT&T.  
Studies which have used predefine training need items in a questionnaire for 
respondents rating were either preceded by a qualitative study alone (Pfleger et al., 
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2008) or aided with literature review (Feletto et al., 2010), used validated 
questionnaires (Scott, 2010) or generic set of proposed competencies required for 
accreditation (Fitzgerald et al., 2009). Since the competency and training framework 
for the accreditation of community pharmacists for delivering chlamydia screening 
and treatment was already laid out (National Health Services and Harmonisation of 
accreditation group, 2008), I used this framework as a basis for the items included in 
the training needs questionnaire.  
The questionnaire was structured into three parts (Appendix 25). Part one ascertained 
the demographic information about the respondent. The remainder addressed the 
self-reported competencies and training needs for different aspects of the intended 
service. Part two of the questionnaire was applicable to all pharmacy staff (15 items). 
Part three addressed competencies required by pharmacists only, so was to be 
completed only by them (8 items). For each competency statement, the respondent 
was asked to respond twice, indicating: (i) the extent to which the competency 
applied in his/her case, on a 4 point likert scale (1=not at all; 2=somewhat; 3=fairly 
well; 4=very much so), and (ii) the level of training in the competency he/she judged 
as needed in his/her case, on a 4 point likert scale (1=none needed; 2=refresher; 
3=top-up; 4=full).  
Three opportunities for free-text comments were provided, regarding suggestions for 
training that would be helpful in delivery of the CT&T service and  any concerns 
regarding the proposed service.  
Initial testing of the questionnaire was undertaken with a lead pharmacist and two 
sexual health specialists, and this resulted in changes to clarify the meaning of 
questions and the order of the competency items. The questionnaire was then pre-
piloted with colleagues uninvolved with the CT&T service, to record the time taken 
for completion of questionnaire and to comment on the comprehensibility of the 
questionnaire. The time taken was approximately 10 minutes and all the questions 
were judged to be clear and easy to understand. Therefore no further changes were 
made to the questionnaire.  
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7.3.3 Recruitment of the study participants 
A list of all the 166 community pharmacies operating in NHS Lothian was provided 
by the Lothian pharmaceutical public health consultant. This total number of 
pharmacies in Lothian made it feasible to survey all of them, so no sampling was 
required and a formal sample size calculation was not undertaken. The pharmacy 
director/manager of each pharmacy were sent an introductory letter (Appendix 23), 
giving details of the study and 5 questionnaire packs. Each pack consisted of an 
invitation letter to the respondent (Appendix 24), a questionnaire (Appendix 25), and 
a reply paid envelope. I took advice from the key stakeholders regarding the number 
of questionnaires that should be sent to each pharmacy. It was suggested that 5 
questionnaires would be sufficient to generally cover the staff within the pharmacy 
eligible for this survey. In case of shortage, the invitation letter to the pharmacy 
managers advised that more questionnaire packs could be requested if these were 
needed (by emailing the investigator). This resulted in sending 12 additional 
questionnaires to three pharmacies.  
The pharmacy managers were requested to distribute packs to all members of staff 
having direct dealings with pharmacy clients. All questionnaires were anonymous 
with respect to identification of individual members of staff, but coded for a specific 
pharmacy. After 4 weeks, reminders were sent to those pharmacies (using the same 
initial pharmacy manager address) from where not all the 5 questionnaire had yet 
been received. This was suitably worded to be ignored if all eligible respondents 
within their pharmacy had already replied. For the subset of pharmacies from which 
no returns at all had been received (n=91), an additional blank questionnaire was 
enclosed with the reminder letter.  
7.3.4 Statistical analysis 
All analysis was undertaken in SPSS Version 17.0. Descriptive statistics were 
produced and the associations of staff categories with respondent characteristics were 
tested using chi square test. In order to simplify tabular/graphical reporting of ordinal 
response for competency and training needs items on likert scale, each item response 
is transformed into a binary categorical variable, with responses of ‘not at all’ or 
‘somewhat’ for a competency statement (rather than fairly well or very much so) 
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being classified as ‘insufficiently competent’ and training need responses of ‘full’ or 
‘top-up’ being classified as indicating need for ‘substantial training’. Furthermore, to 
make the assimilation of the results easier, I have structured the list of 15 ‘all staff’ 
response items into four thematic domains: knowledge about STIs in general and 
chlamydia infection in particular (3 items); understanding about chlamydia screening 
(3 items); communication with client in general, and on sexual health issues (4 
items); and communication around screening service (5 items). Graphs displaying 
competency responses show also a vertical dashed threshold line at 50%, to enable 
easy visual assessment, overall or within domain, of items where more than half of 
all respondents have been classified as reporting ‘insufficient competency’ or they 
require ‘substantial training’. The associations of staff categories with self-reported 
competency and training need were tested by the Kruskal-Wallis method applied to 
the ordinal scale responses on the original likert scale. A p-value of <0.05 was 
considered statistically significant.  
I also examined discordance in reporting of insufficient competency and substantial 
training needs. Responses for each item were therefore examined in terms of a 
within-respondent (paired) discordance of the categorisations of insufficient 
competency and substantial training need, tested by the z-test for comparing paired 
proportions (each competency categorisation against its corresponding training need 
categorisation). Statistically significant discordance between the insufficient 
competency and substantial training need for an item is calculated as the difference 
in (paired) proportions, and reported as percentage point difference (ppd) and 
confidence interval (C.I.). This test was undertaken for items which showed marked 
discordance within individuals of insufficient competence and substantial training 
needs. 
Free text comments have been coded in terms of the main themes that emerged and 
reported quantitatively, but where considered helpful to providing further insight, 
direct quotations have been included (referenced with unique but anonymous code 
number of respondent, categorised as P (pharmacist), T (technician) or CA (counter 
assistant).  
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7.4 Results 
7.4.1 Response rate and demographic characteristics of the 
respondents 
A total of 25.2% (235/933) completed questionnaires were returned, from 88 (53%) 
pharmacies. This gives an average of 2.67 completed questionnaires per pharmacy. 
Of all the respondents, 41% were pharmacists, while 32% & 26% respectively were 
technicians and counter assistants. Overall, the respondents were predominantly 
female (85.5% overall). 
Table 7-1 shows the breakdown of some information across the three staff categories. 
In contrast to pharmacists, where about 70% were females, more than 95% of the 
technicians and counter assistants were female. The largest proportion of pharmacists 
(40%) was aged between 25 and 34 years as opposed to pharmacy technicians and 
counter assistants, where 51% and 35% of them were in the next older age band of 
35 to 49 years. There was striking disparity across staff groups in proportions 
indicating they had received previous sexual health (SH) training (55% of 
pharmacists vs. 7% of the other groups). Of the 53 pharmacists who had received 
training, 35 (62%) received this in the context of provision of EC through 
pharmacies. There was also a significant difference between staff groups in 
expressed enthusiasm for the proposed chlamydia service, with pharmacists and 
technicians most enthusiastic (79% and 84% highly or moderately enthusiastic, 
versus 61% for counter staff (
2
 value 10.041, df 2, p-value=0.007).   
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 n % n % n %  
Gender        
Female 69 71.1 72 96.0 58 95.1 0.000 
Age        
< 25years 11 11.3 9 12.0 18 29.5 0.000 
25 to < 35 years 40 41.2 13 17.3 3 4.9  
35 to < 50 years 26 26.8 38 50.7 21 34.4  
>= 50 years 20 20.6 15 20.0 19 31.1  
















How often do you deal with 
someone asking for advice on 
Sexual Health 
       
Every week 24 25.0 4 5.4 3 5.1 0.000 
Every month 12 12.5 4 5.4 4 6.8  
Very Seldom 48 50.0 40 54.1 27 45.8  
Cant recall 12 12.5 26 35.1 25 42.4  
How enthusiastic do you feel 
about the proposed programme 
       
Not at all or Somewhat 20 20.8 12 16.4 23 39.0 0.037 
Moderately 43 44.8 33 45.2 19 32.2  
Highly 33 34.4 28 38.4 17 28.8  
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7.4.2 Competency levels and training needs of pharmacy 
staff 
7.4.2.1 Competence relevant to all staff: self-reported competencies and 
training needs of all staff combined 
Figure 7-1 shows the proportion of responses coded as indicating insufficient 
competency and substantial training need for all staff items. It can be seen that in 
respect of insufficient competency the 50% threshold was exceeded for only 7 of the 
15 items, compared to 13 items for substantial training need. Looking at responses by 
domain, insufficient competency was most prevalent for the 4th domain items on 
communication around screening service (60% to 83% for four of the five items), 
intermediate for 1st domain items on knowledge about chlamydia (45% to 60%), 
mixed for the 3rd (communication in general and on sexual health) domain items 
(15% to 58%), and uncommon in items of the 2nd domain, understanding service 
aims (20% to 31%). In the 4th domain, insufficient competency was most prevalent 
for giving guidance on the actual use of the screening kit (83%) and making the offer 
of chlamydia screening to eligible men (70%) and to eligible women (67%). 
Proportions responding substantial training need were generally higher, and a similar 
pattern by domain was evident, in that the highest prevalence of substantial training 
need responses were found in the 4th domain-communication around screening 
service (56% to 83%), and there was a mixed picture in the 3rd domain (40% to 
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Figure 7-1: Competencies relevant to all staff - in respect of each, percentage of all 
pharmacy staff responses classified as ‘insufficiently competent’ and/or as having 
‘substantial training need’ 
 
Domain 1: Knowledge about STI & particularly chlamydia 
I know…       the possible consequences of chlamydia infection  
 .. basic information about sexually transmitted infections 
    ..  the signs and symptoms of chlamydia infection 
Domain 2: Understanding about chlamydia screening 
I understand.. the importance of PN after a positive  result  
     ..  the aims of a chlamydia treatment service 
.. the aims of chlamydia screening 
Domain 3: Communication with client in general; & on SH 
I feel able to… communicate with clients appropriately and sensitively 
     .. give a client advice on safer sex        
      ..  respond to a request for sexual health information   
 .. raise the issue of sexual health with a client 
Domain 4: Communication around screening service 
I feel able to  ...   ..  explain the importance of PN to a client  
      .. advise a client regarding screening, if requested  
      make the offer of chlamydia screening to eligible women  
 make the offer of chlamydia screening to eligible men      
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7.4.2.2 Competencies relevant to all staff: self reported competencies 
and training needs, subdivided by staff categories 
Responses to competencies and training needs were also examined separately within 
the three staff groups. Tables 7-2 and 7-3 show for each competency, separately 
across the three staff categories, the proportions categorised with insufficient 
competency and substantial training need. Insufficient competency and substantial 
training need showed an increasing trend across the three staff groups, with 
pharmacists least likely to be thus classified and counter assistants most likely 
(Kruskal-Wallis tests were statistically significant for all but one competency item – 
see Tables 7-2 and 7-3 for p-values). For 4
th
 domain competencies, more than half of 
respondents were classified as having insufficient competency in the case of only 
three of the items for the pharmacists (62% to 79%), four items for technicians (68% 
to 85%) and all five items for counter assistants (51% to 83%). In the same domain, 
more than half of the pharmacists were classified with substantial training needs for 
four items (56% to 77%) in contrast to all 5 items for technicians (71% to 85%) and 
counter assistants (77% to 90%).   
Regarding the other domains (comprising 10 items), there were only three items 
where over half of pharmacists were classified with substantial training need - signs 
and symptoms of chlamydia (58%), advice regarding screening (56%) and raising the 
issue of sexual health (52%). In contrast, for CA this was the case for all 10 items 
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Table 7-2: Proportion of staff category coded as indicating insufficient competency and/or as having substantial training needs in respect of 
each competency  - for domains ‘knowledge’ and ‘understanding’ 
Competencies grouped by domain category Proportion indicating Insufficient 
Competency 
Proportion indicating Substantial Training 
Need 















possible consequences 24 52 70 <0.001 51 70 79 <0.001 
information about STIs  32 49 71 <0.001 49 73 86 <0.001 
signs and symptoms 41 68 78 <0.001 58 77 85 <0.001 
Domain 2: Understanding re chlamydia services               
importance of partner notification if +ve result 8 23 33 <0.001 38 67 73 <0.001 
aims of chlamydia treatment service 9 36 52 <0.001 36 71 79 <0.001 
aims of chlamydia screening  12 36 52 <0.001 38 70 84 <0.001 
*  by responding ‘Not at all’ or ‘Somewhat’ in respect of this competency statement 
** by responding that training need in respect of this competency is ‘Top up’ or ‘Full’ 
$         Kruskal-Wallis p-value for ordinal response of items vs. pharmacy staff category 
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Table 7-3: Proportion of staff category coded as indicating insufficient competency and/or as having substantial training needs in respect of 
each competency – for domains  ‘communications with client’ and ‘communication around screening service’  
Competencies grouped by domain category Proportion indicating Insufficient 
Competency 
Proportion indicating Substantial Training 
Need 
Domain 3: Communication with client in general and 
















communicate appropriately and sensitively 8 16 23 0.298 29 40 60 <0.001 
give advice on safer sex 17 39 53 <0.001 29 55 75 <0.001 
respond to request for SH information  37 58 71 <0.001 44 69 88 <0.001 
raise the issue of SH 50 61 67 0.006 52 67 81 <0.001 
Domain 4: Communication with clients regarding 
screening service 
              
explain importance of partner notification 10 31 51 <0.001 34 71 77 <0.001 
advice regarding screening, if requested  38 72 78 <0.001 56 81 84 <0.001 
offer of  screening to eligible women 62 68 72 0.030 72 79 84 0.005 
offer screening to eligible men  63 73 75 0.026 73 85 84 0.006 
guidance re use of screening kit 79 85 83 0.017 77 85 90 0.032 
*  by responding ‘Not at all’ or ‘Somewhat’ in respect of this competency statement 
** by responding that training need in respect of this competency is ‘Top up’ or ‘Full’ 
$         Kruskal-Wallis p-value for ordinal response of items vs. pharmacy staff category 
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7.4.2.3 Pharmacist only competencies: Self reported competencies and 
training needs  
Figure 7-2 shows, for pharmacist-specific competencies, the proportion of responses 
coded as indicating insufficient competency and substantial training need. It can be 
seen that for 7 out of 8 items over half of all pharmacist respondents were classified 
as having insufficient competency and for all competencies, over half were classified 
as having substantial training need. The competencies with highest prevalence of 
insufficient competency and corresponding substantial training need were items such 
as ‘clear about the medico-legal aspects (Fraser guidelines)’ (77% and 83% 
respectively), ‘able to take a sexual history’ (72% and 78%), ‘clear about what 
features of sexual history require client referral’ (70% and 77%) and ‘able to review 
own and staff competencies against newly specified role in chlamydia screening’ 
(66% & 74%).  
Figure 7-2: Pharmacist-specific competencies – in respect of each, percentage of 
pharmacist responses classified as’ insufficiently competent’ and/or as having 
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I feel able to…  ...advise on & prescribe treatment for
chlamydia infection 
...counsel a client who has received a positive test result 
...explain the process of PN to client with positive
chlamydia test
...review staff competencies against newly specified role
in chlamydia screening
...take a sexual history
I feel clear about...when to ask for support in dealing
with client
...what features of SH require client's referral
...medico-legal aspects (Fraser guidelines)
Percentage
'Insufficient' competency Substantial' training need
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7.4.2.4 Overview of training needs 
Table 7-4 shows for each of the three staff categories, the ten competencies most 
frequently classified as having substantial training needs. To enable cross-
referencing between training needs identified in more than one staff categories, any 
competency in more than one column is colour-shaded, in a distinctive colour.  
For pharmacists, 7 out of 10 competencies identified as needing more training were 
‘pharmacist specific’. The largest proportions of pharmacists indicated training need 
for medico-legal aspects (Fraser competency) (83%) and taking sexual history 
(78%). It is interesting to note that for training needs of technicians and counter 
assistants, all competencies except one in their ‘most frequently classified’ lists, were 
similar, though in different order. A high proportion of all the three staff categories 
indicated ‘substantial’ training needs (as categorized for analysis) for items within 
the domain of communication around screening service (77% to 72% for 
pharmacists, 85% to 79% for technicians and 90% to 84% for counter assistants). 
Furthermore, a high proportion of technicians and counter assistants indicated 
‘substantial’ training needs for items within the domain of knowledge about STI 
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Table 7-4: For each of the three staff categories, the  ten competencies most frequently classified as having substantial training need  
Pharmacists Technicians Counter Assistant 
Training needs Item % Training needs Item % Training needs Item % 
Medico-legal aspects 83 Guidance re use of screening kits 85 Guidance re use of screening kits 90 
Take a sexual history 78 Offer screening to eligible men 85 Respond to request for SH information 88 
Features of SH require client’s referral 77 Advice regarding screening, if 
requested 
81 Basic information about STI 86 
Guidance re use of screening kits 77 Offer screening to eligible women 79 Sign and symptoms of chlamydia 85 
Review staff competency against role 
in chlamydia screening 
74 Sign and symptoms of chlamydia 77 Offer screening to eligible women 84 
Offer screening to eligible men 73 Basic information about STI 73 Offer screening to eligible men 84 
Offer screening to eligible women 72 Aims of chlamydia treatment 
service 
71 Advice regarding screening, if 
requested 
84 
Explain the process of PN to clients 66 Explain the importance of PN 71 Aims of chlamydia screening 84 
Counsel a client with positive test 
results 
65 Aims of chlamydia screening 70 Raise the issue of SH with clients 81 
Advise on and prescribe treatment for 
chlamydia 
61 Possible consequence of chlamydia 
infection 
70 Possible consequence of chlamydia 
infection, tied with 
79 
    Aims of chlamydia treatment service 79 
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7.4.2.5 Suggestions regarding training that would be helpful for delivery 
of a new CT&T service 
There were diverse views as to which staff categories need to be trained. Some 
pharmacists (n=5) proposed that training should be ‘mandatory’ to the pharmacists. It 
was also suggested that locum pharmacists should be trained, in case the regular 
pharmacist in not available when a potential service user requests the CT&T service. 
It was common that respondents suggested training of all staff (n=6).  
There was considerable variation in respondent’s preferences for format of training. 
They requested visual training materials (n=6) such as video clips or a DVD, 
particularly on aspects such as ‘….how to approach and deal with clients waiting to 
access this service’ (P-117) and ‘…chlamydia testing and treatment service in 
action’ (P-212). Two respondents felt strongly that the ‘training should not be 
distance learning’, while other suggestions were a clear and well designed training 
pack, with MCQs, or an online reference tool.  
Respondents commented that general STI training was required, and not chlamydia 
solely/specifically, and were of the view that there should be training for technicians 
and counter assistants with regards to sensitive communication on sexual matters. 
7.4.2.6 Respondent’s concerns about proposed CT&T service 
When respondents were asked to comment on their concerns about the proposed 
service, 23% (n=51) specify some of their concerns. The most common concerns 
raised by pharmacists were workload (n=21) and time (n=19) required for 
consultations for the CT&T service. One pharmacist noted her concerns as follows: 
 ‘It is yet another service thrust upon pharmacists that we have no 
time to deal with. Just because we are open on weekends doesn’t 
mean we should be taking on the roles of doctors/nurses/GUM 
specialists’. (P-161) 
Another pharmacist indicated that small independent pharmacies would not be able 
to cope with this workload, particularly those pharmacies with only one pharmacist. 
‘In single pharmacist’s pharmacies, this is not possible at the moment’. (P-
112) 
Many pharmacy staff also showed concerns about lack of or inadequate refresher 
training (n=17), being unclear about different components of the service (n=14) and 
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having doubts about the effectiveness of the service (n=7), and about lack of 
promotion or publicity of the service (n=5). There was also concern that low demand 
for the service would mean training would be forgotten by the staff. Some identified 
privacy and confidentiality concerns as reasons for expected low uptake (n=5). An 
owner of a small pharmacy from a village shared his experience of a very low uptake 
of EC service and indicated that a pharmacy in a small village poses a risk of not 
providing a confidential service.  
‘[In a] small community pharmacy, local people work in store and 
know everyone in village. Doubt if youngsters will come in- [We also] 
have poor uptake of emergency contraception service’ (P-205). 
Some technicians (n=3) highlighted concerns on health and safety issues related to 
handling of the sample and others expressed doubt as to being adequately clinically 
trained to provide such kind of service (n=4). A technician sees her little role in 
providing such services.  
‘I think this should be the pharmacist job as he is the professional and 
best qualified to do this’ (T-136).  
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7.4.3 Further analyses of training needs and competency 
responses 
7.4.3.1 Analysis of within-respondent ‘discordance’ in response 
regarding competence and training need for the same 
competency 
In the methods section, I have explained the intention to look at within-respondent 
discordance of responses to competency and training need items. Across all staff 
items, there was a general tendency for categorisation with substantial training needs 
being more common than insufficient competency. That is, a substantial number of 
respondents reported adequate competency but nevertheless indicated a need to 
substantial training for that aspect of the service. These can be seen in the figure 7-1 
as those competencies with greatest disparity in the pair of column heights. The 
greatest discordance (in the sense of ‘substantial training need’ despite not being 
categorised as having ‘insufficient competency’) was for the competencies 
understanding the importance of partner notification (37 percentage point difference 
(ppd), 95% C.I. 28 to 41 ppd), understanding the aims of chlamydia screening, (29 
ppd, 95% C.I. 21 to 33 ppd), understanding the aims of chlamydia treatment service 
(29 ppd, 95% C.I. 21 to 33 ppd), explaining partner notification (30 ppd, 22 to 34 
ppd) and appropriate/sensitive communication with client (26 ppd, 95% C.I. 18 to 30 
ppd).  
Paired categorisations (substantial training need by insufficient competency) were 
also examined within staff groups separately, and the item with greatest discordance 
overall, ‘understanding the importance of partner notification’, showed discordance 
in all three staff groups (for pharmacists 30 ppd, 95% C.I. 18 to 36 ppd; for 
technicians 41 ppd, 95% C.I. 25 to 50 ppd; and for counter assistants 42 ppd, 95% 
C.I. 23 to 51 ppd). Within-pharmacist discordance in categorisation (substantial 
training need by insufficient competency) for pharmacist’s only items was most 
evident for the competency ‘able to advise on and prescribe treatment’ (21 ppd, 95% 
C.I. 9 to 27 ppd). 
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7.4.3.2 Association of prior sexual health training with pharmacist self-
report of training need for CT&T service 
It is noteworthy that for all but four of the 23 competencies enquired about, whether 
or not the pharmacist had had previous sexual health training had no statistically 
significant association with their professed training needs (Kruskal-Wallis, all p > 
0.142). The four competencies for which there was an association were two ‘all staff’ 
items  - knowledge of ‘signs and symptoms of chlamydia’ (‘full’ training judged 
needed by 15% of pharmacists responders if had had SH training, 59% if not, 
Kruskal-Wallis p-value 0.001) and possible consequences of chlamydia (13% v 49%, 
Kruskal-Wallis p-value 0.006) – and for two pharmacist-specific items - ‘clear about 
the medico-legal aspects (Fraser guidelines)’ (54% v 72%, Kruskal-Wallis p-value 
0.044) and ‘able to advise on and prescribe treatment for chlamydia’ (29% v 44%, 
Kruskal-Wallis p-value 0.025). 
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7.5 Discussion 
High rates of self reported substantial training needs are evident for almost all 
competencies necessary for delivering a CT&T service, in that for 13 out of the 15 
items for all staff, and for all 8 pharmacist-only items, over half of all respondents 
were thus classified. Considering separately the three staff groups surveyed, 
categorisation as having substantial training needs showed a general trend that 
pharmacist responses were least likely to be thus classified and counter assistants’ 
responses most likely, so that for only 7 of the 15 ‘all staff’ items were over half of 
pharmacist respondents thus classified. The highest rates of substantial training needs 
were found for inter-communicative aspects of the ‘all staff’ competencies, in 
particular the five competencies specific to communicating about the CT&T service - 
for respondents overall, 56% to 83%, and for the pharmacists’ subgroup of 
respondents, 34% to 77%. The highest rates of substantial training need for 
pharmacist-only competencies were for clarity regarding Fraser guidelines, criteria 
for referral, taking a sexual history and reviewing own and staff competencies for 
CT&T service (83% to 77%). The prevalence of competency responses classified as 
insufficient was generally lower, but the pattern was similar to that for training 
needs. 
The following limitations are noteworthy. The pharmacy response rate was not high 
(50%) which may reflect time constraints on pharmacy staff and the sensitive nature 
of the research topic. Hence the respondent sample may be biased towards pharmacy 
staff more interested in the pharmacy sexual health role. Previous research has also 
suggested that the response rate for the postal surveys are comparatively lower then 
for the surveys administered face-to-face or through telephone (McColl et al., 2001). 
In order to increase the response rate of the postal survey, I employed a number of 
techniques as recommended in the literature, such as using stamped return envelopes, 
coloured paper for questionnaire, sending a reminder and providing non-respondents 
with a second
 
copy of the questionnaire (Edwards et al., 2002, Edwards et al., 2009) 
(McColl et al., 2001). It is also possible that some questionnaires might not have 
been received, due to postal problems, incorrect or out of date addresses, and the 
reliance on the pharmacy manager to distribute questionnaires to other pharmacy 
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staff. There might also have been absence of some staff during the study period, due 
to annual leave.  
The decision to send a questionnaire pack comprising 5 questionnaires to each 
pharmacy also might have limited the response rate, since it is possible that some 
pharmacy employs more pharmacists and support staff than the number of 
questionnaires sent. However it was clearly indicated in the letter to the pharmacy 
manager that more questionnaires could be obtained, should this be required, by 
contacting the investigator at the email address provided. An additional 12 
questionnaires were posted to three pharmacies on their request. After the TNA 
survey, an additional short questionnaire was sent to pharmacy managers of each of 
the 166 pharmacy in Lothian (Appendix 26), in order to estimate the pharmacy staff 
workforce in Lothian who might need training for CT&T service (i.e. who had 
dealings with pharmacy customers/clients). The questionnaire response rate was low 
(a total of 66 questionnaires were returned) but these responses suggest that the 
number of staff per pharmacy who have face-to-face dealing with clients has mean of 
6.94 (±SD 3.96). Thus there might be a slight under-representation of pharmacy staff 
in the current study, given that initially 5 questionnaires were posted to each 
pharmacy. 
Although I was unable to compare respondents and non-respondents, the 
composition of the pharmacist respondents in terms of gender (29.5% male, 70.5% 
female) is broadly in line with the Scottish data in the UK-wide 2005 workforce 
survey for community pharmacists (35% male, 65% female) (Hassell et al., 2006). 
Comparing by age, 79% of the pharmacists in this survey are ≤ 50 years of age which 
is similar to workforce data, which indicates that in 2005 71% of pharmacists were 
under 50 years of age. This may indicate slightly more representation of younger 
pharmacists in this survey, perhaps because of more interest in the service as 
compared to older pharmacists, or it could reflect differences in workforce 
demographics for Lothian compared to Scotland, or changes between 2005 and 2010.  
Another limitation of this survey is the overall generalisability of the study findings. 
Given the survey was undertaken in only one health board in Scotland, the findings 
might not describe the situation in UK more widely. The essential foundation for the 
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provision of an effective CT&T service depends on what pharmacy staff are willing 
to provide and their relevant competence to do so. However, of the 15 competencies 
identified as required by all pharmacy staff for delivery of the CT&T service, more 
than half of all the community pharmacy staff responses were categorised as 
insufficiently competent for 7 of them. The finding of self reported substantial 
training need among counter assistants in general communication skills is 
concerning, particularly given the fact that they are very often the frontline 
‘gatekeepers’ controlling clients’ access to the pharmacist. Research has shown that 
training increases the involvement of pharmacy staff in such interventions, enhances 
their confidence and increases client uptake and satisfaction (Smith and Watson, 
2004, Armstrong M et al., 2005). A London pilot of community pharmacies has 
reported that clients emphasise the importance of excellent communication skills of 
counter staff (Baraitser et al., 2007).  
A self-report survey has limitations in terms of ascertaining actual competence or 
training need. Colthart et al. (2008), in their systematic review of self assessment of 
training needs by health professionals, reported over-estimation by poor performers 
and under-estimation by those who perform well. Accuracy of the self-assessment 
may be influenced by the purpose of the self assessment activity, that is whether self-
assessment contributes towards formative or summative outcomes. The author 
suggested further research to explore the impact of the purpose of self-assessment on 
its accuracy. 
At the time of this survey, the CT&T service had not been rolled out in community 
pharmacies of Lothian, so the high levels of insufficient competency regarding 
service process such as offering the service to the client and guidance about the 
actual use of the testing kit is perhaps not surprising, nor the fact that more than 56% 
of all staff were categorised as having substantial training needs in relation to one or 
more of these competencies. However it would be more worrying if pharmacists 
started providing services without receiving adequate training in the provision of 
different services (Cameron et al., 2006). The high proportion of the three categories 
of pharmacy staff requiring training in offering the screening kit may also reflect that 
they perceived more training in communication skills. An Australian study also 
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reported that pharmacists shows reluctance to offer the kits to their potential clients 
and suggested more training on communication aspects (Taylor et al., 2007). Those 
aspects of the service that require proficiency in specific communication around 
sexual health counselling could be best provided through face-to-face training. 
However those aspects requiring improvement in knowledge, for example, 
knowledge about STI might be provided successfully through written information 
materials (paper or online). High proportions of technicians and counter assistants 
indicated substantial training needs for knowledge about STI (with 77% to 70% of 
the technicians, and 86% to 79% of counter assistants requiring ‘substantial training’ 
in the knowledge domain). Therefore what is needed is a combination of face-to-face 
training on communication aspects and traditional written information about 
chlamydia and other STI to the pharmacy staff.  
For all staff items, within respondent (paired) discordance in categorisation as having 
‘insufficient’ competency and ‘substantial’ training needs indicates a high 
discordance for item response to ‘communication with the clients appropriately and 
sensitively’ (26 ppd). The discordance observed indicates that despite feeling 
competent in general communication aspects with the clients, the pharmacy staff 
respond in a way that suggests substantial training needs. This further emphasises the 
need for face-to-face training with role play on general communication aspects, to 
enhance confidence in communicating sensitively and appropriately with their 
clients. A high discordance was also found for the domain of ‘understanding about 
chlamydia service’. Understanding is an abstract concept and discordance in 
responses seen for these items may suggest that the degree of this effect might 
depend partly on a competency context. Colthart et al. (2008), in their review of self 
assessment of learning needs of health professionals, reported that practical skills are 
better self assessed than knowledge. This might also explain some of the discordance 
identified in the domain of ‘understanding about chlamydia service’. A further 
consideration might be to explore discordance in response with gender. However, 
Colthart et al. (2008) found inconclusive evidence regarding gender differences in 
the accuracy of self assessment.   
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It is interesting that a pharmacist specific item most notably showing ‘discordance’, 
as defined above, is regarding ability to advise and prescribe treatment for 
chlamydia. This discordance was least expected and suggests that despite feeling 
competent to advise and prescribe treatment for chlamydia, pharmacists were also 
extra cautious with respect to something so fundamental to their profession. 
Moreover, the evidence suggests that health professionals have a general tendency to 
favour ‘more training’ (Kerby et al., 2005). This scenario might have contributed to 
some of the discordance in paired categorisations for the same competence, if the 
respondents tended to indicate a need for training despite self-report of apparently 
adequate competency.  
A high prevalence of insufficient competency among pharmacists in respect of most 
of the activities specific to them, such as counselling, taking sexual history, partner 
notification procedures and referral, is of particular concern because taking a sexual 
history and establishing ‘Fraser ruling’ competency with under 16 year olds have for 
some years been important components of practice for contraceptive consultations in 
community pharmacies in the UK. Among pharmacists, previous sexual health 
training appears to have had little impact in terms of improving confidence regarding 
the more inter-communicative aspects of sexual health consultations with clients. A 
literature review of the role of pharmacists in public health provision has identified 
an association between pharmacists competency and their confidence in the 
provision of public health services (Eades et al., 2011). It is therefore possible that 
the lack of association of prior sexual health training of pharmacists, with their 
training needs for CT&T provision is actually confounded by their lack of 
confidence in the provision of such services. While it may be possible to provide 
distance learning for knowledge about STI and chlamydia, or treatment guidelines 
for pharmacists, competencies involving practical skills, such a communication 
strategies and counselling skills tend to need training face-to-face and ideally also by 
role play exercises. An evaluation of the training of pharmacists for the provision of 
emergency contraception demonstrated that role-play was a successful training 
method (Bacon et al., 2003). Such a face-to-face training may also be able to boost 
their self confidence in the provision of such services. 
 
 
Chapter 7: Training needs assessment survey……………………………………………………  
210 
The general enthusiasm among pharmacy staff to deliver the chlamydia service, 
found in our survey, echoes the findings of an earlier Lothian survey, that nearly all 
of the community pharmacists (49/50) were willing to provide free chlamydia testing 
kits on their premises (Cameron et al., 2007). However, previous research on 
pharmacists’ views revealed that their motivation for offering an enhanced pharmacy 
service was to increase job satisfaction and to demonstrate to the public that the 
pharmacy was progressive and proactive (Thomas et al., 2010). While such a 
scenario could lead to greater customer satisfaction and return visits by clients, it is 
noteworthy that in the London pilot there was no increase in business for the 
pharmacists involved (Baraitser et al., 2007). There is a therefore a need for more in-
depth exploration of their enthusiasm and monitoring of the extent to which this is 
sustained.  
Qualitative responses to this survey brought to light their concerns regarding lack of 
training and their self-judgement as not qualified to deliver the service. Some 
pharmacists commented on the increase workload on them, to deliver many public 
health services. This supports the view that it would be helpful to spread the work of 
delivering such a service to pharmacy support staff, which further highlights the 
importance of training designed for this staff group.  
The comparison of competence and training need carried out between pharmacists 
and pharmacy support staff in the present study was not performed to put 
comparative value judgement on their competencies. Rather the variation in the 
training need identified across the three categories of pharmacy staff suggests a 
requirement to develop tailored training catering the specific needs of different staff 
groups. The findings of this survey were communicated to the strategic stakeholders 
by presentations in two separate meetings with the stakeholders working on sexual 
health policy making in Lothian. The findings were used to inform two separate 
training sessions for pharmacists in Lothian. In addition, the report on the findings 
was distributed on request to other public health pharmacist leads involved in the 
implementation of pharmacy chlamydia service in other health boards of Scotland.   
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7.6 Chapter overview 
This chapter has described the self-judged competence and training needs of 
pharmacy staff to provide the CT&T service. The training needs were demonstrated 
to vary significantly according to pharmacy staff group (pharmacists/ technicians/ 
counter staff). Competencies receiving the least affirmative responses by pharmacy 
staff (i.e. with greatest ‘gaps’ in knowledge/skills, as subjectively reported) were 
knowing signs and symptoms of chlamydia, raising the issue of sexual health, and 
offering, and advising on, chlamydia screening. Substantial training need is 
particularly indicated for inter-communicative aspects of sexual health, which is a 
challenge for pharmacy practice because training in such skills is likely require 
greater allocation of resource (staff time to undergo training and employing face-to-
face trainers).
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CHAPTER 8: SURVEY OF STRATEGIC 
STAKEHOLDERS 
8.1 Introduction 
The CDC framework for programme evaluation recommends identifying, involving 
and retaining stakeholders in the process of evaluation of a programme/service. The 
engagement of stakeholders in the evaluation of a programme/service mirrors the 
increasing prominence in research endeavours, of participatory models or “action” 
research. Stakeholders have the right and the responsibility to know what is 
happening in the programme, which aspects need corrective action, what the results 
are, and which lessons can be learned and shared with one another. However they 
should not simply be recipients of evaluation reports. One effective way for 
stakeholders to contribute to the evaluation of a programme is to involve them in the 
formulation of critical questions. They may also be involved in the collection and 
analysis of data. This enables them to participate directly in the assessment of the 
relevance, performance and success of the programme and in recommending how to 
improve the quality of current and future interventions.  
A survey with the stakeholders was undertaken to elicit their views on the CT&T 
service, and on its evaluation. The exercise of identification of the stakeholders for 
the CT&T service evaluation has been discussed in detail in chapter 6 (section 6.3.1). 
This survey is restricted to the strategic stakeholders - those involved in the policy, 
design and implementation of the CT&T service (see section 6.3.1.1 for the 
definition of strategic stakeholders).  
8.2 Objectives 
The key objectives of the strategic stakeholder survey were as follows: 
 To offer this subset of stakeholders the opportunity to provide input into the 
“evaluation objectives”, to ensure that the key questions of most importance 
to them were included.  
 To identify their interests, perceptions, and concerns in relation to the CT&T 
service initiative, and its evaluation.  
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8.3 Methods 
8.3.1 Study design 
The views of the stakeholders regarding the CT&T service were elicited through a 
self administered postal and online survey.  The rationale for choosing self 
administered postal survey for this study has been described in section 6.6.1.2 
8.3.2 Identification of strategic stakeholders 
The strategic stakeholders for this survey represent those identified from 
stakeholders types suggested in Table 6-1. These stakeholders included public health 
pharmacists, other public health practitioners with special interest in sexual health, 
sexual health consultants, general practitioners, community outreach groups involved 
in sexual health care provision and partners of the CT&T service, for example lab 
personnel involved in chlamydia testing or involved in maintaining sexual health 
records. These stakeholders were identified in an early meeting with programme 
implementers and also from the list of board members involved in developing 
Edinburgh & Lothian Sexual Health Strategy for 2005-2010 (NHS Lothian, 2005). 
GPs whose practices are closer to the pilot CT&T pharmacies were also identified as 
strategic stakeholders, since they would potentially create an important collaboration 
with the pharmacists in terms of referring the patients to pharmacies or vice versa. 
8.3.3 Development of the questionnaire 
An open ended semi-structured questionnaire was developed (see Appendix 27). 
Details of the CT&T service were provided to the participants of the survey in a 
separate information sheet, so that they could give ‘informed’ responses to the 
questions in the survey (Appendix 28). 
The questionnaire comprised three sections. Section A elicited the strategic 
stakeholders’ concerns regarding different aspects of the CT&T service. For 
assessing the potential concerns that the stakeholders might have regarding the 
CT&T service, a first step was to identify the challenges that have been identified in 
the published literature on a pharmacy-based chlamydia services. I therefore enlisted 
the key items that were identified in my structured literature review to potentially 
impact the implementation or accessing the CT&T service (from the perspective of 
providers and users respectively). These items were then broadly categorised into 
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those related to the delivery of the CT&T service (7 items); concerns regarding 
provision of sexual health care via community pharmacies (3 items) and concern 
regarding young people knowledge of and views about the CT&T service (3 items). 
For each item, the respondents were asked to quantify their degree of concern on a 4 
point likert scale (none at all; a little; moderate and strong) and then to elaborate the 
nature of their concern if they identified their concern as ‘moderate’ or ‘strong’. 
After each question with listed items, the respondent was given an opportunity for 
free-text comments to communicate any additional concerns which were not among 
those listed.  
Section B requested the respondent to focus on the evaluation questions devised for 
the CT&T service, as so far formulated, by quantifying the importance to the 
evaluation of each question, on a three point likert scale (not important; important 
and very important). These evaluation questions were identified in my initial 
meetings with key stakeholders to identify what these stakeholders want this 
evaluation to address. In this section a further opportunity was given to identify any 
additional evaluation question considered important (free text response). Information 
was also elicited in this section to broadly classify the respondent in terms of their 
stakeholder category i.e. public health pharmacist, general practitioner, sexual health 
specialist, community outreach group, public health promotion group, partner of the 
CT&T service, and other. Due to small number of stakeholders involved, other 
demographic information such as age or gender was not elicited in this survey, so as  
to be seen to be protecting respondent’s identity, hoping thus to enhance the 
likelihood of frank responses.  
Section C was optional, inviting the respondent to make suggestions in the free-text 
box provided to improve the CT&T service. Their suggestions were particularly 
sought in respect of what they think would enhance the CT&T uptake and any other 
aspect that they consider would potentially improve the success of the service.   
Great care was taken in iterating to the final version, with much reflection and 
discussion with supervisors as to wording, structure and layout, aiming to maximise 
response rate. The final version of the questionnaire was pre-piloted with colleagues, 
but no changes to the questionnaire's wording or general design were suggested at 
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this stage. No formal pilot was undertaken, mainly because of the very small size of 
the pool of potential respondents, but also partly because of pressure of time to start 
final planning of the evaluation. 
8.3.4 Recruitment and data collection 
The total of 26 strategic stakeholders identified included public health pharmacists 
(n=3), public health practitioners with special interest in sexual health (n=7), general 
practitioner with special interest in sexual health (n=1), sexual health consultants (n= 
5), community outreach groups involved in sexual health care provision (n=7) and 
partners of the CT&T service i.e. chlamydia reference laboratory representatives 
(n=3). An invitation was sent by email to all of these stakeholders, asking them to 
complete an online survey (Appendix 29). In addition to this recruitment through 
email, questionnaire packs were provided in a meeting of a subset of these strategic 
stakeholders which was held to discuss the implementation of the CT&T service. 
Stakeholders at the meeting were requested to pick up the questionnaire pack if they 
wished to respond via a paper questionnaire. The questionnaire pack consisted of the 
invitation letter (Appendix 30) and a reply paid envelope, in addition to the 
information sheet and the questionnaire as provided in the online survey. It is 
therefore possible that some stakeholders might have received questionnaires through 
both routes of recruitment.  
A purposive sample of 7 GPs in Lothian was selected whose practices are closer to 
the pilot pharmacies. These GPs were handed out the questionnaire pack by my GP 
supervisor in a meeting of the general practitioners in Lothian.  
The anonymous nature of the survey means that I could not differentiate which of the 
stakeholders contacted had replied. Therefore all the stakeholders who were sent an 
online survey invitation were sent an email reminder after two weeks, suitably 
worded to be ignored if they had already replied. No reminder could be sent to the 
GP stakeholders who were handed out the paper questionnaire. 
8.3.5 Data analysis and synthesis 
Data was imported from the online responses into SPSS (n=9). For paper 
questionnaire responses, data was directly entered into SPSS (n=8). The quantitative 
data (sections A and B) are presented graphically as stacked bar charts with each 
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stacked bar representing the distribution of responses across the likert scale offered 
for answering that section. These graphs allow easy visual comparison of 
strength/direction of responses across sub-items within a question, and because a 
single likert scale was used throughout an entire section, cross-referring between 
figures will enable comparison of strength/direction of responses across sub-items of 
questions within the same section. 
Due to the small number of respondents, n’s are reported rather than percentages, 
which would imply more reliability than is the case. All textual data (from free-text 
items) were transferred to MS word and repeatedly read to identify themes. Further 
analysis employed a constant comparison method in which the textual data is 
scrutinised for differences and similarities within themes, keeping in mind the 
stakeholder category of the respondent. This analytic approach ensured that findings 
are systematically compared with the stakeholder categories. Qualitative data is 
reported using the acronyms: GP for general practitioner; SH for sexual health 
specialist and PT for the CT&T service partner such as GUM/lab, followed by a 
unique ID.  
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8.4 Results 
8.4.1 Response rate 
In all, 33 strategic stakeholders were invited to take part in the survey; 21 were sent 
an email invitation whereas 12 were posted or handed out a paper copy of the 
questionnaire; 5 of these stakeholders were those who were also invited through 
email as well for the online survey. In total, 17/33 stakeholders responded to our 
survey invitation. The overall response rate was 51.5% (for paper version 67% 
(8/12), for online survey 34.6% (9/26)). Figure 8-1 shows the distribution of 
respondents by stakeholder category. None of the respondents categorised 
him/herself under public health promotion or community outreach group. Since only 
one public health pharmacist responded to my survey, s/he was grouped under the 
CT&T service partner to ensure anonymity of his/her responses.  
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8.4.2 Responses regarding challenges to the CT&T service 
This section reports the distribution of responses of the stakeholders on their strength 
of concerns about the specified challenges to the CT&T service. As explained in 
methods, the stacked bar graphs show the distribution of responses across the likert 
response scale offered, with strongest concerns shown in darker colouring (shown as 
a legend key in each figure). 
8.4.2.1 Delivery of the CT&T service  
Figure 8-2 (corresponding to question 1 in the survey questionnaire) shows the 
distribution of respondents’ level of concern about the delivery of the CT&T service 
in community pharmacies. More respondents identified training of support staff for 
CT&T service as of concern (n=16 responding a little or moderate concern), than did 
for training of pharmacists (n=13). 
Figure 8-2: Strategic stakeholders’ concerns about the delivery of CT&T service in 
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In added comments it was suggested that the only way to achieve quality and 
consistency of service would be by first specifying the core service expected, and 
then devise pharmacist training to reflect that, with accreditation.  
Only by instituting a core service spec[ification] with associated 
training and awarding accreditation status will you ensure 
consistency of approach and up-to-date knowledge and awareness 
through standard training or online training. (SH-4) 
A few respondents also highlighted the importance of ongoing training for pharmacy 
support staff, to address the high turnover in staff. 
Is there a high turnover of staff and therefore ongoing training need? 
(SH-5) 
Two respondents indicated that training of support staff is needed to develop an 
‘empathic’ and ‘friendly’ attitude among them for young people. 
Looking at the combined response regarding the provision of privacy in a pharmacy 
setting (2 items) all but 3 respondents had some level of concern. Sexual health 
specialists, GPs and CT&T service partners highlighted the difficulty of achieving 
privacy in a pharmacy setting, primarily due the space issue.  
Not all have suitable spaces. (SH-7) 
Other concerns were related to the shop environment, that it is not being conducive 
to achieving privacy. 
Assessing client need to talk to pharmacist can be overheard by 
shoppers. Discretion [is] difficult if pharmacy [is] full of other clients 
/ shoppers. (GP-4) 
One respondent also quoted occasions where he/she witnessed the consultation of the 
client out of the private area or consultation room even when it was available, or the 
consultation room was not free and hence pharmacist provided advice on the shop 
floor. 
In almost all circumstances this is not a concern, however, I have 
witnessed occasions when although a private area existed it was not 
used as it was either already engaged or the pharmacist was busy and 
gave a quick answer. (PT-3) 
It is interesting to note that advertising of CT&T service elsewhere was identified as 
more of a concern than advertising in pharmacies. One respondent indicated a strong 
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concern and another four respondents indicated a moderate concern to advertising 
elsewhere than in pharmacies. This is in contrast to only two respondents indicating 
moderate concerns on advertising in the pharmacies. A GP respondent who indicated 
strong concerns regarding the advertising of service expressed doubts about the 
message reaching the target audience. 
Not sure if the message has got there yet? My feeling is not. (GP-1) 
A sexual health specialist also indicated concerns regarding very low awareness in 
SH services (SH 7) among young people.  
With regard to staffing for CT&T service, two respondents were concerned about the 
amount of workload that would be increased due to this service, whereas a sexual 
health specialist indicated that pharmacists might not always be available to respond 
to the clients need.  
We know from EC72 it is difficult sometimes to get pharmacist (on 
lunch, A/L [annual leave], S/L [sick leave]) so service was not always 
available. Will YP be sent away if pharmacist is too busy? (SH-8) 
The above quote further supports the importance of training pharmacy support staff 
for CT&T service to provide advice to young people about the service, as also 
highlighted in the TNA survey (chapter 7), but still leaves the dilemma that if an 
actual consultation with a pharmacist is needed – for example having the testing 
explained or to be treated, then either the client has to wait, or be asked to come back 
later, because counter staff cannot do that part of the consultation. 
8.4.2.2 Provision of sexual health care via community pharmacies 
Figure 8-3 (corresponding to question 3) shows the distribution of respondents’ level 
of concern about the sexual health care provision through community pharmacies. In 
each of the three items all but two stakeholders indicated some level of concern, and 
the most frequent recording of strong concern was regarding concern about CT&T 
service missing the opportunity to provide sexual health counselling to young people 
(n=5).  
Strong concerns regarding SH care provision were predominantly reported by SH 
specialists (7/8 responses of strong concern across the three items were indicated by 
SH specialists).  
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Figure 8-3: Strategic stakeholders’ concerns about the sexual health care provisions 













The most often cited explanatory factor was the nature of the pharmacy business with 
high workload which makes them less likely to do in-depth counselling.  
Gaining trust and honesty, assessing risk and wider sexual health 
need is time consuming...very much doubt that pharmacists will have 
time or expertise to work with the youngest clients. (SH-5) 
An even stronger theme that emerged from the above quote and also often quoted 
particularly by the sexual health specialists was their concern that pharmacists lack 
expertise and are unfamiliar with sexual counselling of young people.  
They [pharmacists] will also be less well informed than most doctors 
and nurses working in specialist sexual health settings. (SH-3) 
Concerns were also raised that pharmacy support staff were also inadequately trained 
to respond to sexual health queries from young people. 
Strongly feel that is may be a missed opportunity, especially if 
pharmacy staff assisting the young person is not educated to answer 
questions relating to other areas of sexual health. (PT-2) 
The amount of concern I feel about the 














CT&T might miss the opportunity to provide
adequate sexual health counselling to young
people
CT&T might fail to motivate young people, as well
as testing in other settings, to provide details for
partner notification
There will be a missed opportunity to recruit
young people for CT&T who come for other sexual
health care (e.g. EC consultation) in a pharmacy
Cumulative frequency
Strong Moderate A little None at all
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One stakeholder cited the possible low uptake of the service might result in a lack of 
practice and a resultant lack of confidence. Clear service specifications were deemed 
necessary to avoid unnecessary tests and the resultant wastage of resources. 
Need to be really clear as to the age and gender that chlamydia 
testing is most efficacious rather than blanket spread and 
inappropriate use of lab time and CT&T resources. (SH-4) 
Another concern identified was the possible failure of the pharmacies to ‘refer or 
signpost YP to service locally’. (SH-8) 
 In terms of partner notification aspect of the service, all but two stakeholders 
indicated some level of concern. However the two stakeholders, who were both 
sexual health specialists, also noted that concern regarding partner notification is not 
specific to pharmacies. 
This is a problem everywhere, not just in pharmacies. (SH-2) 
However one stakeholder took a different perspective on partner notification through 
community pharmacies that less pressure on young people to notify their partners 
(compared to attendance at a sexual health clinic) would increase the likelihood that 
they could be engaged in testing for chlamydia in pharmacies.  
Although I expect this to hold true (i.e. CT&T in pharmacies may 
leave young people feeling less pressure to disclose to partners), by 
reducing this pressure we may be more likely to engage young people 
in the service - it is a balance of the good and bad and whether T&T 
[testing and treating] chlamydia on a one to one basis is enough to 
have a larger scale effect. (PT-2) 
The respondents have a range of views in terms of proactive vs. reactive
6
 (or 
opportunistic) offering of the CT&T service in community pharmacies (9/17 have 
strong or moderate concerns). One stakeholder indicated that the intervention is not 
designed for opportunistic testing. Some respondents felt that the pharmacy is an 
                                               
6
 The current model of the CT&T service required the client to request the test in the 
pharmacy. Thus it is a reactive model where the pharmacist offers consultation on clients 
request for chlamydia testing. It is different from the proactive model implemented in other 
parts of UK, Australia and Netherlands which used an opportunistic screening approach 
whereby the pharmacist offers chlamydia testing during EC consultation and/or offer it to all 
young people of the target age group.  
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inappropriate point for actively offering the service, despite missing an opportunity 
for increasing coverage of testing. One reason cited was that the young person may not 
have same relationship / trust in pharmacist as doctor / nurse (GP-4). 
Those who were in favour of proactive offer strategy suggested linking it with the provision 
of EC, C:Card and other sexual health consultations. The proactive approach was also 
indicated as a possible way of increasing the awareness of this service.  
Increased knowledge of one service (EC) can help increase knowledge 
/ literacy of the other (chlamydia) and vice versa. (GP-1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
The above stakeholder further explained that increased use of long acting 
contraception has led young people to consult less for EC and this has resulted in less 
opportunity for health professionals to provide sexual health counselling.  
 As LARC [Long Acting Reversible Contraceptive] use increases in 
YP, they are consulting less for contraception, so we are more reliant 
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8.4.2.3 Young people’s knowledge of and views about the CT&T service  
Figure 8-4 (corresponding to question 5) shows the distribution of respondents’ level 
of concern about young people’s knowledge/ perceptions of the CT&T service. 
Across the three items there were only two responses (out of 51) that did not express 
some degree of concern. The strongest concern was expressed regarding whether 
young people would know about the service, with nearly three-quarters (12/17) 
reporting moderate/ strong concern. About half of respondents also reported 
moderate/ strong concern regarding both whether young people would feel 
arrangements for privacy were adequate, and whether they would have confidence in 
the CT&T service. 
Figure 8-4: Strategic stakeholders’ concerns about young people’s knowledge of and 













Many stakeholders acknowledged the difficulties of promoting the service among 
young people, while two respondents indicated that only a universal service through 
all pharmacies could help in promoting and advertising the service among young 
people.  
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adequacy of arrangements within
pharmacies regarding privacy &
confidentiality
the degree of confidence young people will
have in the CT&T service offered by
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Need to get YP through door. This can be difficult and take time. 
Advertise in places where YP go and ensure professionals who work 
with YP are aware of service. (SH-8)                       
It is difficult to know how to advertise this effectively. (SH-1) 
Publicity around this type of service is always a bit tricky and only 
once the service is delivered universally can the message be spread in 
a more organised manner. (PH-1) 
When asked to suggest ways to promote the service among YPs, the most common 
suggestion was promotion through schools (n=5). However one stakeholder noted 
that educational institutions should not be the only locus for promotion since 
vulnerable young people often do not attend. 
If educational institutions are the main way of sharing info it is clear 
that not all young people are in education, and that those who are not 
are often the most vulnerable and hardest to reach group. (PT-2) 
Other service promotion suggestions were through local youth services (n=4), social 
networking sites and websites (n=2), posters (n=1), leaflets handed out in GP clinics 
(n=1) and through referral agencies (n=1). It was also indicated that the best 
advertising would be by ‘word of mouth’ (n=3) or ‘following a positive experience’ 
(n=1).  
There were a range of views among stakeholders with regard to the level of 
confidence that young people would have in community pharmacies delivering the 
CT&T service (8/17 have strong or moderate concerns). Stakeholders indicated that 
the degree of confidence of young people would depend on their previous experience 
with the pharmacy service. While it was acknowledged by a respondent that 
‘confidence is very difficult to win in young people’, a CT&T service partner stated 
that the belief that YP had a low level of confidence in the pharmacy service is a 
misconception. The importance of training all pharmacy staff to improve the image 
of the pharmacy was emphasised. 
 This is a perception rather than actuality and we need to work on the 
image of pharmacy in general and the level of service provided as 
well as the level of training required to be demonstrated by all 
members of staff not just the pharmacist. (PT-4) 
Achieving privacy and confidentiality in a community pharmacy setting is indicated 
by a partner stakeholder as ‘a big hurdle in relation to all its services [and] not just 
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CT&T’. Many other stakeholders also indicated concerns regarding difficulties in achieving 
confidentiality and/or privacy at the pharmacy counter. A suggestion given by a GP 
stakeholder to overcome this problem is for the pharmacist to offer telephonic 
consultation with young people who wish this.  
Would pharmacies do telephone consultations for this. Then young 
people could just come in and pick up a pack (named) and might find 
that easier? (GP-1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
Another potential problem that was identified by the stakeholders was related to child 
protection issues, raised by 4/8 sexual health specialists who responded to this survey. 
One stakeholder explained it as follows; 
Assessment of child protection issues and what pharmacists do when 
they have cause for concern in black, white and 'grey' situations. 
Issues for both young person and professional if wrong call is made or 
issue ignored. (SH-5) 
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8.4.3 Perceived benefits of the service  
The respondents were also asked to indicate in free text what they think are key 
benefits of the service from three perspectives: to young people, to community 
pharmacy and with respect to public health. For each perspective, themes found in 
the key benefits stated have been further categorised into the sub-themes, as shown 
in tables 8-1 to 8-3 (one table for each perspective). For young people, increased 
accessibility to chlamydia testing was the most often cited benefit of the CT&T 
service (n=14) (Table 8-1). For pharmacists, many respondents felt that CT&T would 
extend the role of community pharmacists towards patient care (n=8) and would 
improve their knowledge and skills (n=5) (Table 8-2). From a public health 
perspective, some respondents considered this service as a way of decreasing 
prevalence of chlamydia (n=6) and inequality in health outcome (n=3) (Table 8-3). 
Table 8-1: In respect of young people - key benefits of the CT&T service 




Geographical access ‘Potentially superb access which I 
think currently being partly loss as not 
sufficient awareness’ (GP-1) 
‘Another good alternative to going to 
GUM’ (PT-1) 
‘Wider access - especially for boys 
and in areas of high prevalence’ (SH-
5) 
‘Easy access in areas away from 
main services’ (SH-6) 
‘Anonymity especially if able to travel 
to pharmacy out with locality’ (SH-5) 
More options and 
choice  











‘Increased normalization / knowledge 
of chlamydia testing as an ordinary 
routine aspect of life of an urban 
youngster’ (GP-1)                                                                                                                                                                                                                                                                                       Destigmatize testing 
Providing SH 
service to ‘hard to 
reach’ population 
(n=3) 
Treatment of partners ‘Treatment of partners of index cases 
will be expedited’ (SH-1) 
‘Might catch young people who would 
otherwise not use GP or clinic 
services’ (SH-3) 
Reaching  young 
people in general & 
boys in particular 
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Table 8-2: In respect of community pharmacy - key benefits of the CT&T service 
Theme Sub themes Examples of views 
Extended role 
(n=8) 
Holistic role ‘Increase health provider (holistic role), 
Linking in with other health promotion 
work they do’ (GP-1) 
‘Allowing them to be more involved in 







 ‘Would add to their awareness of sexual 
health issues’ (PT-1) 
Business (n=3) More customers ‘Should attract more people into the 
shop’ (SH-2)   
‘May reach new customers’ (PT-3) 
 
Table 8-3: In respect of public health - key benefits of the CT&T service 
Theme Sub themes Examples of views 
Prevalence (n=6) Reduce prevalence ‘May reduce burden and chlamydia in 
young people’ (PT-3) 
‘Reduced ongoing transmission of 
chlamydia and any other STIs 
identified following CP [community 




Inequality (n=3) Deprived areas ‘If targeted in areas of deprivation, 
could reduce health inequalities of 
access’ (SH-4) Wider cultural groups 




 ‘I think increased knowledge / 
awareness is as important as the test 
and treat’ (GP-1) 
‘Break down stigma of chlamydia 
testing and sexual health’ (SH-8)                                           
Cost effective 
(n=1) 
 ‘Affordable increase in chlamydia 
testing in under 25 age group’ (SH-6) 
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8.4.4 Strategic stakeholders views on proposed questions to 
be answered through this evaluation 
Figure 8-5 shows the ratings by respondents regarding the importance of the 
questions that I propose for this evaluation. The evaluation questions proposed were 
classified as either very important or important by all the respondents for 3 
evaluation questions, and by all but one respondent for the remaining three 
evaluation questions.  
Figure 8-5: Strategic stakeholders’ ratings of importance of the evaluation questions 











Other evaluation questions that stakeholders suggested are grouped under the 
following themes: 
Client satisfaction 
 Would clients find it acceptable to provide information on sex partners (via 
proposed form that will go to GUM)? (SH-1) 
 Client satisfaction with the service?(PT-1)                                                         
 Has anyone asked YP if they want to get tested in pharmacies? (SH-8) 
Service promotion 

















Potential clients perceived factors affecting their access to
the CT&T service
Proportion of infected clients in this age range treated in
pharmacies? (compared to GP, clinic and GUM)
Challenges faced by community pharmacies in implementing
CT&T service
Socio demographic profile of the population using the CT&T
service 
Pharmacy staff perceived factors contributing to the success
or failure of the CT&T initiative
Proportion of partners of infected clients treated in
pharmacies? (compared to GP, clinic and GUM)
Cumulative frequency
Very Important Important Not Important
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 How to promote? (SH-7)                                                                                                                  
Service / logistical planning                                                                 
 Are there links to local YP services? (PT-1) 
 How likely is it that clients would have had a test elsewhere / attended for 
treatment elsewhere if this facility had not existed? (PT-2) 
 Do pharmacists discourage some people in low risk group from being tested? 
(GP-1) 
 What if demand increases? Where will pharmacy find time / resources to deal 
with increased numbers? (GP-4)    
Outcome evaluation questions 
 What is the prevalence of infection [among those tested in pharmacy CT&T] 
compared to other testers?(SH-2) 
 How many [clients with] positive results do not attend for treatment and 
contact tracing? (GP-5)   
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8.5 Discussion  
This study has ensured that I have involved the strategic stakeholders, from a very 
early stage, in the evaluation of a public health programme, in accordance with the 
‘good practice’ of programme evaluation. Areas of concerns for stakeholders on 
different components of the CT&T service were identified. In addition, key 
evaluation questions were explored in terms of their relative importance from the 
stakeholders’ point of view and suggestions were sought to add other possible 
questions that this evaluation should address.  
Survey limitations include the possibility that stakeholders’ views were not 
necessarily representative of pharmacy chlamydia service stakeholder nationally in 
Scotland or more broadly in the UK. For example, the stakeholders were surveyed 
before the implementation of the CT&T service; hence they might have offered 
responses that reflected what they had read in the literature or received wisdom. 
Their views might differ from those stakeholders who actually experienced the 
implementation of chlamydia service in their health boards. Following the service 
termination in Lothian, there was not time for a formal study to be undertaken with 
the same stakeholders, to compare any change in their views and to reflect on their 
overall view of the service. However, after the CT&T service ended, a subset of four 
stakeholders (3 of them having also been among those invited to participate in this 
survey) were contacted to give their reflections on the reasons for Lothian Health 
Board’s decision to terminate the service and to identify any obstacles to the service 
implementation in Lothian. This contact was to help me in my discussion of the 
service failure in Lothian. Some of the views expressed in the replies are quoted 
(anonymously) in the final discussion chapter of this thesis (section 11.2). 
Despite the invitation to health promotion and community outreach groups to take 
part in the strategic stakeholder survey undertaken prior to the implementation of the 
CT&T service, none of the respondents categorised themselves as such. Therefore I 
cannot be sure whether these groups are represented in this survey or not. However, 
it may be possible that the stakeholders whom I pre-classified as belonging to health 
promotion and community outreach groups, have labelled themselves as SH 
specialists or partners of the CT&T service.  
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A potential limitation of this study, a survey, is that it is unable to elicit rich 
background information that can shape further enquiry relevant to the topic. It is 
arguable that views of strategic stakeholders should have been sought through in-
depth interviews, in which case more nuanced understanding might have been 
possible. Well conducted in-depth interviews are also able to provide contextual 
information, and are considered more suitable for eliciting a detailed account of 
people’s knowledge, perceptions, experience and interactions to meaningfully 
understand social reality (Mason, 2002, Miles and Huberman, 1994). However, 
knowing from the outset that interviews would not be feasible for this study 
component, it was decided to have a semi-structured format for the survey 
questionnaire (by giving frequent opportunity to respondents for free text comments). 
This allowed for any views or concerns not actively sought in the questionnaire to be 
put forward by respondents. Another potential limitation of this study was the 
variation in response rate for the online and paper versions of the survey (35% 
response rate for the online survey versus 67% for the paper version of the survey). 
There could be several explanations for this variation. Firstly, a meta-analysis 
comparing response rates from online and paper surveys found that response rates 
have been consistently very low for online surveys (Shih and Xitao, 2008). Secondly, 
the provision of the questionnaires to a GP personally, by my GP supervisor at a GP 
meeting, might have enhanced response rate either because the GPs might feel more 
obliged to respond to their colleague’s request, or because of the nature of the 
meeting, which might have had attending more public health spirited GPs. Thirdly, 
the GPs who knew that their neighbouring pharmacies would be providing the CT&T 
service, might have had more interest in the service, and been more likely to respond 
than other stakeholders who were recruited for online survey.  
It should be noted that an assessment of the training needs of pharmacists and 
support staff was not included as a potential evaluation question in the stakeholders’ 
survey. This is because the training needs assessment (TNA) survey of pharmacy 
staff had already been undertaken before the stakeholder survey. However when 
asked to reflect on their concerns regarding training of the pharmacists and their 
support staff, 13/17 stakeholders noted strong or moderate concerns for the training 
of pharmacists and 16/17 noted strong or moderate concerns for the training of the 
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pharmacy support staff. Most of their concerns highlighted here echoed the findings 
of the TNA survey (chapter 7) such as a need of ongoing training due to the low 
uptake of the service, training focusing on the eligibility criteria and importance of 
signposting and referrals and child protection issues. However in the survey of 
stakeholders it was also suggested that in the training to be provided, a non-
judgemental attitude should be encouraged among pharmacy staff. Moreover, clear 
service specifications were recommended as the way to achieve quality and 
consistency of the service. The importance of clear service specification and well 
structured training to ensure that all staff and pharmacists follow strict protocol has 
been raised in the previous pharmacy chlamydia service evaluation as well (Taylor et 
al., 2007). Clear service specifications are important to avoid wastage of resources, 
as would occur if the service is provided to ineligible clients.  
In addition to reflecting on their concerns regarding training, stakeholders indicated 
that sexual health counselling is difficult to achieve in the pharmacy setting due to 
the difficulty in achieving privacy and business nature of the pharmacy environment. 
The sexual health specialists particularly indicated their perceptions towards the 
entrepreneurial attitude of the pharmacists. Many stakeholders highlighted their 
concerns regarding insufficient skills of pharmacists to provide sexual health 
counselling to young people. In the TNA survey, pharmacists indicated insufficient 
competency to take a sexual history (72%), raise the issue of sexual health with the 
client (51%) and respond to sexual health requests (37%). Provision of a sufficient 
number of pharmacy support staff may allow pharmacists to provide adequate 
counselling as suggested in the current survey. Another pharmacist survey exploring 
their ability to provide partner notification for STIs in the pharmacies showed that, 
pharmacists’ perceived lack of ability to provide sexual health counselling was not 
the result of insufficient skills and knowledge, but was perceived to be due to the 
lack of time to undertake such a task (McNutt et al., 2009).  
Advertising of the CT&T service in pharmacies and elsewhere was identified as a 
‘strong’ or ‘moderate’ concern by only 2/17 and 5/17 of the stakeholders. This is in 
contrast to their concerns about the young peoples’ knowledge of this service (12/17 
stakeholders indicated strong and moderate concerns). The pharmacists’ in-depth 
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interview findings also highlighted inadequate advertising as a major concern of a 
low uptake of the service. These contradictory findings might be because of their 
mentioned underlying belief of the difficulties of advertising such a service among 
young people. A previous study of chlamydia screening activity in general practice 
identified hesitance of prominently displaying chlamydia screening promotional 
material in most practices (Freeman et al., 2009). Reported barriers in that study 
were staff’s perception that displaying posters would cause offence or 
embarrassment to young people and distribution of chlamydia leaflets by 
receptionists was also considered inappropriate due to the same reasons. 
Provision of a private discussion area and achieving privacy were identified as 
concerns primarily due to the shop environment not being conducive to achieving 
privacy. This has been reported as a barrier in many previous pharmacy chlamydia 
service pilot studies as well (Baraitser et al., 2007, Bloomfield et al., 2002, McNutt 
et al., 2009, Taylor et al., 2007). However it was also acknowledged in the present 
study that achieving privacy in a pharmacy setting is a hurdle in relation to all its 
services and not just the pharmacy chlamydia service. Current changes in the 
pharmacy contract require the pharmacy to provide a private consultation area / 
room. However, requesting such a consultation at the reception, and the fact that the 
pharmacist may resort to giving quick advice at the counter due to a busy shop 
environment are the underlying reasons for not achieving privacy, as explained by 
respondents in this survey and also in the pharmacists’ in-depth interviews. Similarly 
there were mixed views on proactive versus active service offer to young people in 
the pharmacy setting. Those stakeholders not in favour of actively offering the 
service explained it as an inappropriate point of proactive offer due to the lack of 
privacy. However some stakeholders identified it as a feasible add-on to EC service 
and such like. Most of the previous pilots of chlamydia service in pharmacies 
adopted a proactive offer approach by offering chlamydia test to YP during EC 
consultation (Brabin et al., 2009b, Gudka et al., 2010, Taylor Nelson Sofres 
Healthcare, 2007, Thomas et al., 2010, van Bergen et al., 2004). However this 
strategy means that men would be excluded from being tested.  
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Undertaking partner notification, by filling out partner notification forms, was 
identified as difficult not only in a pharmacy setting but also in other clinical settings. 
However it was also considered to provide a less pressurised setting for young people 
to provide partner’s contact information and a resultant increased likelihood of 
getting tested in a pharmacy. Previous studies have identified other strategies for 
encouraging partner notification through pharmacies. Pharmacies have been 
identified as feasible for accelerated partner therapy (vouchers for treatment of 
partners from a pharmacy) and patient delivered partner therapy (treatment for 
partners is handed out to index patient in a pharmacy) (McNutt et al., 2009, Cameron 
et al., 2010).  
Potential benefits identified for this service by stakeholders were increased 
accessibility in terms of geographical access, no need of appointment, extended 
opening hours and wider availability. Increased accessibility has been a major 
facilitator identified in a number of other studies (Anthony and Watson, 2008, 
Baraitser et al., 2007, Taylor et al., 2007, Taylor Nelson Sofres Healthcare, 2007). 
However, a trade off between increased accessibility and lower level of privacy 
achieved needed further exploration from young peoples’ perspective. The 
stakeholders also noted that the service would be able to reduce the overall 
prevalence of chlamydia and inequity by providing access in deprived areas and to 
wider cultural groups. Previous evaluation of chlamydia service in large chain 
pharmacies in London identified that the chlamydia testing was less likely to reach 
deprived population (Taylor Nelson Sofres Healthcare, 2007). The uptake of 
chlamydia testing was not proportionate across the ethnic populations in London and 
more likely to reach woman and those working full time, who have achieved or are 
receiving higher university education. 
All the potential evaluation questions listed in this survey were considered important 
by the stakeholders (at least 16/17 stakeholders rated it as very important or 
important for every question listed). In addition new questions were identified by the 
stakeholders. Some of these questions were incorporated into my later evaluation 
components, such as questions about young peoples’ knowledge about the service; or 
whether they wanted to be tested in pharmacies; or the appropriateness of filling out 
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the partner notification form in the pharmacy. However some of the identified 
questions could not be incorporated as the numbers of pharmacy CT&T tests were 
negligible to answer those questions. These questions were primarily related to the 
clients’ satisfaction with the service or related to service logistic planning and 
outcome evaluation. However these potential questions identified could be used for 
future evaluations of a pharmacy-based chlamydia service or in other health care 
settings.  
8.6 Chapter overview 
This chapter provided new insights into stakeholder concerns regarding different 
aspects of the CT&T service. Sexual health counselling for young people was 
identified as difficult to achieve due to their perceived lack of privacy in a pharmacy 
setting and insufficient sexual health consultation skills among pharmacists. 
However, in order to achieve quality and consistency in provision of the CT&T 
service, clear service specifications were considered important in addition to ongoing 
training of the pharmacists and their support staff. Although stakeholders indicated 
their concern regarding young people knowing about the service, they also 
acknowledged difficulties in promoting the service among young people. All the 
proposed evaluation questions were identified as important and some additional 
questions suggested by stakeholders were incorporated in the later components of 
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CHAPTER 9: POTENTIAL SERVICE USER’S 
VIEWS ABOUT THE CT&T SERVICE IN 
LOTHIAN 
9.1 Introduction 
Community pharmacists have expressed their willingness to provide chlamydia 
service to young people (Cameron et al., 2007).  More broadly, the feasibility of 
community pharmacy based approaches to chlamydia service has been demonstrated 
(Baraitser et al., 2007, Brabin et al., 2009b, Gudka et al., 2010). However, a 
pharmacy-based chlamydia service needs also to be acceptable to the target 
population for whom a service is designed, since there is little utility in offering 
chlamydia testing in community pharmacies if there is unwillingness among this 
group to accept the offer.  
In this chapter, I report a survey of potential users to quantify the extent to which 
different facilitators of and barriers to access a pharmacy-based chlamydia service, as 
identified in the literature and in the stakeholder survey, might impact their decision 
to access the CT&T service.  
9.2 Objectives 
The objectives of this study were: 
 To assess acceptability to young people of the various aspects of community 
pharmacy-based  chlamydia service  
 To describe the level of importance that the young people place on various 
facilitators and barriers identified from the literature  
 To investigate whether the degree of acceptability by young people for 
different aspects of CT&T service differ by their age category, previous 
experience of EC access from a pharmacy and previous experience of 
chlamydia testing in other venues 
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9.3 Methods 
9.3.1 Study design 
A self administered survey was undertaken with potential service users accessing 
sexual health services in Lothian. The rationale for choosing self administered postal 
survey for this study has been described in section 6.6.1.3 
9.3.2 Study population   
The ideal study population for this study would have been all the sexually active 
young people in Lothian. However, information regarding their current sexual 
activity status is not readily available, and it would be fairly impossible to maintain 
such information in primary care setting databases. It would, therefore, require 
explicit elicitation of sexual activity status from all potential respondents, and that 
would have been inappropriate and unethical to elicit such information in a pharmacy 
setting. Seeking care in the sexual health clinics for services - such as EC, long 
acting reversible contraception, C-card scheme, pregnancy testing, abortion, STI 
testing and sexual health counseling - is indicative that they are sexually active. 
Hence the study population for this survey comprised young people aged 15-24 years 
seeking care for sexual health at three clinical settings in Lothian: the GUM clinic, 
Mid-Lothian Young People Advise Service (MYPAS) and Caledonian Youth (CY).  
9.3.3 Brief overview of the study settings 
Genitourinary Medicine (GUM) Clinic 
This is an NHS run sexual health clinic that offers services on all aspect of sexual 
health, including but not limited to STI testing and treatment, provision of 
contraception and advice on sexual health. Its services are not limited to any 
particular age group. In Lothian, the GUM clinic is located in Edinburgh. There are 
also a number of outlying smaller satellite GUM clinics in Lothian, which provide 
specialized sexual health services, usually once a week for approximately 2 hours. 
For the current research, the questionnaires were distributed at the reception of the 
main GUM clinic, Edinburgh.  
Midlothian Young People's Advice Service (MYPAS) 
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This is a community based charitable organization that works with young people in 
the areas of sexual health, mental health and substance abuse. It provides free service 
to young people and has three drop-in clinics across Midlothian. For the current 
research, the questionnaires were distributed from all the three branches. 
Caledonian Youth (CY) 
This is a charitable organization that provides free sexual health education and 
services to young people in Scotland. It is partly funded by the Scottish Government. 
It is located in Edinburgh, Forth Valley and Grampian and annually provides nearly 
20,000 consultations to young people. For the current research, the questionnaires 
were distributed only from the Lothian branch (Edinburgh). 
9.3.4 Sample size and sampling 
Probability sampling techniques have been recommended to elicit views in a survey 
because these increase the likelihood of obtaining samples that are representative of 
the population. They provide the most valid or credible results because they are most 
likely to reflect the characteristics of the population from which they are selected (De 
Vaus, 2002). However, one of the pre-requisites of a probability sample is to have a 
sampling frame. For the current research, it was not possible to obtain such a list 
from the SH clinics as young people accessing the GUM clinic as well as MYPAS 
and CY mostly use the drop-in service and need not to be registered at the clinic. 
Hence, recruiting young people accessing a sexual health service makes a reasonable 
choice for two reasons. Firstly, young people can be deemed to be sexually active if, 
they are seeking a contraceptive service, or care for STI or pregnancy. This would 
avoid having to elicit their eligibility by explicitly asking whether they are sexually 
active. Secondly, it provides a sample of the population from which to elicit 
preference for a CT&T service as an alternative to other options such as a GUM 
clinic, GP or SH drop-ins, since they are already accessing a sexual health service 
and hence could make an informed judgment.  
It was indicated by the contact persons at all the three sites that the survey 
questionnaires could be distributed only for a limited time frame (on an average of 3 
weeks each), since a number of other research and evaluations were also taking place 
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at these sites. Hence a time frame of three weeks was agreed to prevent research 
overload on patients. The numbers of questionnaires handed over to be distributed at 
each site were roughly to cover the expected turnover of young people during the 
study period in each site: 240 in the GUM clinic (including 40 in the pilot phase), 
100 in MYPAS and 100 in CY. Only 45 questionnaires were distributed within the 
study time frame from CY. 
9.3.5 Recruitment of the study participants 
In each setting, young people who were aged 15-24 years were identified by the 
reception staff at the time of their registration for a consultation. The reception staff 
were directed to supply a sealed questionnaire pack to any eligible young person. 
Each questionnaire pack comprised an invitation letter to the young person along 
with an information sheet (Appendix 31), a self administered questionnaire 
(Appendix 32), and a reply paid envelope. The person thus invited to participate was 
asked to complete the questionnaire and return by means of the reply paid envelope 
supplied. The questionnaire was distributed from each setting for three weeks 
between December 2010 and April 2011.  
9.3.6 Development of the questionnaire 
The survey questionnaire contains 44 questions / items (Appendix 32). Of these, 5 
pertain to socio-demographic characteristics such as age, gender, years of schooling 
and ethnicity and 5 questions pertain to the previous use of pharmacy for EC or the 
testing for chlamydia in the last 12 months. The socio-demographic information was 
assessed towards the end of the questionnaire. A further 34 questions/items covered 
ten topic areas of using a CT&T service. These topic areas were informed by my 
earlier literature review of the facilitators and barriers for young people in terms of 
accessing the pharmacy chlamydia service The ten topic areas were: (a) service 
access options (5 items); (b) sample return procedures (single choice question); (c) 
arrangements for reporting results (best choice question); (d) testing venue options 
(best choice question); (e) treatment venue options (4 items); (f) partner notification 
procedures (3 items); (g) selection of a pharmacy based on store facilities and 
pharmacy profile (7 items); (h) selection of a pharmacy based on opening times (best 
choice question); (i) selection of a pharmacy based on different location options (4 
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items); and (j) confidence in a CT&T service (4 items). Items within topic areas ‘a, e, 
f, g, i and j’ were assessed on a 4 point likert scale (1=definitely not; 2= probably 
not; 3=probably yes; 4=definitely yes). Items within topic area ‘g’ were assessed on a 
4 point likert scale (1=very important; 2=moderately important; 3= of little 
importance; 4= of no importance).  
An information box was incorporated within the questionnaire at three instances 
before introducing topic areas that are related to chlamydia testing, treatment and 
partner notification. Respondent were also offered opportunities (at three different 
points in the questionnaire) of making a free text comment to identify any other 
aspect that they considered important in relation to accessing CT&T service. 
9.3.6.1 Pilot testing of the questionnaire 
The questionnaire was pilot tested by giving it out to young people at the GUM clinic 
to assess the feasibility of distributing it in a clinic setting and to assure that it could 
be easily understood and completed by young people in less than 10 minutes. In 
total, 40 questionnaires were distributed in one week before the Christmas holidays 
in 2010. Thirteen respondents returned the questionnaire by using a reply paid 
envelope. The respondents had been asked to record the time taken to complete the 
questionnaire and the average time recalled for filling in the questionnaire was 7.6 
minutes (range 2-15 minutes). The level of comprehension of the questionnaires was 
measured by the number of questions left unanswered in the questionnaire and by 
asking respondents to identify any questions which they found was difficult to 
comprehend. The respondents did not identify any particular question as difficult to 
understand and / or answer. Therefore no modifications to the questionnaire were 
needed and since the target population was identical to that of the survey proper, the 
completed questionnaires were included for the final analysis. 
9.3.6.2 Further amendments in the questionnaire 
After all the GUM clinic questionnaires had been distributed, and approximately 8 
questionnaires had also been distributed through MYPAS, it was realised that no 
question ascertaining the gender of the respondent had been included. Hence the 
remaining questionnaires from MYPAS were recalled; the question on gender was 
added and new questionnaire packs were submitted for distribution through MYPAS 
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and CY.  Therefore gender of the respondents was ascertained only in MYPAS and 
CY settings.  
9.3.7 Statistical analysis 
Data was entered in MS access and transferred to SPSS version 17 for analysis. 
Descriptive statistics were produced. In questions where respondents were asked to 
tick more than one response (multiple choice question), the multiple response 
frequency percentages were produced from a denominator of total respondents 
(n=78). Hence adding up the multiple response frequencies would sum to more than 
100%. However where respondents were asked to indicate a single best choice, a few 
respondents nevertheless indicated more than one choice. In such a case, frequencies 
were adjusted for multiple responses by diving it with the total number of multiple 
responses to provide an adjusted percentage of responses rather than the percentage 
of cases (to imply that each person has given one preference). In such a case, the 
percentage response would add up to 100%.  
The questionnaire items which were assessed on a likert scale are presented 
graphically in the stacked bar chart. I have not plotted ‘of no importance’ in figure 9-
5 in the stack bars but would make the bars total 100%. This means that the total 
height of the bar shows some degree in favour of importance. Similarly those 
indicating ‘definitely not’ in figures 9-1 to 9-4 are not shown in the graph.   
Spearman’s Rank order correlation coefficient test was applied to likert response 
items and age categories (1=15-19, 2=20-24); previous EC access from pharmacy 
(1=No, 2=Yes) and reported chlamydia testing in the last 12 months (1=No, 2=Yes). 
In terms of p-value, the Spearman’s correlation coefficient test is equivalent to 
Mann-Whitney U test but have a benefit of giving a correlation coefficient that 
shows the strength and direction of association that exists between two variables. 
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9.4 Results 
9.4.1 Response rate 
A total of 78 out of 385 questionnaires distributed were returned by young people, 
hence an overall response rate of 20%. Responses by health care settings were: GUM 
clinic 13% (32/240); CY 13% (13/100); and MYPAS 73% (33/45).  
9.4.2 Characteristics of survey respondents 
Table 9-1 shows the socio-demographic characteristics of the respondents and their 
access to pharmacy EC service, and chlamydia testing in last 12 months. Of all the 
respondents, 53% were 15-19 years old. In the later questionnaire responses, when 
gender of the respondents were asked (n=40), female respondents predominate 
(85%). Respondents were predominantly of white UK origin. None of the 
respondents indicated their origin as Asian or African. Nearly 29% of the 
respondents are still studying in school. Half of the respondents were tested for 
chlamydia in the past 12 months; the GUM clinic was the most common venue of 
testing (63%). Among those tested for chlamydia, 24% were diagnosed positive. 
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Table 9-1: Characteristics of the respondents including previous testing for chlamydia 
and use of EC  
Variable n % 
Age of the respondent   
15-19 41 53 
20-24 36 47 
Gender (n=40)   
Male 6 15 
Female 34 85 
Ethnic origin   
White UK 67 88 
White others 8 11 
Mixed 1 1 
Age leaving school   
Not Yet finished 22 29 
15-17 years 38 49 
18+ years 17 22 
Current status*   
Working full time 22 29 
Working part time 13 17 
Unemployed 5 7 
Studying full time 46 60 
Studying part time 3 4 
Tested for chlamydia in the past 12 months 38 50 
Diagnosed with chlamydia in the past 12 months 
(n=38) 
9 24 
Venue of testing for chlamydia in the past 12 
months (n=32) 
  
GUM 19 63 
SH drop-in 8 27 
GP 3 10 
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Table 9-2 shows the previous knowledge of the respondents about the CT&T and EC 
services and their suggestions for promoting CT&T service. 42% of the respondents 
already knew about the pharmacy CT&T service. Of those who knew about the 
service, they mainly learned through their family or friends (53%) or through their 
GP (40%). Of all the respondents, 72% suggested it being advertised in SH clinics, 
and another 66% and 65% through SH drop-ins and pharmacies. The knowledge of 
the pharmacy EC service was indicated by 85% of the respondents and 42% of those 
who knew had previously accessed pharmacy EC service.  
Table 9-2: Knowledge about the pharmacy EC and CT&T services and suggestions for 
promoting CT&T service 
Variables n % 
Already know about the CT&T service 32 42 
                        How did you know about the service (n=32)*   
Through media 5 17 
By pharmacy staff  4 13 
In-store promotion 4 13 
Told by GP 12 40 
Learned from family or friends 16 53 
Suggestions to promote/advertise CT&T service through 
various venues* 
  
Sexual health clinics 55 72 
SH drop-in 50 66 
Pharmacies 49 65 
GP practice and health centres 44 58 
Social networking sites on internet 41 54 
Web based information 27 36 
Pubs and clubs 27 36 
Others 2 3 
Knowledge about the pharmacy EC service 65 85 
       Previously received EC from a pharmacy (n=65) 27 42 
* Multiple responses possible 
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9.4.3 Acceptability to respondents of different aspects of the 
CT&T service 
Table 9-3 describes the preference of the respondents for different aspects of the 
CT&T service. When asked to identify their preferred location for the chlamydia 
testing, 32% indicated the GUM clinic and 34% indicated SH drop-ins. Among those 
who preferred the GUM clinic, 70% of them were the respondents from the GUM 
clinic (n=20). Similarly those who preferred SH drop-in, all were either respondents 
from MYPAS (n=25) or CY (n=6) (data not shown). Pharmacy was indicated as 
preferred by only 11% of the respondents (equally distributed among the three 
survey venues). 59% of the respondents indicated their preference to hand over their 
urine sample to the pharmacy rather than directly posting it to the laboratory. For a 
test notification, a phone call was the preferred choice (34%), following by face-to-
face consultation (24%). For timings of accessing the CT&T service, 44% of the 
respondents favoured early evening (between 5 pm to 8 pm) to visit the pharmacy. 
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Table 9-3: Respondent preferences regarding venue for chlamydia testing and for 
different aspects of the CT&T service 
Variable n % 
Preference for the venue of testing for chlamydia*   
SH drop-in 31 34 
GUM clinic 29 32 
GP clinic 14 16 
Pharmacy 10 11 
Family planning clinic 6 7 
Preference re sending urine sample bottle to the 
laboratory 
  
I would prefer to give it to the pharmacy for them to post it 
to the laboratory 
46 59 
I would prefer to post it my self to the laboratory 32 41 
Preference about the test result notification*   
Phone call 28 34 
Face-to-face consultation 20 24 
Text on mobile phone 14 17 
Email 11 13 
Letter 9 11 
Comfortable about filling out partner notification form 
in the pharmacy 
  
Very Comfortable 10 13 
Fairly Comfortable 34 44 
Fairly uncomfortable 21 27 
Very uncomfortable 12 16 
Preferred time to visit a pharmacy*   
Early morning 22 29 
Office Hours (9 am to 5 pm) 15 20 
Early evening (between 5 pm to 8 pm) 34 44 
Saturday 7 9 
Sunday 4 5 
* Adjusted for multiple responses. ‘n’ shows exact number of responses. % has denominator 
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Figure 9-1 shows the respondents indication of the level of acceptability for different 
venues for treatment of chlamydia. Although these responses are not directly 
comparable with their preference for chlamydia testing (as different response options 
were used in the two questions), however as was the case with testing, 76% indicated 
SH drop-ins as a possible treatment venue (i.e. indicated ‘definitely yes’ to sexual 
health drop-in as a treatment venue), followed by the GUM clinic (53%) as a 
possible treatment venue. A likelihood for a pharmacy as a possible treatment venue 
was indicated by only 38% of the respondents. A Spearman’s rank order correlation 
(Appendix 33) shows a strong positive correlation between age category and a 
likelihood of accessing treatment from a GUM clinic (rs =0.52, p=0.000); and a weak 
positive correlation between age category and a likelihood of accessing treatment 
from a pharmacy (rs=0.26, p=0.028).  
Figure 9-1: If needing a treatment for chlamydia, likelihood of accessing this at 













If you found you had chlamydia, where might you go to get your treatment?  







Def initely Yes Probably Yes Probably Not
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A positive correlation was also seen between respondents’ previous access for EC 
from a pharmacy and a likelihood of accessing treatment from a sexual health drop-
in (rs=0.37, p=0.032). 
For filling out partner notification form in the pharmacy, 57% of the respondents 
indicated that they would be ‘very comfortable’ or ‘fairly comfortable’ (Table 9-3). 
Figure 9-2 shows the respondents indication of their acceptability for different 
options of partner notification. A likelihood for different partner notification options 
(indicating ‘definitely yes’ or ‘probably yes’) was for them telling their partners 
(87%), whereas a likelihood for other PN options were indicated by only half of the 
respondents.  












Who should contact your partner about chlamydia testing/treatment?  
0 20 40 60 80 100
Me, telling him/her
myself
A nurse at GUM
clinic
An advisor at a
sexual health ‘drop-
in’ clinic
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Figure 9-3 shows the respondents indication for their level of acceptability for 
different approaches of getting chlamydia testing kit from a pharmacy. The most 
acceptable approach was by asking the pharmacist for the test (85%), and if the test 
is offered by the pharmacist during EC consultation (845%). Picking up a free kit 
from the shelf was indicated as acceptable for 77% of the respondent. All the above 
three options were positively correlated with age category (Appendix 34). Pharmacy 
staff offering of chlamydia test at the counter when buying other products or 
medicine was least likely to be accepted by the respondents (21 % indicated 
‘definitely yes’).  
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Figure 9-3: Acceptability of various approaches to obtaining chlamydia testing kit 











Respondents were overall confident (indicating ‘definitely yes’ or ‘probably yes’) 
about the confidentiality of testing (93%), reliability of result (93%) and 
knowledgeable staff (90%) in a community pharmacy setting (Figure 9-4).  










Which of the following ways would be acceptable for you to get a testing kit form the pharmacy?  
Are you confident that pharmacy testing and treatment service would have?  
0 20 40 60 80 100
I ask the pharmacist for the test 
The test is offered to me by a pharmacist during a
consultation for emergency contraception 
I can pick up a free testing kit from the shelf without
asking anyone
Pharmacy staff offers it to me at the counter when I
buy/collect condoms
Pharmacy staff offers it to me at the counter when I buy
/ collect other products or medicine
Proportion
Definitely yes Probably yes Probably not
% distribution 
0 20 40 60 80 100
Complete conf identiality of  
my testing
Reliable test results
Knowledgeable staf f  to 
provide testing/treatment
Less waiting time for test as 
compared to GUM or GP or 
sexual health ‘drop-in’
% distribution
Definetly Yes Probably Yes Probably Not
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Figure 9-5 indicated the level of importance of various aspects in selecting one 
pharmacy store over another for chlamydia testing. The most important aspects 
(indicating very important or moderately important) were convenient location of a 
pharmacy (89%) and pharmacy with a private area or a consultation room (84%). 
Importance of a pharmacy with an in-store toilet was weakly negatively correlated 
with previous chlamydia testing (rs=-0.23, p=0.049) suggesting that those not 
previously tested for chlamydia are more likely to place importance on an in-store 
toilet (Appendix 35). Importance of a less busy pharmacy was negatively correlated 
with age category (rs=0.36, p=0.002) indicating that younger respondents (aged ≤ 19 
years) are more likely to place importance on a less busy pharmacy.  
Figure 9-5: Importance of various aspects in selecting one pharmacy store over 






How important is it that you choose a pharmacy that ….? 
0 20 40 60 80 100 
.. is an easy place to get to 
.. has a private area / consultation room 
.. is open at the weekend, or after 6 pm on weekdays 
 
.. has in-store toilet to fill the urine sample pot 
.. is less busy 
.. does not have staff who know me  
.. has a pharmacist who I know 
% distribution 
Very important Moderately important Of little importance 
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9.5 Discussion 
The results of this study suggest that respondents felt confident that a pharmacy 
would offer complete confidentiality for testing, provide reliable test results and have 
knowledgeable staff to provide the service (90% to 93%), demonstrating that for 
young people the pharmacy could be an acceptable additional venue for testing. That 
said, respondents indicated a preference to be tested in a GUM clinic (32%) or drop-
in clinics (34%), with only 11% indicating a preference for pharmacy testing. 
However, when the respondents were asked to indicate their level of acceptability for 
each choice of treatment venue, 38% of the respondents indicated ‘definitely yes’ for 
getting treatment from the pharmacy. The most important aspects in selecting a 
pharmacy for the CT&T service were identified, by indicating the feature as ‘very 
important’ or ‘moderately important’, as: pharmacy with a convenient location 
(89%); a consultation room (84%); in-store toilet (80%); and long opening hours 
(81%). Those not previously tested for chlamydia placed more importance on toilet 
facilities at the pharmacy chosen for chlamydia testing, whereas younger respondents 
(≤ 19 years) placed more importance on a less busy pharmacy.  
An important feature of this study is that it was preceded by the stakeholder survey 
(chapter 8) and a number of questions are derived from that survey in addition to 
those identified in the literature review. One example of such a question was to elicit 
young peoples’ preference for different options of partner notification and whether 
they would feel comfortable to fill in the partner notification form in a pharmacy, as 
given in the Lothian CT&T service specifications. The results of this survey showed 
that 43% of the respondents felt uncomfortable in filling out a partner notification 
form in a pharmacy and preferred that they would themselves tell their partner about 
the possible risk of chlamydia (87%). These results might indicate that other options, 
for example, treatment vouchers handed over by index patient to their partners may 
be more feasible option and would result in an effective partner notification 
(Cameron et al., 2010).  
This is the first study to quantitatively explore young people’s preferences and level 
of acceptability for different aspects of a pharmacy-based chlamydia service. 
Previous studies have identified facilitators and barriers mostly through qualitative 
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interviews (Anthony and Watson, 2008, Dabrera et al., 2011, Taylor Nelson Sofres 
Healthcare, 2007). Quantifying the preferences of young people with respect to 
different aspects of a pharmacy service could help in developing a pharmacy model 
in terms of aspects which are most important to them. Potential clients’ preferred 
model would improve their uptake of the service.  
More than 42% of the respondents in our survey indicated that they already knew 
about the service. However it may indicate a ‘social desirability bias’ as the service 
was not promoted in any of the health care setting and the uptake of the service does 
not reflect that it would have been advocated by family or friends who previously 
used it. It is regrettable that the service was withdrawn within 10 months of its 
launch and hence the survey also had to be discontinued. It also severely limits the 
sample size that could be achieved for this survey; otherwise more survey venues 
could have been explored.  
 An important consideration of this study is a choice of the study design. Qualitative 
research on sexual health matters with young people have been acknowledged to be 
very difficult in terms of receiving participation and suffered from various setbacks 
(Heritage and Jones, 2008, Balfe et al., 2010). In the Heritage and Jones (2008) focus 
group study, in order to improve participation of young people, the researchers had to 
diverge from their original plan on conducting focus groups and needed to use 
individual interviews in addition to the planned focus groups. In an in-depth 
interview study on the perspective of young people on undertaking chlamydia 
screening, Balfe et al. (2008) reported that despite their efforts to recruit young men, 
they receive no participation from them. Even for women who agreed to be 
interviewed in the first place, there was a fairly high dropout rate. The authors 
acknowledged that their inability to recruit men in the research would be an 
important absence especially when men are an important vector of chlamydia 
infection. As discussed in section 6.6.1.3, there was also a danger of not eliciting 
frank response from young people in a qualitative research method.  
The reluctance of young people to participate in qualitative research also became 
evident by my experience in the pilot of this survey through the GUM clinic, where 
the respondents were invited to take part in the in-depth interview to further elaborate 
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on their views about the proposed service. However, despite the fact that those 
completing the pilot questionnaires were offered some incentive to agree to 
interview, in appreciation of their time for participation, none of the pilot 
respondents showed any willingness to be interviewed. It was further considered that 
social and academic time constraints for young people would also make their face-to-
face participation in qualitative research more difficult. Anticipating a difficult 
participation of men in qualitative research and also to enhance a frank account of 
their perspective, a self-administered interview was therefore considered the most 
appropriate method for the current study. It was also decided that an invitation to be 
interviewed would not be made in the survey proper. 
A limitation of this study is an overall low response rate of 20% which might have 
introduced non-response bias. The response rate for this survey was anticipated to be 
low since it has been demonstrated that questionnaires eliciting views and/or 
behaviour of a sensitive nature are less likely to be returned (Edwards et al., 2002, 
Edwards et al., 2009). The response rate from hard-to-reach groups such as young 
people and ethnic minorities have also been identified as low compared to the 
general population (Sheldon and Rasul, 2006). Many techniques have been 
recommended to increase response rate as much as possible. I adopted suggestions 
by Edwards et al (2002, 2009) to use a personalised invitation letter, using university 
logo, coloured questionnaire and postage stamped reply paid envelope. The 
questionnaire also underwent several revisions to ensure the shortest possible 
questionnaire and readability. In this regard it is encouraging to know that the item 
non-response to the questionnaire was minimal and ranged from 1 to 7 of the 34 
items. Sending reminders was not possible in the current study since, for 
confidentiality reasons, contact information was not recorded when handing out the 
questionnaire. One measure that is commonly employed to evaluate the potential bias 
introduced by study non-participation is the collection of minimal data on non-
respondents for comparison with respondents. However, most studies have found 
little evidence for substantial bias due to non-participation by comparing the 
characteristics of respondents and non respondents (Galea and Tracy, 2007). 
Institutional review boards and ethic committees also usually prohibit the collection 
of such data. It was planned that more survey venues would be explored such as 
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Healthy Respect drop-in sites in high schools and further education. However the 
short span of the service resulted in a limited time to implement such plans.  
The response rate for the survey differed markedly across the three health care 
settings. In MYPAS, the response rate was 73% (33/45 questionnaires returned). The 
reception staff handed out the questionnaire and suggested the option to YP of filling 
in the questionnaire while waiting for the consultation. In contrast, only 13% 
(13/100) questionnaires were returned from Caledonian Youth. The response rate 
from the GUM clinic during the pilot phase of the survey was 33% (13/40 
questionnaires returned) in contrast to only 8% (16/200) questionnaires returned in 
the survey proper at the GUM clinic. One possible explanation might be that during 
the period of survey proper the GUM clinic was in a transition phase of its relocation 
and merger with a family planning clinic. This might have distracted staff from the 
process of handing out questionnaire packs. The remarkably higher response rate 
from MYPAS might represent the research culture of that organisation, perhaps 
leading to extra enthusiasm by counter staff, to hand over the questionnaire to 
respondents, and greater encouragement to potential respondents to complete the 
questionnaire while they waited for their consultation (personal observation). 
Another possibility is that selection bias might have occurred in this study such that 
despite the reception staff being instructed to hand out the questionnaire to all 
eligible patients, it might be possible that MYPAS pre-selected recipients as folk 
likely to respond. One study has shown that recruiters for sexual health studies often 
do not approach all eligible young people, for various reasons such as their 
perception of young people’s lack of knowledge about screening, time pressure and a 
lack of guidance (McNulty et al., 2004). Reminders to the reception staff about the 
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The profile of GUM clinic respondents differ from MYPAS and CY respondents in 
terms of age category and the history of chlamydia testing, for example, 19% of the 
GUM clinic survey respondents were in the ≤ 19 years old age category as opposed 
to 81% and 69% of the respondents in MYPAS and CY respectively (p-value 
<0.001). There was also a statistically significant association (p-value <0.004) of the 
history of chlamydia testing in the past year across the three study locations (72% in 
GUM clinic vs. 31% and 38% in MYPAS and CY respectively). It is therefore 
possible that any associations seen between the age category and preferences for 
different aspects of the pharmacy service have been confounded by some other 
unknown profile of the respondents that are also related to the sites of this study. 
Similar assumption might also hold true for any association observed between past 
history of chlamydia testing and preferences for different aspects of the pharmacy 
service. The study sample was however not of a sufficiently large size to stratify it on 
survey venue and then to provide reliable estimates for any association between age 
category, or past history of chlamydia, with preferences for different aspects for 
pharmacy service. Also, due to the unavailability of non-responders’ data, it could 
not be evaluated whether this variation reflects the actual difference in the service 
users’ profile in the three settings or the variation also exist in terms of response rate 
across the three survey venues. The fact that respondents profile did not differ 
between MYPAS and CY, despite the wide variations in the response rate from the 
two settings (73% in MYPAS vs. 13% in CY) needed further investigation in terms 
of research culture in the two settings which might have an impact on response rate.  
Considering the overall response rate, it is important to note that it is difficult to 
obtain participation from young people. Previous studies have reported difficulties in 
recruiting young people, particularly for research on sexual health issues (Heritage 
and Jones, 2008) and one other study reported a similar response rate (Brugha et al., 
2011). The low response rate might also reflect an often low uptake of chlamydia 
screening by young people, hence their lower interest in participation in studies 
regarding chlamydia screening. A recent study of NCSP in South East of England 
found that only 1% of male and 3% of female population are being tested for 
chlamydia (Johnson et al., 2010), although this figure would also reflect the low rates 
of young people being offered chlamydia screening. Hence a low response rate for 
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this survey is not unique in the context of research on sexual health in general and 
chlamydia screening in particular.  
I did eventually manage to get participation from a diverse population, including 
respondents in employment, unemployed and/or studying. Respondents were also 
equally spread across the two targeted age bands (i.e. 15-19 years and 20-24 years). 
However female respondents predominated (among those for whom gender was 
ascertained) as did respondents of white UK origin. However this reflects the gender 
profile of young people accessing sexual health services in Lothian, comprising 
predominantly females, and reflects the predominately white local population 
(Taylor Nelson Sofres Healthcare, 2007). Due to the lack of information on gender 
for nearly half of the respondents and hence a very small numbers available for the 
analysis of gender (n=34 females and n=6 males), the gender differences in the 
respondent’s preferences to different aspects of a CT&T service could not be 
ascertained.  Previous studies have found that men were more willing than women to 
be tested in the non-medical settings (Lorimer et al., 2009a, Lorimer et al., 2009b).  
Lower acceptability for the pharmacy as a testing or treatment venue for chlamydia, 
as compared to sexual health clinics, supports the findings of another study that the 
clients would feel stigmatised if offered screening in a non-clinical setting (Lorimer 
et al., 2009a). A recent study from Ireland indicated that more than 90% of 
respondents did not want screening services to be located in pharmacies and almost 
all rejected public non-health care screening settings (Brugha et al., 2011). The 
results of our survey may also be biased because the survey sample was drawn from 
sexual health clinics, and hence it is possible that patient’s preference for a service is 
positively influenced by their familiarity with the service already experienced. A 
similar study conducted among young people who have visited pharmacies might 
have shown different preferences, and/or who are sexually active but have never used 
a city sexual health clinic because of fear or inconvenience in terms of distance or 
hours. Imamoglu et al (2006) proposed a three-factor model in which attitudes 
mediated between familiarity and preferences for various nursing care facilities 
enquired about. Increased familiarity seemed to predict enhanced favourable 
attitudes in the case of assisted living facilities, but to unfavourable attitudes in the 
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case of nursing homes. A recent review of determinants of obstetrics service use 
suggest that specific facility use in previous delivery and antenatal care is highly 
predictive of the health facility used in the index delivery (Gabrysch and Campbell, 
2009). The possible reasons suggested for the ongoing use of the same or similar 
service was that women become familiar with a setting and this makes them more 
likely to use it again. Similarly, previous use of EC has been demonstrated to 
influence women’s choice to use EC again (Bharadwaj et al., 2011). Further 
investigation is needed, however, into the role of familiarity in decision-making 
among young people with respect to drop-in services such as CT&T.  
It is reassuring that the survey respondents have confidence in the level of privacy 
achievable in the pharmacy, knowledge of its staff and the reliability of the results if 
tested in a pharmacy. Hence their indication of a pharmacy as a less likely option for 
testing or treatment could not be linked to the above potential barriers identified in 
the previous research (Taylor et al., 2007, Thomas et al., 2010). A preference for a 
face-to-face consultation for receiving test results by nearly 24% of the respondents 
and the highest level of importance that they had placed on the availability of a 
consultation room (62%) might suggest that consultation and counselling are the 
main reasons that direct their choice of venue for the CT&T service. Previous 
research in relation to pharmacy provision of EC service indicated that the pharmacy 
was perceived as a business environment, making it a less personal space for a 
private consultation and having less scope for counselling (Weiss et al., 2007). 
The study indicates that CT&T service proactively offered by the pharmacist during 
EC consultation or when buying condoms were acceptable to young people. These 
results contradict the findings of our qualitative study of pharmacists who perceived 
that young people might feel offended if offered CT&T service during EC 
counselling. Similarly other studies demonstrated that pharmacists are reluctant to 
offer chlamydia screening during EC consultation (Brabin et al., 2009b). Provision of 
kits on the shelf (to be self picked) as well as young people asking for it from the 
pharmacist is widely acceptable to young people in the current study. However the 
provision of kits on the shelves may result in a low return of sample. The high price 
of a chlamydia testing kit is primarily due to its absorbent packaging needed for 
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postage of the sample. Thus the current screening model of Lothian may be adopted 
by only providing the sample bottles on the shelves with information leaflet and 
asking the clients to return the sample for its postage through pharmacies. 60% of the 
respondents in our study preferred returning the sample to the pharmacy for postage.  
Despite the termination of the service in Lothian as well as the rest of the Scotland, 
community pharmacies are an active venue of chlamydia screening programme in 
England. The proportion of tests offered to the young people through pharmacies in 
South-West England reaches nearly 6% of all tests and 9% of all the treatment 
provided to index patients and 9% of treatment provided to partners (National 
Chlamydia Screening Programme, 2008). The findings of this survey may help in 
improving the uptake of screening in community pharmacies. Further research by 
implementing a similar study on young people accessing chlamydia service through 
different venues such as community pharmacies, SH clinics and GP clinics may be 
needed to validate the findings of this study.  
9.6 Chapter Overview 
 In summary, this chapter has described preferences and acceptability of young 
people attending sexual health services for different components of the CT&T 
service. In addition, it has reported their level of preference to use pharmacies, as 
compared to sexual health clinics or GP surgeries, to get chlamydia testing and 
treatment. The degree of importance which young people would place on choosing 
one pharmacy over the other, were also elicited.  
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CHAPTER 10: QUALITATIVE INTERVIEWS WITH 
PHARMACISTS 
10.1 Introduction 
This chapter explores the views and experiences of pharmacists who were invited by 
NHS Lothian to be the first wave to offer the CT&T service, both those who agreed 
(labelled pilot-service pharmacists) and those who declined to provide the service 
(labelled non pilot-service pharmacists). Understanding of the service provider’s 
perspective increases the scope for improving the service specification of a 
pharmacy-based chlamydia service. The specification can be adjusted to meet 
provider’s concerns, thereby helping in the roll out of the service to all pharmacies 
after the pilot phase and enhancing likely feasibility and sustainability in practice.  
10.2 Objectives 
The following objectives are determined for the in-depth interview study with the 
pharmacists: 
Pilot-service interviewees: 
i. to ascertain the reasons for participating in the CT&T service; 
ii. to explore their experience of the implementation of the CT&T service; 
iii. to explore their views on the subsequent discontinuation of the service.  
Non pilot-service interviewees: 
iv. to ascertain their reasons for not participating in the CT&T service.  
All pharmacist interviewees: 
v. to identify their views on different aspects of the CT&T service; 
vi. to ascertain their perceived facilitators of and barriers to the provision of the 
CT&T service;  
vii. to ascertain their perceived facilitators of and barriers to young people, in 
accessing the CT&T service;  
viii. To explore their views on the perceived attitudes of the key players of this 
service; i.e. other pharmacy staff, GPs and the potential clients. 
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10.3 Methods 
10.3.1 Study design 
This study element employed a qualitative approach by undertaking in-depth 
interviews with pharmacists from both groups i.e. providers and non-providers of the 
CT&T service. The rationale for choosing self administered postal survey for this 
study has been described in section 6.6.1.4 
10.3.2 Sampling strategy 
Having chosen the in-depth qualitative interview approach, the next stage was to 
identify pharmacist interviewees and begin the process of recruiting participants for 
the study. In order to understand the variation in views, interviews were undertaken 
from those pharmacists whose pharmacies participated in the service as well as those 
who did not participate in the service. Figure 10-1 shows the sampling of 
pharmacists for in-depth interviews.  
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In total 66 out of 166 community pharmacies were sent an invitation by NHS, 
Lothian to take part in the CT&T service. Of these, 12 pharmacies took part in the 
pilot. All the 12 pilot service pharmacies were invited to take part in the in-depth 
interview study. Of the 54 invited community pharmacies, which did not participate 
in the service, I used purposive sampling and invited n=32 non pilot-service 
pharmacies to take part in the in-depth interview. Purposive sampling relies on 
selecting interviewees by virtue of characteristics thought by a researcher to be likely 
to have some influence on their perceptions and experiences (Mason, 2002). In the 
current study, I purposively sampled pharmacies to represent a range of deprivation 
areas where located, urban-rural classification and local authority areas of Lothian.  
10.3.3 Recruitment of the study participants 
It was decided to undertake the interviews with non pilot-service pharmacists (NP) 
first, to allow a little more time and experience for the pilot-service pharmacists (PP) 
to deliver the CT&T service. In the first phase, the interviews with the non pilot-
service respondents took place between July and November 2010. The recruitment 
process involved an initial approach by an invitation letter (Appendix 36) with an 
enclosed participant information sheet, and an intention to participate form and a 
reply paid envelope. Only 5 pharmacists replied and indicated their intention to 
participate (n=1) or not (n=4). For those who did not reply, a follow-up telephonic 
call was made approximately two weeks after the initial contact to allow prospective 
participants the opportunity to consider their involvement in the study and identify 
questions. The telephonic recruitment approach was undertaken until the appropriate 
numbers of pharmacists were recruited.  
In the initial stage, four pilot interviews were conducted. There were a number of 
goals for the pilot interviews; such as, whether my initial interview questions were 
comprehensible and seemed relevant to interviewees, whether interviewees required 
prompting, what degree of depth pharmacists would provide, how long interviews 
might take to conduct and what would be the most suitable time and place for the 
interviews. Another important consideration for the pilot interviews was to provide 
me, as a novice researcher, with practical experience in interviewing, in addition to 
my theoretical training. After the pilot interviews, further recruitment of pharmacists 
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was undertaken until it was felt that data saturation has occurred. Any new theme 
that emerged was added in the interview guide for its confirmation in the subsequent 
interviews, for example, one of the themes that emerged in the initial interview was 
miscommunication regarding the mandatory requirement of toilet within the 
pharmacies to be able to provide the service. This theme was then added in the later 
interviews and it emerged that the pharmacists thought that the content of the 
invitation letter sent to them was not clear which lead to this miscommunication. 
Ultimately after 7 interviews, no new information was forthcoming.  
In the second phase, all the 12 pilot-service pharmacies were invited to take part in 
an in-depth interview. Only one replied to take part in the study. The remaining non 
responders were approached through telephone and another 3 interviewees agreed to 
take part in the study. The recruitment took place in April 2011 and the interviews 
were undertaken in May 2011. By this time it was a common knowledge among the 
pilot-service pharmacies that the CT&T service had been withdrawn from Lothian. 
In order to confirm whether data saturation has occurred, it was necessary to 
undertake more interviews from the pilot-service pharmacies. But the rest of the 8 
pilot service pharmacists declined to participate, indicating reasons such as; 
irrelevant as the service has been withdrawn, there was no uptake and hence no 
meaningful experience with the provision of the service. 
10.3.4  The theoretical approach for in-depth interviews 
The main reason for adopting a theoretically informed approach for this qualitative 
research is that it provides a framework to develop new insights and perspectives that 
benefit the gathering, interpretation and analysis of data (Miles and Huberman, 
1994). Such a framework can enable the identification of factors that systematically 
influence the effectiveness of intervention and hence help built a cumulative 
understanding of what works and how (Pawson and Tilley, 2008).  
There is a diverse range of theories potentially relevant to understanding 
implementation of a CT&T service from the perspective of providers, and this 
encompasses a wide range of disciplines from psychology, sociology, behavioural 
economics and management sciences. However these theories are often based upon 
overlapping concepts. For example, Michie et al. (2005) identified a total of 33 
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psychological theories that consist of a total of 128 constructs and that can be 
summarised into 12 common domains. Some of the common domains identified in 
this study - beliefs about capabilities, beliefs about consequences, motivation and 
goals, and social influences - overlapped with those identified by Fishbein et al 
(2001). Michie et al. (2005) further discussed that since the consensus on their 
domain list was reached independently of the Fishbein and colleagues (2001) study 
and in the context of a different set of behaviours, this provides further validation of 
the utility of these domains in understanding of the behaviour change processes 
inherent in implementation of evidence-based practice.  
Previous studies in pharmacy practice have adopted a range of theoretical paradigms 
and no single theoretical perspective is considered ‘right or best’ to explore a certain 
topic of research (Nosrgaard et al., 2000). Each paradigm is chosen to serve a 
specific purpose. Health promotion theories are useful when the purpose is to 
understand priorities and implementation strategies of health promotion interventions 
within an organisation. For the current research, health promotion paradigm was 
chosen because I wanted to investigate the process of implementation of a newly 
developed health promotion intervention, i.e. CT&T service, in pharmacy practice. 
For health promotion theories, the two most commonly used paradigms are those of 
organisational theories and behavioural theories.  
Pharmacy practice studies carried out within an organisational paradigm have 
explored the relationship and interaction that facilitate or inhibit practice change in 
community pharmacies. Some of these have focused on the management practices in 
community pharmacies, using models such as diffusion stages of Rogers’ 
‘Innovations in Organisations’ (Rogers, 1995, Pronk et al., 2001) and Leavitt’s 
diamond of organisational change (Roberts et al., 2005). However, organisational 
theories are most useful when trying to understand how interventions are 
implemented or incorporated into practice once a decision (implicit or explicit) to do 
so has been made. For example, Roger’s Innovation in Organisations theory consists 
of five stages; the first two in the initiation sub process and the later three in the 
implementation sub process. In my research this was not entirely the case since I was 
focussing on explaining why a pharmacist might intend to implement the service or 
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not. My study sample included both the providers and non providers of the CT&T 
service. Hence in order to capture the perspective of both types of participant, it was 
decided to use a common theoretical framework to seek to explain a pharmacist’s 
decision to implement a service in their own organisation, where that decision 
reflects a behavioural intention.  
Studies of changing behaviour in health promotion interventions focused on 
changing the behaviour of patients, consumers as well as providers (Munro et al., 
2007, Eccles et al., 2005). Well-studied theories related to changing an individual’s 
behaviour include the health belief model (Hochbaum, 1958), the theory of reasoned 
action (Fishbein and Ajzen, 1975), the theory of planned behaviour (Ajzen, 1985, 
Ajzen, 1991), and the social cognitive theory (Bandura, 1989).The health belief 
model is one of the oldest theory and was originally developed in the 1950s to 
explain why health screening programmes offered by the U.S. Public Health Service, 
particularly for tuberculosis, were not very successful (Hochbaum, 1958). However, 
the health belief model focuses on an individual’s perception of the threat posed by a 
health problem, the benefits of avoiding the threat and factors influencing the 
decision to act. It is considered more suitable to study the behaviour of those 
receiving the service rather than those of providers. The Social cognitive theory 
explains how people acquire and maintain certain behavioural patterns (Bandura, 
1989). The main concept advocated by Bandura is ‘triasidic determinism’, i.e. the 
behaviour; personal factors and the environment all affect each other. Personal 
factors include cognitive, affective and biological factors. Behavioural factors 
include the concept of ‘self-efficacy’ or the beliefs about the behaviour. 
Environmental factors include the physical space, the equipment available and the 
behaviour of others within the environment.  
The theory of planned behaviour (TPB) (Fishbein and Ajzen, 1975) and its 
predecessor, the theory of reasoned action (TRA), is one of the widely used theories 
to study behaviour change in the health provider and the patient / customer (Godin 
and Kok, 1996, Godin et al., 2008). It is built upon a simple proposition that much 
behaviour that an individual performs can be predicted simply from a person’s 
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intentions to perform those behaviours. Such intentions are called behavioural 
intentions.  
From the general account, it is apparent how these various approaches to theory 
overlap and make each other similar. In particular, there is a considerable overlap 
between the social cognitive theory and the constructs of the theory of planned 
behaviour. Since the Theory of Planned Behaviour has influenced my analysis of 
behavioural intentions of the pharmacist regarding the implementation of the CT&T 
service, this theory is explained further below. 
10.3.4.1 Theory of Planned Behaviour 
The TPB is an extension of TRA developed by Ajzen and Fishbein (Fishbein and 
Ajzen, 1975). It proposes a model about how human action is guided. The TPB is 
based on the premise that behavioural intentions can be used as a proximal measure 
of behaviour. Using the TPB to study the behavioural intention of health providers 
offers an atypical context. It assumes that clinical practice is a form of human 
behaviour and can be described in terms of theories relating to human behaviour that 
will have no influence on their health (although potentially on health of others), 
rather the impact of their behaviour is likely to be on their clinical practices.  
The three core constructs that constitute the TPB are illustrated in Figure 10-2 and 
are explained below:  
Attitudes (towards the behaviour) refer to an individual’s overall evaluation of their 
behaviour. In the case of community pharmacists, for example, they might perceive 
how the implementation of the CT&T service would have an impact on their status 
as a public health professional or on their business.  
Subjective norms (about the behaviour) are an individual’s own estimate of the 
social pressure to perform or not perform the target behaviour. In a community 
pharmacy setting other groups might include other pharmacists, GPs, customers and 
the interviewee’s professional organisation(s).  
Perceived behavioural control is the extent to which an individual feels able to 
perform the behaviour. In the case of community pharmacists, their perception of 
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facilitators of and barriers to providing the CT&T service might influence their 
intention to provide the service.  







The model of the TPB maintains that the relative importance of the constructs in 
influencing behavioural intentions will differ for different behaviours. Furthermore, 
regarding a specific behaviour, they could differ between populations, and even 
between individuals within the same populations.  
The research employing the TPB is most commonly elicited through quantitative 
surveys and Ajzen also suggested some prescriptive questionnaires for eliciting TPB 
for illustrative purpose. However Ajzen acknowledged that these questionnaires, 
despite having been used in prior research, might not be appropriate for a particular 
behaviour, population or time period. Since the focus of this research was to gain in-
depth understanding of the behaviour intention from the perspective of respondents, 
a qualitative approach was chosen as the most appropriate method for addressing the 
research objectives. 
10.3.5 Development of the interview guide 
To address the study objectives, eight major topic areas were explored. These topic 
areas are derived from the findings of the systematic overview of the relevant 
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1. Exploration of specific aspects on the service 
2. Decision to take part in the service 
3. Experience of providing the service 
4. Views on discontinuation of the service 
5. Perceived barriers and facilitators for young people 
6. Perceived barriers and facilitators for pharmacy 
7. Perceived attitude of the key players: pharmacy support staff, GP and potential 
clients opinion of the service  
8. Views on the potential impact of the service 
Topic areas 1-4 covered the objectives i-iv of this study. Topic areas 5 to 8 further 
explored the themes identified in the literature review and grouped under three main 
components of the TPB. The perceived behavioural control (identified barriers and 
facilitators in delivering/accessing the service in terms of staff, capacities, resources 
and structures were assessed and presented in topic area 5 & 6 and it covered 
objectives vi & vii of the study. The subjective norms (perception that pharmacy 
support staff, potential clients and GPs would approve them to provide the service  
was presented in topic area 7 and covered objective ix of the study. An attitudes and 
beliefs of the pharmacists about the benefit of the service was covered in topic area 8 
and constitute objective ix of the study. 
The interview guide underwent several slight revisions as interviews were 
completed; some changes were the simple addition of a question, if a new theme 
emerged, such as the level of decision autonomy to take part in the service. Some 
comprised a prompt, if it tended to yield inadequate responses. The final interview 
guide is attached as Appendix 37. Participants were also given a one-page 
information sheet to read as well as received a verbal explanation of the interview 
process.  
10.3.6 Transcription of interviews 
All interviews were audio recorded after permission had been sought from the 
interviewees. Transcription was undertaken as soon as possible after interviews. The 
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initial 3 transcriptions were undertaken by me, with the later transcriptions 
undertaken by an experienced transcriber in the department. However, I still listened 
to all the recordings repeatedly, to allow me to add comments and some measure of 
conversation analysis in terms of pause and duration, emphasis on particular word or 
phrase, or even laughter and instances of hesitation and hedging (for example, ‘um’s 
and ‘ah’s). Although the intentions were not to undertake a conversation analysis, it 
gave me deeper insights into whether, for example, the interviewee felt strongly 
about some issues. After interviews, brief notes were made such as to reflect on the 
interview process and contextual observations made during the whole process which 
I thought might be useful in interpreting the results (for example, the location of the 
pharmacy in terms of its geographical accessibility, its size, whether promotion 
leaflets were available for clients for other services offered by the pharmacy, its 
opening hours, the level of privacy achievable in the pharmacy and achieved during 
the interview). These field notes were added as memos in the transcripts. These 
memos together with the added comments on the transcripts from listening gave me 
valuable information regarding the context in which the comments were made by the 
interviewees and in the cross-case comparisons. 
10.3.7 Analysis and presentation of data 
Transcripts were uploaded into QSR Nvivo-8 (2008), a qualitative data management 
software package. Data were analysed using a framework analysis approach (Ritchie 
and Spencer, 1994). It employs intensive study of transcripts to define emerging 
themes and form a framework that is applied systematically to the raw data. Briefly 
this process of qualitative data analysis occurs in five key steps: i) familiarization, ii) 
identifying a thematic framework, iii) indexing, iv) charting and, v) mapping and 
interpretation. The benefit of framework analysis is that it allows for the inclusion of 
a-priori as well as emergent concepts and is suited to research that have a pre-
designed sample (for example, professional participants). Hence framework analysis 
is aptly suited for applied social science and policy research and is more commonly 
used in studies in health care settings (Atreja et al., 2005, Gerrish et al., 2004, Lacey 
and Luff, 2001, Read et al., 2004). 
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I followed the overall process of framework analysis, but adapted the different stages 
to the requirements of this study. During the familiarisation stage, I read the 
transcripts extensively and listened to the audio tapes and field notes. An initial 
coding framework was then developed, both from a-priori themes as mapped out in 
the conceptual framework developed from literature review (Figure 3-3) as well as 
from emerging themes from the familiarisation stage. This thematic framework was 
however further developed and refined during subsequent stages. The next two 
stages, indexing and charting occurred simultaneously and involved the process of 
applying this thematic framework to the data and arranging the data according to 
themes. This analytic approach ensures that findings are systematically compared. 
These stages of analysis have been facilitated by use of qualitative data management 
software, such as NVIVO that I have also used for my research. The data have now 
been segregated by main themes and sub ordinate themes, and were revisited and 
resorted on several occasions before settling on the final themes. Appendix 38 
provides an excel output of nodes and sub-nodes developed during this analysis 
process. However the analysis is not presented in the form of charts, rather the data 
reporting undertook a more conventional way of qualitative data reporting involving 
discussion of each theme with supporting data excerpts as well as the discussion of 
relevant literature and cross themes comparison. The data reporting is further 
discussed later in this section.  
A final stage of mapping and interpretation was then undertaken, by identifying the 
relationship between themes and subordinate themes. It was during this stage that a 
cross case and constant comparison method was employed. The latter technique 
involves going back and forth through the interview transcripts to compare the data 
from different transcripts to define concepts and find association between themes and 
provide explanation to different phenomena. Annotations that were added throughout 
the coding process helped to track conceptual decisions and ideas as they occurred. 
During this process, schematic maps of themes and sub themes were also developed, 
individually as well as a final conceptual framework. Some of these thematic maps 
and the final conceptual framework are presented in the result section and in the 
overarching discussion respectively.      
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All primary analyses were undertaken by me. However, credibility of the data 
analysis was established by presenting analyses i.e. themes and conceptual 
abstractions of the data in supervision meetings to challenge the meanings and the 
basis of my interpretation of the data. It is also important to emphasise here that my 
analysis of the interview data is based on the perspective that the responses are a 
straightforward reflection of the interviewee's experience and understanding of 
events in relation to the CT&T service. However I also acknowledge that I had a part 
in defining aspects of their account through my choice of questions and topics for 
inclusion in the interview topic guide and through my requests for clarification and 
expansion during the interview.  
The reporting of interview data has been addressed by Silverman and other 
qualitative methodologists. The use of verbatim versions of participant’s speech has 
been recommended, in contrast to summaries and abstract interpretation (Miles and 
Huberman, 1994, Patton, 1987). Miles and Huberman (1994) advocated that there 
must be a balance between one extreme which involves reproducing large chunks of 
transcribed text and the other extreme, in which attempts are made to cherry pick 
only the most appropriate excerpts from interviews or, worse still, to use them to fit 
emergent themes or theories, at the cost of ignoring deviant data or cases. Hence, in 
this thesis, I have made an attempt to respect the authenticity of the interview data by 
avoiding, wherever possible, reducing pharmacists’ responses to fragmented 
snippets. However this was not always possible, and sometimes it is necessary to 
‘pick’ in order to avoid reproducing large sections of text that contain one relevant 
comment.  
For reporting purposes, pharmacists were assigned an acronym: NP for non pilot-
service pharmacists and PP for pilot-service pharmacists. In each sub group, the 
prefix letters were followed by a unique identification number. In some places, 
where important, the type of pharmacy (chain or independent pharmacy) is also 
reported.  
The format of this chapter is somewhat different to previous chapters. As is usual 
with qualitative research, discussion is interspersed with the reporting of the 
interview data. This is particularly useful in this study because of a number of topic 
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areas explored and the two interviewee groups. This includes making comparison 
with the findings of other studies within this thesis, to discuss the relevant published 
evidence, and to offer my own interpretation of the findings. Hence the next section 
presents the results and a simultaneous discussion of the themes. This is followed by 
considerations of the strengths and limitation of this study and lastly a conclusion 
section presents the summary of findings of this study. 
10.4 Results and discussion  
The interviews lasted from 15 to 40 minutes each. Table 10-1 summarises the 
characteristics of the interviewee pharmacists and the pharmacies. 
Table 10-1: Description of study participants by gender and years of experience and 
by pharmacy classification 










Gender Years of 
experience 
Non Pilot-Service Pharmacists (NP) 





NP-2 Independent 1 Other Urban West 
Lothian 
Female 31 










4 Large Urban Edinburgh 
city 
Female Not Asked 
NP-6 Small Chain 2 Large Urban Edinburgh 
city 
Female Not Asked 
NP-7 Large 
Multiple 
2 Large Urban East 
Lothian 
Female 10 
Pilot- Service Pharmacists (PP) 
PP-1 Independent 1 Large Urban Edinburgh 
city 
Female 4 
PP-2 Independent 1 Other Urban East 
Lothian 
Female 33 
PP-3 Independent 1 Large Urban Edinburgh 
city 
Male 17 
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*Deprivation Quintile: 1 is the most deprived and 5 is the least deprived 
**Telephonic interviews 
All but two interviews were conducted face-to-face. The remaining 2 interviews 
(NP-3 & PP-4) took place by telephone. Potential interviewees were given a choice 
to be interviewed out of work hours, but all preferred to be interviewed during a 
quiet period or a lunch hour and, for convenience, in their work place. All the face-
to-face interviews occurred in the consultation room or a dispensary. 
The eight topic areas explored (section 10.3.5) are presented in this section.  
10.4.1 Exploration of specific aspects of the CT&T 
service specifications 
I asked the interviewees to reflect upon different aspects of the service, particularly 
the age group targeted, mechanism for engaging young people in the service and 
with regard to the aspect of partner notification to be undertaken in the pharmacy. 
10.4.1.1 Age group targeted7 
When asked to comment on whether they think that the targeted age group of 16-20 
years for the chlamydia testing service in Lothian is appropriate, all pilot pharmacists 
and a couple of non-pilot interviewees indicated that the high prevalence of infection 
in this age group suggested a rationale for targeting the service at the under 20’s.   
I understood it, it made utter sense to me but it didn’t fit in to the 
people that were asking me for it and that’s why I only gave out two. 
And I do think you need to restrict it because, you know, it was 
proven, in the data that we were given......that if you’re 27 years old, 
chances are you’ve not got it, although I know there’s exceptions to 
that. (PP-3) 
I assume that this is one of the highest groups so… so that’s the first 
step. (NP-5) 
The reasons given by some interviewees indicate their misapprehension of the 
prevalence data.  
                                               
7
 The current CT&T service in Lothian was targeted for young people aged between 16 to 20 
years. The ‘testing’ service can also be provided to clients 15-24 years of age who request 
the testing kit. Moreover ‘treatment’ could be provided to clients ≥ 13 years old (see also 
section 5.4.1.1).  
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I would probably make it wider, to be honest. You’ve got a lot of 
sexually active girls in their late 20s who can contract chlamydia. 
And, you know, they’re coming into child-bearing age and obviously it 
can affect fertility. […] just personally, I would say late, late 20s, you 
know, you’ve got more uptake, I think, on that. (NP-4) 
Views regarding the age group targeted might reflect their training knowledge for 
CT&T service. While all the service-pilot interviewees attended training, none of the 
non-pilot interviewees attended the training offered to all the community pharmacies 
in Lothian before launching the CT&T service. However despite their understanding 
of targeting a younger age group, all of the interviewees wanted to increase the age 
limit to 25 years or late 20s. The most common argument given for increasing the 
age limit was that an older age group are more likely to use the service. Others 
considered that the service is more needed in this age group because there is more 
involvement in sexual activity in the 20s.  
I sort of think when people go to university they’re more likely to a) 
need it and b) you know, be more confident to come in and speak to 
somebody about it. So I would say to 20 is maybe a bit low, yeah. (NP-
7) 
From the above quotes there is an indication that despite understanding the rationale 
of targeting the younger age group (due to its high prevalence), but still wanting to 
increase the targeted age group (to increase the uptake) rationally reflect their desire 
to provide the service that has a potential to be successful and efficient in terms of 
uptake of the service. However this area needs further exploration.   
10.4.1.2 Child protection issues: Fraser competency 
For the lower age limit, interviewees were also asked if they would be comfortable 
dealing with clients under 16 year olds if they request testing. Most of the non pilot 
interviewees indicated that they would be comfortable dealing with sexual matters of 
this age group, with the major justification cited being their involvement already in 
EC service and that they are thus trained to assess Fraser competency.   
I’m quite comfortable with them because I’ve dealt with them under 
the EC72 service. (NP-6) 
However, some of the pilot pharmacy interviewees had reservations about dealing 
with young clients under 16 years old. One interviewee indicated that she is not 
trained for counselling young people and hence would prefer to refer young people to 
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specialist sexual health services. While recalling his experience with EC provision, 
another interviewee quoted: 
I thankfully never had to. To be honest with you, I probably would 
pass them on to someone else. Yeah. I’m not comfortable with that at 
all, no. I’ve done EC72 for a 14-year-old and several 15-year-olds 
but... yeah, it’s not very... yeah, it’s not very nice. (PP-3) 
There was no suggestion from the available data that the socio-demographic profile 
of the pharmacist, such as gender or age group would affect their reluctance to deal 
with a very young age group. In a training programme for pharmacists for the 
provision of EC, application of the Fraser guidelines for women aged less than 16 
years was found to be problematic, but details of the barriers experienced and how 
they were addressed were not reported (Taylor, 2003). 
10.4.1.3 Mechanism for engaging young people in the service8 
Interviewees were asked to indicate their preference for either a reactive or proactive 
way of engaging young people to the CT&T service. The idea of a proactive offer of 
the service to young people was rejected by all but one of the non-pilot service 
interviewee, and only one of the pilot-service interviewees. Main reasons cited were 
their concern that young people would feel offended to be offered this service.  
I think, you know, people could be quite insulted if you’re going to just 
ask them straight out “do you want this?” or “do you need this?” 
(NP-7) 
I would feel very awkward about that because it’s a very private kind 
of thing anyway…so I really did feel self-conscious offering that to 
someone; yeah, who am I to say that they’ve got a sexually 
transmitted infection? (PP-3) 
Other reasons cited for not favouring a proactive offer were the busy retail 
environment of a pharmacy and the lack of privacy achievable, in a pharmacy 
setting, to offer the service to potential clients.  
                                               
8 The current recruitment model for accessing pharmacy CT&T service in Lothian requires 
the client to request the chlamydia test in the pharmacy. Thus it is a reactive model where 
the pharmacist offers consultation when clients request chlamydia testing. An alternative 
model, which was tested in other parts of UK, Australia and Netherlands, was the proactive 
model using an opportunistic screening approach whereby the pharmacist offers chlamydia 
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I think from a time point of view probably the young person asking. 
Yeah I think probably a young person asking. I think it would be quite 
hard to do it on a whole sale basis on the front shop. (NP-2) 
We’re not usually on a one-to-one with customers, which… you know, 
so it’s not really appropriate, is it, to start asking about (laughs) you 
know “are they at risk of these things?” or whatever, you know, 
so…(NP-5) 
The other issues apparent in the above quotations, of workload and lack of privacy in 
a pharmacy retail environment have also been broadly raised as barriers to chlamydia 
testing and are discussed in detail in the relevant themes.  
Those who were comfortable with the idea of a proactive approach, considered it 
appropriate during an EC consultation. It was described as a way of effectively 
removing the barrier for young people to ask for the service.  
I think it’s hard for people to ask for the service, you know, unless 
they’re very confident and don’t mind anybody really knowing a lot of 
their business. It’s something that we could speak about to women 
who come in for the emergency contraception and we could talk to 
them as well. (PP-1) 
And just because obviously we are very settled with providing 
levonelle, it’s probably just come hand in hand so it would be quite 
easy to just tie in with levonelle, like you could offer it to everyone 
that comes out for levonelle. (NP-4) 
In order to avoid causing offence to young people, alternative strategies suggested 
were handing out health promotion materials during EC consultation, or to have the 
kit available at the till to be picked up.  
I think it would be easier if the patients didn’t have to ask for the kits. 
If they were just available for them to lift. (PP-2) 
I mean, if there was a leaflet that you could hand out, yes, so that 
when you were doing a, you know… administering contraception or 
something like that, you know “have you thought about this?” I mean, 
that might be useful, but erm… (NP-5) 
Previous evaluations of pharmacy chlamydia services have reported that in practice 
testing kits have been offered only to a selected subset of eligible EC clients, for 
similar reasons of causing offence (Brabin et al., 2009b). This is particularly true if 
screening is to be offered in a non-sexual health consultation context (Taylor Nelson 
Sofres Healthcare, 2007). A study undertaken in GP surgeries also reported that staff 
were failing to back up the advertising of chlamydia screening, in that they were not 
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routinely offering opportunistic screening to their target population (Freeman et al., 
2009). The study further reported that staff believed giving young patients a leaflet 
would cause patients embarrassment, resentment or offence. However these views 
are contradicted by the perceptions of young people who preferred chlamydia 
screening to be offered to all young people in the target age group, rather than being 
offered only in the sexual health context, to prevent them feeling singled out (Pavlin 
et al., 2008, Hogan et al., 2010). However, pharmacy practices differ from GP 
practices in terms of the amount of privacy achievable in pharmacy to offer such 
services. It emerged in the potential service user’s survey that they would feel 
comfortable being offered a service in a sexual health context. Therefore, there is a 
need to explore the perspective of young people about the best approach of engaging 
them for community pharmacy-based chlamydia service.   
10.4.1.4 Partner notification9 
All the interviewees except one expressed positive views about the partner 
notification (PN) aspect of the service, understanding its importance, and describing 
it as necessary for preventing further transmission of infection.  
I don’t think anybody sensible would disagree with it really, you 
know. (PP-2) 
I’m not uncomfortable with asking them, it’s just whether you actually 
get the results back, you know, whether people would actually be 
willing to give it to you, I don’t know. (PP-4) 
M: Do you have any issues asking for partner information from young 
people? 
No, because they can only say yes or no. I mean, they’ll either give 
you or they won’t and if they won’t give you, there is nothing you can 
do. But if they say yes then you’re preventing someone else from 
having chlamydia so I think I’d be quite happy to ask them. (NP-4)  
The above quotes also indicate that despite appreciating the importance of PN, the 
interviewees recognise the difficulties inherent in successfully carrying it out, and its 
                                               
9
 The current CT&T model in Lothian encouraged clients to fill in the partner notification form 
in the pharmacy at the time of receiving treatment. The clients are encouraged to fill in the 
form by giving contact details of their partner(s) and return the form in the sealed envelope to 
the pharmacist. The pharmacist would post it to the GUM clinic for the health advisor to 
contact the partners. If the client wants to contact the partner(s) themselves, then an 
appropriate number of information leaflets for the partner would be handed out.  
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ultimate reliance on the client. However they consider the current pharmacy model as 
not only an opportunity to emphasize the importance of PN to the clients, but also 
consider it as an enabler for young people.  
Obviously it’s more awkward for them to do it as well if they were to 
contact their partners or ex-partners directly, I think it’s better for 
them to write it down, let us send it away and then let the GUM clinic 
get in touch with them. (PP-1) 
The pharmacist who expressed a negative attitude about the PN and absolutely 
rejected the idea of carrying out PN through pharmacies, cited a number of 
objections for example, the lack of training of the pharmacist to carry out such task, 
people’s perception about the liability of the pharmacist, inadequacy of privacy that a 
shop environment could offer, and people’s expectation of carry out such task by 
GPs and specialists.  
We’re not really trained up for that sort of thing, you know! It would 
really be just to know how liable we are for things you know, because 
quite often people don’t seem to think that it’s our place to do stuff 
like that and we get… you can get a lot of complaints and, you know, 
we try to explain that we’re just doing our job but…They seem to think 
that may be tit’s information that we shouldn’t have. They expect that 
sort of thing to come from doctors or hospitals or, you know, 
specialists. (NP-3) 
The above pharmacist had a consistently negative attitude on most aspects of the 
service and had also declined outright the invitation to carry out the CT&T service 
through their pharmacy. However she was not the only one who identified 
confidentiality issues in the pharmacy related to PN. Another pharmacist working in 
a small chain pharmacy also put it as follows: 
I would think they’d be much more likely to want to go to the GUM 
clinic or their GP. Because they’re passing over confidential 
information, they may not be happy passing that information over in 
the shop, even if they’re told that it’s sealed and that no-one else can 
read it. (NP-6) 
The above views are contradictory to those interviewees who work in the large chain 
pharmacies, who considered that pharmacists have only limited involvement in the 
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I’m not going to ask their details, I don’t need to know!  But I mean, it 
would be… And again, they could use the consultation room for that, 
they can sit down and they can do it and it’s quiet and private and 
they don’t have to worry about it, I think it’s OK. (NP-7)  
This contrast in views of the interviewee working in a small chain or independent 
pharmacies as opposed to those working in large chain adds weight to another 
pharmacist’s suggestion to offer the service in large pharmacy with ‘less personal’ 
(NP-1) settings. Besides the barrier related to achieving confidentiality and privacy 
in a pharmacy setting to carry out PN, there was also an indication of a selective 
approach of carrying out PN. Those having multiple partners or in an older age group 
were described by one interviewee as an appropriate target group for carrying out 
PN.  
Well we have to rely on them being honest. I don’t mind approaching 
them with it. Probably 16-20s won’t be very happy but with maturity 
that does change doesn’t it. You gotta take on it on person to person 
basis. It depends whether they have multiple partners or not. (NP-2) 
However the barriers stated in terms of patient’s age and relationship status are not 
exclusive to the pharmacy setting, it apply in all health care settings including GUM 
clinics and general practices (Pavlin et al., 2010). The difficulties inherent in 
carrying out PN have been acknowledged in the stakeholders’ survey as well (section 
8.4.2.2). A systematic review of partner notification did not find sufficient evidence 
of younger people being most at risk of chlamydia re-infection due to failure to 
undertake PN by this age group (Trelle et al., 2007).  
In general, most of the pharmacists stated they were comfortable dealing with PN 
processes and considered PN through a pharmacy to be acceptable. Previous studies 
reported that 80% of pharmacists found patient delivered partner therapy (PDPT) 
acceptable through a pharmacy (Cameron et al., 2007) and that it was a popular 
choice among partners of index patients as well (Cameron et al., 2010).  
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10.4.2 Decision whether pharmacy will take part in CT&T 
service 
I asked each pharmacist to indicate the reasoning for his/her decision to take part or 
not in the service. The themes that emerged from the response data were broadly 
categorized as reasons for non-participation and reasons for participation. 
10.4.2.1 Reasons for participation 
Enthusiasm for the CT&T service seems to be related to the location of the 
pharmacy, which would influence the likely uptake of the service. Some define it as 
a location in a deprived area, whilst other as an area that have a good proportion of 
young population client base.  
Mufiza: Do you think that your pharmacy is appropriate for this 
service? 
Interviewee: Mm-hm, mm-hm. 
Mufiza: In what aspect?   
Interviewee: From both the deprivation and the high proportion of 
young people. (PP-2) 
However one pharmacist also considered the location of the pharmacy close to the 
GP as an enabler to the service, in addition to its location in the deprived area, due to 
the likelihood of easy referral when needed. 
It was obviously a good idea for us to get involved with it because of 
the [deprived] area that we’re in and we have a good relationship 
with the surgery next door as well, so any query in that sort of area, 
you know, we can always phone them and talk to them about it. (PP-1) 
Two pharmacists indicated their experience of providing EC, which had a good 
uptake in their opinion, and they considered CT&T as a natural progression from 
providing the EC service.  
Well, it just seemed like a good service because we do give out quite a 
lot of the emergency hormonal contraception and it seemed like the 
obvious kind of step to go along with it. (PP-3) 
The above quotes suggests that the pharmacists anticipated a good uptake of the 
service either because of their location in an area which they believed would trigger 
demand (area of high deprivation or relatively predominant young population) or the 
current practice environment (i.e. the provision of EC) that enables the provision of 
CT&T as well.  
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A higher demand would also mean that pharmacies were more likely to benefit in 
terms of remuneration. An incentive for the provision of the service was explicitly 
mentioned by one pharmacy owner.  
You know, any kind of service like that, which is a) a good service and 
b) we actually get paid for, you know, I’m happy to do. (PP-3) 
A recent survey of community pharmacists in Grampian, Scotland also indicated the 
lack of remuneration was a barrier of provision of SH service in pharmacies (Gale 
and Watson, 2011). As discussed in detail, under the ‘incentives’ theme (section 
10.4.6.3), this remuneration would infact benefit only the owner of the pharmacy. 
Therefore, an appropriate remuneration model for such a public health service 
provision should ensure that any pharmacist employee’s contribution to service 
delivery is rewarded in the same way (Grindrod et al., 2009).  
Two pharmacists also indicated that their decision to take part in the service was 
facilitated by its pilot nature and their previous involvement in the pilot service for 
EC.   
I know now that pharmacies across the board are providing 
emergency contraception but prior to that we were involved in EC72 
but not all pharmacies were and I just thought that because we were 
one of the pharmacies that was providing that at that stage it might be 
a good addition. (PP-4) 
There is a suggestion that their willingness to be involved in the pilot might also 
hinge upon the potentially greater demand for the service if it is limited to only a few 
pharmacies rather than if provided as a blanket service in all the pharmacies. This is 
also apparent in the following quote:  
This shop was an EC72 pharmacy and we did a lot of them and then 
when it went all over, you know... I suppose then you’ve got, you 
know... I did about 700 of the things, of the EC72s over the five years 
or whatever it was. But I suppose what the problem now is that we’re 
all doing it. (PP-3) 
Figure 10-3 illustrates a conceptual diagram of various factors that were identified to 
contribute to the pharmacists’ decision regarding participation in a pilot CT&T 
service. As can be seen, the various reasons noted by the interviewees can be directly 
or indirectly linked to their perception of increasing profitability in their business.  
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The impact of perceived demand on pharmacists’ participation in a service has been 
discussed in-depth in the previous literature (Mackie et al., 2004). Another 
evaluation of a pharmacy-based chlamydia service found that pharmacists linked 
their participation to the increased sales of other products, greater customer 
satisfaction and return visits, factors responsible for increase business profit 
(Baraitser et al., 2007). Incentives are further discussed in detail in section 10.4.6.3.  
10.4.2.2 Reasons for non-participation 
For the interview sample of non pilot-service pharmacists, only one out of 7 
interviewees indicated that their pharmacy decided not to take part in the service:  
I think it was decided not to do that. (NP-3) 
However, the above respondent did not provide any further reasoning for such a 
decision. The remaining six pharmacists were keen to provide the service. The major 
themes that emerged for the remaining interviewees for non participations were 
failure in communications at various levels, lack of decision autonomy and based on 
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Figure 10-4: Reasons for non-participation, given by pharmacy interviewees who did 







10.4.2.2.1 Failure in communication 
The failure in communication appeared to have occurred at three levels; i) between 
NHS and the pharmacies, ii) within the pharmacy chain, between pharmacy manager 
and pharmacists, and iii) between pharmacists within a pharmacy. At the NHS level, 
many pharmacists indicated that they had never come across with any such 
invitation.  
Mufiza: What I know is that this invitation was sent in July 2009? 
Interviewee: Mmm… holiday time!  Sorry! (laughs). I don’t know… 
well, I would not remember July 2009, I have to say. I would actually 
be on holiday in July 2009 so…! (laugh). Because I’m always away on 
the first weeks of the school holidays. (NP-5) 
Another interviewee noted: 
Certainly since I said I would do it, I haven’t had any body enquire. 
(NP- 3) 
The above quote hinted to the possibility of missing an invitation if sent in a holiday 
period, and was noted by another non-pilot pharmacy interviewee as well. The fact 
that no reminders were sent by the NHS would have resulted in a missed opportunity 
to recruit more pharmacies, had who not received / acted upon the initial invitation.  
One pharmacist was not clear whether or not she had signed up for the service. In her 
immediate response she explained that she had signed up for the service, but later in 
the interview expressed doubts as NHS didn’t approach her to implement the service.  
I haven’t been sent any sample pots. I wonder if I have signed up. I am 
not sure. I need to talk to somebody to see. (NP-2) 
 
 
Chapter 10: In-depth interviews with pharmacists……………………………………………………  
288 
The above quote indicates that the failure of communication, or perhaps deficiencies 
in communication also resulted because the NHS didn’t acknowledge the pharmacy 
reply. Another aspect of failure of communication was related to the ambiguity about 
the toilet requirement for community pharmacies, as reflected in the following quote:  
Well, we had initially said that we were quite keen on participating. 
And to be honest, this might even be just crossed wires and poor 
communication, but I got the impression – and I thought there was 
maybe some paperwork which mentioned this where they were looking 
for people to pilot it yet there was a requirement to allow the patient 
access to, or they thought it would be useful to allow the patient 
access to a toilet and toilet facilities for doing the testing. (NP-1) 
As can be seen in the NHS Lothian invitation letter to pharmacies for participation in 
the service (Appendix 12), the fact that a public toilet is not obligatory for 
participation was not explicitly indicated in the invitation letter. Instead an 
impression was given that the public toilet is actually needed, either within the 
pharmacy or if they know of its availability in the vicinity. 
A second level of failure of communication occurred within pharmacy chains where 
the employee pharmacists might not know what decision was taken at the senior 
managerial level. Due to the hierarchy of the decision making process in chain / 
multiple pharmacies, the senior managers based at headquarters usually 
communicate decisions about service delivery within their pharmacies (Phipps et al., 
2009). Thus it may happen that if a pharmacy chain decides not to take part in a 
certain service, the decision might not be adequately and explicitly communicated to 
all the pharmacists working within the chain store. 
I don’t know actually because that’s…If we haven’t signed up I would 
be surprised we haven’t signed up because we usually do but I’m not 
aware of this service. (NP-5, chain pharmacy) 
A third level of failure of communication occurred within a pharmacy, where more 
than one pharmacist works. In such scenarios, deficiencies in communication might 
have occurred due to a rota system for alternating two or more pharmacists, and 
hence decisions within the pharmacy are not adequately communicated among each 
other. As a pharmacist from a chain pharmacy noted: 
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It doesn’t mean it hasn’t got buried, which unfortunately 
happens…You see, because we both work opposite ends of the week, 
occasionally we get miscommunication! And I’m wondering if this is 
one of them. (NP-5, chain pharmacy) 
This statement implies that failure of communication is more likely to happen in 
multiple / chain pharmacies which often operate a rota system between the 
pharmacists. This disconnection from the day-to-day activity of the pharmacy, of the 
part-time pharmacists (or even more so of the locum pharmacists), results in them 
dealing in a partial knowledge environment (Phipps et al., 2009). This may become 
more of a problem as pharmacies introduce new services. In any case, there is 
perhaps a need for more documentation of processes and decisions taken within the 
pharmacy for the purposes of information sharing. 
10.4.2.2.2 Decision autonomy 
The hierarchy of decision making processes in chain pharmacies may act as a barrier 
to providing a service within pharmacies. The following quote from a pharmacist 
working in a chain pharmacy reflects that such decisions occurs at the higher 
organizational level, and cultural ethos of the chain pharmacies meant that employee 
pharmacists as well as other staff working in a chain pharmacy embraced the policy 
of their pharmacy chain:   
Mufiza: Do you think there are any factors that would deter the 
pharmacies from doing a service like this? 
Interviewee: No (Very spontaneously). Not for [Name of their chain], 
no because we’re being very pharmacy-services aware and this is a 
pharmacy service. So no, I think I would be surprised if anyone who 
works for [Name of their chain] didn’t want to do this. (NP-4, chain 
pharmacy) 
It is not clear that how far such decision would affect or is based on pharmacists’ 
personal interest in any such services. One could envisage circumstance when there 
is a mismatch between what chain pharmacy decides in contrast to what employee 
pharmacists want. As suggested by the following quote, pharmacists working in 
independent pharmacies are more autonomous in terms of their decision of whether 
to be involved in a service or not.  
I usually say yes to most things. Because I quite like development 
work you know. I think pharmacy could develop quite nicely along 
these lines. (NP-2, an independent pharmacy) 
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Following the emergence of the above theme about decision autonomy, I explicitly 
asked the pharmacists in the pilot pharmacy interviews about who took the decision 
whether to take part in the service or not. In the three instances of independent 
pharmacies, the owner pharmacist took the decision.  
I’m the manager and a partner in the business as well. Well, I mean 
it’s really up to me because it is an independent pharmacy; it’s really 
up to me what we do. (PP-3) 
But in the instance of a small size chain pharmacy, this decision was taken by the 
employed pharmacists as quoted below: 
It was basically myself and my job share partner [name of colleague], 
the other pharmacist that works the other days from me. You know, I 
just checked with her that she was happy to do it. And then I think we 
must have e-mailed the boss just to, you know, verify with him whether 
he was alright with it. (PP-4) 
Since none of the pilot pharmacies was a large chain, there is a need to further 
explore the levels of perceived autonomy in large chain pharmacies compared to 
independently owned pharmacies and small chain pharmacy.  
10.4.2.2.3 Past Experience  
Past experience also guided the decision of some pharmacists on whether or not to 
take part in the service. One pharmacist, who had worked in another health board in 
Scotland, explained that she was part of a group that had pioneered the pharmacy-
based chlamydia service in their respective health board. She left before the service 
was implemented, but knows that the service was successful in that health board.  
Interviewee: They did this very early on. They did this about may be 
four five years ago […] and everybody was quite positive about the 
outcomes. 
Mufiza: O.K. And you were also involved in that [service]? 
Interviewee: I left sort of about that time. But I was part of sort of 
group that was piloting it. So it was very well thought of in Town D & 
E. And it would seem to work fine. (NP-2) 
This interviewee currently works in an independent pharmacy in Lothian and was 
quite keen to take part in the service. Conversely, the other pharmacist described her 
negative experience with a similar pilot service, where she handed out chlamydia test 
kits during EC consultations. She illustrated her experience as follows: 
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I don’t think I did, simply because we’ve had it available for a while 
and absolutely zero interest in it, nobody’s interested at all. Not even 
asking, you know “do you do it?” or... nobody’s interested. (NP-6) 
These two contrary views point towards the individual nature of perceptions 
regarding success or failure of the same programme, and that the provider’s decision 
to deliver the service depends greatly upon their past experience. This pharmacist 
(NP-6) further elaborated that even during EC consultations, when she tried to bring 
up the issue of STIs and testing, the client became ‘uncomfortable’. It raises the 
possibility that concerns of displeasing the customers could also potentially influence 
the intentions of the pharmacists to offer the service. However it is important to note 
here that the CT&T service in Lothian, did not require proactive offering of the 
service to their clients. 
10.4.3 Experience of being part of a pilot roll-out of CT&T 
Overall only 4 clients were handed out a chlamydia test kit; and this involved only 
two pharmacies since one pharmacy was responsible for handing out 3 of these kits. 
Hence none of the pilot-service pharmacists have any meaningful experience to 
reflect on. All the pilot-service pharmacists indicated their disappointment with the 
low uptake.  
Well, I was actually very disappointed because we had no customers 
at all. You know, we put up the notices, the surgery knew we had it, 
no-one came. Big disappointment! (laughs) (PP-2) 
Notwithstanding this outcome, one pharmacist was satisfied about the fact that he 
contributed in some way to public health. Another pharmacist described it as a waste 
of resources.  
I only gave it out twice so it was limited but, you know, I was happy to 
do something. (PP-3) 
Very, very low uptake! Hardly anybody came at all […] so it’s such a 
waste of resource really, you know. (PP-4) 
This issue of low uptake was also indicated in the stakeholder survey, TNA and by 
the non-pilot pharmacy interviewees before the start of this pilot service. Previous 
evaluations of a pharmacy-based chlamydia service also reported a low uptake, but 
even in such a scenario, the uptake in a similar service was reported to be on average 
10 tests / pharmacy / month (Baraitser et al., 2007), whereas in another pilot, the test 
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uptake ranged from 2 per month to 9 per week in different pharmacies (Taylor 
Nelson Sofres Healthcare, 2007).  
10.4.4 Delays in service implementation by the Lothian 
Health Board 
Some evidence also suggest that there were concerns regarding prolonged delays in 
the implementation of CT&T service in pharmacies, due to the unexpected 
emergence of swine flu, which he thought diverted all NHS attention.  
It was unfortunate the way swine ‘flu just fell right in the middle. And 
I kept on asking [name of colleague] about it –[…] I kept on asking 
her “when’s this chlamydia thing starting?” and she was just saying 
“we’re just so busy with swine ‘flu, I don’t know, it’s just getting 
pushed back and back.” (PP-3) 
As discussed in detail in section 5.4.2, the CT&T service suffered many delays in its 
implementation in Lothian. Pharmacists received a two hour training session in 
October 2009 and March 2010 and ultimately the service was started in June 2010. 
However, since the second training evening was very brief and did not cover all 
aspects of service provision, a couple of pilot pharmacists felt that they were not 
ready to deliver the service. 
There was a big gap between our training and actually going live so 
by the time we got to going live I had forgotten a lot of how to fill out 
the form, you know. (PP-3) 
This might indicate that pharmacists required a full training, particularly on those 
aspects related to the practical aspects of service provision.   
10.4.5 Discontinuation of the service 
Pilot pharmacy interviewees have mixed feelings about the discontinuation of the 
service. Two interviewees indicated that they expected the service to continue for 
some time, to observe its effect. It was felt that the service was discontinued too 
soon. However, one interviewee indicated that it is inappropriate to direct resources 
and time to a service which had not demonstrated any demand.  
 I was actually quite surprised when it stopped as early as it did 
because it hadn’t really been given a fair crack but I know that the 
GUM clinics and doctors are seeing to it, but anyway… (PP-3) 
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I’m not all that disappointed about that because I think if you are 
going to put the time into getting yourself fully up to speed with 
something and then it doesn’t really happen it’s almost a bit of a 
waste of your time. (PP-4) 
Many interviewees also indicated their experience with the EC provision, which took 
a long time to catch on. The evaluations of similar service indicated that the service 
took time to gain popularity (Anthony and Watson, 2008, Taylor Nelson Sofres 
Healthcare, 2007). A similar concern was also raised in the stakeholder survey who 
indicated that these services usually gain popularity with time (section 8.4.2.1). 
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10.4.6 Interviewees’ perceptions of facilitators of and 
barriers to CT&T service for pharmacists as providers 
To understand the facilitators and barriers that may have an influence on 
pharmacists’ decision to take part in the CT&T service, participants were asked what 
factors they thought would make it more difficult or easy for a community pharmacy 
to provide a CT&T service. The key facilitators and barriers identified were 
workload, physical infrastructure of pharmacies and business incentives. These 
themes, and their subordinate themes, are listed in Table 10-2 and described in detail 
below.  
Table 10-2: Facilitators of and barriers to provision of CT&T service 
General Themes Subordinate Themes 
Workload New pharmacy contract 
 Workforce shortage 
 Paperwork 
Physical infra-structure of the pharmacy Consultation room 
 Toilet facility 
 Area dedicated to service provision 
 Health & Safety 
Incentives Financial incentives 
 Meeting business targets 
 Professional development 
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10.4.6.1 Workload 
With the new pharmacy contract in force, community pharmacies are now asked to 
expand their role to provide a number of public health services (Scottish Executive, 
2003). Typically, this has meant that community pharmacies are extending their roles 
and taking on tasks previously performed by general practitioners. Published 
evidence generated after these contractual changes suggests that community 
pharmacists enjoy aspects of their new roles, particularly those enhancing their 
professional status and enabling the pharmacist to move from a monotonous role of 
dispensing (Eden et al., 2009). However as suggested from the following quotes, 
pharmacists also experience a sense of burden and that for some there is a lack of 
endorsement of the new role of pharmacists in providing a number of public health 
services. They indicated that they felt their workload and dispensing volumes are 
already very high and expressed concerns about the number of new services which 
they perceived as being imposed on them. 
I think a lot of things being put into community pharmacy; we don’t 
always have the time we would like to give to these things because it 
obviously takes us off the shop floor. (NP-5) 
A lot of pharmacies don’t really want to do extended services because 
we’re so busy; the new contract has given us a huge workload now 
and that’s just another extra thing. (PP-2) 
Due to the increasing involvement of pharmacists in the provision of public health 
services and a resultant increase in the workload, their work environment has become 
increasingly pressurized, which increases the likelihood of dispensing errors and 
compromising patient safety (Gidman et al., 2007), as also typified from the 
following statements: 
Sometimes it’s just really, really busy and if you know that you’ve got, 
you know, loads of prescriptions waiting to get checked, somebody 
else waiting for methadone, blah, blah, blah, blah, it can be really 
distracting, you know, so yeah, time’s definitely one thing. (PP-4) 
I tend to think of developing our role is important. It makes it more 
interesting. The only thing is that it’s difficult to give this type of new 
service a lot of attention when you are still doing volume dispensing 
and you are sort of on your toes and something would happen. 
Funding has got to be right. (NP-2) 
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The latter quote also indicated that the enthusiasm for the new opportunities to 
enhance the pharmacist’s professional role is tempered by the realization that the 
extra services are an addition to an existing heavy dispensing workload, unless their 
extra work is appropriately incentivized. In this regard it is important to note that 
pharmacy contractors are remunerated for providing extra services (The Scottish 
Government, 2008). However, this does not translate into increased personal income 
for employed pharmacists such as those working in chain pharmacies (discussed in 
detail under the theme ‘Incentives’ in section 10.4.6.3). This is further complicated 
by the fact that a competitive business environment in a community pharmacy often 
necessitates meeting certain business targets as well as pleasing their customers by 
providing quick services, as suggested in the following quote: 
So time is always the thing with the community pharmacy, I’m afraid, 
so it’s time. Because nothing’s done by appointment, you know, it’s 
just… people just walk in and expect to be seen. Which, you know, 
nine times out of ten is fine but there’s always… (NP-5) 
However, one pharmacist, although mentioning increased work load, did not 
anticipate that demand for this service would be high enough to cause an actual, extra 
burden. 
But workload, I suppose; if someone felt they really didn’t have time. 
But given that the numbers aren’t likely to be massive that you’re 
seeing on a weekly basis, I can’t really see that is valid either. (NP-1) 
In contrast only one interviewee from a large chain pharmacy did not view the 
proposed service as an extra burden, and she assumed that the CT&T would be 
provided as an adjunct to an EC service.  
I don’t think it would be seen as a big workload to do it because we 
are already doing levonelle. (NP-4) 
A workforce shortage partly explains increased workloads, a concern particularly 
noted for independent pharmacies with limited staff, as narrated in the following 
example:  
When I first put my name down for it I was the only pharmacist 
working here…But now I have a second pharmacist working in the 
shop so I suppose a limit to the service is if I’m on my own and too 
busy… you know, I’m not giving a good service by, you know… not 
only to the person who’s getting EC72 or a chlamydia testing but also 
to the other customers as well. (PP-3) 
 
 
Chapter 10: In-depth interviews with pharmacists……………………………………………………  
297 
Maybe ones that have larger premises with more pharmacists. We’ve 
got only one on at a time so… I mean, the larger [name of a chain 
pharmacy] stores and things maybe have a couple so they’ve got more 
scope to be able to do the extra services. (NP-3) 
However this increased workload is not just perceived as due to the workforce 
shortage. The following quote from an interviewee working for a large multiple 
store, assumes that the additional paperwork needed results in increased workload: 
A paper-work is a big issue because there’s always a lot of paper-
work with the smoking cessation and paperwork with, you know, 
supplying the emergency contraception. There seems to be a lot of 
paperwork … (NP-7) 
Thus increased workload is considered due to heavy dispensing responsibility, with 
shortage of staff to carry out some tasks of the pharmacist and increased paperwork 
related to these services. Previous evaluation of the new pharmacy contract also 
highlighted that increased requirements of recording and paperwork has substantially 
contributed increased workload (Blenkinsopp et al., 2007). 
10.4.6.2 Physical infra-structure of the pharmacy 
The interviewees highlighted the physical infra-structure needed within a pharmacy 
to support the implementation of the CT&T service. Two facilities particularly 
indicated as important for CT&T service provision were the presence of a 
consultation room and a toilet. A dedicated area for service provision was also noted 
as important. 
10.4.6.2.1 Consultation room 
All the interviewees considered the presence of a consultation room as a pre-requisite 
to deliver the CT&T service through pharmacies.  
I think it should be do-able in most places, providing you’ve got 
consultation rooms or just some sort of level of confidentiality 
available, I think that is probably fairly important. (NP-1) 
And those pharmacies which do not have a consultation room (one pilot and one 
non-pilot pharmacy), describes it as a barrier as exemplified in the following quote: 
We don’t actually have a completely private consultation room at the 
moment… and I think that for us is probably… and for the client, is 
probably a barrier because although for emergency contraception we 
tend to take them through back into the dispensary we’re not really 
technically supposed to do that. But there’s not another, you know… 
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there’s not really another option because I feel that talking to them 
about that in the middle of the front shop is not acceptable either. 
Which takes them away from all the other customers but it’s not 
completely private in terms of there are other staff in the dispensary 
and then, depends on what time of day, there can be delivery drivers 
banging on the back door, you know, so it’s not…  Yeah, certainly if I 
was the client and that was happening, I would probably feel quite 
uncomfortable. (PP-4) 
Similar views were exemplified by other pharmacists, as to the importance of having 
a consultation room for the provision of confidentiality and privacy (see section 
10.4.7.2).  
Since the implementation of the new pharmacy contract, all pharmacies are required 
to provide a professional service area, particularly a consultation room/area available 
from the pharmacy (Annex to NHS Circular PCA(P)(2007)28). The Scottish 
Government also provided grants to pharmacies to support improvement and 
upgrading to pharmacy premises, including the consultation area, to facilitate the 
provision of core and additional services through pharmacies (NHS circular 
PCA(P)(2008)21). Currently 36% (n=65) of the pharmacies in Lothian do not have a 
consultation room (Data courtesy: Aileen Muir, Public Health Pharmaceutical 
consultant for Lothian)  
10.4.6.2.2 Toilet  
Another facility which interviewees considered key to the delivery of this service, yet 
which is not widely available in pharmacies, is a toilet for the clients.  
The only thing is we don’t have a toilet out here, we have it in the 
back shop where the staff room is so…I mean, it would be possible but 
it wouldn’t have been ideal but that was one of the things that we were 
a wee bit concerned about. (PP-1) 
Some pharmacists considered the toilet as important to increasing the return rate of 
urine sample: 
As the toilet’s actually there and they do it there and then. It’s very 
easy to go home and dump it down and forget all about it or 
continually put it off. (NP-6) 
Despite the fact, that toilet facility was not a mandatory requirement for service 
delivery (see section 10.4.2.2.1), it was considered as an enabler by both the pilot and 
non-pilot pharmacists.  
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10.4.6.2.3 Area dedicated to service provision 
Despite the presence of a consultation room in most pharmacies, and toilet access in 
some, many interviewees suggested improvement in the physical layout of the 
pharmacy. They particularly indicated the importance of having a dedicated area for 
the service provision, which includes facilities such as a consultation room and a 
toilet facility in one place or in close proximity. Based on her experience with the 
pregnancy testing service, one interviewee described the importance of having a 
toilet close to the consultation room: 
And the toilet, well here the toilet’s right next door to the consultation 
room, it’s not a problem. When I was doing the EC72, when I had to 
do pregnancy testing, I just used to get them to go straight into the 
toilets, do it, you know, the test […] but then it depends how handy the 
toilet is to the consultation room, you know. Because in some of the 
shops you might have to parade the person through the shop to go to 
the toilet, you know. (NP-6) 
Another non pilot-service interviewee highlighted the difficulties with the layout of 
the pharmacy where the consultation room is not close to the dispensing area:  
Well, the problem probably with every pharmacy is it takes the 
pharmacist off the shop floor. And as you see, we’re not very well set 
up because our consultation room is not attached to our dispensary, 
which is really a problem for us, it takes us away. (NP-5) 
However, the above quote also suggested that the desire to remain close to the 
dispensary during a consultation might impede an uninterrupted and a completely 
private consultation to their client due to pharmacist requiring a continuous 
involvement with the dispensing. On one hand, it impedes the confidentiality 
available for consultation due to the possible interruption by other pharmacy staff, on 
the other hand it was noted that such a layout would provide a more discrete service 
to the clients, as noted in the following quote:  
Well, we’ve got a consultation room that you can access from both the 
dispensary and the shop...so it needn’t be obvious; we’re not going 
out and hauling them in. You know, we can just sort of pop our head 
out the door and say “come on”, mm-hm. It’s quite good that way. 
(PP-2) 
A dedicated area is also considered important on health and safety grounds, as 
explained by the following pharmacist:  
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And just where ours is positioned, which is right through the 
dispensary and directly opposite the controlled drug cabinet, with 
health and safety and just, you know… you have seen through the 
back there, it’s not very big, you know, we are really very limited and 
with the number of staff that work in there, three or four, it really 
probably wouldn’t have been practical. (NP-1) 
As evident from the above quote and also further elaborated later, pharmacists 
interviewed from non pilot pharmacies generally described independent pharmacies 
as ‘quite tight for space’ (NP1). However pilot-service pharmacists either did not 
bring up the issue of inadequate physical space, or as in a case of an independent 
pharmacy owner, considered the shop layout appropriate in terms of a space within 
his pharmacy:   
Mufiza: Do you think there are any structural factors which would 
impact the service in some way? 
Interviewee: No, my shop is set up well for this kind of thing, I’ve got 
the consultation room through there with a computer in it and I’ve got 
an advice room through there which is generally used for supervision 
of methadone. Yeah, so there’s the consultation room and it’s only a 
small shop so it’s really well laid-out in my opinion. (PP-3) 
It should be kept in mind that pilot-service pharmacies are a self selected sample, and 
it is hence likely that they were tend to be those pharmacies who considered their 
physical layout and space as suitable for the service.  
A previous bio-photographic study, which aimed to analyse the relationship between 
community pharmacy workspace and practice, has indicated an inadequacy of space 
in pharmacies to incorporate the provision of public health services (Rapport et al., 
2009). However pharmacists working in large multiples are, in general, perceived as 
more satisfied with the space and layout. The same study identified that the current 
layout used by many pharmacies is designed to maximize product sales and is not 
conducive to service provision.  
10.4.6.3 Incentives 
Many interviewees indicated that if the service generated income, this would be a 
key facilitator for provision of CT&T. This factor was identified irrespective of 
whether it was an independent or a chain pharmacy or whether it was a pilot or a 
non-pilot pharmacy.  
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Umm…was there payment for the service? Because that may 
influence…Because [Name of a chain pharmacy] is about business, 
just being honest about it, I think probably a lot of pharmacies would 
be aware that it’s going to generate income. And also they have got 
targets to reach for services, income and things, so that probably 
would be a factor, they would be willing to do it on that basis. (NP-4, 
a chain pharmacy) 
Any kind of service like that, which is a) a good service and b) we 
actually get paid for, you know, I’m happy to do. (PP-3, an 
independent pharmacy) 
The financial benefits were seen to drive participation of independent and chain 
pharmacies in different ways. In case of an independent pharmacy, the incentives 
directly benefited the pharmacist who was often also the owner of the business. 
Whereas, in case of a chain pharmacy, the employee pharmacist needs to reach 
business targets. The second quote above echoed the findings of another study that 
pharmacists working in chain pharmacies are often under pressure to reach business 
targets (Murphy, 2007).  
However, when asked which pharmacies should be targeted for invitation to provide 
this service, the independent pharmacists were perceived as being attracted more to 
such a service, due to the direct financial benefits to them. The employee pharmacists 
described the lack of financial benefits to them personally, in terms of bonuses or 
wages, if they got involved in such services.  
It won’t have as much an impact on a pharmacist that works for 
chain. They wouldn’t particularly benefit. I don’t know you want to go 
down the road targeting her… difficult. (NP-2, an independent 
pharmacy) 
But I think when you’re based in a store it’s not quite so immediate, 
the need (laughs) to get more money, so it’s not something that, you 
know, affects us really directly, it doesn’t affect wages or anything. So 
I think that would probably be the main thing; it would be the small, 
independent who would be more likely to say yes straight away, yeah. 
(NP-7, a chain pharmacy) 
I am not too sure of the incentives, to be honest, because I’m not a 
manager here, you know, I’m just one of the pharmacists that works 
here (PP-1) 
In contrast to the above findings, which indicated that pharmacists perceived more 
benefits for owner pharmacists and hence their likely involvement in the service 
provision, a survey of community pharmacists conducted in 2009 indicating that 
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11% of the chain pharmacies in Great Britain were providing chlamydia testing as 
opposed to 3.1% of independent pharmacies (Bush et al., 2009). It might be due to 
the fact that despite independent pharmacies wishing to be more involved in the 
service oriented roles due to the financial pressure from chain pharmacies, the latter 
are more likely to attract commissioning from the NHS due to an obvious ease of 
doing so whereby a contractual agreement with the chain pharmacy meant that a 
number of pharmacies working within the chain would provide the service. This 
dilemma might be seen in the earliest pilot of pharmacy chlamydia service in the UK, 
which was commissioned by the Department of Health through the pharmacies of a 
large chain (Taylor Nelson Sofres Healthcare, 2007).  
In addition to the business reasons, some interviewees however also indicated 
professional satisfaction gained by providing patient-oriented services and in 
developing a new pharmacist’s role in service provision.  
I usually say yes to most things. Because I quite like development 
work you know. I think pharmacy could develop quite nicely along 
these lines. (NP-2) 
We’re being very pharmacy-services aware and this is a pharmacy 
service. So no, I think I would be surprised if anyone who works for 
Boots didn’t want to do this. (NP-4) 
In an evaluation of the recruitment strategies of pharmacists in dispensing EC, 
pharmacists who participated in the project considered that non-participation would 
be costly, not only in terms of client flow but, just as importantly, in terms of being 
viewed as old fashioned and not oriented to providing a health service (Cockerill et 
al., 2004).  
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10.4.7 Interviewees’ perceptions of facilitators of and 
barriers to CT&T service for young people 
Interviewees were asked to provide an assessment of the CT&T service in terms of 
facilitators and barriers to young people accessing it. They spoke about the factors 
which they believed were clear benefits of the service in comparison to other 
providers of chlamydia testing such as GP practices, GUM or FP clinics. They also 
described the drawbacks that such a pharmacy setting could have for young people 
who wish to get tested for chlamydia. Across all in-depth interviews (both pilot and 
non pilot interviewees), the factors thought to act as barriers and facilitators were 
summarized using five main themes: convenience and access; privacy, anonymity 
and confidentiality; lack of promotion of the service; motivation for testing; and 
attitude and manner of the pharmacists. These themes, and their subordinate themes, 
are listed in Table 10-3 and described in detail in the respective theme heading.  
Table 10-3: Facilitators of and barriers to access CT&T service for young people 
General Themes Subordinate Themes 
Convenience and Access  Availability, when other are closed 
 Geographical access 
 No need for appointment 
Privacy, Confidentiality and Anonymity Embarrassment 
 Stigma 
Lack of promotion of the service Inadequate advertising 
 Difficulties in targeted promotion 
Motivation for testing Perceived risk of chlamydia 
 Socio-demographic of the client 
 Socio-demographic of the pharmacist 
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10.4.7.1 Convenience and access 
Ease of access and the convenience of a CT&T service, were mentioned by the 
majority of the interviewees as facilitators for young people to use the service. 
Important aspects were availability when other health care services are closed, 
geographical access and no need for appointment for a pharmacy service.  
Some interviewees considered that no need for an appointment with the pharmacists 
would alleviate a current frustration for many people wanting to otherwise arrange 
appointments with other health care professionals. One interviewee cherished the 
perceived access advantage that community pharmacies offer over other health care 
providers. 
You can get access to something easier is better than having to make 
an appointment or the rest of it. I mean that’s the beauty of community 
pharmacy really that there is almost a no wait situation. So if there 
are any worries and concerns than you can alleviate from it quite 
quickly. I think it’s a good idea. (NP-2) 
What emerged from the above quote is the fact that a ‘no wait’ situation could also 
provide better outcomes as anxieties are relieved more quickly. This view was 
echoed in another pharmacist’s response as well: 
I think it’s important to have things like that in pharmacies as well 
because they can have someone to talk to there and then as well. As I 
say, it’s by no appointment so they can come in even if they wanted to 
ask about it without getting tested, just maybe find out some 
information. (PP-1) 
However this quick advice could lead to a trade-off against the more detailed 
consultation that the GPs could provide, which is particularly warranted in a sexual 
health consultation. A survey of patients’ satisfaction with pharmacist consultation 
indicated that patients who received longer consultations and were provided with 
more types of information during consultation, reported the highest satisfaction with 
the service (Schommer, 1995). Another survey reported that although people 
frequently identify the pharmacist as a good source of advice, in practice they 
generally prefer to consult with a GP (Hughes et al., 2008). However no need for an 
appointment remains a unique selling point for community pharmacies, as the clients 
are more likely to access a service if they are not required to make an appointment 
within the pharmacy (Blenkinsopp et al., 2007).  
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Some interviewees also described convenience of a pharmacy service in terms of it 
being a one-stop shop, where testing, treatment and partner notification could all be 
carried out in one place, without needing repeated appointments, as is the case in GP 
surgeries.  
I think it’s so much easier for them to come in here, get the test, then 
come in here, we’ll do the prescription, we’ll get all the contacts... 
Yeah, it’s just so much easier; we’re far more accessible than making 
appointment. (PP-2) 
Accessibility of the service was described in terms of the long opening hours that the 
pharmacy offers and its opening over the weekend. Some interviewees indicated that 
a pharmacy may be an alternative option when other health care services are not 
available. This was particularly compared with GUM clinic which offers drop-in 
services only on selected days/hours in a week. Another interviewee compared it 
with the GP surgeries which are not open over the weekend. 
Pharmacies are kind of  ... they’re all over the place, they’re open 
weekends, they’re open kind of later as well sometimes and you can 
just pop in and, you know. (NP-7)  
So particularly at weekends and things like that, normally GPs aren’t 
available, you know, at least somebody could come in on a Saturday 
and be treated. (NP-5)  
The geographical advantage that community pharmacies offer was compared by 
interviewees to the specialist sexual health services (such as GUM clinics). The fact 
that community pharmacies are distributed widely within the community, close to 
work, home or on the way to school has been cited as advantages by many 
interviewees. A location close to home gives an advantage particularly to YP in 
terms of maintaining confidentiality of access from their parents as it would require 
less time to be away from home, as compared to accessing GUM clinics that are far 
away and would require longer time for them to access those clinics. 
They can find one that’s local to them, it’s going to take them much 
less time – because I think these things are the things that put them off 
going to certainly the GUM clinic, you know, it’s the journey in, the 
wait all day…you know, if they’re 15 or whatever, how do they 
explain to a parent where they’re going and why they’ve been away 
all that time whereas they can probably manage to squeeze a visit into 
a pharmacy without too much difficulty. (PP-4) 
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The issue of anonymity and the interlinked theme of confidentiality and privacy are 
discussed further in detail in the next section. 
10.4.7.2 Privacy, confidentiality and anonymity 
The notion of ‘confidential’ or ‘confidentiality’, ‘private’ or ‘privacy’, and 
‘anonymous’ or ‘anonymity’ for YP were invariably raised and discussed by the 
interviewees. Whilst these are inter-related concepts, there are distinctions, so it is 
important to define these terms before these are further discussed. The Concise 
Oxford Dictionary defines confidentiality as: ‘intended to be kept secret’ while 
privacy is defined as ‘the state of being free from public attention’. Anonymous is 
defined as: ‘of unknown name, of unknown authorship’. In the ethics literature, 
confidentiality is commonly understood as akin to the principle of privacy. 
When asked to reflect upon the barriers for young people in accessing the pharmacy 
CT&T service, immediate issues were identified by a few interviewees in terms of 
respecting the confidentiality of clients in pharmacies. It was perceived by many 
interviewees that young people might consider a pharmacy as a less confidential 
place to access such a service. 
I think; a shop like this is the type of place where our staff here will 
know virtually everyone who comes through the door, young or old, 
and they all know them… I mean, I like to think that our staff are 
100% on that and everyone here is certainly very, very clear on the 
need for confidentiality. And they do see things on the daily basis 
which would probably be fodder for gossip but I am pretty sure that, 
in a community of this size, had any of that been leaked we would 
know about it by know. So I like to think that we would be well set up 
for that. (NP-1) 
Another interviewee quoted: 
I mean, I wonder sometimes whether people are maybe put off if they 
perceive that maybe not all of the pharmacy staff will keep it to 
themselves. (PP-4) 
Such comments also hinted at the traditional image of the local independent 
pharmacies where staff are engaged, both as having a health care role but also as 
being ordinary members of society. The staff and the owner are often on first name 
terms with customers and there is thus a potential for confidential information to be 
leaked. However it was not just the matter of confidentiality being maintained at staff 
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level. Some pharmacists also discussed the potential barrier for a young person if 
s/he believes that the pharmacy consultation might be disclosed to his / her GP.    
It’s a busy shop, they’ll see other people they know so we’ve got to be 
very discreet. If they know a member of staff, that’s another thing. Or 
if they suspect that we’re going to tell the surgery, a lot of them don’t 
want that reported – well, we don’t but I don’t think they realise that 
we don’t. (PP-2) 
This fear of inadequate confidentiality might not be limited to the nature of a 
pharmacy staff-client interaction or the possibility of a pharmacist-GP interaction. It 
was also viewed as a result of the shop environment, with open access and, often, 
limited space. Hence many pharmacists considered the consultation room to be a pre-
requisite, to establish privacy in their consultations.   
You do need to have a consultation room, there is NO WAY you can 
do something like that. (NP-6) 
We have a consultation room so we’re quite happy about that. And I 
mean, at quiet times they can come in and speak to us, at the minute 
they can ask to use the consultation room, I don’t think that’s a 
problem if they want to speak privately, yeah, to us. (NP-7) 
While consultation rooms are now often a part of community pharmacies, they are 
not universally available. In my interviewee sample, only one independent pharmacy 
from the non-pilot pharmacies was without a purpose made consultation room. She 
particularly felt the limitations and described her situation as follows:  
I take people into the kitchen or to this office, we have a private area 
but it’s not really confidential. I think that puts people off. (NP-2) 
Furthermore the necessity for making an initial request for a consultation at the 
counter constitutes a barrier of stigma and embarrassment to many young people. 
This embarrassment is considered less of an issue in a clinic environment, whereas a 
busy shop environment can be daunting to young person, if needing to ask for the 
service at the counter.  
I mean, especially with the consultation rooms and things like that, 
it’s confidential to sit down and speak about these things and things 
shouldn’t really get heard out there if we’re in here anyway. The only 
thing is the initial coming in and asking for it. […] It is embarrassing, 
especially for young people. I think it is… sometimes for them to go to 
a clinic they see that as a place to go so they’re quite happy to do that 
whereas here they’re scared in case they have to ask in front of people 
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in the shop and if they’re from this area and they know people that 
work here, they might not want to ask. (PP-1) 
One of the primary objectives of the pharmacy chlamydia service was to provide 
accessible care to young people in a non stigmatised environment. It is important to 
note here that there are many reasons of embarrassment associated with accessing a 
pharmacy-based chlamydia service, as identified in the literature, such as knowing 
someone in the store, knowing the pharmacist, having to ask for the kit, and the 
pharmacist’s age and gender (section 4.3.7.1.2). However, it may be that if the 
service is accessed in an area where the staff or other shop clients are un-known to 
the young person, then the concerns of embarrassment and stigma may be 
diminished. Thus a choice of getting CT&T in any pharmacy, and not necessarily 
close to their home, might overcome the embarrassment as well as the fear of not 
getting an anonymous service, as the following quote suggests:  
... and they can probably go into… they can change area if they want, 
can’t they, they can come into one where they’re anonymous…?, 
which a lot of people do. (NP-5)  
Another pharmacist quoted: 
I think if there’s an awareness that the service is there and you can get 
it in literally any pharmacy in Lothian, I think that will be a good 
thing, or even a list of the pharmacies that do offer it, because then 
they can choose to go to a pharmacy on their way to school where no 
one will know them or on way to work or on the way home from work 
or in a city centre or…if they don’t want to go to their local pharmacy 
but they’ll know that the services are there. (NP-1) 
The choice to access any pharmacy is particularly considered as an advantage over a 
GP setting by several pharmacists in terms of offering anonymity, as was also 
indicated in a following quote of the pharmacist working in a pharmacy from a large 
urban area:  
You don’t necessarily have to go to your own GP … or you would 
have to with your own GP but you don’t necessarily have to go to your 
usual pharmacy so you can go to a pharmacy somewhere else if 
you’re… you know, if embarrassment is a problem. (NP-7) 
These findings echoed the findings of other evaluation studies of a pharmacy-based 
chlamydia service that considered the issue of anonymity less of a case in a 
pharmacy service than having to go to their own GP (Anthony and Watson, 2008, 
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Taylor et al., 2007, Taylor Nelson Sofres Healthcare, 2007). Another study exploring 
the facilitators of EC provision through a community pharmacy indicated that 
pharmacist perceived EC provision as a means of accessing EC to those who wished 
to remain anonymous to their GP or other provider (Bissell et al., 2006).  
Although a community setting offers its own advantage, of being close to the service 
user’s home or work, thus providing easy access, it is clear from above examples that 
pharmacists believe that young people might prefer to go to a place where their 
identity remain anonymous. However there is a need to weight the advantage of 
providing an anonymous service from a pharmacy against the important 
epidemiological information that might be missed out. Some level of identification of 
the individual is crucial in risk factors identification and further follow-up of at risk 
individuals. The routine data analysis (chapter 3) identified the lack of patient’s 
information on postcode as a hindrance to identify the equity of coverage and 
diagnosis of chlamydia in a Lothian population.  
10.4.7.3 Lack of promotion of the service  
All the interviewees (both pilot and non pilot pharmacies) commented that the CT&T 
service was not adequately advertised by the NHS and that for young people a lack 
of awareness of the service would be a main barrier to the uptake of the service.  
They don’t know it’s available. It’s not been advertised. They just 
don’t know it’s around so they just don’t know to ask for it. (NP-6) 
I think potentially people are not aware that it was in existence…and 
then it potentially… I mean, I don’t know but potentially the 
perception of how much privacy they would get may have impacted 
whether people would come to us or not. But I do think in the main it 
was probably because people didn’t know it was even there, you 
know. (PP-4) 
Most of the interviewees refer to their experience with EC provision, where due to 
similar lack of promotion, the service took a long time to take on.  
So I think it’s basically because it’s not advertised, they don’t know 
it’s available. I think more people are becoming aware of the fact that 
you can get emergency contraception in pharmacies. And I mean, 
that’s been going for quite a long time, about a year now?....I think 
there’s still quite a few people out there who know that you can 
actually get it in a pharmacy, they still think they’ve got to go to the 
doctor or they’ve got to go to family [planning clinic]. (NP-6) 
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The most common suggestions for promotion of the CT&T service were through 
schools, colleges and in-store pharmacy promotion.  
I mean obviously posters in the pharmacy where it’s done is going to 
be a big help because people will catch sight of those. And I would say 
in schools, school nurses? I don’t know if they do have anything to do 
with it. So erm… I don’t know, what are young people up to these 
days? (laughs) I would say probably through the schools is the best 
thing. (NP-7) 
Other suggestions given were promotion through GP surgeries, GUM clinics, 
recommendations during EC consultation by the pharmacists, information on 
NHS24, and teenage magazines.  
In my earlier interviews with the non-pilot pharmacies, having identified the theme 
of ‘lack of promotion of the service’ as a potential reason of the low uptake of the 
service by the clients, I asked specifically the pilot pharmacy interviewees for views 
on how the service was advertised. They highlighted the ineffective advertising 
material provided by the NHS from in-store pharmacy promotion. Another 
interviewee criticised the little attention given by the NHS on the promotion of the 
service. Following are some of the quotes of the interviewees from pilot pharmacies: 
Well, the notices that we were given were tiny wee ones…and with just 
writing on them, you know, there were no pictures or…they weren’t 
attractive, you know, and I think it would have been appropriate for 
colourful, bigger ones to go up in libraries, health centres, in our 
window. Do you not think so? Sorry, I’ve taken it down (while 
referring to the poster she has), we had one and it was an A3.[…] it 
didn’t stand out. (PP-2)  
If you are going to put money and time into providing a service then, 
you know, you have spent all that money on resources and it almost 
seems a little short-sighted not to promote it. (PP-4) 
Although the lack of advertising was considered the main barrier, the intrinsic 
complexities and difficulties in carrying out promotion were also acknowledged by 
the pilot service interviewees. It was the views of pilot interviewees that promotion 
strategies needed to be targeted but cost efficient, and that promotion through TV 
would be inappropriate.  
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I don’t think nightclubs would be too happy having it up on their wall, 
would they? (laughs) I mean, TV but TV’s expensive. You know, in the 
middle of Coronation Street or something like that, imagine how 
expensive that would be! (PP-3) 
The stakeholder survey respondents have also identified difficulties in carrying out 
promotion of the CT&T service to young people (section 8.4.2.1). The hesitance of 
GP surgery staff to display posters or hand out leaflets about chlamydia screening 
has also been recognised in previous studies (Freeman et al., 2009). In a promotional 
campaign for chlamydia in England called ‘Worth talking about’, it was advocated 
that, in order to be effective and to avoid causing offence to young people, chlamydia 
screening promotional strategies should be positive, non-judgemental and action 
oriented (Quilliam, 2011).  
10.4.7.4 Young person’s motivation for testing 
Some interviewees stated that although discussing sexual health would be expected 
to be a barrier for young people, this barrier might be easier to overcome if a young 
person perceived him / herself to be at high risk of having contracted chlamydia.  
It’s very much depend on the client and what’s their motivation for 
being tested. There might be a very high motivation for being tested in 
which case you would probably overcome the uncomfortable feelings 
that you would have discussing it. (NP-2) 
Thus the perceived risk of getting chlamydia and its consequences may overcome the 
barrier of communication with the pharmacist. There are multiple factors assumed to 
contribute to the perception of risk including previous diagnosis of chlamydia, 
multiple or new sexual partners and not using a condom, as discussed by 
interviewees. Risk perceptions are further complicated by the fact that chlamydia 
often does not produce physical symptoms. Another study reported that in the 
absence of symptoms, young people were not sufficiently motivated to seek out 
screening themselves (Pimenta et al., 2003). This concern was also raised by a few 
pharmacists as follows:  
Just knowing that even if they haven’t used protection and they don’t 
have any symptoms that they might still have something but, you 
know, a lot of people aren’t educated to know that sort of thing so 
they’re not going to come in if they don’t feel like they have anything 
wrong with them just to be tested to make sure. (PP-1) 
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It depends on the client really, on how mature they are. You know 
whether they want to be tested or not or whether they think it’s worth 
it. (NP-2) 
Personal attributes of a young person is also perceived to contribute to the motivation 
for testing. For example, some interviewee considered ‘older ones’ tend to get tested 
and other described it to depend on the ‘education of the patient’. However in terms 
of gender of the young person, being male was not considered to be a barrier for 
getting tested for a young person. 
Mufiza: What do you think about the boys? Are they going to come to 
get the service?  
Interviewee: Erm… yeah I think… I think if they know that they’ve got 
it, they will. I think if they know, because they’re going to panic if they 
think it’s going to affect their fertility or like do things down below 
and I think boys will be quite quick to protect that area. But I think as 
long as the boy gets to find out, I think if he is made aware, I think the 
boy will come in. I don’t think a boy would carry it and not care. I 
think he’d be quite worried about protecting his ‘area’ (laughs). So I 
think if they know they had it I think they would come in, traditionally. 
(NP-4) 
However, for young girls, it was perceived to be barrier in deciding to seek testing in 
a pharmacy where they find male pharmacist.  
I think perhaps young women might not come in and speak to a young 
male pharmacist about it. That could be a factor. (NP-2) 
These views were from the non pilot-service pharmacists, but amongst the pilot 
pharmacy interviewees, apart from the young age of the clients, other socio-
demographic factors of the client such as their gender and education level or the age 
or gender of the pharmacists were not identified as barriers to testing in a pharmacy 
setting. My argument is further strengthened in the next section on ‘attitude of the 
pharmacist’, in that participating pharmacists do not recognise or acknowledge 
personal factors, such as their attitude or socio-demographic profile as affecting the 
uptake of the service. However their views are different from those pharmacists who 
participated in a pilot chlamydia service in Manchester, where the pharmacists felt 
the gender and age of young people might have been a barrier to their choice when 
seeking a test in the pharmacy (Thomas et al., 2010). In another evaluation of a 
pharmacy-based chlamydia service, a pharmacy who withdrew from the pilot study 
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indicated their lack of a female pharmacist as a barrier to recruiting young girls 
(Gudka et al., 2010). Moreover clients (young people) also indicated their selective 
approach of getting tested, if the pharmacist was identified as being young and/or 
female (Taylor et al., 2007).  These contradictory perceptions of the pilot 
pharmacists and non-pilot pharmacists in my study compared to those recruited in 
previous evaluations might result from the virtually non uptake of the chlamydia 
testing in the present study. Hence the pilot-service pharmacists might have been 
cautious in describing any personal factors as the potential reason of the failure of the 
service.  
10.4.7.5 Attitude and manner of the pharmacists 
A few non pilot-service pharmacists indicated that the uptake of service would also 
depend on what contributed to the young person’s expectations of the attitude of the 
pharmacist. Young people would feel at ease if the pharmacist is ‘approachable’ and 
‘non-judgmental’ (NP-1). Some pharmacists reflected on this aspect while referring 
to their experience of EC service provision. 
I think it depends again on how approachable the pharmacist is 
really? We tend to get quite a lot of people coming in here for advice 
[for EC]. You know I am quite open and I don’t mind talking about 
things. We give a lot of advice. (NP-2) 
Sexual health care provision such as EC and CT&T are relatively new roles to 
pharmacists. Judgmental attitudes revealed by the pharmacist or by their support staff 
toward the young people accessing sexual health services would impede quality of 
service delivery, influence uptake of the service and ultimately would have a 
negative influence on the service user (Gudka et al., 2010). It was also emphasized, 
in the stakeholder survey, on the training of the pharmacists to adopt a non-
judgmental and friendly manner towards the clients. This is further discussed in 
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10.4.8 Interviewees’ perceptions of attitude of key 
players of the CT&T service - pharmacy staff, GP and 
potential clients 
According to the Theory of Planned Behaviour, an important component that 
determines a person’s intention to perform some action is a subjective norm. 
Subjective norms (about the behaviour) are an individual’s own estimate of the 
social pressure to perform or not perform the target behaviour. In a community 
pharmacy setting, these ‘subjects’ might include GPs, other pharmacy staff and 
potential clients. The need for policy makers to consider the influence that clients’ as 
well as doctors’ attitude could have in a pharmacy service delivery has been 
highlighted (Hoti et al., 2011). Therefore, I asked pharmacists their perceptions of 
their support staff, potential clients and GPs attitude towards a CT&T service.  
10.4.8.1 Perceived attitude of the pharmacy staff  
In the current CT&T service model, pharmacy support staff are not involved in 
delivering the service. However they are the gatekeepers, controlling a client’s access 
to the pharmacist. Most pharmacists indicated that their pharmacy staff would be 
comfortable with the availability of the service in the pharmacy. They perceived that 
their staff are clear about their level of involvement in the service and would refer the 
client to the pharmacist immediately. 
I think it was just that, you know, the service was there, they weren’t 
uncomfortable with it, they were quite happy that it was there but they 
didn’t see it as their role, you know, it was really the pharmacist’s 
role. (PP-4) 
I think they would be quite happy. They are very good at referring. 
(NP-4) 
Many pharmacists explained their staff attitude, by referring to the other services 
which their pharmacies are already providing, particularly the EC, methadone, needle 
exchange and smoking cessation. Although it is not a direct measure of pharmacy 
staff attitude towards the service, 61% of the counter staff in our TNA survey 
indicated their ‘moderate’ or ‘high’ enthusiasm for the service. Only 14% of the 
counter staff expressed concerns about the proposed CT&T service and this was 
mostly regarding their insufficient knowledge or training to communicate with the 
customer. This finding is also echoed in the following response of a pharmacist: 
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I think they might be a bit uncomfortable about talking to a client and 
in this pharmacy they are not awfully comfortable about doing these 
extended services. But they don’t mind dropping me in it (laughs). 
[…].Although again that might be just the training issue. I have 
tended not to develop that very much here because of our premises. 
(NP-2) 
Thus from those interviewed/surveyed, the issue is not so much of the staff 
disapproval of the service per se, but their lack of confidence to deliver the service, 
which could be overcome by training, if the pharmacists provides this. Thus it could 
be speculated that the pharmacist’s attitude, and resulting training provision to their 
staff, has an important effect on the attitude of his/her staff.  
10.4.8.2 Perceived attitude of the potential clients 
Extending the role of the community pharmacist will only be effective if the new 
roles are what the potential clients find acceptable. A few pharmacists felt that clients 
would respond positively to this service being provided by the pharmacy. Some 
interviewees indicated that trust building would depend upon the increasing use of 
service, a relationship that is dynamic and evolving. 
But these sorts of things have been growing in popularity, people are, 
I think, more aware of what a pharmacy can do. (NP-1) 
I think that the more people maybe see us as the point to come to, 
probably the better these services will do, they’ll maybe actually think 
of coming and asking us rather than going straight to the GP or 
whatever so...(NP-5) 
The above quotes indicates that as the public become more accustomed to the 
extended role of pharmacists, a newly added service is more readily accepted by 
customers. The above interviewee also foresees the shift of first port of call to 
pharmacies rather than to GPs, which might result in improved access to health care. 
However the pilot service pharmacy interviewees had different views. They 
perceived that young people would prefer to go to the GP or specialist SH clinics, an 
opinion which might partly reflect their experience with the very poor uptake of the 
service.  
I don’t think they would prefer to come here. And I think that’s 
probably backed up by the fact that we only did two. GUM clinics are, 
you know, very specialized and...Yeah, I’d say we were the last port of 
call out of the three (referring to GP and GUM clinic). (PP-3) 
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The findings of the potential service users’ survey indicated that young people 
preferred to be tested or treated in the specialist SH clinics. However these results 
may be biased because the sample was primarily derived from the SH clinics. In 
another in-depth interviews study conducted with women on the perception of EC 
provision by pharmacists, it was found that women do not see pharmacists as health 
professionals but rather associate pharmacy as a place of business, which is less 
personal and will not tend to give counseling and advice (Weiss et al., 2007).  
10.4.8.3 Perceived attitude of general practitioners 
As pharmacists are extending their roles and taking on tasks previously performed by 
GPs, it would be interesting to know how pharmacists perceive the attitude of GPs 
towards this shift of the pharmacist’s role to a more patient oriented service. Overall 
the pharmacists perceived that the GPs would be very supportive of delegating their 
role to pharmacists to perform the CT&T service.  
Well, the ones here are very encouraging. They want us to do it. (PP-
2) 
I think they’re getting used to pharmacies, aren’t they, getting more 
and more involved in these things! (NP-5) 
The benefits indicated by most pharmacists were mainly related to ‘self interest’ of a 
GP on shifting their work load to pharmacists.  
I think they’re probably quite glad of it. Obviously it takes away some 
of their workload. (PP-1) 
On the contrary, the main reason given for the perceived lack of GPs support can be 
described as ‘political’, i.e. pharmacists’ encroachment on GPs territory.  
Doctors are not sort of, erm... a homogeneous lot. There’s good, bad, 
there’s ones who would be quite happy for the pharmacist to be 
completely involved in everything and others who think pharmacists 
should be just standing there counting pills, […] I think we’re 
stepping on their prescribing toes, you know… (NP-6)  
The more negative perceptions of GP behavior towards pharmacist’s role, such as the 
pharmacists’ encroachment of boundaries and business, were indicated only by non-
pilot pharmacists. This might suggest that once the pharmacists get involved in this 
new role, their negative perceptions towards GP’s attitude would wear off.  
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However it was not just the case that interviewees perceived GPs as reluctant to 
delegate the clinical role to pharmacists. There was also evidence of some 
pharmacists not wanting to move into diagnosis and prescribing and exhibiting a 
differential attitude towards doctors. As one pharmacist quoted: 
I don’t think there’s many pharmacists… they’re not experts in this 
unfortunately, so us giving advice sometimes is a bit… you know, it’s 
not the best because we’re not experts, so whether we’re giving the 
right advice sometimes, you wonder. (NP-5) 
These findings seem to confirm the conclusions of other studies that suggest 
community pharmacists’ reluctance to encroach on doctors’ territory, for example by 
refusing to accept a prescribing role, meant that they ‘unwittingly committed 
themselves’ to remain in a subordinate role in a paramedical occupation (Eaton and 
Webb, 1979). However few pharmacists were quite positive and confident about 
their newly developed public health role. As one pharmacist said: 
I think there are even more things which we can obviously do. So 
yeah, I think it’s evolving the right way and I think this is the sort of 
thing that we should be doing, rather than just checking prescriptions 
all the day. So yeah, I quite enjoy doing things like that. (NP-4) 
It appeared that young pharmacists were more enthusiastic to take on a new role of 
extended public health service provision. A study by Hughes and McCann confirms 
some of the above findings that community pharmacists were considered by GPs on 
the periphery of the primary health care team and conflict between business and 
health care permeated the GPs attitude (Hughes and McCann, 2003). Similarly 
community pharmacists also felt that such views influence their position in the 
hierarchy of health care professionals.   
10.4.9 Potential impact of the CT&T service 
The interviewees’ attitude towards the potential impact of the CT&T service was 
generally favorable. The interviewees considered this service as not only effective 
from a ‘society perspective’ (i.e. by reducing prevalence), but also considered the 
cost effectiveness of this service from ‘health service perspective’. By taking part in 
the service, they see themselves as health professionals contributing to public health 
by reducing chlamydia prevalence.  
 
 
Chapter 10: In-depth interviews with pharmacists……………………………………………………  
318 
Well only in that, chlamydia is one of those hidden diseases the more 
people you can reach the more you can help. And I see that it is a part 
of my role as a community pharmacist just helping people in my 
community. The fact that people can have chlamydia and would not 
know is a worry. (NP-2) 
Well, I knew the statistics for chlamydia with the youngsters and I 
thought “well, it’d be good if we could do something about that”. 
(PP-2) 
It is reflected from the above quotes that pharmacists see themselves as public health 
providers who perceive the CT&T service as an opportunity to deal with the disease, 
hence benefiting their community. One pharmacist however attempted to provide 
another perspective of the effectiveness of the CT&T service. While giving an 
example of the pharmacy smoking cessation service, he indicated that these services 
would also benefit the NHS in the long run.  
And I think we can make an impact really and we definitely have an 
impact in this community with smoking [cessation], I mean, there are 
probably upwards of a hundred patients who were smoking who we’ve 
managed to get off in the last year or year and a half. So that’s going 
to have a knock-on effect for what the cost of these patients to the NHS 
is, going forward. And I think same is certainly true of chlamydia as 
well. If the pharmacy can make a large reduction in the prevalence of 
this, a pharmacy in general, then obviously it’s going to be cheaper 
than treating separate related problems down the line or just the 
number of people needed to treat to keep this down or to, hopefully, 
virtually eradicate it locally. (NP-1) 
Although the interviewees were generally pessimistic about the possible impact that 
the service could have in terms of lowering prevalence and cost saving impact on the 
NHS, but at the same time they also anticipated a low uptake of the service.  
I am not overly sure how much uptake there would be of it. (NP-2)  
They linked the low uptake mainly with an inadequate service promotion (a theme 
discussed in detail in section 10.4.7.3) and consequently young people are ‘unaware’ 
of the service. The way in which pharmacists frame the outcome of a pharmacy 
CT&T service (positively or negatively), indicates the combination of their realistic 
and unrealistic approach. In the above scenario while the pharmacist perceive this 
service as a way of reducing or ‘virtually eradicating’ (NP-1) chlamydia, they also 
expects a low uptake of the service. This indicates that interviewee’s perception of 
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impacting the chlamydia prevalence through the CT&T service is rather theoretical 
or aspirational.  
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10.5 Discussion 
10.5.1 Strengths and limitations  
A major strength of this study is that the interview questions for this study were 
underpinned from the outset by a theoretical model for behaviour (i.e. the Theory of 
Planned Behaviour (TPB)) as well as being informed by a structured literature 
review on a pharmacy-based chlamydia service. This provided me with a priori 
evidenced model within which the data was explored. The TPB proved to be a useful 
framework for examining a pharmacist’s motivations for the provision of a CT&T 
service. The analysis and interviewing occurred iteratively with the findings from 
earlier interviews checked and expanded upon in later interviews. The study is also 
unique in that the perspectives of both the non-pilot and pilot pharmacists were 
included in this study. None of the previous evaluations of a pharmacy-based 
chlamydia service incorporated the views of non-pilot pharmacist, which I consider 
is a crucial exclusion in the sense that the reasons of non participation in the service 
could not be elicited. Identification of reasons for non participation of pharmacists in 
the current study led to an important finding of miscommunication that existed at 
various levels. Had the service been continued, these finding would have led to the 
recruitment of many more invited pharmacies in the service. Nevertheless these 
important findings would help improving the recruitment of potential providers in the 
future services.  
Overall the pharmacists who participated in this study presented positive views of the 
intervention. They generally showed enthusiasm to provide the CT&T service, but 
due to deficiencies in communication with NHS Lothian, many of them were unable 
to do so. Those interviewed may represent a self selected sample of those 
pharmacists who were interested in providing the service and might not represent the 
views of those who declined to be interviewed. Moreover there is also a possibility 
that some participants may have self-censored their comments or provided socially 
acceptable or politically correct responses during the interview process (Creswell, 
2007). 
Given the very poor uptake of the service, the pilot-service interviewees did not have 
enough experience to reflect meaningfully on different aspects of the service. This 
 
 
Chapter 10: In-depth interviews with pharmacists……………………………………………………  
321 
meant that both the non pilot-service interviewees and pilot-service interviewees 
considered hypothetical the facilitators and barriers for the service as well their 
perception on the clients, GPs’ and staff attitudes towards the service. However, 
many interviewees indicated their thoughts while exemplifying other pharmacy 
service provision, particularly in relation to the EC service. It may be possible that 
their response might differ had they been actively involved in the service. However 
the findings of this study not only confirmed those of other chlamydia service 
evaluation studies, but also offered an unfolding of the connection among different 
themes which was not possible in the review of the literature.   
The poor response of potential clients to the service also affected the participating 
pharmacists’ motivations to take part in the in-depth interview study. Out of a total of 
12 participating pharmacists, I was able to recruit only 4 pharmacists to the in-depth 
interviews. The primary reason cited for declining the invitation to participate in in-
depth interviews was that the uptake of service was very low and hence they had no 
meaningful experience to share. It might be possible that if local public health 
pharmacists were collaborated in the recruitment process, the participation of the 
pilot pharmacists could have been improved. Seven out of 32 non participating 
pharmacists were recruited for interviews. It was felt that saturation was reached at 
this stage for non participating pharmacists’ interviews. Strauss and Corbin 
suggested that saturation is about reaching the point in data collection where it 
becomes ‘counter-productive’ and ‘the new’ that is discovered does not necessarily 
add anything to the overall story, model theory or framework (Strauss and Corbin, 
1998). Ritchie et al. (2005) outline seven factors that would determine how quickly 
or slowly saturation would be achieved in qualitative interviews. These included "the 
heterogeneity of the population; the number of selection criteria; the extent to which 
'nesting' of criteria is needed; groups of special interest that require intensive study; 
multiple samples within one study; types of data collection methods use; and the 
budget and resources available" (Ritchie and Lewis, 2005). The most important 
factor among the above six is the heterogeneity of the population that determines the 
sample size. Guest et al. (2006) undertook a systematic analysis of their data from a 
study involving reproductive health care in Africa. They examined the codes 
developed from the sixty interviews undertaken for this study, to evaluate at which 
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point their data were returning no new codes, and were therefore saturated. Their 
findings suggested that data saturation had occurred at a very early stage - thirty four 
of the thirty six codes developed for their study, were developed from their first six 
interviews. Guest et al. (2006) concluded that for studies with a high level of 
homogeneity among the population, a sample of six interviews may [be] sufficient to 
enable development of meaningful themes and useful interpretations. Despite the fact 
that I carefully sampled my study population so as to include the perspectives of 
pharmacists from a wide variety of settings, such as urban vs. rural, deprivation 
quintiles and large chain vs. independent pharmacies, it turned out to be rather a 
homogenous sample of pharmacist with not much diversity identified in their views 
and so that the saturation might have achieved early. Another reason for achieving 
early saturation might be that an extensive literature review informed the 
development of the interview guide such that almost of the possible topic areas and 
probes were covered. This was further aided by an iterative interview process in the 
sense that previous interview informed the modification of interview guide for the 
next interview. Such a systematic process of data collection also resulted in an early 
saturation of concepts.   
External reliability of the qualitative study – the extent to which others may be able 
to replicate the findings given the same study design and sample – was addressed by 
overall transparency in the research process including details on how sampling 
occurred,  a full description of the interview guide and details on how existing theory 
influenced the research. In terms of internal reliability, a number of techniques were 
used to attend to this. These included: recording the interview so that an accurate 
record of what was said could be maintained; presenting verbatim quotes of what 
was said in the interview; and avoiding unnecessary truncation of quotes or 
convenient summaries of what pharmacists might have meant.  
Both the interviews and the analyses were conducted by me. The lack of an 
additional perspective in analyzing the qualitative data, was compensated for by a 
general process of peer review in the form of discussion with my supervisors about 
the data and its interpretation.  
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10.5.2 Discussion on the main findings 
This study explored the perspective of pharmacists on the implementation of a 
CT&T service. Facilitators and barriers for the clients and service providers were 
identified and an acceptable pharmacy chlamydia service model was explored. Those 
pharmacists who participated in the pilot CT&T service anticipated a good uptake of 
the service because of the location of the pharmacy in an area of high deprivation, 
with higher clientele of young people, or close to the health service. However the 
interviewees were disappointed with the very low uptake of the service. Lack of 
promotion of the service was indicated as the main reason of such a low uptake and 
as a result continuation of the service for longer might have been needed to see an 
effect on uptake. Failure of communication between pharmacies and NHS Lothian 
was identified as a primary reason of non participation of the pharmacies in the 
service.  
In this chapter the intention has been to identify a CT&T service model that reflects 
the perspective of the service providers. Table 10-4 summarizes the findings of 
interviewees’ suggestions on the CT&T service model for community pharmacies in 
Lothian. Most interviewees wanted to increase the age group to at least up to 25 
years, in order to increase the uptake of the service. Provision of the service upon 
client’s request was considered most favourable, due to the business nature of the 
pharmacy and privacy concerns. The partner notification model was broadly 
acceptable for almost all the pharmacists, considering it as a health care professional 
duty. A consultation room was indicated as a definite requirement, however given 
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Table 10-4: Identifying an acceptable CT&T service model  
Components of the 
service 
Current Model Recommendations 
Age Group Targeted - Particularly for clients aged 
16-20 Years. 
- Could be provided to 15-24 
years. 
Targeting under 20’s is considered 
logical due to high prevalence in 
this age group. 
Increasing the age group to at least 
mid 20’s is desirable to increase 
the uptake of the service. 
Preferred to refer the younger 
clients to specialist clinics. 
Mechanism of 
engaging YP in the 
service 
Reactive engagement: 
Pharmacist responding to 
client’s request for CT&T. 
Reactive engagement of YP by 
responding to client’s request for 
CT&T –Most favourable. 
Proactive offer by the pharmacist 
during EC consultation-Less 
favourable. 
Proactive offer by the pharmacists 
during non-sexual health context-
Not at all favourable. 
Partner notification 
model 
Asking patient to fill in 
contact information within the 
pharmacy. 
Broadly acceptable. 
Consultation room Definitely needed. Definitely needed.  
Toilet Access Desirable. Not possible in a current pharmacy 
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Figure 10-5: Extension of preliminary conceptual model to create the final model of facilitators and barriers to the provision of, and access to 
a pharmacy-based chlamydia service
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This study also offered better understanding of the facilitators of and barriers to 
accessing of the CT&T service by young people, and also the facilitators and barriers 
relating to the provision of the service, in the pharmacy setting. The conceptual 
model developed earlier following my literature review (Figure 4-3) is now revisited 
and the revised model is given in Figure 10-5. The themes identified in yellow boxes 
with bold boundaries represent those additional themes identified in this study. 
Moreover many of the themes identified earlier in the literature review are now 
unpacked so that the connections between them become more evident and many of 
the sub themes linked to the major theme are now identified. These sub-themes and 
their connection with the major themes have been revealed both explicitly as they 
were identified by pharmacists but also as they emerged from analysis of interviews 
to reveal the aspects of the service which were not immediately apparent. For 
example in the case of convenience of access to the service as a perceived facilitator 
for young people, the study identified many dimensions of convenience such as its 
availability when other health services are unavailable due to long opening hours of 
the pharmacy and its availability over the weekend, no need for appointment, choice 
of access to any pharmacy rather than having to go to only their registered GPs, and 
easy geographical access. A further analysis suggested that easy geographical access 
becomes less imperative if the client wants an anonymous service. In such a case, a 
client may prefer to travel a distance to access a service where he/she is unknown to 
the provider, other clients in the shop and there is less chance of being caught by 
their parents. Similarly the inter-related concept of privacy, confidentiality and 
anonymity was unpacked. It emerged in this study that although lack of privacy for 
young people was perceived as a key barrier, the provision of a consultation room 
might not overcome this and offer complete privacy because pharmacists needed 
consulting rooms to be close to the dispensary due to the workload of the pharmacist 
warranting their continuous involvement with dispensing. Similarly the need to ask 
for a consultation at the counter of a busy pharmacy in itself creates a great barrier 
for the potential client. The issue of confidentiality was interpreted differently for the 
small and the large pharmacies. For the small independent pharmacies, the provision 
of confidentiality was considered challenging to the personalised nature of the 
pharmacy setting with pharmacy staff often on first name terms with their customers. 
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While this might increase the chance of potentially leaking the information regarding 
a client’s access to the CT&T service, the pharmacist felt confident that this did not 
happen in their pharmacies. The large chain pharmacies are considered to provide a 
‘less personal setting’ that might be more reassuring to the clients in the sense of 
them not knowing the staff. The issues of embarrassment and stigma were interlinked 
to anonymity in the sense that getting a service in an area where the staff and other 
customers are ‘unknown’ to the client could help in alleviating their embarrassment 
about requesting the service at the counter.  
Due to increasing involvement of pharmacists in the provision of public health 
services in addition to their core dispensing work, appropriate incentives for the 
provision of this service may help counter their perception of a high workload on 
them. However an important theme emerged in this study was that it is equally 
necessary to incentivise employee pharmacists for the provision of these extra 
services in addition to any direct benefit available to the proprietor pharmacists. It 
became apparent in many instances that pharmacists would prefer a model of service 
with greater potential to generate an income. Hence their consideration of a wider 
age range for potential service clients which might increase uptake; and their 
preference for being part of a ‘pilot’ service that would potentially attract new 
customers to their pharmacy; and the pharmacy location which has a higher 
proportion of young client base for their pharmacy and also due to the location of the 
pharmacy in an area with higher deprivation. .  
Similarly it would appear that the proprietor pharmacist might prefer to provide the 
service as it increases their income directly, whereas employee pharmacists might 
prefer to provide it in order to achieve business targets for their pharmacy. However 
the theme relating to incentives was further unfolded and it emerged that it is not 
only the financial benefits that matters to pharmacists but also their professional 
development and the reputation of the pharmacy as service oriented entity. It was 
encouraging to note that both the participating and non participating pharmacists 
were enthusiastic to deliver the CT&T service and were positive to see the emerging 
role of pharmacists as public health providers. However, they were equally 
concerned about the increased workload due to their new role as public health 
 
Chapter 10: In-depth interviews with pharmacists...………………………………  
328 
providers and indicated that the extensive paper work and limited staff resource 
accentuated these problems.   
Interviewees generally perceived the attitudes of support staff, clients and GPs to be 
positive about pharmacist involvement in the CT&T service. The pharmacy support 
staff were seen as referring agents at the counter, and the pharmacists believed that if 
staff were uncomfortable, this would be a result of their lack of training in 
communication with the client on SH issues. Pharmacists reported their staff 
attitudes had generally been positive towards the provision of other public health 
services. While reflecting on the low uptake of the service, some interviewees 
believed that the clients might prefer to seek care from specialist health care 
facilities. This might be due to interviewees perceiving that pharmacists are not yet 
seen as health care professionals. GPs were perceived to be largely supportive of 
delegating their role to pharmacists for such a service due to shifts in their own 
workload. However the subordinate role of the pharmacist was either preferred by 
some pharmacists or was the result of their perception that GPs would consider them 
as encroaching on their territory. The role of stakeholders involved in policy making 
emerged particularly in relation to provision of training to all staff and the 
consideration of financial incentives for pharmacists delivering the service, including 
the employee pharmacists. The emergence of competing public health priorities also 
had an impact on the service as pharmacists indicated that the CT&T service 
implementation was considerably delayed due to the swine flu and consequently also 
there was a long time between training and actual implementation of the service.  
10.6 Conclusion 
This study provided a valuable understanding of the perceptions of service providers 
on different aspects of offering the CT&T service in community pharmacies. It 
provides a framework for an evaluation of a service from the pharmacist’s 
perspective. It also suggested an acceptable model of a chlamydia service in those 
settings where the service is in place (such as in England) or is planned to be 
developed. Future research should also directly explore the perspectives of pharmacy 
support staff, potential clients and GPs regarding pharmacist involvement in this 
public health role. 
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CHAPTER 11: RESPONSES RECEIVED TO 
POST-SERVICE INFORMAL CONTACTS WITH 
CT&T STAKEHOLDERS  
 
11.1 Introduction regarding  rationale for contact 
made 
In order to help with my reflections on the trajectory and ultimate cancellation of the 
CT&T service in Lothian, I contacted by email a small subset of key stakeholders of 
the CT&T service, and asked for their reflections on the factors that might be 
associated with the CT&T service cancellation. I also elicited the views of a 
government representative about the rationale for Scottish government changing the 
pharmacy-based chlamydia service status from a ‘national service’ (which all health 
boards were obligated to provide) to a ‘locally negotiated service’ (where offering it 
or not was the decision of the local health board). This chapter presents the findings 
of these informal email contacts.  
11.2 What I asked 
In April 2012, nearly 12 months after the CT&T service terminated in Lothian, I 
contacted by email 3 key stakeholders for the CT&T service, to ask for their 
understanding of the rationale for the decision by Lothian Health Board to 
discontinue the service. These three key stakeholders were a small subset of 
stakeholders initially contacted for the Stakeholder Survey. The question asked 
regarding the termination of CT&T was ‘what were the additional reasons (over and 
above withdrawal of direct funding) that led to Lothian Health Board’s decision to 
terminate the service in Lothian?’   
An additional question asked from two of the stakeholders who were involved in 
service implementation was ‘what you think were the obstacles in the successful 
implementation of the service in pharmacies in Lothian?’ 
I also contacted through email a representative of the Pharmacy and Medicines 
Division of the Scottish Government (PMDSG), to ask for a copy of the report on the 
review of a pharmacy Chlamydia service in Scotland which was mentioned in their 
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earlier communication to local health boards (Appendix 10). However, the 
representative replied that, in fact, no formal review of the service had been 
undertaken. I then replied enquiring as to the rationale for Scottish government 
changing the pharmacy-based chlamydia service status from a national service (with 
specific additional funding) to a locally negotiated service (which would have to be 
funded out of the health board’s general budget). In the first instance the 
representative responded informally, but when I requested permission to quote from 
this response, with the assurance of preserving anonymity, the representative 
provided instead ‘attributable comments’ (Appendix 19 provides a full transcript).  
The responses received are reported in this chapter. Quotations from the Scottish 
government representative will be attributed, but the other 3 stakeholders have been 
promised that quotations from their responses will preserve their anonymity. For this 
reason, they will be referred to only as stakeholders I, II and III.  
11.3 Responses received  
Responses from the above four stakeholders (i.e. three key stakeholders and a 
representative from the PMDSG) were very brief – a total of 788 words from the 
three CT&T stakeholders, and 177 words from the Scottish government 
representative.  
The CT&T stakeholders suggested a number of reasons that led to the termination of 
the CT&T service in Lothian. One of the stakeholders suggested that one reason for 
failure to press for CT&T continuation by Lothian Health Board was that the GUM 
clinicians were unwilling to delegate this aspect of sexual health service provision to 
pharmacies. 'Perhaps most importantly the GUM service was very lukewarm about 
the pharmacy chlamydia project... It was always rather ironic that they were loudly 
claiming they had far too much to do and could not cope with the demand at GUM 
but were determined not to hand over any part of their workload to any other 
provider, they just wanted more staff for GUM' (Stakeholder I).  
Another point of view that emerged was a lack of need for such a service in certain 
health boards. For example, it was noted that in Lothian ‘screening of chlamydia was 
not seen as an area with any great gaps in accessibility to existing services’ 
(Stakeholder II). 
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The premise on which the pharmacy-based chlamydia service was introduced in 
Scotland was to expand outreach. However, one stakeholder noted that not all health 
boards took steps to realise the government’s vision in this respect. For example, 
‘two health boards, NHS Greater Glasgow & Clyde and NHS Lothian have elected 
to pilot the service in a small number of pharmacies rather than implement the 
service in all pharmacies’ (Representative from PMDSG - April 2012). 
While the question asked was for reasons apart from funding, that might explain 
Lothian Health Board’s decision to terminate the service, one respondent judged that 
withdrawal of government funding was the main reason: 
 ‘I am not sure [if] there are many more reasons beyond the withdrawal of funding’ 
(Stakeholder III).  
In the opinion of stakeholder II, the reason why CT&T service was not considered a 
priority in terms of continuing the service out of the routine budget of the Lothian 
Health Board was due to changing beliefs about the cost effectiveness of chlamydia 
screening. The premise upon which screening, or at least encouragement of 
chlamydia testing, was initially based, was a widely held belief that chlamydia 
infection risked causing long term complications such as PID and infertility. 
However, the newly-emerging evidence was far less strong regarding such 
consequences (section 2.2.3). Hence stakeholder II noted that: ‘The national stand on 
screening has not yet changed but this was definitely a factor in the decision making 
[of service termination in Lothian] as it was considered unlikely to be cost effective 
and no longer such a priority’.  
This view was further supported by the Scottish government representative: 
‘The revised SIGN guidelines of March 2009 on the management of genital 
chlamydia infection recommended that resources for chlamydia testing in women 
should be targeted firstly in those aged 15-19, then those aged 20-24; and in men at 
those aged under 25 and all patients attending GUM services. The guideline did not 
recommend more universal screening. Therefore changing the community pharmacy 
chlamydia testing and treatment service to a locally negotiated service allowed NHS 
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Boards to apply a more targeted approach, based on local needs, which fitted better 
with the SIGN guidelines.’ (Representative from PMDSG - April 2012). 
The CT&T stakeholders also suggested a number of reasons that led to the delays in 
implementation of the CT&T service. A view expressed about the barriers to 
implementation was that ‘everyone, particularly senior clinical management staff 
have too much to do and so they prioritise according to what they personally believe 
to be the most important things’ (Stakeholder I).  
The above stakeholder further explained that: 
‘A lot of activities in Lothian Health [Board] at that time ground to a halt because 
public health people were heavily involved with preparing contingency plans for bird 
flu (including …the pharmacy team)’ (Stakeholder I). 
With respect to the CT&T service, some of the practical constraints were not 
anticipated at the outset. An unbudgeted cost was noted: 
‘[there was] no transport infrastructure to support transport of tests from community 
pharmacy to labs. The solution was to provide postal kits which are more expensive’ 
(Stakeholder II).  
A further issue was inadequate infrastructure in pharmacies to support a pharmacy-
based chlamydia service: ‘Few pharmacies have a toilet and this means an 
inconvenient method of obtaining a sample’ (Stakeholder II). 
11.4 Further discussion 
Further discussion drawing on stakeholders’ responses to my follow-up emails will 
be integrated into the final discussion chapter 12, as part of a broader discussion of 
both obstacles to the launch, and the subsequent termination of the CT&T service. 
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CHAPTER 12: CONCLUDING DISCUSSION 
12.1 Introduction 
This final chapter provides an integrative discussion of the key findings of my 
research, and their implications for policies on pharmacy-based chlamydia services. 
Included in this discussion is some reflection on Lothian Health Board’s decision to 
cancel the CT&T service as well as the earlier obstacles to its implementation. The 
chapter concludes with recommendations for future research in this area.  
12.2 Further consideration of the delayed launch and 
subsequent cancellation of the CT&T service  
When I commenced the intended evaluation it was expected that the CT&T service 
would be launched around July 2009, and continue in the long term as an option for 
chlamydia testing and treatment among young people. However the unforeseen 
circumstances and events outlined in chapter 5 meant that the evaluation I could 
eventually undertake for my thesis was curtailed radically. This was because there 
was a considerable delay in implementation of the service, negligible uptake of the 
service in the first months, and then the final straw, termination of the service only 
10 months after its launch.  
This discussion draws on my own observations and reflections during my research, 
evidence from official documents relevant to the service, on the published literature 
that discusses the obstacles to implementation of public health programmes and on 
stakeholders viewpoints sought after the discontinuation of the service in Lothian (as 
reported in chapter 11).  
12.2.1 Competing priorities 
Implementation of the CT&T service suffered from competing priorities, both 
ongoing and temporary. For Lothian Health Board, one important competing priority 
at the time of implementation of the CT&T service, as indicated by the stakeholders, 
was the threat of swine flu pandemic  (Section 11.3).  This view is supported in the 
following extract from the minutes of a meeting of the National Sexual Health and 
HIV Advisory Committee (National Sexual Health and HIV Advisory Committee, 
2009), where Professor Anna Glasier (the Sexual Health Lead of Lothian Health 
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Board at that time) raised her concern about the potential impact of a swine flu 
pandemic on sexual health services generally in Lothian and elsewhere in Scotland: 
‘In the pandemic phase, it is intended that sexual health and contraception services 
would be suspended. Repeat prescriptions provided by GPs would also be suspended 
and would be maintained by pharmacies. She expressed concern that contraception 
would not be available from GPs and that pharmacies could be inundated with 
prescriptions’ 
The threat of swine flu might explain some delays in implementation of the 
programme, due to contingency planning for swine flu, and wishing in the interim to 
avoid introduction of any additional workload for pharmacies. However, it cannot be 
the entire explanation, given the relatively brief swine flu peaks and the fact that this 
outbreak did not attain the feared pandemic status.  
12.2.2 Evidence of effectiveness 
The policy stakeholders also suggested that the newly emerging evidence on the 
effectiveness of chlamydia screening was far less strong regarding its consequences 
on long term complications such as PID and infertility (Section 11.3).  This 
weakened the rationale for the Scottish government specifying provision of 
pharmacy-based chlamydia testing as an obligatory national service for all the health 
boards in Scotland. In this regard, it is of note that it has been demonstrated in the 
literature that in the past health programmes have been encouraged to expand at a 
national level because government policies have evolved in parallel with, rather than 
as a consequence of, the development of an evidence base (Sowden and Raine, 
2008). It has been observed that this raises the risk of programme failure, if newly 
emerging evidence does not support what have been, essentially, pre-emptive service 
policy decisions. This seems to echo what has occurred in the case of the pharmacy-
based chlamydia service in Scotland, since the service expansion was decided in 
August 2008, whereas the SIGN guideline for chlamydia, which was known to be in 
preparation at the time, was published only in March 2009. That guideline 
discouraged universal screening. It is noteworthy that Scottish government’s 
decision to downgrade the status of the pharmacy-based chlamydia testing service, 
 
Chapter 12:  Concluding Discussion …………………..……….……………………………………..  
335 
from national to a local service, was not made until two years after the publication of 
this SIGN guideline. 
12.2.3 Inter-professional barriers 
When stakeholders were contacted post CT&T service, about the reasons for delays 
in implementation of the CT&T, an important viewpoint that emerged was resistance 
from GUM clinic to delegate provision of sexual health care to pharmacies (Section 
11.3).  Professional resistance to delegating responsibility to other health care 
providers is not a new phenomenon. Hughes and McCann (2003) described 
‘professional autonomy and professional dominance’ – how certain professions not 
only control the scope of their own work, but also define the limits of work of other 
professionals. They noted a hierarchy in the attitude of physicians towards 
pharmacists, in that physicians questioned the role and skills of pharmacists in 
certain activities and felt greater involvement of pharmacists in prescribing to be 
inappropriate (Hughes and McCann, 2003). Similarly, Bradshaw and Doucette 
(1998) suggested that the attitudes of physicians could either hinder or facilitate an 
expansion of the community pharmacist’s role. Inter-professional relationships and 
their potential impact on the success or failure of a service need further exploration 
so that, in any future service innovation in pharmacies such problems might be 
minimised and stronger inter-professional relationships be developed. For example, 
pharmacists expressed positive attitudes towards a proposal of a provision of a 
consultation room in pharmacies for sexual health specialists to provide a local clinic 
services (Gale and Watson, 2011).   
12.2.4 Conflicting vision of the service 
Evidence also suggests that programmes sometimes fail due to a loss of direction and 
conflicting vision of programme stakeholders (Ritchie et al., 2008). With respect to 
the pharmacy-based chlamydia service in Scotland, the government vision had been 
to ‘expand outreach’ by making chlamydia services available to young people 
through all community pharmacies within a respective health boards. However, even 
if that vision existed at governmental level, it was not shared at all local health board 
levels. Hence, as noted by representative from PMDSG (Section 11.3), the Lothian 
and the Glasgow and Clyde health boards modified the government vision by making 
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chlamydia services available only through selected pharmacies in deprived areas. 
Therefore, the key theoretical underpinning of this service, in the sense of providing 
wide geographical access to the service, was lost in some health board areas by 
offering the service in only a limited number of pharmacies. This loss of universal 
availability might be especially problematic regarding the initial vision for the 
service, given it is aimed at young people, whose confidence to ask at a pharmacy 
counter for a test might be undermined if there is any doubt whether that particular 
pharmacy actually provides a testing service.  
The original government vision could be viewed as a health promotion activity, in 
that the Scottish government directive was to make the pharmacy-based chlamydia 
service available to ‘client[s] requesting a chlamydia test or to those identified as 
suitable by the pharmacist or a member of their support staff’ (NHS Circular: 
PCA(P)(2008)17, underlining added by me). In other health boards in Scotland, 
active ‘recruitment’ was adopted, for example by pharmacists offering chlamydia 
testing during EC consultation. It has been found that while the passive recruitment 
might ensure higher motivation for the service among users, health promotion 
through active recruitment supports efforts to expand reach (Lee et al., 1997, Vidrine 
and Vidrine, 2011). However this ‘health promotion’ aspect of the vision was not 
operationalized in the specification of the CT&T service in Lothian, which was as a 
personalised care model delivered from pharmacies. As described in section 5.4.1.3, 
the service specification for Lothian directed that the service would be available to 
only users requesting it - that is through passive ‘recruitment’. 
Another viewpoint of key stakeholders that emerged from the post CT&T service 
email contacts with a small subset of stake-holders, and which is relevant to 
implementation of government vision for sexual health services, is that the objectives 
of the service were not clearly communicated to the stakeholders and that they were 
not always informed about the outcome of the service (Section 11.3). Those sexual 
and pharmacy health professionals in Scotland who did try to implement the 
government vision might well feel a little betrayed by this lack of sharing 
information/rationale. Sexual health professional generally might well feel (even) 
more cautious about investing too much resource and effort on the next government 
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directive for some ‘national and specifically funded’ service innovation (the special 
funding for which might be later withdrawn). It is important that the government 
should have a more collaborative relationship with service providers, sharing the 
evidence and reasoning for their service decisions, so that health professional 
stakeholders feel they are active partners in achieving future new policy ‘visions’. 
12.2.5 Advertising and promotion 
Persistent evidence that emerged during my data collection with pharmacists was a 
lack of effective advertising of the service. It was felt that this was the main reason 
the uptake of the service remained very low. The letter from the Scottish government 
to heath boards informing them of their ultimate decision regarding the withdrawal 
of a pharmacy-based chlamydia service as a national service is attached in Appendix 
11. One of the reasons indicated in this letter was ‘the evidence of low uptake of the 
national service to date’. For public health services such as CT&T, awareness 
through health promotion campaigns has been identified as a key factor in ensuring 
uptake (Carr et al., 2009). In addition, active promotion is required by the use of 
other media, such as local newspapers, billboards, buses, television; and 
collaboration with other providers (Carr et al., 2009). This issue has also been 
highlighted in a recent evaluation of the pharmacy smoking cessation service, where 
service users indicated that they only became aware of the service while passing or 
visiting their pharmacy (Hametz et al., 2011).  
For some years health promotion campaigns have been part of the community 
pharmacy contract in Scotland (The Scottish Government, 2008). Under this 
umbrella, in-store advertising must be provided in all community pharmacies within 
the health boards, for up to four campaigns per year, each for at least a 6 week 
period. This mode of advertising has been utilised for a number of services that were 
made available in pharmacies, such as smoking cessation and seasonal flu 
vaccination. In contrast, chlamydia services have never been advertised in 
community pharmacies through any such PHS health promotion campaigns. 
Furthermore, given that the CT&T testing service provision in Lothian was limited to 
only 12 of the 166 community pharmacies and that the only mode of advertising of 
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the service was through an A4 size (black and white) poster display in pilot 
pharmacies, the service remained largely unnoticed to the potential target audience. 
12.2.6 Funding the service 
When the policy stakeholders were contacted to suggest reasons why the Lothian 
Health Board decided to terminate the CT&T service, the withdrawal of government 
funding had been described as one of the key reason (Section 11.3). Adequate 
funding and budgeting is crucial for service success and sustainability. McNaughton 
et al. (2011) noted that one reason for an unsustainable service was that much of the 
ancillary cost in a public health intervention delivered through community 
pharmacies were either not anticipated in advance or were underestimated in 
budgets. Hence there needs to be a rational and realistic prior budgeting of the 
funding required for any public health programme, and careful decision making so as 
to ensure a balance between the need for a service and its value-for-money in the 
long run.  
When the Scottish government decided to alter the status of the pharmacy-based 
chlamydia service from an ‘obligatory national service’ to an optional ‘locally 
negotiated service’, it meant that local health boards were required to find funds for 
the service from their routine budget, if they decided to continue the service. The 
government stated that this removal of dedicated funding was because there was a 
‘lack of value for money’ from the national service (Appendix 11). It is notable that 
the Lothian Health Board decided to terminate the service, and did not try to secure 
any funds from within its local budget in order to be able to continue CT&T. This 
indicates that the CT&T service was not considered a priority, presumably for the 
board for the reasons previously described.   
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12.3 Discussion of main findings across studies  
While in chapters 7 to 11, specific findings of each study are discussed in relation to 
the published evidence, this section offers an integrative discussion of those findings 
across the studies. Despite the limitations in the scope of the evaluation that could be 
eventually undertaken, the completed research nevertheless makes a substantive 
contribution to the evaluation literature on pharmacy chlamydia services. The 
findings of this PhD research are reflectively reported so that, over and above the 
evaluation objective of the research, the results and discussion can in the future 
contribute to planning of chlamydia services in other areas/countries, and to planning 
of other pharmacy services and other public health services aiming to improve sexual 
health. 
12.3.1 Service planning 
The evaluation findings show flaws in CT&T service planning and execution. For 
example, failure of clear communication has been identified as a key reason why 
many pharmacists did not take part in the service (section 10.4.2.2.1). Better 
communication between those strategic stakeholders involved in the implementation 
of the service, and candidate pharmacies, might have increased the chance of 
recruiting more pharmacies and increasing coverage. As further discussed in section 
12.3.6, in order to improve the uptake of the service by young people, promotion of 
the service should become a key ingredient of service planning and implementation 
(sections 8.4.2.3 & 10.4.7.3). Given the concerns raised by pharmacists, there is also 
a need to develop infrastructure standards for delivering such a service in 
pharmacies, for example ensuring privacy of consulting space, and appropriate 
availability of health and safety procedures (for example, availability of hand 
washing facilities), which are not available in many pharmacies (section 10.4.6.2).  
12.3.2 Accessibility versus anonymity  
Increased accessibility is identified, both by strategic stakeholders and pharmacists, 
as a unique selling point of the pharmacy chlamydia service (sections 8.4.3 and 
10.4.7.1 respectively). When young people were asked what aspects would be 
important in selecting a pharmacy for the CT&T service, the three key aspects 
identified were a pharmacy with a convenient location (89%), a consultation room 
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(84%), and extended opening hours (81%) (Figure 9-5). Similarly, in-depth 
interviews with pharmacists have identified a number of dimensions to the enhanced 
accessibility that pharmacies can offer, such as availability of a CT&T service when 
other health services are unavailable, no requirement for a prior appointment, and 
easy geographical access. However, further analysis of the in-depth interviews 
suggested that easy geographical access might become less imperative if a client 
wants an anonymous service, which could argue for attending a pharmacy a bit 
further away from home/ family/neighbours. The fact that a consultation room is on 
offer to provide an adequately private consultation would not remedy this situation. 
The intending CT&T client has to ask for the service at the counter and this could be 
challenging, because the young person might be known by some of the counter staff, 
perhaps even by the pharmacist. Other shoppers also might recognise the client, and 
hence pose a risk to confidentiality/privacy. This issue was especially raised by 
pharmacists in a sub-rural or rural location, where convenient access would mean 
accessing a service in a local pharmacy only and pharmacists and other staff are 
often on first name terms with their clients (Sections 7.4.2.6 and 10.4.7.2). This also 
argues against the decision by Lothian health board to offer the CT&T service in 
deprived areas, whereas it seem young people might prefer to avail themselves of 
such a service at a slightly less local pharmacy, but one still accessible on foot or by 
bus. 
One way of improving accessibility, while also maintaining anonymity, would be 
through the provision of kits on the shelves to be self picked by young people. This 
option was identified as ‘definitely’ acceptable to nearly 55% of young people, 
second only to the most frequent preference of being offered the test by pharmacists 
during an EC consultation (57%) (Figure 9-3). The Lothian CT&T service had tried 
to offset the cost of the service by providing only partial kits (the sample bottle 
without the absorbent packaging sleeves), and this provision being preceded by a 
consultation with the pharmacist. This service model could be modified in a way that 
preserves the cost saving, but enables greater anonymity, by providing similar low 
cost partial kits on the shelves to be freely picked by young people. However, in the 
absence of a pharmacist’s consultation, there would still be a risk of wastage of the 
partial kits unless precise and easy-to-follow instructions are provided on their use.   
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12.3.3 Work load  
The busy retail environment of pharmacies has been cited by stakeholders as a 
barrier to provision of chlamydia service by pharmacies (section 8.4.2.2). A 
persistent finding that appeared in this research (sections 7.4.2.6 and 10.4.6.1), as 
well as in published literature (section 4.3.7.2.6), is that pharmacists express the view 
that the continued growth in the delivery of public health through pharmacies is 
steadily increasing the work load for pharmacists. The in-depth interviews identified 
two key aspects that contribute to the work load of pharmacists. Firstly, lack of 
training of pharmacy support staff to further support the work of pharmacists in some 
areas of public health provision has been identified as a factor contributing to 
increasing work load. Secondly, complicated paper work in relation to existing 
services is perceived by pharmacists to further contribute to work load. The 
importance of developing pharmacy workforce for the provision of CT&T service 
will be discussed in detail in section 12.3.5. However in addition to effective 
workforce development, it may also be important to take measures to minimise the 
paperwork related to the service provision.  
In the survey of potential service users, 11% of respondents indicated their 
preference to be tested for chlamydia in a pharmacy (section 9.4.3). If we take this 
figure to be true, and also assume that 35% of the young population, aged 16-24 
years, would be tested for chlamydia (the figure set for NCSP targets for 2010/11) 
every 1.5 years, then an average of 21 tests per month would be requested by young 
people from each of the 12 selected Lothian pharmacies (Appendix 39). It might be 
advisable to inflate the percentage of young people deciding on pharmacy testing to 
16%, since the 11 % estimate was based on my survey of young people from sexual 
health clinics only, and the preference for pharmacy testing may be higher among 
those who would like testing but do not go to GUM or a drop-in clinic. In such a 
scenario, a total of 30 tests per month would be requested in each of the 12 selected 
pharmacies in Lothian. Hence the pharmacists need to be reassured of the minimal 
day-to-day workload that would be anticipated from the provision of the CT&T 
service (section 10.4.6.1). Moreover, with this level of uptake, the pharmacy 
chlamydia service might be viewed as an adjunct to other sexual health services, by 
providing opportunistic screening to young people living in deprived areas.  
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12.3.4 Sexual health counseling 
Strategic stakeholders raised a concern that in a pharmacy setting, sexual health 
counselling for young people would be less well delivered (section 8.4.2.2). Multiple 
factors were indicated as contributing to this perception such as; lack of privacy in a 
pharmacy setting, the high workload of pharmacists, and pharmacists having 
insufficient counselling skills. Partly echoing this, competencies for which the largest 
proportions of pharmacists were categorized as having substantial training needs 
were those aspects related to sexual health communications (section 7.4.2.4), such as 
investigating medico-legal criteria (Fraser competency) (83%), taking sexual history 
(78%), explaining the process of PN to clients (66%) and counseling a client who has 
received positive test results (65%).  
It is furthermore interesting to note that prior sexual health training of pharmacists 
had no statistically significant association with their professed training needs (section 
7.4.3.2). This finding is particularly interesting since pharmacists indicated that their 
prior training on sexual health provision occurred mainly through distance learning, 
for the provision of emergency contraception. This lack of association between 
currently self-reported training needs for CT&T provision and general aspects of 
sexual health service provision, such as taking a sexual history and advice on safe 
sex that were also covered in EC training, suggests a need for ongoing training, in 
particular face-to-face training suited to learning needed for conducting sexual health 
consultations.  
12.3.5 Workforce development 
Pharmacy workforce development is crucial for the success of a service. With the 
introduction of public health services in pharmacies, it is equally important to train 
pharmacy support staff, such as technicians and counter assistants, in addition to the 
provision of training to pharmacists. This is firstly because the counter staff are often 
the front line gatekeepers of the service. Amongst pharmacy support staff self-
reported training needs were most marked for inter-communicative aspects of 
providing the service (sections 7.4.2.2 and 7.4.2.4). Hence, support staff as well as 
pharmacists, need to be trained in communication skills in sexual health matters. A 
few stakeholders suggested that training of pharmacy staff would also aid their 
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understanding of the importance of the service and promote a non-judgemental 
attitude towards young people (section 8.4.2.1). Secondly, with the increasing 
provision of multiple public health services through pharmacies, well trained support 
staff would be able to ease work pressure on pharmacists by undertaking initial 
explanation and discussion with the potential clients about a service. This would 
allow more time for pharmacists to undertake in-depth counselling of their clients 
(section 8.4.2.2 & 10.4.6.1). It is notable that while the Scottish government 
specification indicates that the pharmacy-based chlamydia service may be offered by 
pharmacists or other member of the staff, the distance learning pack referred in the 
specifications were developed for pharmacists only (NHS Circular: 
PCA(P)(2008)17) .  
It may be possible to provide distance learning about the facts of STIs and 
chlamydia, and treatment guidelines. However, developing competencies involving 
practical skills such as communication strategies tends to need training face-to-face, 
and ideally also by role play exercises, particularly for an issue such as sexual health. 
Face-to-face training would require greater allocation of resources (such as logistical 
arrangements for training, staff time to undergo training and employing face-to-face 
trainers). Of course this would add to the cost of the service.  
Despite the evidence provided to key stakeholders through the report on the training 
needs survey, regarding the differential training needs of pharmacy staff, the two 
training evenings organised by NHS Lothian demonstrated very limited participation 
of support staff. This is despite the finding of them being ‘highly’ or ‘moderately’ 
enthusiastic to provide the service (technicians 84% and counter assistants 61%) 
(section 7.4.1). Several factors might have contributed to their low participation; 
such as training being provided in the evenings with no incentives or reimbursements 
offered. It is also likely that pharmacy support staff judge that attending training 
would give little advantage in terms of their professional development. 
Reimbursement for their time to attend the training and provision of other incentives 
such as certification for CPD might help in improving participation.  
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12.3.6 Advertising and promotion of the service 
A major setback to the CT&T service was the very low uptake. In the interviews 
with the pharmacists, the key explanation proposed for this was inadequate 
advertising (10.4.7.3). A number of strategic stakeholders acknowledged difficulties 
in promoting the service among young people (section 8.4.2.3). They felt that the 
impact of service promotion through educational institutes such as schools or 
colleges would be limited, since hard-to-reach groups in deprived communities were 
often absent from school and seldom went on to further education. Hence multiple 
channels of promotion were advocated by stakeholders and pharmacists such as 
through social media, other venues of NHS, in-store promotion and educational 
institutes (sections 8.4.2.3 and 10.4.7.3). While referring to their experience in the 
provision of EC, pharmacists further indicated that the EC service also suffered from 
inadequate advertising and suggested that this might indicate short sightedness by 
those who planned the implementation of the service, since they failed to address 
such a crucial element of service planning.  
12.3.7 Targeted testing and service standards 
The analyses of routinely collected chlamydia data complemented other studies by 
describing the context in which policy developments for chlamydia testing in 
community pharmacies took place (chapter 3). While the sexual health service 
standards for chlamydia surveillance among 15-24 year olds were met briefly for 
females in 2009 only, these service standards were not ever achieved for males in the 
years analysed. Similarly the recommendations in the 2009 SIGN guideline to 
achieve 60% of all chlamydia tests among <25 year olds was not ever met (section 
3.4.5). These findings suggest that service audits should also focus on identifying 
barriers to achieving the targets and in this way enable timely action to be taken to 
tackle any barriers identified. For example, if service advertising appears to be a 
barrier then health boards might make more concerted efforts to remedy this. Perhaps 
in addition to the development of service standards, it might also be important to 
incentivise health boards to achieve any targets set.  
Routine data analysis further highlighted that among those requesting testing 
positivity rates for 20-24 year old males were comparable to those aged 15-19 years 
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old (section 3.3.5.3). This suggests that might be important to emphasize testing 
among both 15-19 and 20-24 year old males, contrary to the CT&T service 
specifications in Lothian which put extra emphasis on testing 16-19 year olds.  
12.3.8 Routine data specifications 
In addition to the recommendations specific to the successful service 
implementation, the collection of routine chlamydia data for surveillance needs to be 
improved. The stakeholder survey raised a number of ‘outcome’ related questions of 
interest to sexual health policy makers and practitioners (sections 6.3.3.1 and 8.4.4). 
Even if the uptake of the CT&T service had been sufficient to provide reliable testing 
activity data on CT&T, few of these questions could not have been answered through 
an analysis of routine laboratory data. This is mainly because of the unavailability of 
key variables in these routine data, such as information on reason-for-test and, within 
the GUM service, the socioeconomic status of the person tested (such as could be 
obtained via residential postcode or Scottish datazones) (section 3.4.1) Similarly, for 
CT&T testing, it was envisaged that there would be no information on postcode of 
the tested person, which would have been needed if wishing to evaluate the area 
deprivation status of those using the CT&T service. 
Postcode information was largely available for those who were tested via their GP. 
The decision not to collect postcode information in GUM clinics and the CT&T 
service has been justified on the basis of ensuring confidentiality and anonymity. 
However, since SIMD categorisation is based on datazone information, it is not be 
necessary to collect full postcode information from patients. Instead, an automated 
computer system could be developed that would derive datazone from a patients’ 
postcode without recording postcode information in the patient’s record, thus giving 
reassurance to patients as to the ‘anonymity’ of this level of data recording.  
Furthermore, if these data are to be useful for monitoring of public health 
interventions, information on reason-for-test is needed. This is partly because 
positivity rate is strongly related to reason for test, but also because it would enable 
determination as to whether an increasing testing trend reflects increased 
opportunistic testing or is a result of testing following partner notifications, 
diagnostic testing following abortion, or symptomatic testing. Lack of this 
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information also prevents investigation of the variations in rates of opportunistic 
testing by health care settings and health board areas. 
12.4 Policy making and political considerations 
As Pawson and Tilley (2008) said ‘programmes are products of the foresight of 
policy-makers. Their fate ultimately depends on the imagination of practitioners and 
participants. Rarely do these visions fully coincide’. The reasons suggested in the 
policy literature for unsustainable services are numerous (Garn, 1999, McNaughton 
et al., 2011, Ritchie et al., 2008, Petticrew et al., 2004). Pressure to achieve targets in 
too short a timeframe is an obvious contender, and arises when there is felt to be a 
need to satisfy public and health professionals needing to be seen as action oriented, 
or to appease powerful lobbies. Service is also unsustainable when there is local 
strategic stakeholders’ disagreement regarding the effectiveness of the service and 
lack of programme ownership. Such factors often lead to short-lived community 
partnerships and programme failures. All of these factors could have impacted on the 
short existence of Lothian Health Board CT&T service. In respect of the pharmacy-
based chlamydia service in Scotland, policy makers were faced with a dilemma of 
having insufficient evidence of the effectiveness of chlamydia screening, coupled 
with an imperative to be seen to be taking action to tackle the (apparently) rising 
prevalence of chlamydia infection in young population that was projected as an 
emerging public health problem. This might have become particularly crucial when 
their counterparts in England were spending £150m in total on chlamydia screening 
campaign.   
A notable aspect of the pharmacy-based chlamydia service in Scotland was that no 
formal evaluation was built into it by the Scottish government. In contrast, other 
pharmacy public health services, such as smoking cessation and emergency 
contraception had concurrent evaluations commissioned by the Scottish government. 
This also included the requirement for health boards to adhere to the government’s 
directions to create national dataset for evaluation purposes (Hametz et al., 2011, The 
Scottish Government, 2008). Given the lack of a national dataset, for the pharmacy-
based chlamydia service in Scotland, it is difficult to make any comparison of service 
effectiveness across the different health boards. This overall lack of evaluation also 
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means that if, in the future, evidence and/or circumstances emerge that argue for 
reintroduction of a pharmacy-based chlamydia testing service, there would be little 
documented past experience to guide the service specification and implementation, 
and so optimise its chances of effectiveness and efficiency. 
12.5 What could have been done better in this PhD? 
 Doctoral study is a process of becoming a trained professional researcher. Hence it 
would not be surprising if at the end there are some misgivings, when looking back 
on the research undertaken. Certainly in this case there are things I wish I had (could 
have) done differently. In particular, if the local NHS REC deemed the research 
studies proposed as service evaluation, and hence not requiring ethical review, I 
would have sought ethical approval outside the NHS REC system. Putting aside any 
feasibility constraints (in terms of resources or time), other improvements would 
have been: (i) regarding the potential service users survey, for it to have 
encompassed both GUM & sexual health clinic service users and young people who 
had not ever used such services, and even better for it to have been preceded by some 
in-depth interviews and then piloting with them of the questionnaire; (ii) to have 
included a final interview study with key stakeholders, about the  CT&T service in 
Lothian, and in particular to have included some formal interviews with non-
pharmacy health professionals involved in sexual health - general practitioners and 
GUM clinic and sexual health drop-in centre clinical staff. (iii) There are also 
considerable regrets that the service was launched so late, and half-heartedly, 
because I had particularly looked forward to interviewing pharmacy staff about their 
experience of delivering the service, and had hoped to elicit some CT&T-service-
users views as well. (iv) Regarding TNA, it would have been more useful to re-
assess their training needs after the CT&T service had started to investigate the 
impact of training on their skills and change in their competence level.  
That said, I nevertheless feel that I have learned a huge amount from my PhD studies 
and the entire process, both about research and more broadly, much more than might 
have been the case if the launch and delivery of the service had gone as 
expected/hoped, and a straightforward evaluation had been possible. 
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12.6 Recommendations  
Research to date suggests that the pharmacy-based chlamydia services usually have 
low uptake. However, what is not clear is whether it is nevertheless an efficient way 
of reaching an otherwise hard-to-reach, if small, subset of the population. Research is 
needed therefore to examine the long term effectiveness of pharmacy-based 
chlamydia services, in achieving the desired outcomes of reducing chlamydia 
prevalence particularly among hard-to-reach populations. There is also a need to 
critically examine the cost effectiveness of the intervention from an equity 
perspective i.e. whether the ability to benefit from the service differs according to the 
socio-economic circumstances. This information would enable conclusions to be 
drawn as to whether access to a pharmacy-based chlamydia service would improve 
health outcomes among the deprived community.  
The future collection and analysis of data on chlamydia screening requires the 
monitoring of both surveillance rate (population tested) as well as positivity (positive 
results as a proportion of all tested). Both of these require information on reason-for-
test if useful interpretations are to be possible. 
Expansion of chlamydia surveillance may not be cost effective, unless it is able to 
target high risk sub-populations and therefore surveillance data also requires 
information on the socio-economic indicators of the tested population. Subtle 
analysis of changes in surveillance and positivity rates constitutes a potentially 
illuminating area of investigation. For the purpose of evaluation of any national 
public health service, there is therefore a need to develop nationally agreed minimum 
datasets containing well specified standard variables providing socio-demographic 
information, and an agreement on process and outcome measures. These could be 
established at the outset of service planning and enable ongoing high-quality routine 
monitoring and evaluation of service delivery.  
Strategic stakeholders’ involvement should be ensured throughout the evaluation of a 
programme. It would be worthwhile to elicit the views of strategic stakeholders on 
the policy goals in relation to the implementation of any intervention/service. Some 
of the main questions that should be addressed in future might be: which issues do 
stakeholders believe to be the most important and relevant to the successful 
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implementation of a service?; to what extent do stakeholders’ personal views on 
issues such as the policy goals of a service or the potential impact or success of the 
service differ from those which they express as representatives of organizations?; do 
individuals belonging to the same stakeholder group hold similar views and are these 
different to those of other stakeholder groups?   
Future evaluations might also incorporate a before and after design for assessment of 
training needs and competencies of pharmacy staff. Consideration should also be 
given to formal recognition of their training in order to assure competence and 
improve their attendance in training events.  
There were mixed attitudes among pharmacists about their provision of a chlamydia 
service to young people. For the future planning of pharmacy chlamydia services, it 
would be worthwhile to know whether these attitudes vary by age, gender or 
employment status and by pharmacy type such as multiple versus independent 
pharmacies. Many a community pharmacy is now delivering multiple services. Does 
the quality of service delivered differ between pharmacies offering single or multiple 
services?  
Lastly, the general public is accustomed to accessing pharmacy advice and services 
without an appointment. With the move to deliver more pharmacy services (many of 
which would require counselling), it might become necessary for pharmacists to 
operate appointment-based systems. How would clients feel about this in general? In 
particular, would it be acceptable to young people to make appointments for 
community pharmacy services? Given the fact that potential users of pharmacy 
service are typically attracted by the unique selling point of not needing an 
appointment, such a change could render outdate much of the current evidence on the 
appeal of pharmacy based services.  
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12.7 Conclusion 
The Lothian CT&T service was been designed to improve access to chlamydia 
services for young people living in deprived areas in Lothian, which generally are 
more geographically distant from the existing (non-GP) chlamydia services available 
in Lothian. The enthusiasm found among pharmacists to deliver the CT&T service, 
and the acceptability to potential service users of the various characteristics of the 
service, suggests that as part of a multi-faceted approach to chlamydia service, 
pharmacy-based testing and treatment would be a useful additional choice for young 
people.  
Despite this, the uptake of the service was very low. It is possible that this is due to 
the virtual absence of advertising for the service. Furthermore, the service was short 
lived, being cancelled after 10 months. Both these circumstances might reflect the 
fact that the initial impetus for the service was at Government level, not within 
Lothian Health Board, and the service funded mainly by special central government 
funding that ceased after 10 months. This highlights the importance of robust 
commitment to any new service initiative that is being considered, in particular 
among key policy-makers/ budget-holders in the area. 
Nevertheless the research findings of this thesis are useful to inform, and enhance the 
chances of success of planning of future initiatives in provision of chlamydia testing 
to young people in community pharmacies. Furthermore, many of the findings will 
be of considerable utility in developing chlamydia services in other health care 
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Appendix 1: Caldicott Guardian approval letter for accessing routinely collected 






Appendix 2: Univariate logistic regression analyses of each of the three chlamydia 

































         
15-19  1.71 1.68 5.15 4.82 5.50 1.74 3.49 3.26 3.73 
20-24  2.62 2.58 5.55 5.21 5.92 2.66 2.55 2.39 2.72 
25-29 1.56 1.54 2.30 2.15 2.47 1.59 1.58 1.47 1.69 
30-34  1.00   1.00       1.00   
Gender                
Female 3.47 3.43 1.74 1.68 1.79 3.51 0.55 0.54 0.57 
Male 1.00      1.00   
Year of 
testing 
               
2008 1.08 1.06 1.00 0.96 1.05 1.09 0.94 0.90 .98 
2009 1.12 1.10 0.96 0.92 1.00 1.13 0.86 0.82 0.90 
2010 1.02 1.00 0.88 0.84 0.92 1.03 0.85 0.82 0.89 
2006-
2007 





Appendix 3: Multivariate logistic regression analysis of population surveillance rate 
(including interaction term between age group and gender) 
Variables in the 
Equation Log Odds S.E. Sig. 
Adjusted 
OR 
95% C.I. for OR 
Lower Upper 
Age Category (in Yrs)     <0.001*       
15-19 0.12 0.02  1.13 1.09 1.17 
20-24 0.85 0.02  2.34 2.28 2.41 
25-29 0.43 0.02  1.54 1.49 1.59 
30-34 0     1     
Gender     <0.001**        
Female 1.06 0.01  2.88 2.80 2.96 
Male 0     1     
Year of Test     <0.001***       
2008 0.08 0.01  1.08 1.07 1.10 
2009 0.125 0.01  1.13 1.12 1.15 
2010 0.031 0.01  1.03 1.02 1.05 
2006-07 0     1     
Age category by 
Gender     
<0.001**** 
      
15-19 yrs by Female 0.612 0.02  1.84 1.77 1.92 
20-24 yrs by Female 0.193 0.02  1.21 1.17 1.26 
25-29 yrs by Female 0.034 0.02  1.04 1.00 1.07 
30-34 Yrs by Male 0     1     
Constant -2.992 0.013 <0.001 0.05     









Appendix 4: Multivariate logistic regression analysis of population surveillance rate 
(including interaction term between age group and year of testing) 
Variables in the 
Equation 
Log 
Odds S.E. Sig. 
Adjusted 
OR 
95% C.I. for OR 
Lower Upper 
Age Category (in Yrs)     <0.001*    
15-19 0.49 0.01  1.64 1.59 1.68 
20-24 0.95 0.01  2.57 2.51 2.64 
25-29 0.50 0.01  1.65 1.61 1.70 
30-34 0     1.00      
Gender     <0.001**       
Female 1.26 0.01  3.52 3.48 3.56 
Male 0    1.00     
Year of Test     <0.001***       
2008 0.06 0.02  1.06 1.03 1.10 
2009 0.08 0.02  1.08 1.04 1.12 
2010 -0.01 0.02  1.00 0.96 1.03 
2006-07 0    1.00     
Year of test by Age 
category      
<0.001**** 
      
2008  by 15-19 yrs 0.05 0.02  1.05 1.00 1.10 
2008 by 20-24 yrs 0.07 0.02  1.08 1.03 1.12 
2008 by 25-29 yrs -0.06 0.02  0.94 0.90 0.98 
2009  by 15-19 yrs 0.16 0.02  1.17 1.12 1.23 
2009 by 20-24 yrs 0.08 0.02  1.09 1.04 1.13 
2009 by 25-29 yrs -0.05 0.02  0.95 0.91 1.00 
2010  by 15-19 yrs 0.17 0.02  1.18 1.13 1.24 
2010 by 20-24 yrs 0.07 0.02  1.08 1.03 1.12 
2010 by 25-29 yrs -0.10 0.02  0.91 0.87 0.95 
Constant -3.12 0.01 <0.001 0.04     







































































Diagnostic rate among women Diagnostic rate among men




Appendix 6: Pooled estimates of multivariate logistic regression analysis for positivity 
rate on the imputed datasets 
Wald statistics (df): *1194.23(3), **651.15(1), ***60.38(3), ****171.70(4), *****7.298(1) 
 
Log 
Odds S.E. Sig. 
Adjusted 
OR 
95% C.I for 
EXP(B) 
Lower Upper 
Age Category (yrs)   <0.001*    
15-19 1.530 0.053  4.617 4.160 5.123 
20-24 1.173 0.051  3.231 2.921 3.573 
25-29 0.576 0.056  1.779 1.594 1.985 
30-34 0.00   1.00   
Gender       
Female -0.848 0.033 <0.001** 0.428 0.401 0.457 
Male 0.00   1.00   
Year of testing   <0.001***    
2008 -.084 0.034  0.919 0.860 0.983 
2009 -.231 0.036  0.794 0.740 0.851 
2010 -.216 0.036  0.806 0.751 0.865 
2006-07 0.00   1.00   
SIMD Quintiles   <0.001****    
1 (Most deprived) 0.464 0.039  1.590 1.472 1.718 
2 0.383 0.038  1.467 1.363 1.579 
3 0.238 0.041  1.269 1.171 1.374 
4 0.178 0.043  1.195 1.098 1.299 
5 (Least Deprived) 0.00   1.00   
2 fold Urban Rural 
classification 
      
Rural 0.153 0.057 <0.001***** 1.165 1.043 1.301 
Urban 0.0   1.00   




Appendix 7: Modeling the number of tests required to show a significant change in 
the population surveillance rate, pre CT&T (2009) to when it was expected to be fully 
established (2011)  
My intention had been to use and compare the routine dataset with pharmacy testing 
activity dataset in order to determine whether the introduction of chlamydia testing in 
pharmacies had: (i) produced any statistically significant change in surveillance rate 
overall; and/or (ii) increased the proportions tested in the target population (those 
living in deprived areas). Given a negligible uptake of pharmacy testing and a short 
time span of the service for less than a year, this analysis plan became redundant.  
Instead I have undertaken a modelling analysis to fulfil aim i, by ascertaining what 
increase would have been required, in the number of tests per year among 15-24 year 
olds, in order to give a result of a statistically significant increase in the number of 
tests for chlamydia.  
Aim  
To undertake scenario analyses for a range of increases in annual number of tests, 
from before introduction of CT&T (2009) to once it was fully launched (2011, say, if 
it had not been cancelled), to ascertain the threshold at which the difference in the 
proportion of the 15 to 24 year old population tested is statistically significantly 
different from prior to CT&T.  
Methods 
The total 15-24 year old population in Lothian in 2009 was 115655 (labelled N2009). 
The corresponding population for the (comparator) year 2011 was 117,455, so this 
denominator is labelled N2011. For the year 2009, the number of 15-24 year olds 
tested in Lothian was 22836, which is equivalent to a proportion of tests in this age 
group of 0.197, or annual surveillance rate of 197 tests / 1000 population. These are 
shown in columns 1 and 2 of Table 6-A. I then calculated proportions of young 
people tested in 2011 across a range of ‘scenario’ numbers of tests (larger than the 
2009 figure, ranging from 22900 to 23645) (columns 3 and 4). The z-test for the 
difference in proportions (2009 to post CT&T) was run for each scenario proportion, 
and the p-values were obtained. The z and p values are listed in Table 6-A (columns 




table, calculated as the difference between the scenario number (b) and the actual 
number of tests in 2009 (a) in each row.  
Table 7-A: Scenario analyses for the difference in proportion of tests for chlamydia 
(2009 to post CT&T), for Lothian population 15-24 year olds 







(a/N2009)   
Scenario 
no. of tests 












in  no. of 




22900 0.1950 -1.5081 0.93 64 
23000 0.1958 -0.9898 0.84 164 
23100 0.1967 -0.4723 0.68 264 
23200 0.1975 0.0444 0.48 364 
23300 0.1984 0.5602 0.29 464 
23400 0.1992 1.0752 0.14 564 
23500 0.2001 1.5893 0.06 664 
23511 0.2002 1.6458 0.05 675 
23550 0.2005 1.8461 0.03 714 
23600 0.2009 2.1027 0.02 764 
  
23645 0.2013 2.3334 0.01 809 
*The population estimates for the denominator are obtained from GROS. 
Results  
Table 6A presents the figures used for calculations explained in methods above, and 
the results (p value for difference in proportions of each scenario increase in number 
of tests). It can be seen that as expected, the p value for the difference in proportions 




increase in number of tests required to show a statistically significant change in the 
proportion of the population tested (at 5% level of significance) is 675 tests. 
Similarly, the smallest increase in number of tests required to show a statistically 
significant change in the proportion tested (at 1% level of significance) is 809 tests. 
In the scenario analyses reported above, I have used the binomial test of proportions 
of the population having chlamydia tests, between the baseline and post-CT&T years 
being compared. For baseline, the surveillance rate (proportion of tests, 0.197) used 
was as per data for 2009, and increase in tests required (at 5% level of significance) 
was 675, arising from the increase in proportion tested of 0.27%.  
However this absolute ‘change in number of tests needed’ will partly reflect the 
change in proportions needed to show a statistically significant difference between 
the two years being modelled (absolute difference in proportion =0.27%), but will 
also reflect any  change in population size between the two years. If these scenario 
analyses are re-done for the situation where the population in 2011 is unchanged 
from 2009 (n=115655) then the increase in number of tests needed would have been 
314 (The corresponding absolute difference in proportions remaining 0.27%). This is 
considerably fewer than the 675 in Table 6A.  
However, another consideration is whether 2009 is a good baseline year to choose in 
terms of observed surveillance rate. As reported in chapter 3, the surveillance rate for 
2009 was higher than years before or after, transiently, very likely due in part to the 
introduction of new chlamydia policies/ guidance, and dissemination of these to 
sexual health clinics and GPs. If instead the baseline year is taken as 2010, with 
surveillance rate (proportion 0.185), and the scenario analyses are re-run for 2011 
(actual population denominator), than an additional 445 tests would be required to 
show a statistically significant change (at 5% level of significance), 230 fewer than 
when using 2009 as baseline.  
While the increase in number of tests needed to show statistically significant change 
at x% varies according to base-line rate (to a small degree) and changes in population 
(quite markedly), in all situations modelled the increase in proportion of tests needed 
was fairly constant (for 5% significance, absolute increase in proportion of 0.27%). 




Appendix 8: Example of search strategy used in OvidSP database for literature review  
Search strategy: 
1. Pharmacies/ 
2. Community adj3 pharmacy*.mp. 
3. Pharmacists/ 
4. Community pharmacy services/ 
5. 1 or 2 or 3 
6. Chlamydia/ 
7. Chlamydia infection/ 
8. Chlamydia trachomatis/ 
9. exp Sexually Transmitted Diseases/ not HIV.mp. 
10. Contact Tracing/ 
11. 5 or 6 or 7 or 8  
12. 4 and 9 



























Golden        
(2001)








1. An explicit theoretical framework 
underpinning the study and/or literature P P P P P P X
2. Aims and objectives clearly stated P X P P P P P
3. A clear description of context of the study P P P P P X P
4. A clear description of the sampling and 
recruitment procedures P P P P P P P
5. A clear description of methods used to 
collect and analyse data X P P P P  X P
6. Attempts made to establish the reliability or 
validity of data analysis P P P P P P P
7. Inclusion of sufficient original data to 
















1. An explicit theoretical framework 
underpinning the study and/or literature P X X P P P P
2. Aims and objectives clearly stated P P P P P P P
3. A clear description of context of the study P P P P P P P
4. A clear description of the sampling and 
recruitment procedures P P P X P P P
5. A clear description of methods used to 
collect and analyse data X P P X P P P
6. Attempts made to establish the reliability or 
validity of data analysis P P P P P P P
7. Inclusion of sufficient original data to 















1. An explicit theoretical framework 
underpinning the study and/or literature P P P P P P P
2. Aims and objectives clearly stated P P P P P P P
3. A clear description of context of the study P P P P P P P
4. A clear description of the sampling and 
recruitment procedures P P P P P P P
5. A clear description of methods used to 
collect and analyse data P P P P P,  X P P
6. Attempts made to establish the reliability or 
validity of data analysis P P P P P P P
7. Inclusion of sufficient original data to 
arbitrate between evidence and interpretation P P P P X P P
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Appendix 10: Scottish government reminder to health boards to start the service in 









Appendix 11: Scottish government decision letter regarding reclassification of 
pharmacy chlamydia service from national to local service
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Appendix 12: Invitation letter sent by the Lothian Health Board to selected community 









































Courtesy:  NHS Lothian.  
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Appendix 13: Quick reference guide provided by Lothian Health Board to pharmacies 























Courtesy: NHS Lothian 
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Appendix 16: Lothian Health Board information leaflet given out with the test kit, 






















Courtesy:  NHS Lothian.
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Appendix 17: Lothian Health Board partner notification form to be handed out by 























Courtesy: NHS Lothian. 
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Appendix 18: Lothian Health Board information leaflet for patients diagnosed with chlamydia to be handed out by the pharmacist to index 


















Courtesy: NHS Lothian. 
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Appendix 19: Full transcript of attributable feedback by the Scottish Government 
representative on the pharmacy-based chlamydia service (April 2012) 
 
‘Boards had been slow to implement the Chlamydia testing and treatment service 
through community pharmacy. There were a number of likely reasons for this; 
pressures from pandemic flu had impacted on Board resources available to undertake 
the laboratory testing of Chlamydia samples; the two largest Boards, NHS Greater 
Glasgow & Clyde and NHS Lothian, had elected to pilot the service in a small 
number of pharmacies rather than implement the service in all pharmacies; and other 
Boards had reported difficulties with contact tracing arrangements. In addition, 
revised the SIGN guidelines of March 2009 on the management of genital 
Chlamydia infection recommended that resources for Chlamydia testing in women 
should be targeted firstly in those aged 15-19, then those aged 20-24; and in men at 
those aged under 25 and all patients attending GUM services. The guideline did not 
recommend more universal screening. Therefore changing the community pharmacy 
Chlamydia testing and treatment service to a locally negotiated service allowed NHS 
Boards to apply a more targeted approach, based on local needs, which fitted better 
with the SIGN guidelines.’ 
 
Appendices 
Appendix 20: Differentiating between research and evaluation  
 RESEARCH  SERVICE EVALUATION  
The attempt to derive generalisable new 
knowledge including studies that aim to 
generate hypotheses as well as studies that 
aim to test them.  
Designed and conducted solely to 
define or judge current care.  
Quantitative research – designed to test a 
hypothesis.  
Qualitative research – identifies/explores 
themes following established methodology.  
Designed to answer the question:  
“What standard does this service 
achieve?”  
Addresses clearly defined questions, aims 
and objectives.  
Measures current service without 
reference to a standard.  
Quantitative research -may involve 
evaluating or comparing interventions, 
particularly new ones.  
Qualitative research – usually involves 
studying how interventions and 
relationships are experienced.  
Involves an intervention in use ONLY. 
(The choice of treatment is that of the 
clinician and patient according to 
guidance, professional standards 
and/or patient preference.)  
Usually involves collecting data that are 
additional to those for routine care but may 
include data collected routinely. May involve 
treatments, samples or investigations 
additional to routine care.  
Usually involves analysis of existing 
data but may include administration 
of simple interview or questionnaire.  
Quantitative research - study design may 
involve allocating patients to intervention 
groups.  
Qualitative research uses a clearly defined 
sampling framework underpinned by 
conceptual or theoretical justifications.  
No allocation to intervention groups: 
the health care professional and 
patient have chosen intervention 
before service evaluation.  
May involve randomisation  No randomisation  
RESEARCH REQUIRES R.E.C. REVIEW  SERVICE EVALUATION DOES NOT 
REQUIRE R.E.C. REVIEW  
(Adopted from National Research Ethics Service) 
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Appendix 21: Letter regarding South East Scotland Research Ethics Service advice 




Appendix 22: Letter regarding South East Scotland Research Ethics Service advise 





 Appendix 23: Invitation letter to pharmacy director/manager about participation in the 
























Appendix 26: A short questionnaire sent to pharmacy manager/director to ascertain 
the number of pharmacy staff having face-to-face dealings with clients
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Appendix 28: Information sheet providing extra detail regarding specific questions in 





Appendix 29: Email inviting participation in the stakeholder survey, sent to strategic 
stakeholders other than General Practitioners  
Dear Stakeholder (Name of the Stakeholder) 
 
Evaluation of Chlamydia testing and treatment service (CT&T) in community 
pharmacies of Lothian, Scotland 
 
As you may be aware, NHS Lothian has rolled out a chlamydia treatment service in 
Community Pharmacies, and is in the process of rolling out a Chlamydia testing 
service in a selected subset of community pharmacies. I am a PhD student at the 
University of Edinburgh evaluating various aspects of this service, towards my PhD 
studies. [For more information about the aims of the service, aims of the evaluation 
and what we have done so far, please see the attached information sheet]. 
Why are we writing to you? 
You have been identified as a leader/expert within the wider sexual health services 
arena of Lothian, so your input to the evaluation would be invaluable. In order to 
inform the next stage of the evaluation, we therefore ask that you are kind enough to 
provide us feedback on the proposed evaluation questions and your views and 
concerns about the CT&T service. Such feedback is often elicited by interview, but 
in order to avoid making excessive demands on your time/diary, we have decided to 
offer an anonymous online mode of input. However, if you would prefer to reply to a 
paper version of the survey or a face-to-face or telephone interview, please reply to 
this effect and I will get back to you. 
Please be reassured that all responses will be kept anonymous, and if cited in the 
evaluation report (or PhD thesis), will be unattributable, and sufficiently 
précised/disguised/aggregated to avoid identification. 
The electronic link to the online survey can be found below; 
https://www.survey.ed.ac.uk/stakeholderfinal/ 
It should take you no longer than 10 minutes to complete the survey. Your 
participation is highly appreciated. 
 
Yours faithfully, 
Mufiza Zia Kapadia 
Pharmacy Chlamydia Testing & Treatment Evaluation Group 
Centre for Population Health Sciences 
University of Edinburgh 
EH8 9AG, Edinburgh, Scotland 
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 Appendix 30: Invitation letter to General Practitioner strategic stakeholders for 
participation in the stakeholder survey  
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Appendix 33: Spearman correlations in respect of respondent’s preferences for treatment venue and for partner notification methods, with 
age, previous testing for chlamydia and previous access to EC from a pharmacy 
 Age category Tested for chlamydia in the 
past 12 months 









Preference for the venue of treatment for 
chlamydia (Figure 9-1) 
         
a Sexual Health Drop-in (such as MYPAS or CY)  0.062 0.696 0.142 0.055 0.728 0.152 0.369 0.032 0.089 
a GUM clinic                                               0.524 0.000 0.089 0.192 0.106 0.115 0.071 0.588 0.125 
my GP                                                          0.168 0.150 0.113 0.123 0.292 0.115 0.073 0.570 0.124 
a pharmacy                0.258 0.028 0.111 -0.008 0.945 0.119 0.211 0.100 0.121 
a family planning clinic 0.175 0.139 0.114 0.079 0.507 0.117 0.113 0.383 0.125 
Preference for the method of partner 
notification (Figure 9-2) 
         
By myself, by telling him/her  0.222 0.054 0.109 -0.086 0.458 0.114 0.272 0.029 0.113 
By the nurse at GUM clinic 0.086 0.477 0.119 0.194 0.105 0.115 0.020 0.877 0.127 
By an advisor at sexual health ‘drop-in’  0.075 0.645 0.156 0.015 0.927 0.153 -0.025 0.892 0.180 
By me giving him/her information leaflet -0.089 0.459 0.118 -0.077 0.523 0.121 -0.047 0.721 0.127 
 
Appendices 
Appendix 34: Spearman correlation in respect of respondent’s acceptability for different approaches for getting testing kit and for their 
confidence in a pharmacy service, with age, previous testing for chlamydia and previous access to EC from a pharmacy 
 Age category  Tested for chlamydia in 
the past 12 months 









Acceptable approaches for getting chlamydia testing kits from 
the pharmacy (Figure 9-3) 
         
I ask the pharmacist for the test  0.231 0.049 0.114 -0.044 0.711 0.117 -0.147 0.253 0.126 
The test is offered to me by a pharmacist during a consultation for 
emergency contraception  
0.335 0.004 0.106 0.035 0.768 0.117 0.223 0.081 0.121 
I can pick up a free testing kit from the shelf without asking anyone 0.421 0.000 0.101 0.224 0.055 0.114 0.101 0.431 0.125 
Pharmacy staff offers it to me at the counter when I buy/collect 
condoms 
0.231 0.048 0.111 0.050 0.673 0.118 -0.044 0.731 0.128 
Pharmacy staff offers it to me at the counter when I buy / collect 
other products or medicine 
0.022 0.850 0.114 -0.044 0.702 0.114 -0.014 0.913 0.125 
Confidence of the respondents that CT&T would be able to 
provide the following objectives (Figure 9-4) 
         
Complete confidentiality of my testing -0.011 0.922 0.115 0.134 0.247 0.114 -0.112 0.378 0.124 
Reliable test results -0.012 0.917 0.115 0.015 0.899 0.115 -0.120 0.346 0.125 
Knowledgeable staff to provide testing/treatment 0.024 0.834 0.114 0.153 0.188 0.113 -0.026 0.835 0.122 




Appendix 35: Spearman correlation in respect of respondent’s indicated importance of store facilities and of location, with age, previous 
testing for chlamydia and previous access to EC from a pharmacy 
 Age category  Tested for chlamydia in 
the past 12 months 
Accessed EC from a 
pharmacy 
Importance of various aspects in selecting one pharmacy 








Pharmacy is an easy place for me to get to 0.138 0.241 0.116 -0.028 0.812 0.116 0.003 0.981 0.127 
A pharmacy that has a private area / consultation room -0.068 0.558 0.115 -0.142 0.218 0.115 0.203 0.105 0.119 
A pharmacy that is open at the weekend, or after 6 P.M on 
weekdays  
-0.005 0.968 0.117 -0.047 0.688 0.116 0.236 0.065 0.118 
A pharmacy that has in-store toilet to fill the urine sample pot -0.037 0.756 0.117 -0.231 0.049 0.114 0.219 0.088 0.118 
A less busy pharmacy -0.358 0.002 0.105 -0.142 0.228 0.114 0.073 0.567 0.128 
A Pharmacy where staff do not know me  -0.132 0.261 0.115 0.057 0.629 0.117 0.155 0.228 0.124 






















Appendix 38: Nodes and sub-nodes developed during qualitative analysis of 
interviews  
 Nodes Subnodes_Level 1 Subnodes_Level 2 Subnodes_Level 3
Administrative aspect of the scheme
Mandatory involvement in the 
Training
Availability of trained staff
Gap between training and 
Not involved in CT&T so didnt 






Staff count and role
Years of experience
Barriers and Facilitators for pharmacy
Awareness of staff about CT&T
Incentives Public Health role
Business
Footfall
Experience of providing service
Structural facilities
Consultation room
Area dedicated to service 
Physical layout
Health hazzard and handling Space in the pharmacy
Toilet
Work load More staff
Paper work
Protocol
Barriers and Facilitators for young people
Access and Convinience No need for appointment 
Locality of the pharmacy
One stop shop
Opening hours
Anonymity and Confidentiality Anonymous
Busy pharmacy
Embarassement
Private area or consultation room
Attitude of a pharmacist
Aware of the service and promotion
Choices
Not tested for other STI
Releiving anxiety
Socio-demographic of YP Discussing sexual health
Age of YP










Nodes Subnodes_Level 1 Subnodes_Level 2 Subnodes_Level 3
CT&T invitition
Decision autonomy
Initial response to CT&T invitition
Forward looking pharmacy
Reasons for non-participation Communication and response from 
CT&T (NHS)
Never been approached by NHS Invitation sent in holidays
Past experience
Toilet facility_misunderstanding
Reasons for participation Deprived Area _ Need
Good uptake of EC
High proportion of young people
Incentive
Pilot
Discontinuation of the scheme
Disappointment
Funding again is inappropriate
No experience
Experience of PILOT pharmacies










Previous experience Involved in previous CT pilot
Referal option
Uptake of the service Clientale-demographics
Views on public health role of a 
pharmacist or pharmacy
Perspective on different aspects of the 
scheme
Age group targeted Fraser competency assesement
Comprehensive vs limited service
Partner notification Confidence of YP on pharmacist
Pay to use clamelle kit
Promotion strategy
Recruitment approach EC provision
Proactive Vs. Reactive
Sample return
Treatment Antibiotic provision by 
pharmacists-concerns
Subjective Norm
Confidence in delivering service
Forward looking pharmacy Role of a community pharmacist
GP and other professionals Age of the GP
Altruistic
Confidence on pharmacist 
GP Buissness
GP workload








Pharmacies sites suitable for CT&T
Promotion and Advertisement Leaflets
Schools
Raising awareness of chlamydia 





Appendix 39: Estimation of the number of chlamydia tests expected from community 
pharmacies in Lothian, using data from the survey of the potential service users, 
estimates obtained from other sources and using hypothetical scenarios 
Introduction: 
The following table presents a scenario analysis of the number of tests expected from 
pilot community pharmacies in Lothian in a year. It uses data from the survey of 
potential service users (chapter 9). In addition, population estimates for 2010 for 
Lothian population aged 15-24 year old is obtained from GROS and is equal to 
116734. Furthermore, this scenario analysis also uses an assumption that 35% of the 
15-24 years old population needed to be screened, as per vital sign indicator set by 
NCSP for the year 2010. This will equate to a Lothian population of n=40857 needed 
to be screened in the year 2010. The scenario analysis is presented as follows: 
Scenario percentages of young people who would prefer 
pharmacy for testing as compared to GP or SH clinics 
Scenario 1 Scenario 2 





Number of young people preferring testing in pharmacies (using 
population figure of GROS (out of 40857))  
4494 6537 
Assuming each young person has a test every 1.5 years   
Estimated number of tests per year using pharmacy 
(number/1.5)  
2996 4358 
Estimated number of tests per year per pharmacy (given12 pilot 
Lothian pharmacies)  
250 363 




 derived directly from potential service users survey (chapter 9) 
$$
 derived from potential service users survey, but inflated to better represent likely 
percentage in entire population of young people, since the survey was of current 




Appendix 40: Dissemination of thesis research 
CONFERENCE PRESENTATIONS 
Development of a conceptual framework of pharmacy provision of chlamydia testing and 
treatment service: A structured review of international evidence. World Congress of 
Epidemiology, Edinburgh, United Kingdom, 7-11th August 2011 
Screening for Genital Chlamydia for young people in Community Pharmacies: A structured 
literature review of international evidence. Poster presentation at XI International HIA 
conference; Granada Spain 14
 
– 15 April 2011. A travel grant was awarded by 
Commonwealth Scholarship Commission. 
Screening for Genital Chlamydia for young people in Community Pharmacies: A Meta-
Analysis of chlamydia prevalence. Poster presentation at XI International HIA conference; 
Granada Spain 14
 
– 15 April 2011 
Training needs analysis of pharmacy staff for the provision of chlamydia testing and 
treatment service. Oral presentation at European Public Health Association Conference 
Amsterdam 10-13 November 2010. £450 travel grant was secured by winning Centre for 
Population Health Sciences, University of Edinburgh Travel Grant Competition for 2010. 
Community pharmacy provision of Chlamydia testing and treatment service in 
Scotland: A survey in Lothian of pharmacy staff competencies and training need; 
Oral presentation at Annual Conference of the faculty of Public Health, Peebles, 
Scotland 12-13th November 2009. Registration bursary was awarded by NHS, 
Scotland. 
 
